data_2m87_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m87 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.324 0.583 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.564 HD21 ' N ' ' A' ' 5' ' ' ASN . 0.1 OUTLIER -171.14 124.74 0.63 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 109.213 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 1.3 pm0 -160.64 155.98 24.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.392 -0.818 . . . . 0.0 109.831 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.9 pt -147.17 163.03 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.338 -0.851 . . . . 0.0 109.012 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m -143.74 154.36 43.38 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.238 -0.914 . . . . 0.0 109.712 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.5 t -142.67 99.09 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.15 -119.69 5.69 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -99.29 11.37 39.27 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.455 -1.027 . . . . 0.0 109.738 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 29.6 mt -106.82 130.62 54.48 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.356 -0.84 . . . . 0.0 109.455 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -118.59 141.05 48.96 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.1 tt -129.05 143.53 50.9 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.618 -0.676 . . . . 0.0 109.525 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 19' ' ' ARG . 3.3 m-20 -135.48 100.7 4.58 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.622 -0.674 . . . . 0.0 109.721 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.85 -30.34 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.363 -0.835 . . . . 0.0 109.564 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.497 ' N ' HD22 ' A' ' 5' ' ' ASN . 0.0 OUTLIER -60.75 -49.32 77.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.444 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.408 ' H ' HG21 ' A' ' 17' ' ' THR . 59.4 mtp180 -93.73 -14.53 26.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.129 -0.982 . . . . 0.0 108.378 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 15' ' ' ASN . 5.7 tpt180 64.41 49.25 2.52 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.873 -0.517 . . . . 0.0 109.742 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.3 mt -133.69 153.08 51.96 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.9 t -133.87 134.27 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.422 -0.799 . . . . 0.0 109.319 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -103.17 158.68 16.15 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.429 ' O ' ' OG1' ' A' ' 26' ' ' THR . 1.9 tt -146.41 116.92 7.52 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.27 -0.894 . . . . 0.0 108.714 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.64 41.65 97.66 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 107.727 -2.149 . . . . 0.0 107.727 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 61.63 3.48 0.86 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 122.089 -0.654 . . . . 0.0 110.077 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 60.6 p -108.35 140.8 41.11 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 121.187 -0.946 . . . . 0.0 109.457 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.33 114.58 7.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 109.693 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 12.1 tp -84.94 141.27 30.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 109.023 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -99.78 107.5 19.57 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.322 -0.861 . . . . 0.0 109.795 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.3 140.57 51.8 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.8 p -61.11 145.05 90.32 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.107 -0.996 . . . . 0.0 109.48 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -45.0 -42.72 15.76 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.709 1.606 . . . . 0.0 112.32 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -53.31 -48.24 68.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.885 . . . . 0.0 109.767 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -59.48 -33.37 71.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.973 . . . . 0.0 109.381 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -60.04 -32.03 70.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.128 -0.982 . . . . 0.0 109.369 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.409 ' O ' ' OD2' ' A' ' 57' ' ' ASP . . . -74.27 -53.85 8.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.171 -0.956 . . . . 0.0 109.794 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.5 mp -64.96 -38.47 91.07 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.8 tp -65.23 -46.27 81.3 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.5 m -50.46 -30.15 12.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 109.61 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -77.27 -37.81 52.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.156 -0.965 . . . . 0.0 109.082 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.4 mp -56.53 -47.28 79.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 108.998 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 54.8 mtt -72.28 -30.86 65.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.15 -0.969 . . . . 0.0 109.665 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 20.8 ttt -52.35 -36.03 52.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.159 -0.963 . . . . 0.0 109.443 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -120.92 53.96 1.11 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.64 104.2 3.83 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.305 -0.872 . . . . 0.0 109.919 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.61 -17.45 1.27 Allowed Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.06 159.98 59.72 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.578 -0.954 . . . . 0.0 108.85 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.12 119.97 6.9 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.121 1.88 . . . . 0.0 111.74 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.4 132.63 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.331 -0.856 . . . . 0.0 109.569 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -58.45 147.56 31.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.978 -1.076 . . . . 0.0 108.986 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.0 mtm180 -79.72 -20.94 45.25 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.144 -0.973 . . . . 0.0 110.13 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -72.24 -33.93 67.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.118 -0.989 . . . . 0.0 109.89 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.2 mt -67.16 -33.48 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.029 -1.044 . . . . 0.0 109.548 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.6 mt -64.63 -50.66 66.24 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -58.19 -34.34 70.25 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -70.66 -22.03 62.54 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.528 -0.732 . . . . 0.0 109.958 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.409 ' OD2' ' O ' ' A' ' 36' ' ' ALA . 12.3 t0 . . . . . 0 N--CA 1.487 1.383 0 O-C-N 120.982 -1.074 . . . . 0.0 109.679 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.404 0.621 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.418 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 8.8 mp -62.68 -47.79 82.1 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.43 -0.794 . . . . 0.0 108.938 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -70.99 -31.42 67.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 109.293 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.1 t -73.12 -37.48 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.279 -0.888 . . . . 0.0 109.256 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -56.34 -41.09 75.51 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.49 -36.53 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -64.27 -37.17 86.52 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -68.22 -43.9 76.95 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.0 mt -71.95 -30.0 64.85 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -50.97 -49.25 60.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.665 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -63.87 -26.99 68.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.243 -0.911 . . . . 0.0 110.439 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -71.99 -44.15 63.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.959 -1.088 . . . . 0.0 110.309 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.0 pt -72.51 -15.37 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.177 -0.952 . . . . 0.0 109.655 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 75.57 82.88 0.45 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -46.96 -17.74 0.06 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.476 -1.014 . . . . 0.0 109.902 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' GLY . 22.7 t -56.91 -51.89 67.33 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.446 -0.784 . . . . 0.0 110.23 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -86.56 9.17 19.26 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.0 -1.062 . . . . 0.0 110.603 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.1 mm -121.6 165.92 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -140.98 114.02 8.48 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.436 -0.79 . . . . 0.0 108.947 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.7 p -86.63 138.26 31.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.208 -0.932 . . . . 0.0 109.591 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.9 t . . . . . 0 N--CA 1.499 2.012 0 O-C-N 121.537 -0.727 . . . . 0.0 109.2 179.687 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -129.54 157.12 42.93 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 38.6 ttp -153.05 133.15 13.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.291 -0.881 . . . . 0.0 109.736 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.5 mp -91.0 145.49 24.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.567 -0.708 . . . . 0.0 109.092 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.75 105.78 0.87 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -0.878 . . . . 0.0 109.361 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.905 . . . . 0.0 109.433 -179.982 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.9 p30 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.541 ' N ' ' ND2' ' A' ' 5' ' ' ASN . 0.1 OUTLIER -164.53 125.86 2.17 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.261 -0.899 . . . . 0.0 108.962 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -163.5 158.31 20.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.458 -0.776 . . . . 0.0 109.75 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.9 pt -149.32 163.7 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 80.9 p -128.46 132.24 48.39 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.498 -0.751 . . . . 0.0 109.755 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.26 91.49 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.04 -120.3 8.52 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.746 -1.741 . . . . 0.0 108.746 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -95.46 11.84 31.48 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.311 -1.111 . . . . 0.0 109.26 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.0 mp -104.43 125.77 50.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.492 -0.755 . . . . 0.0 108.988 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -108.7 118.91 38.02 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.3 133.87 46.51 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.486 -0.759 . . . . 0.0 109.366 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -135.53 98.19 3.87 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.43 -0.794 . . . . 0.0 109.467 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.5 t -73.91 -26.32 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.435 -0.791 . . . . 0.0 109.482 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.42 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -58.37 -50.39 73.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.429 -0.795 . . . . 0.0 109.679 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -98.86 -3.72 34.72 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.42 ' NH1' ' O ' ' A' ' 17' ' ' THR . 6.9 mpt_? 56.44 75.33 0.35 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.423 0.63 . . . . 0.0 109.419 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.8 tp -163.99 149.58 10.84 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.8 t -134.25 146.52 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.381 -0.824 . . . . 0.0 109.807 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -113.23 142.54 45.69 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.0 tp -121.86 105.47 10.39 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 71.3 40.55 60.63 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.132 -1.987 . . . . 0.0 108.132 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 70.91 -10.79 0.71 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.996 -0.708 . . . . 0.0 109.645 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.462 ' H ' ' C ' ' A' ' 24' ' ' GLY . 32.2 p -91.66 142.14 27.94 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.041 -1.037 . . . . 0.0 109.631 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.42 112.99 2.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 110.245 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.8 tp -74.66 128.38 35.42 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 3.1 m-20 -96.02 100.64 12.29 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.171 -0.956 . . . . 0.0 110.327 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.529 ' H ' ' CD2' ' A' ' 30' ' ' LEU . 1.3 pt? -121.4 134.13 55.1 Favored 'General case' 0 N--CA 1.504 2.229 0 CA-C-O 121.588 0.709 . . . . 0.0 109.35 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.4 p -52.11 152.48 5.7 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.184 -0.948 . . . . 0.0 109.218 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.34 -45.22 27.98 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.622 1.548 . . . . 0.0 110.804 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -56.19 -47.29 78.64 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.189 -0.944 . . . . 0.0 108.487 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -55.16 -36.36 65.75 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.341 -0.849 . . . . 0.0 109.033 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -57.6 -32.28 67.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.268 -0.895 . . . . 0.0 108.982 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.9 -49.97 63.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 108.983 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.437 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 7.4 mp -58.8 -39.05 79.98 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 12.8 tp -57.14 -42.6 81.26 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.1 t -54.11 -39.2 66.19 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.347 -0.845 . . . . 0.0 109.549 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.2 mmt-85 -76.37 -45.19 33.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.176 -0.953 . . . . 0.0 109.425 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.8 mt -59.46 -52.33 66.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 110.311 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.51 ' SD ' ' N ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -63.93 -38.07 89.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.089 -1.007 . . . . 0.0 110.429 -178.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.51 ' N ' ' SD ' ' A' ' 42' ' ' MET . 46.3 tpp -55.57 -29.6 59.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.062 -1.024 . . . . 0.0 108.762 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -119.36 42.15 2.93 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.89 132.68 51.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.221 -0.925 . . . . 0.0 109.956 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.4 ' C ' ' SD ' ' A' ' 95' ' ' MET . . . 90.35 -6.22 82.46 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.6 t -121.85 116.17 30.36 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.644 -0.915 . . . . 0.0 108.717 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -47.62 119.89 4.11 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.017 1.145 . . . . 0.0 111.676 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.5 t -97.59 137.23 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.46 -0.775 . . . . 0.0 110.376 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.415 ' CD2' ' H ' ' A' ' 52' ' ' GLU . 17.6 t-160 -63.89 121.07 13.17 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.363 -0.836 . . . . 0.0 108.792 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.487 ' NH1' ' OE1' ' A' ' 71' ' ' GLU . 11.3 ttm180 -52.89 -18.42 1.92 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.389 -0.819 . . . . 0.0 108.937 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.518 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 34.2 tt0 -65.48 -48.87 71.13 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.567 -0.708 . . . . 0.0 109.563 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.1 mt -58.0 -31.75 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.08 -1.012 . . . . 0.0 110.177 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.06 -33.06 74.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.042 -1.036 . . . . 0.0 108.991 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -74.06 -33.23 63.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.999 -1.063 . . . . 0.0 108.43 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 44.0 m-80 -64.82 -22.54 67.01 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.543 -0.723 . . . . 0.0 109.764 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.488 1.428 0 O-C-N 121.1 -1.0 . . . . 0.0 109.253 -179.777 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 120.887 0.375 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 pp -70.47 -43.7 69.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.007 -1.058 . . . . 0.0 109.264 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.487 ' OE1' ' NH1' ' A' ' 51' ' ' ARG . 33.6 tt0 -71.75 -33.01 68.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 109.453 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.0 t -70.77 -38.71 73.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.255 -0.903 . . . . 0.0 108.977 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -56.32 -39.6 73.03 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.99 -37.03 79.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -62.49 -36.5 82.69 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -71.57 -41.88 68.49 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.67 -38.11 73.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 0.0 109.412 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -50.57 -47.84 57.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.927 . . . . 0.0 109.669 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -62.47 -24.93 67.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 110.496 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -75.68 -43.6 46.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.936 -1.102 . . . . 0.0 110.466 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.9 pt -76.61 -22.43 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.142 -0.974 . . . . 0.0 109.945 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 82.67 87.76 0.73 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -44.79 -17.17 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.722 -0.87 . . . . 0.0 110.422 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 82' ' ' GLY . 12.9 t -51.72 -47.59 63.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.219 -0.925 . . . . 0.0 109.701 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.531 ' HE ' ' N ' ' A' ' 85' ' ' ARG . 4.4 mmp_? -83.41 9.66 10.56 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.241 -0.912 . . . . 0.0 110.596 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.1 mp -135.67 159.2 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.197 -0.939 . . . . 0.0 109.754 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -123.09 128.01 49.53 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.4 p -94.09 141.03 29.0 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.082 -1.011 . . . . 0.0 109.778 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.423 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.468 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.496 2.667 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 40.7 m-85 -150.99 170.69 18.74 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.363 -1.08 . . . . 0.0 108.579 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.4 ' SD ' ' C ' ' A' ' 46' ' ' GLY . 50.4 ttp -162.5 136.66 6.45 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.142 -0.974 . . . . 0.0 110.469 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.407 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 10.2 mp -88.69 139.04 30.87 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.07 133.48 44.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 109.473 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.7 m120 . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.571 -179.966 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.4 t70 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.187 0.517 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -158.72 122.05 3.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.336 -0.852 . . . . 0.0 108.877 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -161.36 155.59 22.65 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.348 -0.845 . . . . 0.0 109.746 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.8 pt -148.03 163.33 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.378 -0.826 . . . . 0.0 109.07 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -142.24 152.55 43.17 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.223 -0.923 . . . . 0.0 109.777 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.6 t -147.98 95.97 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.27 -116.38 4.3 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.061 -1.615 . . . . 0.0 109.061 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -103.5 7.63 37.83 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.49 -1.006 . . . . 0.0 109.697 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.3 mp -102.35 125.4 49.04 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.346 -0.846 . . . . 0.0 109.224 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -118.07 124.31 47.76 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.508 ' C ' HD21 ' A' ' 15' ' ' ASN . 8.1 mp -107.37 140.24 40.61 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.531 -0.731 . . . . 0.0 109.153 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.508 HD21 ' C ' ' A' ' 14' ' ' LEU . 2.1 m-80 -135.6 97.37 3.65 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.554 -0.716 . . . . 0.0 109.184 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.1 t -69.87 -29.62 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.375 -0.828 . . . . 0.0 109.306 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -55.17 24.56 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.44 -0.787 . . . . 0.0 109.266 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.7 mmt85 -82.68 -16.04 49.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.96 . . . . 0.0 108.481 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 63.36 70.69 0.53 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.609 0.718 . . . . 0.0 109.152 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.7 tp -163.78 154.15 15.42 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.7 t -136.21 143.08 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.297 -0.877 . . . . 0.0 109.853 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -107.93 145.18 34.16 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.408 ' O ' ' OG1' ' A' ' 26' ' ' THR . 67.1 tp -128.75 104.03 7.4 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 72.7 44.68 38.33 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 64.36 -3.17 0.53 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 122.175 -0.603 . . . . 0.0 110.282 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.43 ' H ' ' C ' ' A' ' 24' ' ' GLY . 80.4 p -99.31 139.92 34.26 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 120.995 -1.066 . . . . 0.0 109.612 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.3 116.79 5.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.227 -0.921 . . . . 0.0 110.58 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.9 tp -85.0 128.95 34.85 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -103.93 120.84 41.87 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.347 -0.846 . . . . 0.0 109.825 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.519 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 1.1 pt? -140.51 148.66 41.41 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.398 0.618 . . . . 0.0 109.453 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.3 p -67.32 151.22 97.37 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.057 -1.027 . . . . 0.0 109.83 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -45.19 -41.01 16.65 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 121.928 1.752 . . . . 0.0 112.366 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -53.25 -50.65 64.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.763 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -60.13 -27.62 67.2 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.293 -0.879 . . . . 0.0 109.273 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -71.21 -31.05 67.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.114 -0.991 . . . . 0.0 109.145 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.99 -52.56 10.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.179 -0.95 . . . . 0.0 109.259 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 mt -59.27 -37.08 76.75 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 23.2 tp -63.19 -43.96 96.72 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.712 -0.618 . . . . 0.0 109.706 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.8 m -53.25 -37.75 62.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.225 -0.922 . . . . 0.0 110.158 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -80.35 -43.4 21.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 0.0 109.373 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 27.7 tp -63.73 -40.03 95.75 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.285 -0.885 . . . . 0.0 110.212 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -72.47 -38.95 68.08 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.77 -1.206 . . . . 0.0 109.544 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.468 ' O ' ' SD ' ' A' ' 43' ' ' MET . 1.3 tmt? -53.91 -28.78 38.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.304 -0.872 . . . . 0.0 108.71 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -115.7 43.67 2.04 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.06 140.22 48.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.253 -0.904 . . . . 0.0 110.347 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.09 -17.57 59.0 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.4 m -119.63 151.87 52.49 Favored Pre-proline 0 N--CA 1.501 2.113 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -71.88 119.46 6.21 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.56 1.507 . . . . 0.0 111.519 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.1 t -98.9 136.09 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.399 -0.813 . . . . 0.0 110.209 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -73.7 125.66 28.56 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.276 -0.89 . . . . 0.0 108.619 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.417 ' NH1' ' OE2' ' A' ' 71' ' ' GLU . 13.1 ptp180 -55.24 -15.86 2.77 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.223 -0.923 . . . . 0.0 108.779 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.571 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 41.2 tt0 -61.82 -56.82 15.43 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.623 -0.673 . . . . 0.0 109.481 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.6 mt -54.64 -29.28 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.254 -0.904 . . . . 0.0 110.33 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.8 mt -71.24 -46.72 60.41 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 108.609 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -51.96 -36.05 48.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.957 -1.089 . . . . 0.0 108.957 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.571 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 31.6 m-80 -65.18 -20.86 66.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.663 -0.648 . . . . 0.0 110.476 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.488 1.456 0 O-C-N 120.694 -1.254 . . . . 0.0 109.895 -179.282 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.1 m . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 pp -56.08 -37.79 69.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.353 -0.842 . . . . 0.0 109.644 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.417 ' OE2' ' NH1' ' A' ' 51' ' ' ARG . 7.2 tp10 -67.03 -31.19 71.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.169 -0.957 . . . . 0.0 109.456 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.3 t -73.33 -41.31 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.139 -0.976 . . . . 0.0 109.115 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -56.99 -38.22 72.74 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.0 mm -64.14 -36.91 78.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -67.65 -33.45 74.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.23 -0.919 . . . . 0.0 109.4 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -71.05 -41.9 70.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.34 -0.85 . . . . 0.0 109.802 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.0 mt -71.44 -42.23 68.48 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.291 -0.881 . . . . 0.0 109.892 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -49.7 -44.4 48.14 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.084 -1.01 . . . . 0.0 109.247 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -62.83 -26.8 68.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 110.045 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -75.78 -43.22 47.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.987 -1.071 . . . . 0.0 110.508 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 pt -82.21 -30.26 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.023 -1.048 . . . . 0.0 109.575 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 97.39 85.02 1.77 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -44.48 -16.68 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.545 -0.974 . . . . 0.0 110.396 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 82' ' ' GLY . 56.2 m -51.82 -44.8 63.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.083 -1.011 . . . . 0.0 109.381 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -73.71 8.75 1.74 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.296 -0.878 . . . . 0.0 109.481 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.408 ' H ' ' C ' ' A' ' 84' ' ' SER . 96.6 mt -136.37 159.76 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.288 -0.882 . . . . 0.0 109.159 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.476 HH21 ' CE ' ' A' ' 95' ' ' MET . 39.1 ttp180 -137.28 124.2 21.38 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.555 -0.716 . . . . 0.0 109.271 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.3 p -88.87 141.66 28.31 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.142 -0.974 . . . . 0.0 109.386 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.4 t . . . . . 0 N--CA 1.501 2.08 0 O-C-N 121.479 -0.763 . . . . 0.0 110.377 -178.785 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.644 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -150.98 162.34 41.02 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.357 -1.084 . . . . 0.0 108.407 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.476 ' CE ' HH21 ' A' ' 87' ' ' ARG . 43.9 ttp -163.55 136.16 5.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.179 -0.951 . . . . 0.0 110.548 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.3 mp -91.48 127.32 36.87 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.77 99.69 2.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.318 -0.863 . . . . 0.0 109.42 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.329 -0.857 . . . . 0.0 109.539 179.994 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.266 0.555 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -155.87 119.86 4.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.15 -0.969 . . . . 0.0 108.947 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -162.09 157.42 23.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.326 -0.859 . . . . 0.0 109.713 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.4 pt -147.27 162.54 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.297 -0.877 . . . . 0.0 109.163 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.8 t -145.25 156.11 43.64 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.19 -0.944 . . . . 0.0 109.741 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 p -152.72 101.85 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.15 -109.64 2.84 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.603 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -112.07 4.88 18.31 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.506 -0.996 . . . . 0.0 110.093 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.4 mp -99.07 124.9 44.41 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.151 -0.968 . . . . 0.0 109.083 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -118.53 126.13 51.35 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.49 ' C ' HD21 ' A' ' 15' ' ' ASN . 5.7 tt -114.15 115.19 27.12 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.499 ' OD1' ' NH2' ' A' ' 18' ' ' ARG . 1.7 m120 -113.2 102.21 10.15 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.573 -0.705 . . . . 0.0 109.313 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.3 t -74.9 -27.44 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.439 -0.788 . . . . 0.0 109.454 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -54.1 49.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.536 -0.728 . . . . 0.0 109.507 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.499 ' NH2' ' OD1' ' A' ' 15' ' ' ASN . 89.2 mtm-85 -92.21 -13.43 30.54 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.12 -0.987 . . . . 0.0 108.714 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.5 tpp85 66.31 67.14 0.46 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.419 0.628 . . . . 0.0 109.393 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.5 mt -143.47 158.47 43.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.228 -0.92 . . . . 0.0 108.812 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 t -142.38 120.75 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.283 -0.885 . . . . 0.0 109.757 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 17.8 m-90 -98.93 150.87 21.49 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.175 -0.953 . . . . 0.0 108.812 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.417 ' O ' ' OG1' ' A' ' 26' ' ' THR . 30.9 tp -136.94 107.05 6.33 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 68.84 43.59 73.58 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 64.24 -1.65 0.69 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 122.169 -0.606 . . . . 0.0 110.346 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 65.4 p -100.58 139.9 35.6 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 120.973 -1.079 . . . . 0.0 109.383 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.04 115.54 6.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 0.0 110.161 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.9 tp -78.82 132.31 36.81 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -102.86 112.59 25.46 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.312 -0.868 . . . . 0.0 109.972 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.504 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 1.2 pt? -139.63 148.9 43.1 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.364 -0.835 . . . . 0.0 109.28 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.407 ' OG1' ' OE2' ' A' ' 34' ' ' GLU . 4.1 p -60.52 152.98 63.47 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.056 -1.027 . . . . 0.0 108.881 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -58.95 -41.67 59.65 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.0 1.8 . . . . 0.0 111.735 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -53.97 -45.66 71.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.027 -1.046 . . . . 0.0 109.252 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.407 ' OE2' ' OG1' ' A' ' 31' ' ' THR . 69.8 mt-10 -60.71 -34.61 74.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.322 -0.861 . . . . 0.0 109.223 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.4 ' OH ' ' O ' ' A' ' 15' ' ' ASN . 15.9 t80 -55.62 -34.1 64.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 108.706 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.05 -53.12 28.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 109.303 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 37' ' ' LEU . 8.3 mp -60.3 -39.42 86.88 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.9 tp -59.57 -43.74 93.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.606 -0.684 . . . . 0.0 109.546 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.468 ' C ' ' HE ' ' A' ' 40' ' ' ARG . 33.8 t -52.91 -34.28 54.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.153 -0.967 . . . . 0.0 109.458 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.468 ' HE ' ' C ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -79.44 -45.29 19.72 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 0.0 109.181 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.3 mt -56.72 -40.66 76.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.045 -1.034 . . . . 0.0 109.285 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.7 tpp -75.44 -35.0 61.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 109.56 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.46 ' SD ' ' NH2' ' A' ' 40' ' ' ARG . 24.7 ttt -53.92 -25.93 22.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.327 -0.858 . . . . 0.0 109.229 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -129.08 43.17 3.19 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.74 -0.6 . . . . 0.0 109.678 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.81 143.8 55.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.025 -1.047 . . . . 0.0 109.958 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.462 ' O ' ' SD ' ' A' ' 95' ' ' MET . . . 101.02 -22.75 38.18 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.08 154.55 64.82 Favored Pre-proline 0 N--CA 1.503 2.206 0 O-C-N 121.599 -0.942 . . . . 0.0 108.676 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.42 120.91 7.83 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.826 1.684 . . . . 0.0 111.083 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 80.5 t -92.77 137.04 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 0.0 110.326 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.437 ' CE1' ' CD ' ' A' ' 52' ' ' GLU . 9.0 t-160 -68.83 121.03 15.71 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -51.21 -16.82 0.56 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 0.0 109.792 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.522 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 80.8 mt-10 -65.97 -48.39 71.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.342 -0.849 . . . . 0.0 109.801 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.2 mt -54.65 -30.87 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.19 -0.944 . . . . 0.0 109.949 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.0 mt -70.58 -34.13 71.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.932 . . . . 0.0 109.199 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -70.93 -35.44 72.24 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 41.3 m-80 -59.39 -20.8 57.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.545 -0.722 . . . . 0.0 110.051 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--N 1.306 -1.312 0 O-C-N 121.074 -1.016 . . . . 0.0 109.89 -179.353 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.0 m . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.465 0.65 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.7 mt -70.12 -37.46 75.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.298 -0.876 . . . . 0.0 109.658 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -60.3 -32.43 71.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.081 -1.012 . . . . 0.0 109.504 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.85 -38.92 74.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.214 -0.929 . . . . 0.0 109.096 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -57.22 -38.01 73.1 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.2 mt -63.81 -38.93 83.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.4 ' CE1' HH21 ' A' ' 78' ' ' ARG . 1.2 t60 -60.17 -36.55 77.84 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.511 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.576 ' ND2' ' NZ ' ' A' ' 80' ' ' LYS . 3.2 t-20 -73.34 -41.61 63.26 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.414 ' CD1' ' C ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -66.41 -42.93 87.06 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.4 HH21 ' CE1' ' A' ' 75' ' ' HIS . 52.6 ttp180 -50.15 -50.99 47.07 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.513 -0.742 . . . . 0.0 110.936 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -65.24 -29.27 70.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.963 -1.086 . . . . 0.0 110.613 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.576 ' NZ ' ' ND2' ' A' ' 76' ' ' ASN . 61.7 mttp -66.44 -47.94 71.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.9 -1.125 . . . . 0.0 110.2 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 21.6 pt -74.83 -24.6 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.979 -1.075 . . . . 0.0 110.17 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 84.3 84.37 0.95 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -45.05 -17.01 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.689 -0.889 . . . . 0.0 110.484 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 82' ' ' GLY . 59.5 m -55.12 -48.9 73.0 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.243 -0.911 . . . . 0.0 110.069 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.421 ' N ' ' CD ' ' A' ' 85' ' ' ARG . 8.5 mpt_? -81.48 9.78 6.86 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.972 -1.08 . . . . 0.0 110.473 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.67 162.63 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -118.75 93.61 4.16 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.443 -0.786 . . . . 0.0 109.478 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.0 p -66.1 134.77 53.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.315 -0.866 . . . . 0.0 109.511 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 N--CA 1.497 1.904 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.759 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.442 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -146.04 170.06 17.42 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.462 ' SD ' ' O ' ' A' ' 46' ' ' GLY . 6.1 ttt -161.1 127.81 4.02 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.932 -1.105 . . . . 0.0 110.133 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.408 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 9.4 mp -81.27 139.98 35.12 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.13 106.19 5.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 109.455 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.2 p30 . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.451 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 4' ' ' ASP . 29.4 p-10 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -172.37 107.97 0.2 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.024 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -161.55 154.29 20.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.114 -0.991 . . . . 0.0 109.911 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.7 pt -145.86 163.29 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.476 -0.765 . . . . 0.0 108.983 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.8 p -139.88 151.99 46.08 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.304 -0.873 . . . . 0.0 109.623 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.1 t -146.79 97.6 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.61 -113.68 4.0 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -105.52 5.92 31.86 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.457 -1.025 . . . . 0.0 110.079 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.5 mt -100.69 126.46 47.21 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.129 -0.982 . . . . 0.0 109.186 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -118.05 124.84 49.08 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.6 tp -106.87 141.4 38.15 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.737 -0.602 . . . . 0.0 109.579 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.59 ' ND2' ' NH2' ' A' ' 18' ' ' ARG . 14.8 m120 -135.57 97.69 3.74 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.325 -0.859 . . . . 0.0 109.143 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.1 t -76.63 -28.93 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.297 -0.877 . . . . 0.0 109.97 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.65 -53.44 58.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 0.0 109.405 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.59 ' NH2' ' ND2' ' A' ' 15' ' ' ASN . 12.7 ptt-85 -96.5 -10.32 27.66 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.277 -0.889 . . . . 0.0 108.807 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 64.81 73.66 0.41 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.456 0.646 . . . . 0.0 109.3 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.0 tp -156.98 154.42 29.62 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.3 t -140.1 133.54 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.273 -0.892 . . . . 0.0 109.773 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.488 ' CZ3' ' OD1' ' A' ' 15' ' ' ASN . 8.5 m-90 -100.34 144.26 29.56 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.345 -0.847 . . . . 0.0 109.238 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 25' ' ' GLU . 10.7 tp -117.96 100.24 7.43 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.67 -73.2 0.25 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 23' ' ' LEU . 74.0 mt-10 -154.45 23.13 0.47 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.219 -1.165 . . . . 0.0 109.406 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.3 p -138.83 141.82 38.67 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.455 -0.778 . . . . 0.0 110.07 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.9 121.92 16.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.502 -0.749 . . . . 0.0 109.538 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.5 tp -78.48 128.45 33.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 108.614 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -101.4 110.59 22.61 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.328 -0.858 . . . . 0.0 109.923 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.75 145.75 48.74 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.2 p -58.33 140.26 83.91 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.1 -1.0 . . . . 0.0 109.455 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -44.68 -43.99 14.26 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.526 1.484 . . . . 0.0 112.052 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.404 ' CD ' ' N ' ' A' ' 33' ' ' LYS . 2.4 mptp? -53.54 -46.43 70.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 108.99 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -59.49 -35.07 73.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.348 -0.845 . . . . 0.0 109.213 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -56.66 -33.16 66.09 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.916 . . . . 0.0 109.066 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.422 ' O ' ' OD2' ' A' ' 57' ' ' ASP . . . -68.62 -52.82 27.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.431 -0.793 . . . . 0.0 109.524 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' A' ' 37' ' ' LEU . 7.7 mp -63.54 -36.59 84.27 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.3 tp -64.46 -46.98 80.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.55 -0.719 . . . . 0.0 109.329 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.8 m -53.28 -29.68 34.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.321 -0.862 . . . . 0.0 109.956 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -75.73 -40.57 55.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.065 -1.022 . . . . 0.0 110.018 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.8 mt -61.04 -44.39 97.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.975 -1.078 . . . . 0.0 110.179 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.7 mmm -65.87 -37.07 85.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.819 -1.176 . . . . 0.0 109.739 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 18.1 ttt -57.41 -32.36 66.77 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 108.994 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -116.05 43.46 2.14 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.06 129.12 39.0 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.245 -0.909 . . . . 0.0 110.165 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.89 -11.93 52.87 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 p -124.71 151.89 68.51 Favored Pre-proline 0 N--CA 1.504 2.242 0 O-C-N 121.529 -0.983 . . . . 0.0 108.652 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.18 120.46 6.59 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.781 1.654 . . . . 0.0 111.634 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.5 t -95.69 132.87 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.263 -0.898 . . . . 0.0 109.95 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.435 ' CE1' ' CD ' ' A' ' 52' ' ' GLU . 15.2 t-160 -73.04 126.19 29.41 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.19 -0.944 . . . . 0.0 108.545 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -50.36 -15.07 0.21 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.223 -0.923 . . . . 0.0 109.836 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.527 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 77.4 mt-10 -66.87 -46.35 75.23 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.319 -0.863 . . . . 0.0 109.881 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.5 mm -57.56 -32.36 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.083 -1.011 . . . . 0.0 109.923 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.42 -45.3 69.5 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.241 -0.912 . . . . 0.0 108.746 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -62.33 -36.86 83.52 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 74.1 m-80 -70.33 -21.77 62.87 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.641 -0.662 . . . . 0.0 109.993 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 36' ' ' ALA . 5.2 t0 . . . . . 0 N--CA 1.485 1.318 0 O-C-N 120.81 -1.181 . . . . 0.0 109.271 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 13.9 mt -70.64 -33.49 71.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 109.403 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -60.36 -35.59 76.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.009 . . . . 0.0 109.385 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.2 t -73.82 -38.95 51.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.166 -0.959 . . . . 0.0 108.827 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -58.71 -40.38 83.53 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.402 HG23 HD11 ' A' ' 74' ' ' ILE . 62.7 mt -62.98 -31.48 52.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -72.28 -22.38 61.21 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 118.947 -1.101 . . . . 0.0 108.086 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -77.43 -45.43 25.8 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.6 -0.687 . . . . 0.0 110.337 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 pp -74.58 -43.98 53.0 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.813 -1.179 . . . . 0.0 109.747 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -50.59 -46.12 57.68 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.554 -0.717 . . . . 0.0 110.144 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -65.65 -13.8 59.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.167 -0.958 . . . . 0.0 110.118 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -81.43 -40.23 23.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.084 -1.01 . . . . 0.0 110.02 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 11.0 pt -78.56 -14.94 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 109.777 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 85.68 81.41 1.12 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -44.42 -16.41 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.779 -0.836 . . . . 0.0 110.583 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 82' ' ' GLY . 44.5 t -50.17 -43.95 52.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.144 -0.973 . . . . 0.0 109.612 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -77.52 9.05 3.59 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.234 -0.916 . . . . 0.0 109.937 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.0 mt -137.97 158.12 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.2 -0.937 . . . . 0.0 109.1 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 65.7 ttt-85 -141.04 122.62 15.12 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.598 -0.689 . . . . 0.0 109.212 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.7 p -89.36 142.51 27.6 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.302 -0.874 . . . . 0.0 109.282 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.5 2.069 0 O-C-N 121.405 -0.809 . . . . 0.0 110.171 -179.404 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.8 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -150.76 159.24 44.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.452 -1.028 . . . . 0.0 108.257 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 43.1 ttp -163.82 127.61 2.7 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.131 -0.981 . . . . 0.0 110.391 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.424 ' CD1' ' N ' ' A' ' 96' ' ' LEU . 9.6 mp -90.2 133.22 35.05 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.88 137.2 50.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -0.931 . . . . 0.0 109.498 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.4 m120 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.618 179.997 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.6 t70 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.311 0.577 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -165.71 113.54 0.95 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.266 -0.896 . . . . 0.0 108.975 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -162.36 157.44 22.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.109 -0.994 . . . . 0.0 110.008 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.4 pt -144.78 162.91 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.309 -0.869 . . . . 0.0 109.008 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 m -143.05 152.92 42.41 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.284 -0.885 . . . . 0.0 109.699 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 p -149.41 99.2 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.54 -116.64 4.74 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -104.06 6.95 36.31 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.439 -1.036 . . . . 0.0 109.622 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.7 mt -100.68 122.08 42.73 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.274 -0.891 . . . . 0.0 109.602 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -114.84 134.44 55.13 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.4 tt -126.55 127.9 46.01 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.553 -0.717 . . . . 0.0 109.823 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.483 ' C ' ' HH ' ' A' ' 35' ' ' TYR . 5.3 m-20 -121.44 104.41 9.66 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.757 -0.59 . . . . 0.0 109.62 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.2 t -68.77 -30.31 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.264 -0.898 . . . . 0.0 109.44 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.74 -53.98 38.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.908 . . . . 0.0 109.16 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.2 mtp-105 -83.72 -16.52 44.56 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 15' ' ' ASN . 15.1 tpp180 58.78 75.73 0.38 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.449 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 23.9 tp -170.33 127.35 0.81 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.359 -0.838 . . . . 0.0 108.964 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.1 t -104.33 138.21 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.509 -0.745 . . . . 0.0 109.682 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.449 ' CZ3' ' O ' ' A' ' 20' ' ' LEU . 28.5 m-90 -105.6 142.26 35.64 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.454 -0.779 . . . . 0.0 109.225 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.409 ' O ' ' OG1' ' A' ' 26' ' ' THR . 37.7 tp -118.11 102.26 8.88 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.94 44.95 54.3 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 107.946 -2.062 . . . . 0.0 107.946 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 65.65 -1.23 1.07 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 122.132 -0.628 . . . . 0.0 110.218 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 43.0 p -99.23 140.94 32.65 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.042 -1.036 . . . . 0.0 109.699 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.53 110.47 1.99 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.921 . . . . 0.0 109.862 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.9 tp -71.43 133.37 45.86 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -91.01 94.06 9.47 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.051 -1.031 . . . . 0.0 110.267 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.488 ' CD2' ' H ' ' A' ' 30' ' ' LEU . 1.4 pt? -127.45 135.54 50.56 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.1 p -63.81 152.98 85.51 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 120.978 -1.076 . . . . 0.0 109.567 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -44.9 -48.13 11.13 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.848 1.698 . . . . 0.0 112.433 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -53.25 -47.99 68.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.446 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -55.24 -45.16 76.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.249 -0.907 . . . . 0.0 109.289 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.483 ' HH ' ' C ' ' A' ' 15' ' ' ASN . 31.2 t80 -50.2 -30.04 10.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.229 -0.919 . . . . 0.0 109.701 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.8 -49.38 47.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.352 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 mp -59.2 -44.5 92.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.093 -1.004 . . . . 0.0 108.785 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.6 mp -58.01 -42.06 84.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.919 . . . . 0.0 108.521 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.1 m -50.73 -37.08 39.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.229 -0.919 . . . . 0.0 109.653 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -80.22 -43.58 21.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.031 -1.043 . . . . 0.0 109.911 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.7 mt -59.34 -49.07 79.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.12 -0.988 . . . . 0.0 109.961 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 42.2 mtt -66.83 -35.46 80.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.991 -1.068 . . . . 0.0 109.645 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 25.7 ttt -56.05 -29.21 60.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.201 -0.937 . . . . 0.0 108.833 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -116.68 40.69 2.87 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.22 103.15 1.5 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.135 -0.978 . . . . 0.0 109.802 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.402 ' CA ' ' OD1' ' A' ' 98' ' ' ASN . . . 137.85 -13.36 3.64 Favored Glycine 0 N--CA 1.502 3.062 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.9 m -132.56 152.54 80.17 Favored Pre-proline 0 N--CA 1.502 2.131 0 O-C-N 121.697 -0.884 . . . . 0.0 108.806 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -71.73 120.19 6.72 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 121.774 1.649 . . . . 0.0 111.544 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.0 t -91.11 133.72 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.883 . . . . 0.0 109.612 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.413 ' C ' ' N ' ' A' ' 52' ' ' GLU . 10.3 t-160 -65.54 122.5 17.35 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -50.65 -15.94 0.33 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.166 -0.959 . . . . 0.0 109.6 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.531 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 17.0 mm-40 -65.78 -50.5 64.48 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.313 -0.867 . . . . 0.0 109.875 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.9 mt -57.07 -31.92 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.131 -0.98 . . . . 0.0 110.044 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.7 mt -66.47 -33.31 75.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.996 -1.065 . . . . 0.0 108.307 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -73.51 -35.69 65.65 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 41.4 m-80 -63.53 -22.07 66.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.848 -0.533 . . . . 0.0 110.039 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.486 1.374 0 O-C-N 121.027 -1.046 . . . . 0.0 109.243 -179.835 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 90.0 m . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.433 ' CD2' ' H ' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -70.61 -48.93 52.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 108.88 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -70.3 -25.39 63.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 109.44 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.4 t -75.3 -43.55 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.176 -0.952 . . . . 0.0 109.505 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -54.55 -39.05 67.33 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.3 mt -67.38 -39.55 82.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -60.67 -34.67 74.67 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.122 -0.986 . . . . 0.0 109.072 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -76.73 -40.9 47.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.397 -0.814 . . . . 0.0 108.993 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.406 ' CD1' ' C ' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -67.71 -43.36 80.24 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -51.76 -50.09 61.34 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.464 -0.772 . . . . 0.0 110.243 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -64.98 -27.37 68.79 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.252 -0.905 . . . . 0.0 110.834 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -71.01 -45.35 64.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.985 -1.072 . . . . 0.0 110.439 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.7 pt -75.04 -18.69 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.977 -1.077 . . . . 0.0 110.718 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 81.28 79.53 0.92 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -46.63 -15.9 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.688 -0.89 . . . . 0.0 110.662 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.499 ' CB ' HH11 ' A' ' 85' ' ' ARG . 10.5 t -48.2 -43.39 31.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.16 -0.962 . . . . 0.0 110.443 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.499 HH11 ' CB ' ' A' ' 84' ' ' SER . 12.5 mpt_? -91.48 11.03 25.33 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.164 -0.96 . . . . 0.0 110.163 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 30.2 mm -115.75 164.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 O-C-N 121.35 -0.844 . . . . 0.0 108.98 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 61.5 ttt-85 -135.69 118.56 16.24 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.399 -0.813 . . . . 0.0 108.898 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.5 p -94.93 137.64 33.73 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.235 -0.916 . . . . 0.0 109.766 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.5 2.052 0 O-C-N 121.569 -0.707 . . . . 0.0 109.756 -179.868 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.486 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.494 2.516 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 27.3 m-85 -151.44 157.44 42.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.385 -1.068 . . . . 0.0 108.87 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.6 ttp -157.7 128.89 6.66 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.36 -0.837 . . . . 0.0 109.675 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.487 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 9.2 mp -85.47 136.54 33.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.357 -0.839 . . . . 0.0 108.891 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.13 112.54 1.56 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 109.681 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.636 ' N ' HD21 ' A' ' 98' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.29 -0.882 . . . . 0.0 109.414 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.437 ' C ' ' ND2' ' A' ' 5' ' ' ASN . 33.2 t0 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.437 ' ND2' ' C ' ' A' ' 4' ' ' ASP . 14.9 m-80 -156.67 119.77 4.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 0.0 109.081 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -164.94 158.5 17.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.377 -0.827 . . . . 0.0 109.737 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.2 pt -149.94 164.0 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.378 -0.826 . . . . 0.0 108.943 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.1 t -136.96 150.36 48.12 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.392 -0.818 . . . . 0.0 109.283 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.2 t -143.13 93.8 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.27 -108.4 2.48 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -104.88 3.51 31.02 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.48 -1.011 . . . . 0.0 109.863 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.1 mt -97.8 115.1 27.37 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.215 -0.928 . . . . 0.0 109.849 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -106.98 115.54 30.36 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.2 mp -104.94 138.44 41.16 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.502 -0.749 . . . . 0.0 109.873 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.489 ' C ' ' HH ' ' A' ' 35' ' ' TYR . 2.9 m120 -136.24 101.87 4.82 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.723 -0.611 . . . . 0.0 109.355 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.4 t -76.73 -28.88 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.84 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -54.3 46.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.237 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -93.86 -9.57 36.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.131 -0.981 . . . . 0.0 108.665 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 63.35 78.35 0.29 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.341 0.591 . . . . 0.0 110.017 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.1 tp -166.89 153.25 8.38 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.087 -1.008 . . . . 0.0 108.822 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.9 t -137.5 147.7 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.331 -0.856 . . . . 0.0 109.957 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 31.2 m-90 -115.84 137.1 52.42 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.5 tp -112.4 105.73 14.06 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.47 39.9 68.62 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 107.578 -2.209 . . . . 0.0 107.578 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 69.06 -3.4 1.51 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 122.197 -0.59 . . . . 0.0 109.924 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.7 p -98.22 139.54 33.85 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.078 -1.014 . . . . 0.0 109.893 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.23 115.05 7.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 110.012 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.0 tp -85.94 138.85 31.7 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 27.0 p-10 -93.81 103.8 15.91 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.101 -0.999 . . . . 0.0 110.732 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.502 ' CD2' ' H ' ' A' ' 30' ' ' LEU . 1.3 pt? -126.22 135.06 51.14 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.415 ' OG1' ' OE2' ' A' ' 34' ' ' GLU . 3.1 p -62.84 151.91 83.98 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.856 -1.153 . . . . 0.0 109.379 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -44.8 -44.12 14.54 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.784 1.656 . . . . 0.0 112.142 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -53.75 -50.54 65.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.272 -0.892 . . . . 0.0 109.686 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.507 ' N ' ' OE1' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -54.08 -41.43 68.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.389 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.489 ' HH ' ' C ' ' A' ' 15' ' ' ASN . 11.3 t80 -56.75 -30.33 63.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.101 -1.0 . . . . 0.0 109.289 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.19 -52.53 26.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.079 -1.013 . . . . 0.0 109.77 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.427 ' CD1' ' H ' ' A' ' 37' ' ' LEU . 7.2 mp -55.87 -39.32 71.33 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.4 tp -58.36 -43.21 88.31 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.489 ' HG ' ' N ' ' A' ' 40' ' ' ARG . 30.5 p -50.72 -39.32 51.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.417 -0.802 . . . . 0.0 110.229 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.489 ' N ' ' HG ' ' A' ' 39' ' ' SER . 14.1 tpt180 -79.76 -42.58 24.22 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.855 -1.153 . . . . 0.0 109.828 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 26.3 mt -58.88 -47.75 83.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.155 -0.966 . . . . 0.0 109.897 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.1 ptt? -67.91 -36.0 79.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.022 -1.049 . . . . 0.0 109.975 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 21.7 ttt -54.26 -29.05 45.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -0.885 . . . . 0.0 108.763 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -124.04 45.02 2.58 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.6 133.66 51.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.104 -0.998 . . . . 0.0 110.095 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.53 -10.47 59.36 Favored Glycine 0 N--CA 1.501 3.004 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 p -127.11 151.9 75.03 Favored Pre-proline 0 N--CA 1.504 2.25 0 O-C-N 121.537 -0.978 . . . . 0.0 108.696 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.22 120.15 6.4 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 121.749 1.633 . . . . 0.0 111.652 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.9 t -96.2 136.67 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.412 -0.805 . . . . 0.0 109.736 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -62.09 120.13 10.26 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.211 -0.931 . . . . 0.0 108.725 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -57.24 -18.76 17.63 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.339 -0.851 . . . . 0.0 109.178 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.531 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 0.2 OUTLIER -65.39 -48.81 71.59 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.378 -0.826 . . . . 0.0 108.981 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.5 mt -58.76 -30.23 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.25 -0.906 . . . . 0.0 110.324 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.3 mt -69.61 -29.77 67.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.922 -1.111 . . . . 0.0 108.976 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -71.57 -33.09 68.79 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 17.7 m-80 -65.33 -22.21 66.79 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.655 -0.653 . . . . 0.0 109.941 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 O-C-N 120.902 -1.124 . . . . 0.0 109.403 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.542 ' CD2' ' H ' ' A' ' 70' ' ' LEU . 1.9 pt? -69.09 -38.9 79.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.041 -1.037 . . . . 0.0 109.76 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.481 ' O ' ' CD2' ' A' ' 75' ' ' HIS . 59.1 mt-10 -71.23 -26.55 62.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.988 -1.07 . . . . 0.0 109.563 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 49.1 t -75.43 -47.85 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.19 -0.943 . . . . 0.0 109.303 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -55.85 -37.18 68.4 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.2 mt -67.51 -39.95 83.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 71' ' ' GLU . 43.1 m170 -60.95 -35.96 78.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.082 -1.011 . . . . 0.0 108.861 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -74.44 -41.73 60.34 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.437 ' C ' ' CD1' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -67.86 -42.46 81.31 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.485 ' NH2' ' OH ' ' A' ' 94' ' ' TYR . 41.0 ttm180 -49.9 -50.7 45.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.216 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -62.31 -27.08 68.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.241 -0.912 . . . . 0.0 110.817 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -73.22 -43.83 60.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.947 -1.096 . . . . 0.0 110.424 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.0 pt -73.76 -18.53 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.073 -1.017 . . . . 0.0 109.884 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.57 82.12 0.6 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -52.56 -18.23 1.63 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.515 -0.991 . . . . 0.0 110.111 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.9 m -52.37 -46.4 66.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.267 -0.896 . . . . 0.0 109.924 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -87.97 10.69 18.05 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.209 -0.932 . . . . 0.0 110.025 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.7 mm -119.58 168.07 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.461 -0.775 . . . . 0.0 108.962 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 61.3 mtp85 -140.19 114.05 8.86 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.0 p -81.82 138.05 35.18 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.267 -0.896 . . . . 0.0 109.768 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 N--CA 1.5 2.05 0 O-C-N 121.518 -0.738 . . . . 0.0 109.29 179.607 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.485 ' OH ' ' NH2' ' A' ' 78' ' ' ARG . 32.5 m-85 -148.57 169.94 19.19 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.6 ttp -164.09 130.28 3.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.166 -0.959 . . . . 0.0 109.969 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 9.8 mp -83.38 144.2 29.8 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.58 -0.7 . . . . 0.0 109.155 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.69 119.69 20.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.493 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.182 -0.949 . . . . 0.0 109.453 -179.937 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 . . . . . 0 N--CA 1.501 2.087 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -169.59 101.29 0.33 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.182 -0.949 . . . . 0.0 109.247 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -162.29 155.76 20.68 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.153 -0.967 . . . . 0.0 109.93 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.5 pt -147.94 163.33 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.373 -0.83 . . . . 0.0 109.017 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.2 m -144.9 158.96 43.62 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.145 -0.972 . . . . 0.0 109.912 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.0 t -148.35 101.04 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.36 -108.4 2.48 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -109.05 4.6 23.29 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.541 -0.976 . . . . 0.0 109.589 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.516 ' N ' ' CD1' ' A' ' 12' ' ' LEU . 7.0 mp -95.51 123.55 39.11 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.288 -0.882 . . . . 0.0 108.83 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -118.85 128.78 54.77 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.443 -0.786 . . . . 0.0 109.094 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.505 ' C ' HD21 ' A' ' 15' ' ' ASN . 51.5 tp -116.43 128.28 55.35 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.607 -0.683 . . . . 0.0 109.206 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.505 HD21 ' C ' ' A' ' 14' ' ' LEU . 1.3 m-80 -122.91 98.11 5.75 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.516 -0.74 . . . . 0.0 109.366 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.4 t -71.06 -27.0 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.47 -0.769 . . . . 0.0 109.23 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.405 HG23 ' H ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -64.7 -53.92 39.78 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.593 -0.692 . . . . 0.0 109.657 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.405 ' H ' HG23 ' A' ' 17' ' ' THR . 82.3 mtt180 -91.01 -12.83 34.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.249 -0.907 . . . . 0.0 108.862 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.479 ' NE ' ' CD1' ' A' ' 35' ' ' TYR . 9.5 tpt180 64.98 61.62 0.76 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -140.09 154.78 47.15 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.424 -0.798 . . . . 0.0 109.045 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.5 t -139.28 126.82 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.375 -0.828 . . . . 0.0 109.371 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 18.4 m-90 -103.44 148.18 26.24 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.223 -0.923 . . . . 0.0 109.128 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.425 ' O ' ' OG1' ' A' ' 26' ' ' THR . 24.4 tp -128.77 102.89 6.76 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.439 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 76.71 46.01 12.06 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 -178.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 61.91 -0.67 0.42 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 122.022 -0.693 . . . . 0.0 110.25 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.439 ' H ' ' C ' ' A' ' 24' ' ' GLY . 50.2 p -103.76 140.32 37.78 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.211 -0.931 . . . . 0.0 109.862 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.95 110.83 1.91 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 109.996 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.9 tp -76.9 134.89 38.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 108.622 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -101.77 111.45 23.71 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.315 -0.866 . . . . 0.0 109.615 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.499 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 1.1 pt? -140.51 150.86 44.26 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.327 -0.858 . . . . 0.0 109.853 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.4 p -58.07 152.85 37.92 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.361 -0.837 . . . . 0.0 109.239 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.21 -36.35 80.69 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.853 1.702 . . . . 0.0 111.188 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -55.84 -47.4 77.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 108.931 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -58.61 -39.62 80.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.319 -0.863 . . . . 0.0 108.893 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.479 ' CD1' ' NE ' ' A' ' 19' ' ' ARG . 16.7 t80 -52.89 -31.85 41.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.168 -0.958 . . . . 0.0 109.087 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.61 -52.76 10.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -0.87 . . . . 0.0 109.389 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.6 mp -58.59 -40.66 83.82 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tt -67.37 -43.89 80.29 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.602 0.715 . . . . 0.0 109.306 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.0 t -48.42 -41.64 29.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.127 -0.983 . . . . 0.0 111.134 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.8 ttt-85 -80.73 -35.06 33.97 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.533 -1.354 . . . . 0.0 109.485 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.5 tp -60.3 -36.73 78.56 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.34 -0.85 . . . . 0.0 109.34 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 41.0 tpp -75.22 -38.68 60.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 0.0 109.259 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 42.1 ttm -52.4 -27.05 14.26 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.6 mmtt -118.99 42.76 2.73 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.29 137.06 55.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 110.215 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.85 -14.31 65.56 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.5 p -117.42 151.85 48.63 Favored Pre-proline 0 N--CA 1.501 2.115 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -73.87 119.43 5.87 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.594 1.529 . . . . 0.0 111.999 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -103.99 135.95 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.518 -0.739 . . . . 0.0 109.475 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.774 ' HD1' ' H ' ' A' ' 52' ' ' GLU . 7.2 t-80 -72.87 125.77 28.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.059 -1.026 . . . . 0.0 108.647 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -58.4 -16.25 14.01 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.469 -0.77 . . . . 0.0 109.291 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.774 ' H ' ' HD1' ' A' ' 50' ' ' HIS . 34.1 tt0 -67.61 -50.4 58.33 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.499 -0.75 . . . . 0.0 109.363 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.5 mt -58.1 -25.0 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.36 -0.838 . . . . 0.0 110.381 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 38.1 mt -72.11 -48.16 45.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.038 -1.039 . . . . 0.0 108.356 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -52.25 -34.59 46.76 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.568 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 30.4 m-80 -63.84 -21.13 66.3 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.967 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.493 1.707 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.034 -179.492 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.4 m . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.417 0.627 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.403 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 9.7 mp -56.0 -49.4 73.72 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.391 -0.818 . . . . 0.0 109.598 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -59.86 -30.02 68.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.156 -0.965 . . . . 0.0 109.729 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 t -70.41 -41.43 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.094 -1.004 . . . . 0.0 109.139 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.425 ' HD1' ' N ' ' A' ' 73' ' ' HIS . 1.8 m80 -54.56 -37.64 65.71 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 35.2 mm -65.63 -41.42 90.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.436 ' ND1' HH21 ' A' ' 78' ' ' ARG . 13.4 t60 -65.73 -41.55 92.09 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.36 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.575 ' N ' HD21 ' A' ' 76' ' ' ASN . 0.9 OUTLIER -67.88 -44.58 76.72 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.195 -0.941 . . . . 0.0 109.091 179.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 74.3 mt -70.34 -38.63 74.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.417 -0.802 . . . . 0.0 109.919 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.436 HH21 ' ND1' ' A' ' 75' ' ' HIS . 44.6 ttp85 -49.19 -48.6 45.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.13 -0.981 . . . . 0.0 109.786 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -57.24 -27.28 61.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.957 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -78.4 -40.68 35.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.938 -1.101 . . . . 0.0 110.636 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.7 pt -85.11 -39.56 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.885 -1.135 . . . . 0.0 110.313 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 91.18 106.76 1.42 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 107.386 -2.286 . . . . 0.0 107.386 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 86' ' ' ILE . 52.2 pttt -43.61 -18.15 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.678 -0.895 . . . . 0.0 110.467 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 82' ' ' GLY . 47.3 t -62.93 -54.86 31.98 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.825 -1.172 . . . . 0.0 108.708 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 54.8 ttp85 -54.94 -10.97 0.55 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.396 -0.815 . . . . 0.0 110.803 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' A' ' 83' ' ' LYS . 9.4 mt -143.4 119.35 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.394 0 O-C-N 120.891 -1.13 . . . . 0.0 110.646 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 63.4 mtp85 -86.95 130.35 34.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.3 -0.875 . . . . 0.0 108.711 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 p -80.94 128.76 34.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.051 -1.031 . . . . 0.0 109.491 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.0 t . . . . . 0 N--CA 1.5 2.061 0 O-C-N 121.539 -0.725 . . . . 0.0 109.181 179.552 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.391 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -146.16 171.09 15.44 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.467 ' SD ' ' O ' ' A' ' 96' ' ' LEU . 11.6 tmm? -163.57 142.86 8.23 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.85 -1.156 . . . . 0.0 110.704 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.467 ' O ' ' SD ' ' A' ' 95' ' ' MET . 11.1 mp -89.43 132.79 34.83 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.18 121.02 8.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.213 -0.929 . . . . 0.0 109.082 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 0.0 109.712 -179.684 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 5.7 p-10 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -160.43 121.02 2.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.135 -0.978 . . . . 0.0 109.38 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -158.91 156.24 29.17 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.479 -0.763 . . . . 0.0 109.364 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.4 pt -148.83 163.67 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.298 -0.876 . . . . 0.0 109.393 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.6 m -136.2 146.53 46.92 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.472 -0.768 . . . . 0.0 109.542 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -146.46 93.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.67 -114.09 3.91 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -106.06 6.27 30.97 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.492 -1.005 . . . . 0.0 109.66 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.4 mt -100.89 122.04 42.77 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.258 -0.901 . . . . 0.0 109.946 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -115.19 129.46 56.66 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.511 ' C ' HD21 ' A' ' 15' ' ' ASN . 46.9 tp -114.65 138.67 50.4 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.535 -0.728 . . . . 0.0 109.415 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.511 HD21 ' C ' ' A' ' 14' ' ' LEU . 2.1 m-80 -135.02 97.63 3.79 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.576 -0.702 . . . . 0.0 109.236 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.2 t -73.34 -28.51 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.376 -0.827 . . . . 0.0 109.282 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -63.13 -55.47 25.02 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.444 -0.785 . . . . 0.0 109.454 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.407 ' H ' HG23 ' A' ' 17' ' ' THR . 64.8 mtm180 -88.62 -16.02 33.54 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.307 -0.871 . . . . 0.0 108.847 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? 68.83 65.19 0.3 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.2 mt -143.93 142.32 30.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.303 -0.873 . . . . 0.0 108.724 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -129.61 127.57 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.5 -0.75 . . . . 0.0 108.977 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -103.72 142.21 34.73 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.269 -0.894 . . . . 0.0 109.173 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.423 ' O ' ' OG1' ' A' ' 26' ' ' THR . 28.0 tp -127.2 102.9 7.14 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 75.93 47.3 11.76 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.131 -1.988 . . . . 0.0 108.131 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 60.68 2.58 0.52 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.979 -0.718 . . . . 0.0 110.33 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.431 ' H ' ' C ' ' A' ' 24' ' ' GLY . 50.4 p -108.81 141.72 40.42 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.15 -0.969 . . . . 0.0 109.846 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.03 115.29 4.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.247 -0.908 . . . . 0.0 110.075 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.3 tp -81.73 132.99 35.3 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -101.34 111.81 24.15 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.305 -0.872 . . . . 0.0 109.483 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.46 147.51 47.23 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.453 -0.779 . . . . 0.0 109.274 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.1 p -57.9 152.15 39.92 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.89 -33.73 92.15 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.84 1.693 . . . . 0.0 111.359 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -57.52 -50.88 71.64 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.206 -0.934 . . . . 0.0 109.045 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -56.89 -35.58 69.14 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.151 -0.968 . . . . 0.0 109.032 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.4 ' OH ' ' O ' ' A' ' 15' ' ' ASN . 7.3 t80 -55.47 -33.9 64.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -0.888 . . . . 0.0 108.962 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.422 ' O ' ' OD2' ' A' ' 57' ' ' ASP . . . -67.89 -52.96 30.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 109.518 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.47 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 7.2 mp -60.75 -32.61 71.9 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 12.5 tp -63.31 -45.63 90.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.535 -0.728 . . . . 0.0 109.28 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.3 p -53.79 -32.66 53.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.902 . . . . 0.0 109.327 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -79.8 -45.42 18.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 109.549 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.0 mt -58.21 -46.65 85.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.925 . . . . 0.0 109.937 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.545 ' SD ' ' N ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -70.83 -36.15 72.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 110.047 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.545 ' N ' ' SD ' ' A' ' 42' ' ' MET . 22.3 ttt -52.9 -29.2 27.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.099 -1.001 . . . . 0.0 108.873 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -122.39 46.72 2.06 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.37 134.51 52.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.886 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.99 -8.86 78.85 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.3 t -118.46 115.1 35.93 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.61 119.95 4.16 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.038 1.159 . . . . 0.0 112.001 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -98.7 136.67 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.41 -0.806 . . . . 0.0 110.116 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 -71.18 124.25 24.05 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.241 -0.912 . . . . 0.0 108.931 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.469 ' NH1' ' OE1' ' A' ' 71' ' ' GLU . 53.3 ttp180 -51.35 -17.53 0.77 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.402 -0.811 . . . . 0.0 109.31 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.517 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 18.9 tt0 -68.01 -47.8 67.48 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.383 -0.823 . . . . 0.0 109.974 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.0 mt -57.45 -29.55 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.161 -0.962 . . . . 0.0 110.194 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.9 mt -68.58 -46.79 68.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.159 -0.963 . . . . 0.0 108.835 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -60.84 -34.47 74.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 70.3 m-80 -70.08 -21.67 63.12 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.443 -0.785 . . . . 0.0 110.145 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 36' ' ' ALA . 11.3 t0 . . . . . 0 N--CA 1.485 1.304 0 O-C-N 121.0 -1.063 . . . . 0.0 109.414 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.528 ' CD2' ' N ' ' A' ' 70' ' ' LEU . 1.6 mm? -66.1 -49.28 68.09 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.469 ' OE1' ' NH1' ' A' ' 51' ' ' ARG . 64.2 mm-40 -64.07 -24.99 67.91 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.34 -0.85 . . . . 0.0 108.793 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.0 t -74.83 -41.02 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.411 -0.806 . . . . 0.0 109.425 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -54.29 -39.33 66.85 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 35.6 mm -65.08 -40.21 88.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -67.18 -40.69 86.62 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.153 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -64.75 -44.49 89.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.26 -0.9 . . . . 0.0 109.311 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.7 mt -70.19 -34.19 72.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -0.876 . . . . 0.0 109.478 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -49.35 -49.35 44.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.252 -0.905 . . . . 0.0 109.765 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -58.01 -28.9 64.86 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.352 -0.842 . . . . 0.0 109.804 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -74.24 -43.19 58.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.138 -0.976 . . . . 0.0 110.445 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.5 pt -82.6 -36.95 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.935 -1.103 . . . . 0.0 110.171 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 93.12 103.45 1.6 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 107.161 -2.376 . . . . 0.0 107.161 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 86' ' ' ILE . 9.8 ptpp? -42.95 -19.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.791 -0.829 . . . . 0.0 110.724 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.595 ' HG ' ' H ' ' A' ' 85' ' ' ARG . 36.4 p -64.21 -55.35 22.26 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.966 -1.083 . . . . 0.0 108.905 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.595 ' H ' ' HG ' ' A' ' 84' ' ' SER . 66.9 ttt-85 -47.9 -14.07 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.307 -0.871 . . . . 0.0 110.793 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 84' ' ' SER . 12.8 pt -135.56 168.5 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.095 -1.003 . . . . 0.0 110.759 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -137.5 122.15 18.58 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 p -90.27 135.54 33.61 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.128 -0.982 . . . . 0.0 109.628 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.501 2.086 0 O-C-N 121.532 -0.73 . . . . 0.0 110.189 -179.343 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.466 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.496 2.662 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.466 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 31.0 m-85 -151.06 162.16 41.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.475 -1.015 . . . . 0.0 108.445 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 55.8 ttp -163.02 127.55 3.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.061 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 9.4 mp -82.29 135.11 35.27 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.62 118.43 15.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.931 . . . . 0.0 109.695 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.59 ' N ' HD21 ' A' ' 98' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.261 -0.899 . . . . 0.0 109.433 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 26.6 p-10 . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -167.35 125.58 1.28 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.298 -0.876 . . . . 0.0 109.088 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -163.12 157.91 21.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.907 . . . . 0.0 109.892 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.9 pt -150.68 163.37 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.324 -0.86 . . . . 0.0 108.755 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.2 m -145.15 158.22 43.88 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.214 -0.929 . . . . 0.0 109.926 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.5 p -152.47 97.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.03 -118.17 4.65 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -101.56 8.99 41.67 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.402 -1.058 . . . . 0.0 110.207 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 17.2 mt -106.52 126.52 52.36 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.275 -0.891 . . . . 0.0 109.925 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -116.85 130.68 56.86 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.9 tp -115.05 116.96 29.28 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.455 -0.778 . . . . 0.0 110.109 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -111.32 97.69 6.95 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 121.506 -0.746 . . . . 0.0 109.027 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.3 t -69.35 -28.6 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 109.534 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.49 -53.14 52.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.467 -0.771 . . . . 0.0 109.478 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 -90.26 -8.54 50.72 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.181 -0.95 . . . . 0.0 108.803 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 56.45 67.63 0.97 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 98.6 mt -143.72 158.47 43.65 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.6 t -142.5 123.8 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.227 -0.921 . . . . 0.0 110.012 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 16.0 m-90 -99.42 153.39 19.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.367 -0.833 . . . . 0.0 109.121 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.415 ' O ' ' OG1' ' A' ' 26' ' ' THR . 1.2 tt -146.15 116.05 7.32 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 62.58 39.68 98.18 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 107.623 -2.191 . . . . 0.0 107.623 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 65.87 -4.6 0.61 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 122.263 -0.551 . . . . 0.0 109.875 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.44 ' H ' ' C ' ' A' ' 24' ' ' GLY . 73.7 p -100.27 139.87 35.32 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.082 -1.011 . . . . 0.0 109.535 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.11 115.24 3.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 0.0 110.041 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.1 tp -75.1 127.28 32.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.3 -0.875 . . . . 0.0 108.684 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.402 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 5.7 m-20 -94.16 101.24 13.24 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.242 -0.911 . . . . 0.0 110.303 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.495 ' H ' ' CD2' ' A' ' 30' ' ' LEU . 1.4 pt? -128.33 137.45 51.94 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.5 p -62.8 151.42 84.97 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.795 -1.191 . . . . 0.0 109.475 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -44.91 -46.94 12.44 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 121.792 1.662 . . . . 0.0 112.35 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -53.34 -42.17 66.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.7 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -63.23 -36.06 82.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.154 -0.966 . . . . 0.0 109.336 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -57.03 -30.65 64.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.295 -0.878 . . . . 0.0 109.243 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.401 ' O ' ' OG ' ' A' ' 39' ' ' SER . . . -74.43 -53.3 9.84 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.241 -0.912 . . . . 0.0 109.733 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.06 -39.48 92.52 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.6 tp -65.61 -46.12 80.52 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.61 -0.681 . . . . 0.0 109.678 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 36' ' ' ALA . 87.8 p -50.77 -29.84 12.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 110.378 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.488 ' NH2' ' CG2' ' A' ' 53' ' ' ILE . 6.3 tpt180 -79.18 -36.89 39.58 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.85 -1.157 . . . . 0.0 110.173 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.29 -38.57 91.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.962 -1.086 . . . . 0.0 110.261 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.4 ' SD ' ' CD2' ' A' ' 96' ' ' LEU . 13.0 mmt -65.39 -42.93 92.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.768 -1.207 . . . . 0.0 110.077 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 51.8 mtt -58.72 -32.25 69.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.223 -0.923 . . . . 0.0 109.505 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -106.19 35.34 2.96 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.637 -0.664 . . . . 0.0 109.44 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.1 103.16 2.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 109.885 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.26 -16.58 2.31 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.64 155.72 79.29 Favored Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.718 -0.872 . . . . 0.0 108.707 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.52 120.46 7.13 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.928 1.752 . . . . 0.0 111.554 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.5 t -91.57 136.6 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.8 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.413 ' C ' ' N ' ' A' ' 52' ' ' GLU . 19.7 t-160 -72.26 123.36 22.81 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.156 -0.965 . . . . 0.0 108.607 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -52.99 -15.57 0.82 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 0.0 109.082 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.555 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 36.1 tt0 -69.38 -48.24 61.81 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.601 -0.687 . . . . 0.0 109.764 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.488 ' CG2' ' NH2' ' A' ' 40' ' ' ARG . 77.9 mt -57.83 -30.04 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.048 -1.032 . . . . 0.0 110.099 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.1 mt -67.51 -48.67 66.38 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -54.96 -35.81 64.66 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.555 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 55.8 m-80 -67.3 -22.02 65.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.412 -0.805 . . . . 0.0 110.379 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.56 -179.631 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.409 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 87.1 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.377 0.608 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 pp -67.37 -38.25 84.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.354 -0.841 . . . . 0.0 109.698 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -60.77 -32.79 72.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.032 -1.042 . . . . 0.0 109.877 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.2 t -70.88 -40.11 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.089 -1.007 . . . . 0.0 109.45 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.409 ' ND1' ' O ' ' A' ' 69' ' ' THR . 17.1 m80 -55.74 -37.93 69.12 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.3 mt -66.07 -39.5 84.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -59.05 -36.02 74.31 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.365 -0.934 . . . . 0.0 108.918 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -76.14 -40.24 53.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.447 -0.783 . . . . 0.0 109.088 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -44.07 82.83 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -50.73 -50.28 55.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.388 -0.82 . . . . 0.0 110.228 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -61.74 -27.98 69.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.168 -0.957 . . . . 0.0 110.616 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -74.36 -44.27 52.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.937 -1.102 . . . . 0.0 110.862 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.8 pt -74.43 -21.2 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.854 -1.154 . . . . 0.0 110.212 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 81.27 82.73 0.8 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.413 ' O ' ' O ' ' A' ' 86' ' ' ILE . 18.1 pttp -45.48 -16.57 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.673 -0.898 . . . . 0.0 110.442 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 82' ' ' GLY . 78.8 p -53.66 -49.76 67.24 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.985 -1.072 . . . . 0.0 109.752 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 25.3 mmt-85 -79.34 11.02 3.17 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.313 -0.867 . . . . 0.0 110.402 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 87' ' ' ARG . 4.7 mp -138.86 163.56 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.088 -1.007 . . . . 0.0 109.268 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.416 ' N ' ' CG2' ' A' ' 86' ' ' ILE . 76.6 ttt180 -138.13 127.41 24.52 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.361 -0.837 . . . . 0.0 109.72 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.9 p -93.24 142.41 27.34 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.306 -0.871 . . . . 0.0 109.202 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.5 t . . . . . 0 N--CA 1.501 2.088 0 O-C-N 121.412 -0.805 . . . . 0.0 110.119 -179.365 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.473 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.497 2.755 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.473 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 23.8 m-85 -151.33 157.62 42.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.422 -1.046 . . . . 0.0 108.565 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.418 ' C ' ' SD ' ' A' ' 95' ' ' MET . 1.5 tmt? -157.75 123.01 4.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.347 -0.845 . . . . 0.0 109.523 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.434 ' CD1' ' N ' ' A' ' 96' ' ' LEU . 9.2 mp -82.43 139.09 34.2 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.406 -0.808 . . . . 0.0 108.848 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.89 113.48 1.52 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.929 . . . . 0.0 109.501 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 0.0 109.54 -179.965 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 10.8 p-10 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -164.99 124.87 1.88 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.141 -0.975 . . . . 0.0 109.444 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -163.48 156.06 18.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.465 -0.772 . . . . 0.0 109.474 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.7 pt -147.84 163.97 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.357 -0.839 . . . . 0.0 109.167 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.4 m -133.99 145.43 49.49 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.533 -0.729 . . . . 0.0 109.558 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.4 t -141.44 93.4 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.87 -109.5 2.83 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.65 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -105.84 4.1 29.37 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.593 -0.945 . . . . 0.0 109.865 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.4 mp -98.68 117.63 33.58 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.234 -0.917 . . . . 0.0 109.602 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 59.9 mtp85 -108.46 116.06 31.27 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.2 mp -103.11 136.13 43.49 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.482 -0.761 . . . . 0.0 109.428 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -134.98 98.71 4.08 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.7 t -71.64 -29.39 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.498 -0.751 . . . . 0.0 109.449 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -56.88 -52.7 64.13 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.42 -0.8 . . . . 0.0 109.231 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.6 mtp180 -97.01 -6.71 34.74 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.485 ' NH2' ' O ' ' A' ' 30' ' ' LEU . 1.4 tmt_? 55.23 81.73 0.11 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.81 0.814 . . . . 0.0 109.248 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -167.76 132.34 1.82 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.2 t -117.44 132.75 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.587 -0.695 . . . . 0.0 109.816 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -103.97 124.67 49.42 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.425 -0.797 . . . . 0.0 108.967 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.407 ' O ' ' OG1' ' A' ' 26' ' ' THR . 20.4 tp -104.15 111.77 24.5 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.68 37.4 93.48 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 107.311 -2.315 . . . . 0.0 107.311 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 69.89 2.11 3.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 122.35 -0.5 . . . . 0.0 109.826 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 33.5 p -103.65 138.06 40.83 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.129 -0.982 . . . . 0.0 109.97 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.9 113.14 5.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 110.225 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.3 tp -81.56 136.12 35.58 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -93.06 102.76 15.09 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.023 -1.048 . . . . 0.0 110.464 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.487 ' H ' ' CD2' ' A' ' 30' ' ' LEU . 1.3 pt? -128.53 136.52 50.88 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 p -55.05 152.99 12.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 120.99 -1.068 . . . . 0.0 108.865 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.06 -40.93 47.58 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 122.054 1.836 . . . . 0.0 111.26 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -55.81 -41.91 74.86 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.188 -0.945 . . . . 0.0 108.509 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -63.32 -36.34 83.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.456 -0.778 . . . . 0.0 109.114 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -56.25 -28.22 57.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.161 -0.962 . . . . 0.0 108.633 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.24 -50.91 34.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.315 -0.866 . . . . 0.0 108.891 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.424 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 8.4 mp -58.22 -39.96 80.4 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 12.8 tp -58.45 -41.99 86.36 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.509 ' C ' ' HE ' ' A' ' 40' ' ' ARG . 15.7 m -51.7 -35.48 43.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 109.17 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.509 ' HE ' ' C ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -76.38 -43.26 41.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.466 -0.771 . . . . 0.0 109.031 179.307 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.6 mt -59.7 -50.84 72.3 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.219 -0.926 . . . . 0.0 110.018 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -67.65 -36.45 80.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.923 -1.11 . . . . 0.0 110.196 -179.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.548 ' N ' ' SD ' ' A' ' 42' ' ' MET . 10.8 ttt -54.04 -28.4 38.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.089 -1.007 . . . . 0.0 108.96 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -122.34 44.54 2.59 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.37 132.16 49.32 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.195 -0.941 . . . . 0.0 109.909 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.17 -6.09 57.92 Favored Glycine 0 N--CA 1.501 3.032 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.3 m -132.75 150.82 76.81 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.591 -0.946 . . . . 0.0 108.718 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.07 120.25 5.65 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.803 1.669 . . . . 0.0 112.189 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.0 t -93.38 138.33 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -0.838 . . . . 0.0 109.273 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -68.85 122.27 18.27 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.185 -0.947 . . . . 0.0 108.759 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -52.33 -17.12 1.03 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 109.266 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.558 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 68.5 mm-40 -66.53 -50.24 63.84 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.401 -0.812 . . . . 0.0 109.361 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.4 mt -55.0 -29.77 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.271 -0.893 . . . . 0.0 109.784 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.9 mt -72.95 -30.32 63.77 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.211 -0.931 . . . . 0.0 109.385 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -71.4 -34.13 70.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.752 -1.217 . . . . 0.0 107.837 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 24.4 m-80 -62.89 -20.82 65.51 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.362 0.601 . . . . 0.0 109.767 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.305 -1.359 0 O-C-N 120.814 -1.179 . . . . 0.0 109.507 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.488 ' CD1' ' H ' ' A' ' 70' ' ' LEU . 6.8 mp -59.77 -50.48 73.66 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.449 -0.782 . . . . 0.0 109.855 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -69.7 -26.01 64.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.094 -1.004 . . . . 0.0 109.754 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.6 t -75.23 -45.66 40.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.294 -0.879 . . . . 0.0 109.477 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -55.14 -37.45 66.96 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 89.0 mt -67.35 -40.45 84.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -59.78 -37.37 78.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.194 -0.941 . . . . 0.0 108.681 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.489 ' N ' HD21 ' A' ' 76' ' ' ASN . 1.4 m120 -72.71 -42.12 64.52 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.418 ' CD1' ' C ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -64.42 -41.23 96.71 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -49.72 -50.39 44.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.334 -0.854 . . . . 0.0 109.815 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -59.52 -31.78 69.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.873 . . . . 0.0 110.803 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -68.32 -45.5 72.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.875 -1.141 . . . . 0.0 109.817 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.4 pt -74.88 -31.94 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.014 -1.054 . . . . 0.0 109.924 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 86.0 87.9 0.98 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.409 ' O ' ' O ' ' A' ' 86' ' ' ILE . 22.7 pttm -45.54 -17.33 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.573 -0.957 . . . . 0.0 110.31 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 82' ' ' GLY . 48.4 t -56.51 -52.06 66.15 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.185 -0.947 . . . . 0.0 109.897 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -87.75 10.06 19.6 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.179 -0.95 . . . . 0.0 110.942 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.409 ' O ' ' O ' ' A' ' 83' ' ' LYS . 5.1 mp -133.08 164.04 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -140.85 128.02 20.89 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.075 -1.016 . . . . 0.0 110.085 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.2 p -88.57 142.24 27.86 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.498 -0.751 . . . . 0.0 109.096 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.7 t . . . . . 0 N--CA 1.502 2.151 0 O-C-N 121.368 -0.832 . . . . 0.0 110.236 -179.318 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.456 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.497 2.736 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 12.1 m-85 -151.29 149.98 30.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.388 -1.066 . . . . 0.0 108.335 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.477 ' SD ' ' O ' ' A' ' 95' ' ' MET . 3.4 ppp? -149.22 127.45 12.11 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.212 -0.93 . . . . 0.0 109.542 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.8 mp -79.87 132.74 36.16 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.08 132.1 46.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.347 -0.846 . . . . 0.0 109.615 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.9 m120 . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 109.456 179.92 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.4 p30 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 17' ' ' THR . 4.1 p30 -178.09 111.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -163.24 156.01 18.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 109.863 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.2 pt -146.38 163.12 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.347 -0.846 . . . . 0.0 109.084 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.8 t -134.49 142.15 46.97 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.336 -0.852 . . . . 0.0 109.8 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.77 92.88 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.55 -119.79 5.38 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -101.09 10.84 40.53 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.407 -1.055 . . . . 0.0 109.794 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.4 mt -108.33 123.59 49.04 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.413 -0.805 . . . . 0.0 109.672 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -108.1 146.98 31.87 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.6 tp -130.84 120.97 24.48 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.482 -0.762 . . . . 0.0 109.176 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 19' ' ' ARG . 13.2 m-20 -118.55 97.85 5.95 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.531 -0.731 . . . . 0.0 109.525 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.94 -27.51 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.449 -0.782 . . . . 0.0 109.216 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.463 ' N ' ' OD1' ' A' ' 5' ' ' ASN . 0.1 OUTLIER -63.18 -53.83 47.19 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.508 -0.745 . . . . 0.0 109.645 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.401 ' H ' HG21 ' A' ' 17' ' ' THR . 73.1 mtm180 -92.73 -14.62 27.71 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.153 -0.967 . . . . 0.0 108.814 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 15' ' ' ASN . 5.6 tpt180 68.18 61.31 0.4 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.312 0.577 . . . . 0.0 109.604 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.9 mt -138.89 156.65 47.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.38 -0.825 . . . . 0.0 108.973 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 t -143.69 127.73 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.255 -0.903 . . . . 0.0 109.388 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 12.3 m-90 -102.38 154.87 18.66 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.247 -0.908 . . . . 0.0 108.898 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.433 ' O ' ' OG1' ' A' ' 26' ' ' THR . 1.1 tt -144.5 115.09 7.68 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.439 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 63.5 43.47 98.08 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 107.805 -2.118 . . . . 0.0 107.805 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 61.28 0.43 0.42 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 122.129 -0.63 . . . . 0.0 110.213 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.439 ' H ' ' C ' ' A' ' 24' ' ' GLY . 68.1 p -106.47 139.85 40.29 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.215 -0.928 . . . . 0.0 109.452 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.03 114.56 3.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.412 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 32.2 tp -75.27 128.75 36.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.252 -0.905 . . . . 0.0 108.657 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -97.39 104.8 16.86 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.164 -0.96 . . . . 0.0 109.657 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.47 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 1.4 pt? -131.32 141.83 50.0 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.67 -0.644 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.3 p -62.36 152.19 80.29 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.155 -0.966 . . . . 0.0 109.961 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.04 -45.23 14.5 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.779 1.653 . . . . 0.0 112.013 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -53.63 -48.62 69.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.357 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -56.43 -35.26 67.64 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.324 -0.86 . . . . 0.0 109.536 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.401 ' OH ' ' O ' ' A' ' 15' ' ' ASN . 11.7 t80 -60.19 -32.97 71.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 109.198 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.82 -53.45 9.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.155 -0.966 . . . . 0.0 108.583 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 tt -55.94 -45.0 78.91 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.9 tp -64.46 -45.74 86.08 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.3 0.572 . . . . 0.0 109.739 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.8 t -50.59 -39.45 49.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.364 -0.835 . . . . 0.0 110.635 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.36 -41.68 24.29 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.916 -1.115 . . . . 0.0 109.87 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.6 tp -60.69 -41.83 95.94 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 109.325 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.1 mtp -72.35 -37.3 68.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.058 -1.026 . . . . 0.0 109.296 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 13.5 ttt -51.85 -27.3 12.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.28 -0.888 . . . . 0.0 108.766 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm -119.37 46.05 1.99 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.66 141.58 49.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.33 -0.856 . . . . 0.0 110.512 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.54 -22.14 40.63 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 t -114.43 152.99 46.61 Favored Pre-proline 0 N--CA 1.502 2.134 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.77 119.43 6.08 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.557 1.505 . . . . 0.0 111.629 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.8 t -97.11 133.69 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.293 -0.879 . . . . 0.0 110.047 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -68.44 124.75 24.4 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.184 -0.948 . . . . 0.0 108.673 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -52.31 -18.71 1.69 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.345 -0.847 . . . . 0.0 109.008 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.526 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 58.4 tt0 -60.74 -57.15 13.9 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.46 -0.775 . . . . 0.0 109.379 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.2 mt -56.46 -30.67 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.238 -0.914 . . . . 0.0 109.735 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 33.8 mt -68.55 -32.53 72.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.096 -1.002 . . . . 0.0 108.959 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -74.1 -35.52 64.18 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 32.8 m-80 -61.19 -22.05 64.37 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 . . . . . 0 C--N 1.304 -1.394 0 O-C-N 121.386 -0.821 . . . . 0.0 109.751 -179.759 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 98.3 m . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.5 pp -68.1 -33.0 73.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.733 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.455 ' O ' ' CD2' ' A' ' 75' ' ' HIS . 75.7 mm-40 -60.23 -32.09 70.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.022 -1.049 . . . . 0.0 110.026 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.1 t -73.84 -45.68 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.039 -1.038 . . . . 0.0 109.279 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.486 ' ND1' ' N ' ' A' ' 73' ' ' HIS . 1.5 m-70 -55.86 -37.49 68.84 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 86.8 mt -67.79 -39.79 82.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.455 ' CD2' ' O ' ' A' ' 71' ' ' GLU . 34.6 m170 -61.25 -35.84 78.38 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.969 -1.082 . . . . 0.0 108.752 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -74.49 -41.66 60.33 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.479 -0.763 . . . . 0.0 109.017 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.11 -42.83 75.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 0.0 108.85 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -50.82 -50.64 56.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -0.857 . . . . 0.0 110.726 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -64.71 -26.07 68.21 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.036 -1.04 . . . . 0.0 110.769 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -71.44 -45.35 62.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.856 -1.152 . . . . 0.0 110.077 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 21.7 pt -74.84 -22.29 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.122 -0.986 . . . . 0.0 110.09 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 81.6 84.39 0.76 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.576 -1.81 . . . . 0.0 108.576 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 86' ' ' ILE . 18.3 pttp -45.1 -17.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.658 -0.907 . . . . 0.0 110.425 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 82' ' ' GLY . 36.7 p -54.78 -48.73 72.31 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.168 -0.957 . . . . 0.0 109.751 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.83 9.58 4.09 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.056 -1.028 . . . . 0.0 109.893 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.407 ' O ' ' O ' ' A' ' 83' ' ' LYS . 5.2 mp -134.46 159.56 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.214 -0.929 . . . . 0.0 109.307 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -140.73 124.39 17.01 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.419 -0.8 . . . . 0.0 109.689 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.8 p -86.75 138.63 31.45 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.287 -0.883 . . . . 0.0 109.285 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.501 2.117 0 O-C-N 121.375 -0.828 . . . . 0.0 110.535 -179.092 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.428 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.495 2.631 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.428 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 22.7 m-85 -149.51 158.06 43.84 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 45.6 ttp -159.81 126.61 4.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.204 -0.935 . . . . 0.0 110.075 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.4 mp -84.3 131.88 34.68 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.02 127.14 27.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.189 -0.944 . . . . 0.0 109.215 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.4 m120 . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.238 -0.913 . . . . 0.0 109.629 -179.855 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.348 0.594 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.469 ' C ' HD21 ' A' ' 5' ' ' ASN . 0.4 OUTLIER -161.92 125.01 3.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 108.952 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -150.26 146.5 26.83 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.554 -0.716 . . . . 0.0 109.492 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.3 pt -148.92 163.44 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.271 -0.893 . . . . 0.0 108.905 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.1 t -143.24 152.79 42.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.201 -0.937 . . . . 0.0 109.712 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.1 t -147.35 92.92 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.91 -114.84 4.08 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.7 m-20 -103.09 6.19 38.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.421 -1.046 . . . . 0.0 109.893 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.8 mt -101.78 118.31 36.66 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.351 -0.843 . . . . 0.0 109.887 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -110.84 118.97 37.56 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 mp -106.88 126.47 52.35 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.552 -0.717 . . . . 0.0 109.309 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -122.72 97.91 5.67 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.97 -27.34 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.432 -0.792 . . . . 0.0 109.576 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.404 HG21 ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -63.74 -49.11 74.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.273 -0.892 . . . . 0.0 109.867 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.404 ' H ' HG21 ' A' ' 17' ' ' THR . 47.2 mtp85 -97.14 -7.75 31.79 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.164 -0.96 . . . . 0.0 108.611 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? 56.0 73.35 0.44 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 tt -157.7 128.13 6.34 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 t -114.73 136.72 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.499 -0.75 . . . . 0.0 110.264 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 29.0 m-90 -108.18 133.16 52.83 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.411 ' O ' ' OG1' ' A' ' 26' ' ' THR . 1.2 tt -113.75 110.11 19.64 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.37 39.0 91.66 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 107.623 -2.191 . . . . 0.0 107.623 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 69.65 -0.45 2.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 122.324 -0.515 . . . . 0.0 110.025 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 60.7 p -101.93 138.99 38.16 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.064 -1.023 . . . . 0.0 109.789 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.98 112.46 1.34 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 110.012 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.4 tp -75.43 127.89 34.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 108.839 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -92.24 98.76 11.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.115 -0.991 . . . . 0.0 109.926 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.51 ' H ' ' CD2' ' A' ' 30' ' ' LEU . 1.3 pt? -123.84 134.28 53.62 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 121.509 0.671 . . . . 0.0 109.341 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.0 p -59.57 149.15 72.0 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.997 -1.065 . . . . 0.0 109.463 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -45.01 -48.37 11.05 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.719 1.613 . . . . 0.0 112.117 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -54.67 -37.43 65.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.419 -0.801 . . . . 0.0 109.882 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -67.55 -35.06 78.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.095 -1.003 . . . . 0.0 109.261 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -59.12 -33.4 70.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.042 -1.036 . . . . 0.0 108.72 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.53 -53.05 17.7 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.9 tt -52.16 -50.3 62.07 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 13.1 tp -56.09 -40.09 73.13 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.169 0.509 . . . . 0.0 109.854 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.8 m -52.42 -33.31 43.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 109.744 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.492 HH21 ' CE ' ' A' ' 43' ' ' MET . 10.5 mmp_? -78.55 -42.66 28.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.97 . . . . 0.0 109.456 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 17.9 mt -59.22 -48.05 83.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.959 -1.088 . . . . 0.0 110.011 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.417 ' SD ' ' C ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -70.36 -25.96 63.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.985 -1.072 . . . . 0.0 109.746 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.492 ' CE ' HH21 ' A' ' 40' ' ' ARG . 40.2 ttm -61.77 -32.67 72.95 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.161 -0.962 . . . . 0.0 108.872 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -118.13 38.91 3.54 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.79 121.3 9.53 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.262 -0.899 . . . . 0.0 109.753 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.32 -6.85 30.38 Favored Glycine 0 N--CA 1.503 3.14 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.3 m -130.28 151.68 78.9 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 121.535 -0.98 . . . . 0.0 108.771 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.72 120.4 5.51 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.859 1.706 . . . . 0.0 112.186 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.5 t -87.77 131.68 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.241 -0.912 . . . . 0.0 109.78 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -67.15 129.34 39.57 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.309 -0.87 . . . . 0.0 108.675 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.446 ' NH2' ' OE1' ' A' ' 71' ' ' GLU . 13.0 ptm180 -54.04 -22.2 10.15 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.473 -0.767 . . . . 0.0 109.394 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.576 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 38.2 tt0 -72.79 -36.24 67.54 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.524 -0.735 . . . . 0.0 110.409 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.9 mt -75.64 -35.37 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.433 -0.792 . . . . 0.0 111.66 -178.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.401 ' CD1' ' C ' ' A' ' 54' ' ' LEU . 4.2 pp -76.34 -22.43 54.92 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.818 -1.176 . . . . 0.0 109.474 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -64.88 -33.36 75.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.903 . . . . 0.0 109.521 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.662 ' ND2' ' H ' ' A' ' 56' ' ' ASN . 0.4 OUTLIER -61.54 -23.69 66.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 109.669 -179.495 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.386 -0.822 . . . . 0.0 110.175 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.423 0.63 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.432 ' CD2' ' H ' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -70.54 -49.28 49.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.373 -0.83 . . . . 0.0 108.892 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.446 ' OE1' ' NH2' ' A' ' 51' ' ' ARG . 29.8 tp10 -69.87 -31.23 68.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.574 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.9 t -72.4 -40.11 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.181 -0.95 . . . . 0.0 109.0 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -56.95 -39.3 74.31 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 89.9 mt -63.82 -35.9 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -61.97 -32.4 72.84 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.48 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -73.04 -41.78 63.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.505 -0.747 . . . . 0.0 109.255 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.8 mt -72.26 -39.39 68.43 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.227 -0.921 . . . . 0.0 109.544 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -50.32 -51.48 44.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.959 . . . . 0.0 110.181 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.43 -24.79 67.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.055 -1.028 . . . . 0.0 109.803 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -70.95 -45.92 63.31 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.984 -1.073 . . . . 0.0 110.135 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.3 pt -74.89 -19.29 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.104 -0.997 . . . . 0.0 110.121 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 84.19 83.07 0.98 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 86' ' ' ILE . 56.4 pttt -44.51 -17.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.721 -0.87 . . . . 0.0 110.59 -179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 82' ' ' GLY . 57.9 m -59.38 -48.42 81.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.138 -0.976 . . . . 0.0 110.777 -178.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.483 ' N ' ' CD ' ' A' ' 85' ' ' ARG . 10.6 mpt_? -72.72 9.42 1.12 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.025 -1.047 . . . . 0.0 111.003 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' A' ' 83' ' ' LYS . 9.0 tt -146.82 160.96 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 120.934 -1.104 . . . . 0.0 109.29 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -117.1 132.44 56.67 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.42 -0.8 . . . . 0.0 109.703 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.7 p -95.39 142.47 27.74 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.414 -0.804 . . . . 0.0 108.89 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.6 t . . . . . 0 N--CA 1.499 2.002 0 O-C-N 121.352 -0.843 . . . . 0.0 109.787 -179.599 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.472 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.497 2.715 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.472 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 26.0 m-85 -151.21 163.31 39.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.421 -1.046 . . . . 0.0 108.305 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.46 ' SD ' ' O ' ' A' ' 96' ' ' LEU . 1.2 tmt? -163.27 127.79 2.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.981 -1.074 . . . . 0.0 110.261 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.46 ' O ' ' SD ' ' A' ' 95' ' ' MET . 9.6 mp -78.49 142.02 37.77 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.7 120.73 20.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 109.486 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 109.645 -180.0 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -158.26 120.27 3.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.241 -0.912 . . . . 0.0 109.321 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -162.44 154.57 18.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.333 -0.855 . . . . 0.0 109.706 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.8 pt -150.44 164.65 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.5 p -140.39 154.0 46.55 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.294 -0.879 . . . . 0.0 110.028 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.3 t -148.33 93.43 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.67 -115.19 4.19 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -101.44 5.35 41.99 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.396 -1.061 . . . . 0.0 109.837 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.2 mt -101.06 116.24 32.37 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.334 -0.854 . . . . 0.0 109.715 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -108.94 122.04 46.38 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.494 ' C ' HD21 ' A' ' 15' ' ' ASN . 37.1 tp -105.95 134.74 48.6 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.597 -0.69 . . . . 0.0 110.006 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.494 HD21 ' C ' ' A' ' 14' ' ' LEU . 0.9 OUTLIER -131.78 97.36 4.17 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.228 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.9 t -71.89 -27.9 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.317 -0.864 . . . . 0.0 109.403 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.404 HG21 ' H ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -63.7 -54.75 30.65 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.503 -0.748 . . . . 0.0 109.656 -179.93 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.404 ' H ' HG21 ' A' ' 17' ' ' THR . 74.2 mtp180 -86.9 -11.6 50.19 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.169 -0.957 . . . . 0.0 108.697 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 60.29 72.23 0.53 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.441 0.639 . . . . 0.0 109.329 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.5 tp -166.8 153.63 8.83 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.5 t -134.59 135.52 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.298 -0.876 . . . . 0.0 109.876 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 20.0 m-90 -100.0 120.37 39.72 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 26' ' ' THR . 1.2 tt -101.91 110.51 22.5 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.55 43.45 96.54 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 107.212 -2.355 . . . . 0.0 107.212 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 64.75 3.37 1.98 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 122.338 -0.507 . . . . 0.0 110.269 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 23' ' ' LEU . 43.8 p -106.03 138.48 42.14 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 120.95 -1.094 . . . . 0.0 109.711 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.71 113.31 2.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.973 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 29.1 tp -71.04 126.25 29.06 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -96.91 104.93 16.98 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.22 -0.925 . . . . 0.0 110.695 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.512 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 1.1 pt? -143.09 151.48 40.8 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.44 -0.788 . . . . 0.0 109.354 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.08 157.35 62.68 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.141 -0.975 . . . . 0.0 108.71 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -60.8 -39.77 59.72 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.457 2.105 . . . . 0.0 112.069 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -54.54 -36.27 64.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.073 -1.017 . . . . 0.0 109.102 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.486 ' OE2' ' NE2' ' A' ' 73' ' ' HIS . 20.5 mm-40 -70.18 -37.73 75.21 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.449 ' HH ' ' CD1' ' A' ' 14' ' ' LEU . 28.6 t80 -55.25 -27.86 49.28 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.421 ' O ' ' OD2' ' A' ' 57' ' ' ASP . . . -72.83 -50.49 23.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.383 -0.823 . . . . 0.0 109.002 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.471 ' CD2' ' O ' ' A' ' 54' ' ' LEU . 9.9 mt -65.71 -37.73 87.24 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tt -57.58 -42.44 83.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.511 -0.743 . . . . 0.0 109.446 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.5 p -60.78 -45.86 92.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.11 -0.994 . . . . 0.0 109.275 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -55.24 -48.06 74.49 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.368 -0.832 . . . . 0.0 109.29 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.1 mt -61.65 -39.29 90.83 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 109.991 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 8.1 mmt -74.7 -37.03 62.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.874 -1.141 . . . . 0.0 109.888 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 40.5 mtt -55.14 -29.31 57.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.119 -0.988 . . . . 0.0 108.699 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -120.81 47.85 1.73 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.86 129.97 39.89 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.197 -0.94 . . . . 0.0 110.064 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.33 -12.98 43.98 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.8 p -125.75 151.43 70.86 Favored Pre-proline 0 N--CA 1.502 2.165 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.1 119.74 6.2 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.637 1.558 . . . . 0.0 111.709 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.4 t -94.67 135.34 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.349 -0.845 . . . . 0.0 109.81 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.413 ' C ' ' N ' ' A' ' 52' ' ' GLU . 8.2 t-160 -72.72 125.12 26.76 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.044 -1.035 . . . . 0.0 108.492 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.482 ' N ' ' CD ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -50.83 -15.18 0.26 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.489 -0.757 . . . . 0.0 109.787 -179.281 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.544 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 17.2 tt0 -66.47 -49.12 67.69 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.498 -0.751 . . . . 0.0 109.866 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.2 mm -56.24 -33.14 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.034 -1.041 . . . . 0.0 109.93 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.471 ' O ' ' CD2' ' A' ' 37' ' ' LEU . 22.7 mt -65.93 -48.95 69.67 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -57.67 -35.98 71.29 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 68.7 m-80 -66.84 -21.79 66.01 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.528 -0.733 . . . . 0.0 110.693 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.421 ' OD2' ' O ' ' A' ' 36' ' ' ALA . 7.2 t0 . . . . . 0 N--CA 1.485 1.305 0 O-C-N 120.764 -1.21 . . . . 0.0 109.347 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.426 0.631 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.456 ' CD1' ' H ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -55.49 -50.38 70.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.239 -0.913 . . . . 0.0 109.201 -179.684 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -71.57 -27.44 63.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 110.138 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.65 -48.24 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.105 -0.997 . . . . 0.0 109.413 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.486 ' NE2' ' OE2' ' A' ' 34' ' ' GLU . 81.4 t60 -54.73 -36.72 65.07 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 74' ' ' ILE . 90.5 mt -71.61 -42.45 71.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -61.39 -35.43 77.48 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.816 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -74.07 -40.86 62.48 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.512 -0.743 . . . . 0.0 109.402 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.428 ' CD1' ' C ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -67.71 -42.51 81.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 108.665 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.483 ' NH2' ' OH ' ' A' ' 94' ' ' TYR . 35.6 ttm180 -49.85 -51.29 41.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.524 -0.735 . . . . 0.0 110.448 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -62.16 -27.71 69.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 110.642 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -74.47 -45.04 48.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.981 -1.074 . . . . 0.0 110.94 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.7 pt -76.83 -22.23 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.821 -1.175 . . . . 0.0 110.638 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 83.93 82.12 0.99 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.2 pttt -45.07 -15.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.707 -0.878 . . . . 0.0 110.658 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 82' ' ' GLY . 65.1 p -49.44 -45.53 46.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.954 -1.091 . . . . 0.0 109.841 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.497 ' HE ' ' N ' ' A' ' 85' ' ' ARG . 5.4 mmp_? -84.25 9.5 12.79 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.189 -0.944 . . . . 0.0 110.295 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 37.2 mm -116.95 161.5 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 121.372 -0.83 . . . . 0.0 109.617 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 47.4 ttt85 -134.04 110.46 9.66 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.3 p -87.37 138.14 31.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.145 -0.972 . . . . 0.0 110.274 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.499 1.991 0 O-C-N 121.539 -0.726 . . . . 0.0 109.597 -179.947 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.496 2.643 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.483 ' OH ' ' NH2' ' A' ' 78' ' ' ARG . 28.0 m-85 -151.21 159.84 44.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.299 -1.118 . . . . 0.0 108.585 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 43.1 ttp -161.15 131.69 5.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 110.065 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.416 ' CD1' ' N ' ' A' ' 96' ' ' LEU . 9.3 mp -89.64 133.13 34.79 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.17 114.06 1.62 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 109.729 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.294 -0.878 . . . . 0.0 109.243 179.796 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.6 p30 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -158.83 123.93 4.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 108.924 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -161.32 152.36 18.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.394 -0.816 . . . . 0.0 109.546 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.5 mt -137.04 159.97 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.2 m -142.9 146.69 34.29 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.39 -0.819 . . . . 0.0 109.732 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.5 t -142.66 94.65 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.01 -119.41 4.95 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.555 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 0.8 OUTLIER -100.96 10.11 41.49 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.37 -1.076 . . . . 0.0 109.34 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 17.7 tp -104.45 127.85 52.23 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -123.53 135.65 54.13 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 tt -129.2 121.44 27.67 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.622 -0.674 . . . . 0.0 109.582 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -112.12 107.11 15.91 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.629 -0.669 . . . . 0.0 110.241 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.1 t -71.9 -28.58 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.284 -0.885 . . . . 0.0 109.561 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.69 -54.7 20.33 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.368 -0.832 . . . . 0.0 109.303 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -84.01 -18.78 35.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.115 -0.991 . . . . 0.0 108.665 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? 66.11 65.92 0.5 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.9 mt -148.01 158.23 43.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.236 -0.915 . . . . 0.0 108.661 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.7 t -140.35 128.63 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.324 -0.86 . . . . 0.0 109.58 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -103.86 148.0 26.65 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.415 -0.803 . . . . 0.0 109.35 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.9 tp -133.83 102.53 5.48 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.467 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 71.85 40.87 57.06 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.315 -1.914 . . . . 0.0 108.315 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 70.62 -10.86 0.67 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 122.034 -0.686 . . . . 0.0 109.695 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.467 ' H ' ' C ' ' A' ' 24' ' ' GLY . 44.3 p -92.85 142.81 26.91 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.077 -1.014 . . . . 0.0 109.638 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.71 116.68 7.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 110.121 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.3 tp -75.14 130.57 39.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.263 -0.898 . . . . 0.0 108.604 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 29' ' ' ASP . 9.5 p-10 -97.45 102.79 14.64 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.231 -0.918 . . . . 0.0 110.046 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 1.4 pt? -131.29 140.94 49.88 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.0 p -64.59 151.21 92.48 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.026 -1.046 . . . . 0.0 109.703 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -44.71 -44.58 14.03 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 121.734 1.623 . . . . 0.0 112.087 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -53.6 -46.22 70.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 109.325 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -55.55 -44.77 77.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.918 . . . . 0.0 109.786 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -56.29 -28.11 57.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.411 -0.805 . . . . 0.0 109.921 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.64 -54.12 8.04 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.908 -1.12 . . . . 0.0 109.681 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 tt -58.28 -42.73 87.2 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 22.4 tp -62.32 -43.08 99.66 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.291 0.567 . . . . 0.0 109.488 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.8 m -51.44 -36.14 42.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.78 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -77.14 -39.25 49.96 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.738 -1.226 . . . . 0.0 109.725 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.7 mt -57.4 -43.99 84.18 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.097 -1.002 . . . . 0.0 108.961 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.3 mmt -67.93 -28.91 67.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.053 -1.029 . . . . 0.0 109.66 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 24.6 ttt -61.59 -33.16 73.41 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.183 -0.948 . . . . 0.0 108.907 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -124.01 47.32 2.08 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.867 -0.521 . . . . 0.0 109.64 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.45 136.95 52.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.108 -0.995 . . . . 0.0 110.254 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.45 -13.99 61.04 Favored Glycine 0 N--CA 1.501 2.984 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.2 p -119.9 151.32 52.34 Favored Pre-proline 0 N--CA 1.502 2.162 0 O-C-N 121.56 -0.965 . . . . 0.0 108.566 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.03 120.2 5.96 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.639 1.559 . . . . 0.0 111.519 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.0 t -100.0 138.38 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.489 -0.757 . . . . 0.0 109.87 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.439 ' C ' ' N ' ' A' ' 52' ' ' GLU . 18.2 t-160 -79.56 126.35 30.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.344 -0.848 . . . . 0.0 108.764 178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.7 ttp-105 -51.06 -16.77 0.5 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 108.816 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.555 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 31.7 tt0 -65.05 -39.02 92.68 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.5 mt -73.54 -35.05 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.273 0.559 . . . . 0.0 109.529 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.9 mt -73.84 -25.03 59.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.174 -0.954 . . . . 0.0 108.906 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.57 ' HH ' ' CB ' ' A' ' 70' ' ' LEU . 2.6 t80 -60.21 -37.01 78.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.001 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.691 ' H ' HD21 ' A' ' 56' ' ' ASN . 0.6 OUTLIER -59.13 -28.07 66.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.519 -0.738 . . . . 0.0 109.918 -179.447 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--N 1.301 -1.521 0 O-C-N 121.341 -0.849 . . . . 0.0 110.047 -179.573 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.4 m . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.57 ' CB ' ' HH ' ' A' ' 55' ' ' TYR . 2.1 mm? -64.49 -49.36 71.68 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.296 -0.878 . . . . 0.0 109.166 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.14 -34.68 78.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.896 -1.128 . . . . 0.0 108.781 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.6 t -69.1 -35.33 68.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.16 -38.57 80.04 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.96 -36.66 77.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -62.73 -34.22 76.74 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.789 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -77.37 -41.68 39.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.489 -0.757 . . . . 0.0 109.306 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.413 ' CD1' ' C ' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -71.73 -39.22 70.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.292 -0.88 . . . . 0.0 109.276 -179.065 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -56.46 -47.78 78.45 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.775 -0.578 . . . . 0.0 110.62 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -62.3 -15.2 46.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.076 -1.015 . . . . 0.0 110.847 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -88.2 -39.64 14.33 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.849 -1.157 . . . . 0.0 110.681 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.2 pt -81.52 -15.74 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.028 -1.045 . . . . 0.0 110.131 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 78.93 85.82 0.54 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -44.78 -16.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.638 -0.919 . . . . 0.0 110.539 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 82' ' ' GLY . 52.0 p -50.01 -44.74 51.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.601 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -75.29 8.79 2.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.18 -0.95 . . . . 0.0 109.971 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.1 mt -137.56 127.71 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.335 -0.853 . . . . 0.0 108.933 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -97.8 98.09 9.54 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.394 -0.816 . . . . 0.0 109.058 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.9 p -67.43 131.23 45.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -0.945 . . . . 0.0 109.336 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.501 2.094 0 O-C-N 121.487 -0.758 . . . . 0.0 110.246 -179.0 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.422 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.493 2.449 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.422 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 31.4 m-85 -151.98 159.74 43.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -1.131 . . . . 0.0 108.795 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 38.8 ttp -161.94 135.1 6.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.278 -0.889 . . . . 0.0 110.188 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.417 ' CD1' ' N ' ' A' ' 96' ' ' LEU . 9.3 mp -93.12 130.6 38.7 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.44 -0.788 . . . . 0.0 108.921 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.2 123.77 25.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 109.558 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.233 -0.917 . . . . 0.0 109.488 179.997 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -74.16 54.02 0.52 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.345 -0.847 . . . . 0.0 109.462 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 71.07 17.74 75.89 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -167.62 138.48 2.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.306 -1.114 . . . . 0.0 109.501 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.564 ' N ' HD21 ' A' ' 5' ' ' ASN . 0.1 OUTLIER -171.14 124.74 0.63 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 109.213 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 1.3 pm0 -160.64 155.98 24.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.392 -0.818 . . . . 0.0 109.831 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.9 pt -147.17 163.03 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.338 -0.851 . . . . 0.0 109.012 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m -143.74 154.36 43.38 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.238 -0.914 . . . . 0.0 109.712 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.5 t -142.67 99.09 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.15 -119.69 5.69 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -99.29 11.37 39.27 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.455 -1.027 . . . . 0.0 109.738 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 29.6 mt -106.82 130.62 54.48 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.356 -0.84 . . . . 0.0 109.455 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -118.59 141.05 48.96 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.1 tt -129.05 143.53 50.9 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.618 -0.676 . . . . 0.0 109.525 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 19' ' ' ARG . 3.3 m-20 -135.48 100.7 4.58 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.622 -0.674 . . . . 0.0 109.721 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.85 -30.34 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.363 -0.835 . . . . 0.0 109.564 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.497 ' N ' HD22 ' A' ' 5' ' ' ASN . 0.0 OUTLIER -60.75 -49.32 77.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.444 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.408 ' H ' HG21 ' A' ' 17' ' ' THR . 59.4 mtp180 -93.73 -14.53 26.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.129 -0.982 . . . . 0.0 108.378 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 15' ' ' ASN . 5.7 tpt180 64.41 49.25 2.52 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.873 -0.517 . . . . 0.0 109.742 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.3 mt -133.69 153.08 51.96 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.9 t -133.87 134.27 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.422 -0.799 . . . . 0.0 109.319 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -103.17 158.68 16.15 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.429 ' O ' ' OG1' ' A' ' 26' ' ' THR . 1.9 tt -146.41 116.92 7.52 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.27 -0.894 . . . . 0.0 108.714 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.64 41.65 97.66 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 107.727 -2.149 . . . . 0.0 107.727 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 61.63 3.48 0.86 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 122.089 -0.654 . . . . 0.0 110.077 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 60.6 p -108.35 140.8 41.11 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 121.187 -0.946 . . . . 0.0 109.457 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.33 114.58 7.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 109.693 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 12.1 tp -84.94 141.27 30.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 109.023 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -99.78 107.5 19.57 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.322 -0.861 . . . . 0.0 109.795 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.3 140.57 51.8 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.8 p -61.11 145.05 90.32 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.107 -0.996 . . . . 0.0 109.48 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -45.0 -42.72 15.76 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.709 1.606 . . . . 0.0 112.32 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -53.31 -48.24 68.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.885 . . . . 0.0 109.767 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -59.48 -33.37 71.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.973 . . . . 0.0 109.381 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -60.04 -32.03 70.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.128 -0.982 . . . . 0.0 109.369 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.409 ' O ' ' OD2' ' A' ' 57' ' ' ASP . . . -74.27 -53.85 8.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.171 -0.956 . . . . 0.0 109.794 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.5 mp -64.96 -38.47 91.07 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.8 tp -65.23 -46.27 81.3 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.5 m -50.46 -30.15 12.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 109.61 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -77.27 -37.81 52.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.156 -0.965 . . . . 0.0 109.082 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.4 mp -56.53 -47.28 79.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 108.998 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 54.8 mtt -72.28 -30.86 65.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.15 -0.969 . . . . 0.0 109.665 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 20.8 ttt -52.35 -36.03 52.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.159 -0.963 . . . . 0.0 109.443 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -120.92 53.96 1.11 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.64 104.2 3.83 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.305 -0.872 . . . . 0.0 109.919 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.61 -17.45 1.27 Allowed Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.06 159.98 59.72 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.578 -0.954 . . . . 0.0 108.85 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.12 119.97 6.9 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.121 1.88 . . . . 0.0 111.74 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.4 132.63 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.331 -0.856 . . . . 0.0 109.569 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -58.45 147.56 31.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.978 -1.076 . . . . 0.0 108.986 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.0 mtm180 -79.72 -20.94 45.25 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.144 -0.973 . . . . 0.0 110.13 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -72.24 -33.93 67.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.118 -0.989 . . . . 0.0 109.89 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.2 mt -67.16 -33.48 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.029 -1.044 . . . . 0.0 109.548 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.6 mt -64.63 -50.66 66.24 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.403 ' O ' ' O ' ' A' ' 59' ' ' TYR . 32.2 m-85 -58.19 -34.34 70.25 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -70.66 -22.03 62.54 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.528 -0.732 . . . . 0.0 109.958 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.409 ' OD2' ' O ' ' A' ' 36' ' ' ALA . 12.3 t0 -54.58 -54.7 37.86 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.982 -1.074 . . . . 0.0 109.679 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 65.3 mt -83.39 -37.15 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.113 -0.992 . . . . 0.0 109.908 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.458 ' CD1' ' O ' ' A' ' 59' ' ' TYR . 43.0 p90 -163.27 138.57 6.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.057 -1.027 . . . . 0.0 110.094 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.9 t -120.11 20.71 12.02 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.429 ' CD1' ' C ' ' A' ' 61' ' ' TRP . 10.0 t-105 -77.52 -24.8 49.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.337 -0.852 . . . . 0.0 108.939 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 61' ' ' TRP . 16.8 m-20 45.64 97.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.548 -0.72 . . . . 0.0 110.479 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.52 ' ND2' ' H ' ' A' ' 64' ' ' GLU . 8.0 p-10 -78.85 -113.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.93 . . . . 0.0 109.308 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.52 ' H ' ' ND2' ' A' ' 63' ' ' ASN . 59.0 mt-10 -150.78 61.61 4.73 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.065 -1.022 . . . . 0.0 109.272 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.54 83.88 2.08 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.552 2.168 . . . . 0.0 112.026 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.64 -33.67 64.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.223 -0.923 . . . . 0.0 109.438 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -74.27 150.13 40.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.501 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.431 ' C ' ' HG1' ' A' ' 69' ' ' THR . 70.2 m-20 -75.01 125.05 28.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 109.454 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.431 ' HG1' ' C ' ' A' ' 68' ' ' ASN . 85.7 m -165.89 -41.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.334 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.418 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 8.8 mp -62.68 -47.79 82.1 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.43 -0.794 . . . . 0.0 108.938 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -70.99 -31.42 67.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 109.293 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.1 t -73.12 -37.48 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.279 -0.888 . . . . 0.0 109.256 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -56.34 -41.09 75.51 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.49 -36.53 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -64.27 -37.17 86.52 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -68.22 -43.9 76.95 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.0 mt -71.95 -30.0 64.85 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -50.97 -49.25 60.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.665 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -63.87 -26.99 68.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.243 -0.911 . . . . 0.0 110.439 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -71.99 -44.15 63.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.959 -1.088 . . . . 0.0 110.309 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.0 pt -72.51 -15.37 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.177 -0.952 . . . . 0.0 109.655 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 75.57 82.88 0.45 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -46.96 -17.74 0.06 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.476 -1.014 . . . . 0.0 109.902 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' GLY . 22.7 t -56.91 -51.89 67.33 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.446 -0.784 . . . . 0.0 110.23 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -86.56 9.17 19.26 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.0 -1.062 . . . . 0.0 110.603 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.1 mm -121.6 165.92 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -140.98 114.02 8.48 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.436 -0.79 . . . . 0.0 108.947 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.7 p -86.63 138.26 31.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.208 -0.932 . . . . 0.0 109.591 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.9 t -106.1 92.31 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.537 -0.727 . . . . 0.0 109.2 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 50.41 -178.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.293 -0.88 . . . . 0.0 109.732 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.78 55.98 5.0 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -134.74 -31.94 1.02 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.567 -0.96 . . . . 0.0 109.626 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -169.02 -171.73 35.06 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.04 -1.552 . . . . 0.0 110.83 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -129.54 157.12 42.93 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 38.6 ttp -153.05 133.15 13.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.291 -0.881 . . . . 0.0 109.736 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.5 mp -91.0 145.49 24.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.567 -0.708 . . . . 0.0 109.092 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 99' ' ' ASN . . . -63.75 105.78 0.87 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -0.878 . . . . 0.0 109.361 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -67.65 68.74 0.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.905 . . . . 0.0 109.433 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 97' ' ' ALA . 2.6 m-80 51.22 42.16 28.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.3 -0.875 . . . . 0.0 109.654 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 47.9 mt -77.07 -12.06 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.316 -0.865 . . . . 0.0 108.817 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.16 -43.85 90.44 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.407 0.622 . . . . 0.0 109.404 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.6 p -79.29 48.92 0.92 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.339 -0.851 . . . . 0.0 109.389 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.574 179.984 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.6 m120 . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 51.39 42.24 29.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.196 -0.94 . . . . 0.0 109.522 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -165.11 23.26 0.15 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -52.38 164.71 0.3 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -1.173 . . . . 0.0 109.519 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.541 ' N ' ' ND2' ' A' ' 5' ' ' ASN . 0.1 OUTLIER -164.53 125.86 2.17 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.261 -0.899 . . . . 0.0 108.962 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -163.5 158.31 20.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.458 -0.776 . . . . 0.0 109.75 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.9 pt -149.32 163.7 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 80.9 p -128.46 132.24 48.39 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.498 -0.751 . . . . 0.0 109.755 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.26 91.49 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.04 -120.3 8.52 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.746 -1.741 . . . . 0.0 108.746 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -95.46 11.84 31.48 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.311 -1.111 . . . . 0.0 109.26 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.0 mp -104.43 125.77 50.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.492 -0.755 . . . . 0.0 108.988 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -108.7 118.91 38.02 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.3 133.87 46.51 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.486 -0.759 . . . . 0.0 109.366 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -135.53 98.19 3.87 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.43 -0.794 . . . . 0.0 109.467 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.5 t -73.91 -26.32 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.435 -0.791 . . . . 0.0 109.482 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.42 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -58.37 -50.39 73.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.429 -0.795 . . . . 0.0 109.679 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -98.86 -3.72 34.72 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.42 ' NH1' ' O ' ' A' ' 17' ' ' THR . 6.9 mpt_? 56.44 75.33 0.35 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.423 0.63 . . . . 0.0 109.419 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.8 tp -163.99 149.58 10.84 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.8 t -134.25 146.52 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.381 -0.824 . . . . 0.0 109.807 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -113.23 142.54 45.69 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.0 tp -121.86 105.47 10.39 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 71.3 40.55 60.63 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.132 -1.987 . . . . 0.0 108.132 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 70.91 -10.79 0.71 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.996 -0.708 . . . . 0.0 109.645 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.462 ' H ' ' C ' ' A' ' 24' ' ' GLY . 32.2 p -91.66 142.14 27.94 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.041 -1.037 . . . . 0.0 109.631 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.42 112.99 2.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 110.245 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.8 tp -74.66 128.38 35.42 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 3.1 m-20 -96.02 100.64 12.29 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.171 -0.956 . . . . 0.0 110.327 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.529 ' H ' ' CD2' ' A' ' 30' ' ' LEU . 1.3 pt? -121.4 134.13 55.1 Favored 'General case' 0 N--CA 1.504 2.229 0 CA-C-O 121.588 0.709 . . . . 0.0 109.35 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.4 p -52.11 152.48 5.7 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.184 -0.948 . . . . 0.0 109.218 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.34 -45.22 27.98 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.622 1.548 . . . . 0.0 110.804 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -56.19 -47.29 78.64 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.189 -0.944 . . . . 0.0 108.487 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -55.16 -36.36 65.75 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.341 -0.849 . . . . 0.0 109.033 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -57.6 -32.28 67.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.268 -0.895 . . . . 0.0 108.982 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.9 -49.97 63.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 108.983 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.437 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 7.4 mp -58.8 -39.05 79.98 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 12.8 tp -57.14 -42.6 81.26 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.1 t -54.11 -39.2 66.19 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.347 -0.845 . . . . 0.0 109.549 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.2 mmt-85 -76.37 -45.19 33.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.176 -0.953 . . . . 0.0 109.425 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.8 mt -59.46 -52.33 66.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 110.311 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.51 ' SD ' ' N ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -63.93 -38.07 89.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.089 -1.007 . . . . 0.0 110.429 -178.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.51 ' N ' ' SD ' ' A' ' 42' ' ' MET . 46.3 tpp -55.57 -29.6 59.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.062 -1.024 . . . . 0.0 108.762 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -119.36 42.15 2.93 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.89 132.68 51.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.221 -0.925 . . . . 0.0 109.956 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.4 ' C ' ' SD ' ' A' ' 95' ' ' MET . . . 90.35 -6.22 82.46 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.6 t -121.85 116.17 30.36 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.644 -0.915 . . . . 0.0 108.717 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -47.62 119.89 4.11 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.017 1.145 . . . . 0.0 111.676 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.5 t -97.59 137.23 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.46 -0.775 . . . . 0.0 110.376 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.423 ' CD2' ' CD2' ' A' ' 92' ' ' PHE . 17.6 t-160 -63.89 121.07 13.17 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.363 -0.836 . . . . 0.0 108.792 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.487 ' NH1' ' OE1' ' A' ' 71' ' ' GLU . 11.3 ttm180 -52.89 -18.42 1.92 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.389 -0.819 . . . . 0.0 108.937 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.518 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 34.2 tt0 -65.48 -48.87 71.13 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.567 -0.708 . . . . 0.0 109.563 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.1 mt -58.0 -31.75 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.08 -1.012 . . . . 0.0 110.177 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.06 -33.06 74.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.042 -1.036 . . . . 0.0 108.991 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -74.06 -33.23 63.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.999 -1.063 . . . . 0.0 108.43 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 44.0 m-80 -64.82 -22.54 67.01 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.543 -0.723 . . . . 0.0 109.764 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.87 -55.54 31.27 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.1 -1.0 . . . . 0.0 109.253 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.6 mt -77.7 -12.86 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.263 -0.898 . . . . 0.0 109.436 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -145.2 70.61 1.27 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.22 -0.925 . . . . 0.0 109.251 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.472 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 7.9 t -83.06 -48.52 10.5 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.228 -0.92 . . . . 0.0 109.798 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -87.23 41.86 1.0 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.206 -0.934 . . . . 0.0 109.674 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.45 ' C ' HD21 ' A' ' 63' ' ' ASN . 54.2 m-20 -158.31 -55.85 0.07 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.197 -0.939 . . . . 0.0 109.733 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.616 ' N ' HD21 ' A' ' 63' ' ' ASN . 0.6 OUTLIER 54.14 102.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.502 -0.749 . . . . 0.0 109.699 -179.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -157.1 62.74 2.79 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.191 -0.943 . . . . 0.0 109.351 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -78.43 12.79 2.01 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.627 2.218 . . . . 0.0 111.989 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.12 -29.02 66.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 109.472 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 57.2 p -63.86 -141.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 109.527 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.537 ' C ' ' H ' ' A' ' 70' ' ' LEU . 32.4 m120 -156.88 -162.47 1.24 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.277 -0.889 . . . . 0.0 109.33 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.5 m 63.06 -7.47 0.15 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.605 -0.684 . . . . 0.0 110.114 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.537 ' H ' ' C ' ' A' ' 68' ' ' ASN . 2.4 pp -70.47 -43.7 69.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.007 -1.058 . . . . 0.0 109.264 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.487 ' OE1' ' NH1' ' A' ' 51' ' ' ARG . 33.6 tt0 -71.75 -33.01 68.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 109.453 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.0 t -70.77 -38.71 73.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.255 -0.903 . . . . 0.0 108.977 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -56.32 -39.6 73.03 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.99 -37.03 79.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -62.49 -36.5 82.69 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -71.57 -41.88 68.49 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.67 -38.11 73.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 0.0 109.412 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -50.57 -47.84 57.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.927 . . . . 0.0 109.669 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -62.47 -24.93 67.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 110.496 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -75.68 -43.6 46.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.936 -1.102 . . . . 0.0 110.466 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.9 pt -76.61 -22.43 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.142 -0.974 . . . . 0.0 109.945 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 82.67 87.76 0.73 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -44.79 -17.17 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.722 -0.87 . . . . 0.0 110.422 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 82' ' ' GLY . 12.9 t -51.72 -47.59 63.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.219 -0.925 . . . . 0.0 109.701 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.531 ' HE ' ' N ' ' A' ' 85' ' ' ARG . 4.4 mmp_? -83.41 9.66 10.56 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.241 -0.912 . . . . 0.0 110.596 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.1 mp -135.67 159.2 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.197 -0.939 . . . . 0.0 109.754 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -123.09 128.01 49.53 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.4 p -94.09 141.03 29.0 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.082 -1.011 . . . . 0.0 109.778 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.487 ' C ' ' H ' ' A' ' 91' ' ' GLY . 22.2 t -107.5 104.49 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -50.5 -11.0 0.07 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.217 -0.927 . . . . 0.0 109.792 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 89' ' ' VAL . . . -64.2 -85.07 0.07 OUTLIER Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.423 ' CD2' ' CD2' ' A' ' 50' ' ' HIS . 1.6 p90 -170.47 23.46 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.384 -1.068 . . . . 0.0 109.539 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.468 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . -146.23 -163.43 10.34 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 40.7 m-85 -150.99 170.69 18.74 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.363 -1.08 . . . . 0.0 108.579 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.4 ' SD ' ' C ' ' A' ' 46' ' ' GLY . 50.4 ttp -162.5 136.66 6.45 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.142 -0.974 . . . . 0.0 110.469 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.407 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 10.2 mp -88.69 139.04 30.87 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.07 133.48 44.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 109.473 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -53.05 -80.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.571 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -163.76 91.08 0.64 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.473 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.2 mm -73.67 -11.48 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 109.067 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -66.43 -27.85 68.16 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.712 -0.618 . . . . 0.0 109.501 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.9 p -63.74 -15.27 58.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.522 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.228 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -73.78 56.93 0.57 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 109.508 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 60.58 30.07 71.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -170.13 141.05 2.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -1.17 . . . . 0.0 109.613 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -158.72 122.05 3.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.336 -0.852 . . . . 0.0 108.877 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -161.36 155.59 22.65 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.348 -0.845 . . . . 0.0 109.746 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.8 pt -148.03 163.33 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.378 -0.826 . . . . 0.0 109.07 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -142.24 152.55 43.17 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.223 -0.923 . . . . 0.0 109.777 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.6 t -147.98 95.97 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.27 -116.38 4.3 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.061 -1.615 . . . . 0.0 109.061 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -103.5 7.63 37.83 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.49 -1.006 . . . . 0.0 109.697 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.3 mp -102.35 125.4 49.04 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.346 -0.846 . . . . 0.0 109.224 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -118.07 124.31 47.76 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.508 ' C ' HD21 ' A' ' 15' ' ' ASN . 8.1 mp -107.37 140.24 40.61 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.531 -0.731 . . . . 0.0 109.153 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.508 HD21 ' C ' ' A' ' 14' ' ' LEU . 2.1 m-80 -135.6 97.37 3.65 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.554 -0.716 . . . . 0.0 109.184 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.1 t -69.87 -29.62 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.375 -0.828 . . . . 0.0 109.306 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -55.17 24.56 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.44 -0.787 . . . . 0.0 109.266 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.7 mmt85 -82.68 -16.04 49.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.96 . . . . 0.0 108.481 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 63.36 70.69 0.53 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.609 0.718 . . . . 0.0 109.152 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.7 tp -163.78 154.15 15.42 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.7 t -136.21 143.08 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.297 -0.877 . . . . 0.0 109.853 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -107.93 145.18 34.16 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.408 ' O ' ' OG1' ' A' ' 26' ' ' THR . 67.1 tp -128.75 104.03 7.4 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 72.7 44.68 38.33 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 64.36 -3.17 0.53 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 122.175 -0.603 . . . . 0.0 110.282 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.43 ' H ' ' C ' ' A' ' 24' ' ' GLY . 80.4 p -99.31 139.92 34.26 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 120.995 -1.066 . . . . 0.0 109.612 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.3 116.79 5.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.227 -0.921 . . . . 0.0 110.58 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.9 tp -85.0 128.95 34.85 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -103.93 120.84 41.87 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.347 -0.846 . . . . 0.0 109.825 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.519 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 1.1 pt? -140.51 148.66 41.41 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.398 0.618 . . . . 0.0 109.453 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.3 p -67.32 151.22 97.37 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.057 -1.027 . . . . 0.0 109.83 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -45.19 -41.01 16.65 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 121.928 1.752 . . . . 0.0 112.366 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -53.25 -50.65 64.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.763 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -60.13 -27.62 67.2 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.293 -0.879 . . . . 0.0 109.273 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -71.21 -31.05 67.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.114 -0.991 . . . . 0.0 109.145 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.99 -52.56 10.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.179 -0.95 . . . . 0.0 109.259 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 mt -59.27 -37.08 76.75 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 23.2 tp -63.19 -43.96 96.72 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.712 -0.618 . . . . 0.0 109.706 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.8 m -53.25 -37.75 62.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.225 -0.922 . . . . 0.0 110.158 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -80.35 -43.4 21.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 0.0 109.373 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 27.7 tp -63.73 -40.03 95.75 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.285 -0.885 . . . . 0.0 110.212 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -72.47 -38.95 68.08 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.77 -1.206 . . . . 0.0 109.544 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.468 ' O ' ' SD ' ' A' ' 43' ' ' MET . 1.3 tmt? -53.91 -28.78 38.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.304 -0.872 . . . . 0.0 108.71 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -115.7 43.67 2.04 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.06 140.22 48.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.253 -0.904 . . . . 0.0 110.347 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.09 -17.57 59.0 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.4 m -119.63 151.87 52.49 Favored Pre-proline 0 N--CA 1.501 2.113 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -71.88 119.46 6.21 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.56 1.507 . . . . 0.0 111.519 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.1 t -98.9 136.09 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.399 -0.813 . . . . 0.0 110.209 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -73.7 125.66 28.56 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.276 -0.89 . . . . 0.0 108.619 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.495 ' NE ' ' O ' ' A' ' 92' ' ' PHE . 13.1 ptp180 -55.24 -15.86 2.77 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.223 -0.923 . . . . 0.0 108.779 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.571 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 41.2 tt0 -61.82 -56.82 15.43 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.623 -0.673 . . . . 0.0 109.481 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.6 mt -54.64 -29.28 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.254 -0.904 . . . . 0.0 110.33 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.8 mt -71.24 -46.72 60.41 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 108.609 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.577 ' CE1' ' CD2' ' A' ' 59' ' ' TYR . 57.3 t80 -51.96 -36.05 48.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.957 -1.089 . . . . 0.0 108.957 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.571 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 31.6 m-80 -65.18 -20.86 66.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.663 -0.648 . . . . 0.0 110.476 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.3 -55.48 34.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.694 -1.254 . . . . 0.0 109.895 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.0 mm -82.35 -37.84 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.234 -0.916 . . . . 0.0 110.544 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.577 ' CD2' ' CE1' ' A' ' 55' ' ' TYR . 97.7 m-85 -102.89 152.85 20.81 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.362 -0.836 . . . . 0.0 109.791 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.5 t -165.44 21.19 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.057 -1.027 . . . . 0.0 109.617 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.403 ' O ' ' O ' ' A' ' 62' ' ' ASP . 41.3 p-90 -167.35 0.25 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.274 -0.892 . . . . 0.0 109.014 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.493 ' CG ' ' H ' ' A' ' 63' ' ' ASN . 11.4 p-10 -60.65 -112.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.412 -0.805 . . . . 0.0 109.432 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.493 ' H ' ' CG ' ' A' ' 62' ' ' ASP . 50.4 m-80 -158.23 -90.48 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.15 -0.969 . . . . 0.0 109.346 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -168.46 61.9 0.51 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.404 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.47 ' CG ' ' HH ' ' A' ' 55' ' ' TYR . 97.3 Cg_endo -76.93 77.22 3.83 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.489 2.126 . . . . 0.0 111.852 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.64 -8.46 55.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 109.542 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 t -54.73 163.63 0.92 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.347 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.404 ' O ' ' OG1' ' A' ' 69' ' ' THR . 61.9 t30 -68.81 107.72 3.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.921 . . . . 0.0 109.34 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 68' ' ' ASN . 23.1 m -165.58 -75.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.366 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 pp -56.08 -37.79 69.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.353 -0.842 . . . . 0.0 109.644 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.417 ' OE2' ' NH1' ' A' ' 51' ' ' ARG . 7.2 tp10 -67.03 -31.19 71.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.169 -0.957 . . . . 0.0 109.456 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.3 t -73.33 -41.31 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.139 -0.976 . . . . 0.0 109.115 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -56.99 -38.22 72.74 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.0 mm -64.14 -36.91 78.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -67.65 -33.45 74.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.23 -0.919 . . . . 0.0 109.4 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -71.05 -41.9 70.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.34 -0.85 . . . . 0.0 109.802 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.0 mt -71.44 -42.23 68.48 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.291 -0.881 . . . . 0.0 109.892 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -49.7 -44.4 48.14 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.084 -1.01 . . . . 0.0 109.247 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -62.83 -26.8 68.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 110.045 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -75.78 -43.22 47.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.987 -1.071 . . . . 0.0 110.508 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 pt -82.21 -30.26 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.023 -1.048 . . . . 0.0 109.575 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 97.39 85.02 1.77 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -44.48 -16.68 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.545 -0.974 . . . . 0.0 110.396 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 82' ' ' GLY . 56.2 m -51.82 -44.8 63.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.083 -1.011 . . . . 0.0 109.381 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -73.71 8.75 1.74 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.296 -0.878 . . . . 0.0 109.481 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.408 ' H ' ' C ' ' A' ' 84' ' ' SER . 96.6 mt -136.37 159.76 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.288 -0.882 . . . . 0.0 109.159 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.476 HH21 ' CE ' ' A' ' 95' ' ' MET . 39.1 ttp180 -137.28 124.2 21.38 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.555 -0.716 . . . . 0.0 109.271 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.3 p -88.87 141.66 28.31 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.142 -0.974 . . . . 0.0 109.386 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.4 t -100.7 106.92 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.479 -0.763 . . . . 0.0 110.377 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.51 ' N ' ' CD ' ' A' ' 90' ' ' ARG . 0.4 OUTLIER 48.72 37.76 10.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.512 -0.743 . . . . 0.0 110.1 179.206 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.63 52.41 20.12 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.539 ' CD2' ' N ' ' A' ' 93' ' ' GLY . 43.9 t80 -132.56 -81.93 0.49 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.627 -0.925 . . . . 0.0 108.611 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.539 ' N ' ' CD2' ' A' ' 92' ' ' PHE . . . -98.78 -147.57 22.23 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -150.98 162.34 41.02 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.357 -1.084 . . . . 0.0 108.407 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.476 ' CE ' HH21 ' A' ' 87' ' ' ARG . 43.9 ttp -163.55 136.16 5.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.179 -0.951 . . . . 0.0 110.548 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.3 mp -91.48 127.32 36.87 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.77 99.69 2.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.318 -0.863 . . . . 0.0 109.42 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -54.11 117.21 3.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.329 -0.857 . . . . 0.0 109.539 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.48 HD21 ' HG1' ' A' ' 102' ' ' THR . 21.2 m120 53.22 97.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.333 -0.855 . . . . 0.0 109.584 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.4 mt -72.31 -11.94 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.251 -0.906 . . . . 0.0 108.776 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -173.52 -24.38 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.709 -0.619 . . . . 0.0 109.437 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.48 ' HG1' HD21 ' A' ' 99' ' ' ASN . 68.6 p -59.1 173.0 0.51 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.566 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.462 179.976 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.488 ' N ' ' HG1' ' A' ' 17' ' ' THR . 19.6 p-10 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -87.72 50.69 2.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 162.95 -28.79 0.25 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.1 t70 51.7 66.41 1.2 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -1.126 . . . . 0.0 109.754 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -155.87 119.86 4.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.15 -0.969 . . . . 0.0 108.947 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -162.09 157.42 23.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.326 -0.859 . . . . 0.0 109.713 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.4 pt -147.27 162.54 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.297 -0.877 . . . . 0.0 109.163 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.8 t -145.25 156.11 43.64 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.19 -0.944 . . . . 0.0 109.741 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 p -152.72 101.85 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.15 -109.64 2.84 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.603 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -112.07 4.88 18.31 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.506 -0.996 . . . . 0.0 110.093 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.4 mp -99.07 124.9 44.41 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.151 -0.968 . . . . 0.0 109.083 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -118.53 126.13 51.35 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.49 ' C ' HD21 ' A' ' 15' ' ' ASN . 5.7 tt -114.15 115.19 27.12 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.499 ' OD1' ' NH2' ' A' ' 18' ' ' ARG . 1.7 m120 -113.2 102.21 10.15 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.573 -0.705 . . . . 0.0 109.313 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.3 t -74.9 -27.44 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.439 -0.788 . . . . 0.0 109.454 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.488 ' HG1' ' N ' ' A' ' 1' ' ' ASN . 0.1 OUTLIER -60.42 -54.1 49.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.536 -0.728 . . . . 0.0 109.507 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.499 ' NH2' ' OD1' ' A' ' 15' ' ' ASN . 89.2 mtm-85 -92.21 -13.43 30.54 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.12 -0.987 . . . . 0.0 108.714 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.5 tpp85 66.31 67.14 0.46 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.419 0.628 . . . . 0.0 109.393 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.5 mt -143.47 158.47 43.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.228 -0.92 . . . . 0.0 108.812 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 t -142.38 120.75 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.283 -0.885 . . . . 0.0 109.757 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 17.8 m-90 -98.93 150.87 21.49 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.175 -0.953 . . . . 0.0 108.812 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.417 ' O ' ' OG1' ' A' ' 26' ' ' THR . 30.9 tp -136.94 107.05 6.33 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 68.84 43.59 73.58 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 64.24 -1.65 0.69 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 122.169 -0.606 . . . . 0.0 110.346 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 65.4 p -100.58 139.9 35.6 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 120.973 -1.079 . . . . 0.0 109.383 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.04 115.54 6.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 0.0 110.161 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.9 tp -78.82 132.31 36.81 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -102.86 112.59 25.46 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.312 -0.868 . . . . 0.0 109.972 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.504 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 1.2 pt? -139.63 148.9 43.1 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.364 -0.835 . . . . 0.0 109.28 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.407 ' OG1' ' OE2' ' A' ' 34' ' ' GLU . 4.1 p -60.52 152.98 63.47 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.056 -1.027 . . . . 0.0 108.881 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -58.95 -41.67 59.65 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.0 1.8 . . . . 0.0 111.735 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -53.97 -45.66 71.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.027 -1.046 . . . . 0.0 109.252 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.407 ' OE2' ' OG1' ' A' ' 31' ' ' THR . 69.8 mt-10 -60.71 -34.61 74.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.322 -0.861 . . . . 0.0 109.223 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.4 ' OH ' ' O ' ' A' ' 15' ' ' ASN . 15.9 t80 -55.62 -34.1 64.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 108.706 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.05 -53.12 28.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 109.303 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 37' ' ' LEU . 8.3 mp -60.3 -39.42 86.88 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.9 tp -59.57 -43.74 93.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.606 -0.684 . . . . 0.0 109.546 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.468 ' C ' ' HE ' ' A' ' 40' ' ' ARG . 33.8 t -52.91 -34.28 54.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.153 -0.967 . . . . 0.0 109.458 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.468 ' HE ' ' C ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -79.44 -45.29 19.72 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 0.0 109.181 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.3 mt -56.72 -40.66 76.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.045 -1.034 . . . . 0.0 109.285 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.7 tpp -75.44 -35.0 61.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 109.56 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.46 ' SD ' ' NH2' ' A' ' 40' ' ' ARG . 24.7 ttt -53.92 -25.93 22.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.327 -0.858 . . . . 0.0 109.229 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -129.08 43.17 3.19 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.74 -0.6 . . . . 0.0 109.678 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.81 143.8 55.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.025 -1.047 . . . . 0.0 109.958 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.462 ' O ' ' SD ' ' A' ' 95' ' ' MET . . . 101.02 -22.75 38.18 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.08 154.55 64.82 Favored Pre-proline 0 N--CA 1.503 2.206 0 O-C-N 121.599 -0.942 . . . . 0.0 108.676 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.42 120.91 7.83 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.826 1.684 . . . . 0.0 111.083 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 80.5 t -92.77 137.04 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 0.0 110.326 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.437 ' CE1' ' CD ' ' A' ' 52' ' ' GLU . 9.0 t-160 -68.83 121.03 15.71 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -51.21 -16.82 0.56 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 0.0 109.792 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.522 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 80.8 mt-10 -65.97 -48.39 71.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.342 -0.849 . . . . 0.0 109.801 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.2 mt -54.65 -30.87 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.19 -0.944 . . . . 0.0 109.949 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.0 mt -70.58 -34.13 71.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.932 . . . . 0.0 109.199 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.497 ' O ' ' N ' ' A' ' 59' ' ' TYR . 3.0 m-85 -70.93 -35.44 72.24 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 41.3 m-80 -59.39 -20.8 57.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.545 -0.722 . . . . 0.0 110.051 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.06 -53.63 52.82 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.074 -1.016 . . . . 0.0 109.89 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.49 ' O ' ' CG ' ' A' ' 59' ' ' TYR . 4.1 mt -125.92 15.91 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-O 121.508 0.67 . . . . 0.0 109.555 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.497 ' N ' ' O ' ' A' ' 55' ' ' TYR . 78.4 m-85 -156.26 98.26 1.84 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.945 -1.097 . . . . 0.0 109.674 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.7 t -89.91 -18.56 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.293 -0.879 . . . . 0.0 109.367 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.422 ' C ' ' H ' ' A' ' 63' ' ' ASN . 91.3 m95 -54.11 -26.89 29.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.0 109.603 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.9 t70 53.3 11.6 0.27 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 109.625 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' A' ' 63' ' ' ASN . 20.3 p-10 -53.69 -41.07 66.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.502 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 52.13 71.84 1.36 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.345 -0.847 . . . . 0.0 109.809 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -48.0 129.86 18.93 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.64 2.227 . . . . 0.0 112.082 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.32 -27.74 68.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.14 -0.975 . . . . 0.0 109.634 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.8 p -71.58 142.23 50.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.564 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.0 m-20 -58.8 128.04 35.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.403 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.0 m -165.92 -74.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 109.419 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.7 mt -70.12 -37.46 75.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.298 -0.876 . . . . 0.0 109.658 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -60.3 -32.43 71.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.081 -1.012 . . . . 0.0 109.504 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.85 -38.92 74.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.214 -0.929 . . . . 0.0 109.096 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -57.22 -38.01 73.1 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.2 mt -63.81 -38.93 83.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.4 ' CE1' HH21 ' A' ' 78' ' ' ARG . 1.2 t60 -60.17 -36.55 77.84 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.511 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.576 ' ND2' ' NZ ' ' A' ' 80' ' ' LYS . 3.2 t-20 -73.34 -41.61 63.26 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.414 ' CD1' ' C ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -66.41 -42.93 87.06 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.4 HH21 ' CE1' ' A' ' 75' ' ' HIS . 52.6 ttp180 -50.15 -50.99 47.07 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.513 -0.742 . . . . 0.0 110.936 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -65.24 -29.27 70.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.963 -1.086 . . . . 0.0 110.613 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.576 ' NZ ' ' ND2' ' A' ' 76' ' ' ASN . 61.7 mttp -66.44 -47.94 71.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.9 -1.125 . . . . 0.0 110.2 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 21.6 pt -74.83 -24.6 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.979 -1.075 . . . . 0.0 110.17 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 84.3 84.37 0.95 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -45.05 -17.01 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.689 -0.889 . . . . 0.0 110.484 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 82' ' ' GLY . 59.5 m -55.12 -48.9 73.0 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.243 -0.911 . . . . 0.0 110.069 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.421 ' N ' ' CD ' ' A' ' 85' ' ' ARG . 8.5 mpt_? -81.48 9.78 6.86 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.972 -1.08 . . . . 0.0 110.473 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.67 162.63 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -118.75 93.61 4.16 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.443 -0.786 . . . . 0.0 109.478 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.0 p -66.1 134.77 53.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.315 -0.866 . . . . 0.0 109.511 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 91' ' ' GLY . 59.2 t -102.3 98.34 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.6 mtm-85 -61.61 78.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.407 -0.808 . . . . 0.0 109.122 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 89' ' ' VAL . . . -164.29 -69.34 0.02 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -170.87 19.36 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.209 -1.171 . . . . 0.0 109.583 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.46 -167.3 19.08 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.455 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -146.04 170.06 17.42 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.462 ' SD ' ' O ' ' A' ' 46' ' ' GLY . 6.1 ttt -161.1 127.81 4.02 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.932 -1.105 . . . . 0.0 110.133 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.408 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 9.4 mp -81.27 139.98 35.12 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.13 106.19 5.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 109.455 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.408 ' O ' ' O ' ' A' ' 99' ' ' ASN . 10.2 p30 -70.18 124.37 23.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.451 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.408 ' O ' ' O ' ' A' ' 98' ' ' ASN . 2.3 m-80 51.1 97.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.324 -0.86 . . . . 0.0 109.773 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.401 HG23 HD13 ' A' ' 100' ' ' ILE . 9.2 mm -68.43 -13.04 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.173 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -76.6 -14.95 59.95 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.708 -0.62 . . . . 0.0 109.497 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.1 t -167.77 152.18 6.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.207 -0.933 . . . . 0.0 109.499 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.412 179.973 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -71.72 65.29 0.49 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.359 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 65.35 32.32 83.27 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 29.4 p-10 -164.13 179.13 7.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -1.169 . . . . 0.0 109.468 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -172.37 107.97 0.2 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.024 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -161.55 154.29 20.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.114 -0.991 . . . . 0.0 109.911 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.7 pt -145.86 163.29 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.476 -0.765 . . . . 0.0 108.983 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.8 p -139.88 151.99 46.08 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.304 -0.873 . . . . 0.0 109.623 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.1 t -146.79 97.6 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' N ' ' ND2' ' A' ' 99' ' ' ASN . . . 75.61 -113.68 4.0 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -105.52 5.92 31.86 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.457 -1.025 . . . . 0.0 110.079 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.5 mt -100.69 126.46 47.21 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.129 -0.982 . . . . 0.0 109.186 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -118.05 124.84 49.08 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.6 tp -106.87 141.4 38.15 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.737 -0.602 . . . . 0.0 109.579 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.59 ' ND2' ' NH2' ' A' ' 18' ' ' ARG . 14.8 m120 -135.57 97.69 3.74 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.325 -0.859 . . . . 0.0 109.143 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.1 t -76.63 -28.93 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.297 -0.877 . . . . 0.0 109.97 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.65 -53.44 58.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 0.0 109.405 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.59 ' NH2' ' ND2' ' A' ' 15' ' ' ASN . 12.7 ptt-85 -96.5 -10.32 27.66 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.277 -0.889 . . . . 0.0 108.807 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 64.81 73.66 0.41 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.456 0.646 . . . . 0.0 109.3 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.0 tp -156.98 154.42 29.62 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.3 t -140.1 133.54 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.273 -0.892 . . . . 0.0 109.773 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.488 ' CZ3' ' OD1' ' A' ' 15' ' ' ASN . 8.5 m-90 -100.34 144.26 29.56 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.345 -0.847 . . . . 0.0 109.238 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 25' ' ' GLU . 10.7 tp -117.96 100.24 7.43 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.67 -73.2 0.25 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 23' ' ' LEU . 74.0 mt-10 -154.45 23.13 0.47 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.219 -1.165 . . . . 0.0 109.406 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.3 p -138.83 141.82 38.67 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.455 -0.778 . . . . 0.0 110.07 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.9 121.92 16.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.502 -0.749 . . . . 0.0 109.538 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.5 tp -78.48 128.45 33.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 108.614 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -101.4 110.59 22.61 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.328 -0.858 . . . . 0.0 109.923 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.75 145.75 48.74 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.2 p -58.33 140.26 83.91 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.1 -1.0 . . . . 0.0 109.455 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -44.68 -43.99 14.26 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.526 1.484 . . . . 0.0 112.052 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' CD ' ' N ' ' A' ' 33' ' ' LYS . 2.4 mptp? -53.54 -46.43 70.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 108.99 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -59.49 -35.07 73.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.348 -0.845 . . . . 0.0 109.213 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -56.66 -33.16 66.09 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.916 . . . . 0.0 109.066 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.422 ' O ' ' OD2' ' A' ' 57' ' ' ASP . . . -68.62 -52.82 27.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.431 -0.793 . . . . 0.0 109.524 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.42 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 7.7 mp -63.54 -36.59 84.27 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.3 tp -64.46 -46.98 80.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.55 -0.719 . . . . 0.0 109.329 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.8 m -53.28 -29.68 34.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.321 -0.862 . . . . 0.0 109.956 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -75.73 -40.57 55.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.065 -1.022 . . . . 0.0 110.018 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.8 mt -61.04 -44.39 97.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.975 -1.078 . . . . 0.0 110.179 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.7 mmm -65.87 -37.07 85.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.819 -1.176 . . . . 0.0 109.739 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 18.1 ttt -57.41 -32.36 66.77 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 108.994 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -116.05 43.46 2.14 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.06 129.12 39.0 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.245 -0.909 . . . . 0.0 110.165 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.89 -11.93 52.87 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 p -124.71 151.89 68.51 Favored Pre-proline 0 N--CA 1.504 2.242 0 O-C-N 121.529 -0.983 . . . . 0.0 108.652 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.18 120.46 6.59 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.781 1.654 . . . . 0.0 111.634 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.5 t -95.69 132.87 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.263 -0.898 . . . . 0.0 109.95 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.591 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 15.2 t-160 -73.04 126.19 29.41 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.19 -0.944 . . . . 0.0 108.545 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -50.36 -15.07 0.21 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.223 -0.923 . . . . 0.0 109.836 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.527 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 77.4 mt-10 -66.87 -46.35 75.23 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.319 -0.863 . . . . 0.0 109.881 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.5 mm -57.56 -32.36 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.083 -1.011 . . . . 0.0 109.923 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.42 -45.3 69.5 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.241 -0.912 . . . . 0.0 108.746 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -62.33 -36.86 83.52 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 74.1 m-80 -70.33 -21.77 62.87 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.641 -0.662 . . . . 0.0 109.993 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 36' ' ' ALA . 5.2 t0 -55.27 -54.31 45.15 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 120.81 -1.181 . . . . 0.0 109.271 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 68.2 mt -93.94 -37.64 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.276 -0.89 . . . . 0.0 109.504 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.401 ' O ' ' OG ' ' A' ' 60' ' ' SER . 49.9 m-85 -103.86 -163.24 0.96 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.763 0.792 . . . . 0.0 109.792 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 59' ' ' TYR . 24.7 m -171.57 -31.97 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.506 ' O ' ' CD2' ' A' ' 61' ' ' TRP . 31.7 p-90 -75.89 82.02 2.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.0 108.973 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 25.8 p-10 -61.73 -125.03 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.354 -0.841 . . . . 0.0 109.792 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 52.51 16.31 0.61 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.916 -1.115 . . . . 0.0 109.354 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -70.1 150.71 96.13 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.145 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.409 ' C ' ' H ' ' A' ' 67' ' ' THR . 72.8 Cg_endo -72.68 145.22 41.07 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.111 1.874 . . . . 0.0 111.819 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.5 8.35 1.86 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 109.565 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.409 ' H ' ' C ' ' A' ' 65' ' ' PRO . 86.2 m -57.93 141.85 48.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -0.931 . . . . 0.0 109.611 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.477 ' C ' ' HG1' ' A' ' 69' ' ' THR . 2.6 p-10 -65.39 117.64 8.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.882 . . . . 0.0 109.474 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.477 ' HG1' ' C ' ' A' ' 68' ' ' ASN . 14.6 m -165.75 -75.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.923 . . . . 0.0 109.334 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 13.9 mt -70.64 -33.49 71.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 109.403 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -60.36 -35.59 76.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.009 . . . . 0.0 109.385 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.2 t -73.82 -38.95 51.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.166 -0.959 . . . . 0.0 108.827 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -58.71 -40.38 83.53 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.402 HG23 HD11 ' A' ' 74' ' ' ILE . 62.7 mt -62.98 -31.48 52.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -72.28 -22.38 61.21 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 118.947 -1.101 . . . . 0.0 108.086 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -77.43 -45.43 25.8 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.6 -0.687 . . . . 0.0 110.337 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 pp -74.58 -43.98 53.0 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.813 -1.179 . . . . 0.0 109.747 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -50.59 -46.12 57.68 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.554 -0.717 . . . . 0.0 110.144 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -65.65 -13.8 59.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.167 -0.958 . . . . 0.0 110.118 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -81.43 -40.23 23.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.084 -1.01 . . . . 0.0 110.02 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 11.0 pt -78.56 -14.94 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 109.777 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 85.68 81.41 1.12 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -44.42 -16.41 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.779 -0.836 . . . . 0.0 110.583 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 82' ' ' GLY . 44.5 t -50.17 -43.95 52.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.144 -0.973 . . . . 0.0 109.612 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -77.52 9.05 3.59 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.234 -0.916 . . . . 0.0 109.937 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.0 mt -137.97 158.12 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.2 -0.937 . . . . 0.0 109.1 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 65.7 ttt-85 -141.04 122.62 15.12 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.598 -0.689 . . . . 0.0 109.212 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.7 p -89.36 142.51 27.6 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.302 -0.874 . . . . 0.0 109.282 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.1 p -101.62 124.37 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.405 -0.809 . . . . 0.0 110.171 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.5 ttp85 45.0 28.88 0.41 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.513 -0.742 . . . . 0.0 110.204 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.44 55.66 12.73 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.591 ' CZ ' ' CD2' ' A' ' 50' ' ' HIS . 16.7 t80 -138.53 -68.66 0.45 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.524 -0.986 . . . . 0.0 108.829 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.46 ' N ' ' CD2' ' A' ' 92' ' ' PHE . . . -102.08 -147.8 20.14 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -150.76 159.24 44.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.452 -1.028 . . . . 0.0 108.257 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 43.1 ttp -163.82 127.61 2.7 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.131 -0.981 . . . . 0.0 110.391 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.424 ' CD1' ' N ' ' A' ' 96' ' ' LEU . 9.6 mp -90.2 133.22 35.05 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.88 137.2 50.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -0.931 . . . . 0.0 109.498 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -51.63 -75.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.618 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.463 ' ND2' ' N ' ' A' ' 10' ' ' GLY . 31.3 m120 -158.12 41.71 0.28 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.388 -0.82 . . . . 0.0 109.551 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.3 mt -80.71 -2.06 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.274 -0.891 . . . . 0.0 108.858 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -75.82 -30.09 58.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 76.4 p -58.17 96.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.408 -0.808 . . . . 0.0 109.376 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.576 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 3' ' ' GLY . 11.9 m120 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -71.0 40.67 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 0.0 109.795 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 1' ' ' ASN . . . -160.85 19.62 0.21 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -164.05 78.66 0.39 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.312 -1.11 . . . . 0.0 109.444 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -165.71 113.54 0.95 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.266 -0.896 . . . . 0.0 108.975 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -162.36 157.44 22.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.109 -0.994 . . . . 0.0 110.008 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.4 pt -144.78 162.91 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.309 -0.869 . . . . 0.0 109.008 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 m -143.05 152.92 42.41 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.284 -0.885 . . . . 0.0 109.699 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 p -149.41 99.2 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.54 -116.64 4.74 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -104.06 6.95 36.31 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.439 -1.036 . . . . 0.0 109.622 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.7 mt -100.68 122.08 42.73 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.274 -0.891 . . . . 0.0 109.602 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -114.84 134.44 55.13 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.4 tt -126.55 127.9 46.01 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.553 -0.717 . . . . 0.0 109.823 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.483 ' C ' ' HH ' ' A' ' 35' ' ' TYR . 5.3 m-20 -121.44 104.41 9.66 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.757 -0.59 . . . . 0.0 109.62 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.2 t -68.77 -30.31 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.264 -0.898 . . . . 0.0 109.44 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.74 -53.98 38.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.908 . . . . 0.0 109.16 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.2 mtp-105 -83.72 -16.52 44.56 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 15' ' ' ASN . 15.1 tpp180 58.78 75.73 0.38 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.449 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 23.9 tp -170.33 127.35 0.81 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.359 -0.838 . . . . 0.0 108.964 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.1 t -104.33 138.21 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.509 -0.745 . . . . 0.0 109.682 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.449 ' CZ3' ' O ' ' A' ' 20' ' ' LEU . 28.5 m-90 -105.6 142.26 35.64 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.454 -0.779 . . . . 0.0 109.225 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.409 ' O ' ' OG1' ' A' ' 26' ' ' THR . 37.7 tp -118.11 102.26 8.88 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.94 44.95 54.3 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 107.946 -2.062 . . . . 0.0 107.946 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 65.65 -1.23 1.07 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 122.132 -0.628 . . . . 0.0 110.218 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 43.0 p -99.23 140.94 32.65 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.042 -1.036 . . . . 0.0 109.699 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.53 110.47 1.99 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.921 . . . . 0.0 109.862 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.9 tp -71.43 133.37 45.86 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -91.01 94.06 9.47 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.051 -1.031 . . . . 0.0 110.267 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.488 ' H ' ' CD2' ' A' ' 30' ' ' LEU . 1.4 pt? -127.45 135.54 50.56 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.1 p -63.81 152.98 85.51 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 120.978 -1.076 . . . . 0.0 109.567 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -44.9 -48.13 11.13 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.848 1.698 . . . . 0.0 112.433 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -53.25 -47.99 68.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.446 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -55.24 -45.16 76.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.249 -0.907 . . . . 0.0 109.289 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.483 ' HH ' ' C ' ' A' ' 15' ' ' ASN . 31.2 t80 -50.2 -30.04 10.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.229 -0.919 . . . . 0.0 109.701 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.8 -49.38 47.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.352 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 mp -59.2 -44.5 92.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.093 -1.004 . . . . 0.0 108.785 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.6 mp -58.01 -42.06 84.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.919 . . . . 0.0 108.521 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.1 m -50.73 -37.08 39.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.229 -0.919 . . . . 0.0 109.653 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -80.22 -43.58 21.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.031 -1.043 . . . . 0.0 109.911 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.7 mt -59.34 -49.07 79.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.12 -0.988 . . . . 0.0 109.961 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 42.2 mtt -66.83 -35.46 80.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.991 -1.068 . . . . 0.0 109.645 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 25.7 ttt -56.05 -29.21 60.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.201 -0.937 . . . . 0.0 108.833 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -116.68 40.69 2.87 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.22 103.15 1.5 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.135 -0.978 . . . . 0.0 109.802 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.402 ' CA ' ' OD1' ' A' ' 98' ' ' ASN . . . 137.85 -13.36 3.64 Favored Glycine 0 N--CA 1.502 3.062 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.9 m -132.56 152.54 80.17 Favored Pre-proline 0 N--CA 1.502 2.131 0 O-C-N 121.697 -0.884 . . . . 0.0 108.806 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -71.73 120.19 6.72 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 121.774 1.649 . . . . 0.0 111.544 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.0 t -91.11 133.72 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.883 . . . . 0.0 109.612 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.413 ' C ' ' N ' ' A' ' 52' ' ' GLU . 10.3 t-160 -65.54 122.5 17.35 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -50.65 -15.94 0.33 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.166 -0.959 . . . . 0.0 109.6 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.531 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 17.0 mm-40 -65.78 -50.5 64.48 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.313 -0.867 . . . . 0.0 109.875 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.9 mt -57.07 -31.92 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.131 -0.98 . . . . 0.0 110.044 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.7 mt -66.47 -33.31 75.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.996 -1.065 . . . . 0.0 108.307 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 59' ' ' TYR . 22.4 t80 -73.51 -35.69 65.65 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 41.4 m-80 -63.53 -22.07 66.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.848 -0.533 . . . . 0.0 110.039 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.09 -54.23 42.32 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.027 -1.046 . . . . 0.0 109.243 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.406 HD13 HG22 ' A' ' 58' ' ' ILE . 5.6 mm -85.83 -37.46 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.22 -0.925 . . . . 0.0 109.872 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 55' ' ' TYR . 0.3 OUTLIER -179.94 168.25 1.29 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.047 -1.033 . . . . 0.0 110.158 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.455 ' C ' ' H ' ' A' ' 62' ' ' ASP . 1.7 t -173.81 -31.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.336 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -54.06 -10.56 0.35 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -0.905 . . . . 0.0 109.38 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 60' ' ' SER . 28.0 m-20 -156.42 -137.35 0.06 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.378 -0.826 . . . . 0.0 109.057 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 62' ' ' ASP . 13.5 m120 53.01 97.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.931 . . . . 0.0 109.614 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -165.29 61.97 0.82 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.339 -0.85 . . . . 0.0 109.31 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.7 157.97 31.8 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.614 2.209 . . . . 0.0 111.902 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.96 -51.65 30.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 0.0 109.496 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.6 m -55.53 150.31 12.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.225 -0.922 . . . . 0.0 109.554 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -73.27 139.08 45.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 109.497 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 90.0 m -165.79 -36.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.317 -0.864 . . . . 0.0 109.452 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.433 ' CD2' ' H ' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -70.61 -48.93 52.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 108.88 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -70.3 -25.39 63.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 109.44 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.4 t -75.3 -43.55 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.176 -0.952 . . . . 0.0 109.505 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -54.55 -39.05 67.33 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.3 mt -67.38 -39.55 82.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -60.67 -34.67 74.67 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.122 -0.986 . . . . 0.0 109.072 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -76.73 -40.9 47.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.397 -0.814 . . . . 0.0 108.993 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.406 ' CD1' ' C ' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -67.71 -43.36 80.24 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -51.76 -50.09 61.34 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.464 -0.772 . . . . 0.0 110.243 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -64.98 -27.37 68.79 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.252 -0.905 . . . . 0.0 110.834 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -71.01 -45.35 64.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.985 -1.072 . . . . 0.0 110.439 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.7 pt -75.04 -18.69 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.977 -1.077 . . . . 0.0 110.718 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 81.28 79.53 0.92 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -46.63 -15.9 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.688 -0.89 . . . . 0.0 110.662 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.499 ' CB ' HH11 ' A' ' 85' ' ' ARG . 10.5 t -48.2 -43.39 31.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.16 -0.962 . . . . 0.0 110.443 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.499 HH11 ' CB ' ' A' ' 84' ' ' SER . 12.5 mpt_? -91.48 11.03 25.33 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.164 -0.96 . . . . 0.0 110.163 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 30.2 mm -115.75 164.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 O-C-N 121.35 -0.844 . . . . 0.0 108.98 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 61.5 ttt-85 -135.69 118.56 16.24 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.399 -0.813 . . . . 0.0 108.898 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.5 p -94.93 137.64 33.73 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.235 -0.916 . . . . 0.0 109.766 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.8 t -102.14 102.25 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.569 -0.707 . . . . 0.0 109.756 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.51 ' C ' ' H ' ' A' ' 92' ' ' PHE . 40.9 ttt85 52.47 27.12 4.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 109.542 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.78 1.85 1.54 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.519 ' CD2' ' N ' ' A' ' 93' ' ' GLY . 53.6 t80 -75.34 -81.89 0.07 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.233 -1.157 . . . . 0.0 108.756 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.519 ' N ' ' CD2' ' A' ' 92' ' ' PHE . . . -98.36 -150.63 26.31 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 27.3 m-85 -151.44 157.44 42.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.385 -1.068 . . . . 0.0 108.87 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.6 ttp -157.7 128.89 6.66 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.36 -0.837 . . . . 0.0 109.675 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.487 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 9.2 mp -85.47 136.54 33.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.357 -0.839 . . . . 0.0 108.891 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.13 112.54 1.56 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 109.681 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.636 ' N ' HD21 ' A' ' 98' ' ' ASN . 0.9 OUTLIER -75.89 81.0 2.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -0.882 . . . . 0.0 109.414 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 53.43 88.58 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.567 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.2 mt -145.05 -2.02 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.293 -0.879 . . . . 0.0 108.66 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.07 -35.48 61.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.367 -0.833 . . . . 0.0 109.36 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.1 m -78.22 111.03 13.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.869 . . . . 0.0 109.433 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.417 179.964 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.527 ' ND2' ' H3 ' ' A' ' 1' ' ' ASN . 1.7 m120 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -75.93 62.22 1.57 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.28 -0.888 . . . . 0.0 109.554 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.12 18.99 79.84 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.437 ' C ' ' ND2' ' A' ' 5' ' ' ASN . 33.2 t0 -170.2 155.09 5.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.24 -1.153 . . . . 0.0 109.471 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.496 ' OD1' ' ND2' ' A' ' 1' ' ' ASN . 14.9 m-80 -156.67 119.77 4.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 0.0 109.081 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -164.94 158.5 17.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.377 -0.827 . . . . 0.0 109.737 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.2 pt -149.94 164.0 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.378 -0.826 . . . . 0.0 108.943 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.1 t -136.96 150.36 48.12 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.392 -0.818 . . . . 0.0 109.283 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.2 t -143.13 93.8 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.27 -108.4 2.48 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -104.88 3.51 31.02 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.48 -1.011 . . . . 0.0 109.863 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.1 mt -97.8 115.1 27.37 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.215 -0.928 . . . . 0.0 109.849 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -106.98 115.54 30.36 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.2 mp -104.94 138.44 41.16 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.502 -0.749 . . . . 0.0 109.873 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.489 ' C ' ' HH ' ' A' ' 35' ' ' TYR . 2.9 m120 -136.24 101.87 4.82 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.723 -0.611 . . . . 0.0 109.355 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.4 t -76.73 -28.88 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.84 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -54.3 46.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.237 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -93.86 -9.57 36.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.131 -0.981 . . . . 0.0 108.665 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 63.35 78.35 0.29 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.341 0.591 . . . . 0.0 110.017 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.1 tp -166.89 153.25 8.38 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.087 -1.008 . . . . 0.0 108.822 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.9 t -137.5 147.7 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.331 -0.856 . . . . 0.0 109.957 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 31.2 m-90 -115.84 137.1 52.42 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.5 tp -112.4 105.73 14.06 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.47 39.9 68.62 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 107.578 -2.209 . . . . 0.0 107.578 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 69.06 -3.4 1.51 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 122.197 -0.59 . . . . 0.0 109.924 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.7 p -98.22 139.54 33.85 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.078 -1.014 . . . . 0.0 109.893 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.23 115.05 7.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 110.012 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.0 tp -85.94 138.85 31.7 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 27.0 p-10 -93.81 103.8 15.91 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.101 -0.999 . . . . 0.0 110.732 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.502 ' H ' ' CD2' ' A' ' 30' ' ' LEU . 1.3 pt? -126.22 135.06 51.14 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.415 ' OG1' ' OE2' ' A' ' 34' ' ' GLU . 3.1 p -62.84 151.91 83.98 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.856 -1.153 . . . . 0.0 109.379 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -44.8 -44.12 14.54 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.784 1.656 . . . . 0.0 112.142 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -53.75 -50.54 65.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.272 -0.892 . . . . 0.0 109.686 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.507 ' N ' ' OE1' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -54.08 -41.43 68.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.389 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.489 ' HH ' ' C ' ' A' ' 15' ' ' ASN . 11.3 t80 -56.75 -30.33 63.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.101 -1.0 . . . . 0.0 109.289 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.19 -52.53 26.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.079 -1.013 . . . . 0.0 109.77 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.427 ' CD1' ' H ' ' A' ' 37' ' ' LEU . 7.2 mp -55.87 -39.32 71.33 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.4 tp -58.36 -43.21 88.31 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.489 ' HG ' ' N ' ' A' ' 40' ' ' ARG . 30.5 p -50.72 -39.32 51.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.417 -0.802 . . . . 0.0 110.229 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.489 ' N ' ' HG ' ' A' ' 39' ' ' SER . 14.1 tpt180 -79.76 -42.58 24.22 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.855 -1.153 . . . . 0.0 109.828 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 26.3 mt -58.88 -47.75 83.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.155 -0.966 . . . . 0.0 109.897 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.1 ptt? -67.91 -36.0 79.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.022 -1.049 . . . . 0.0 109.975 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 21.7 ttt -54.26 -29.05 45.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -0.885 . . . . 0.0 108.763 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -124.04 45.02 2.58 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.6 133.66 51.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.104 -0.998 . . . . 0.0 110.095 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.53 -10.47 59.36 Favored Glycine 0 N--CA 1.501 3.004 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 p -127.11 151.9 75.03 Favored Pre-proline 0 N--CA 1.504 2.25 0 O-C-N 121.537 -0.978 . . . . 0.0 108.696 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.22 120.15 6.4 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 121.749 1.633 . . . . 0.0 111.652 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.9 t -96.2 136.67 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.412 -0.805 . . . . 0.0 109.736 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -62.09 120.13 10.26 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.211 -0.931 . . . . 0.0 108.725 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -57.24 -18.76 17.63 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.339 -0.851 . . . . 0.0 109.178 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.531 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 0.2 OUTLIER -65.39 -48.81 71.59 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.378 -0.826 . . . . 0.0 108.981 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.5 mt -58.76 -30.23 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.25 -0.906 . . . . 0.0 110.324 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.3 mt -69.61 -29.77 67.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.922 -1.111 . . . . 0.0 108.976 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -71.57 -33.09 68.79 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 17.7 m-80 -65.33 -22.21 66.79 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.655 -0.653 . . . . 0.0 109.941 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.76 -55.45 32.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.902 -1.124 . . . . 0.0 109.403 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.5 mt -74.01 -37.76 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.224 -0.923 . . . . 0.0 110.291 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.413 ' O ' ' O ' ' A' ' 56' ' ' ASN . 87.6 m-85 -105.36 125.46 51.01 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.404 -0.81 . . . . 0.0 109.792 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.6 m -146.13 20.46 1.41 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.092 -1.005 . . . . 0.0 109.454 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 66.5 p-90 -169.46 -17.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.155 -0.966 . . . . 0.0 109.532 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -75.68 -48.7 20.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.28 -0.888 . . . . 0.0 109.435 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.3 m120 51.18 96.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.425 -0.797 . . . . 0.0 109.72 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -166.87 71.45 1.06 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.453 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -47.11 95.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.669 2.246 . . . . 0.0 112.311 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.38 -18.81 60.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.257 -0.902 . . . . 0.0 109.463 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.3 m 57.31 11.65 1.18 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.16 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.5 ' C ' ' H ' ' A' ' 70' ' ' LEU . 63.7 t30 -162.82 163.65 26.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.175 -0.953 . . . . 0.0 109.471 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 m 72.36 -28.6 0.19 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.605 -0.684 . . . . 0.0 109.795 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.542 ' H ' ' CD2' ' A' ' 70' ' ' LEU . 1.9 pt? -69.09 -38.9 79.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.041 -1.037 . . . . 0.0 109.76 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.481 ' O ' ' CD2' ' A' ' 75' ' ' HIS . 59.1 mt-10 -71.23 -26.55 62.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.988 -1.07 . . . . 0.0 109.563 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 49.1 t -75.43 -47.85 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.19 -0.943 . . . . 0.0 109.303 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -55.85 -37.18 68.4 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.2 mt -67.51 -39.95 83.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 71' ' ' GLU . 43.1 m170 -60.95 -35.96 78.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.082 -1.011 . . . . 0.0 108.861 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -74.44 -41.73 60.34 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.437 ' CD1' ' C ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -67.86 -42.46 81.31 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.485 ' NH2' ' OH ' ' A' ' 94' ' ' TYR . 41.0 ttm180 -49.9 -50.7 45.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.216 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -62.31 -27.08 68.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.241 -0.912 . . . . 0.0 110.817 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -73.22 -43.83 60.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.947 -1.096 . . . . 0.0 110.424 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.0 pt -73.76 -18.53 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.073 -1.017 . . . . 0.0 109.884 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.57 82.12 0.6 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -52.56 -18.23 1.63 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.515 -0.991 . . . . 0.0 110.111 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.9 m -52.37 -46.4 66.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.267 -0.896 . . . . 0.0 109.924 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -87.97 10.69 18.05 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.209 -0.932 . . . . 0.0 110.025 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.7 mm -119.58 168.07 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.461 -0.775 . . . . 0.0 108.962 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 61.3 mtp85 -140.19 114.05 8.86 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.0 p -81.82 138.05 35.18 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.267 -0.896 . . . . 0.0 109.768 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.589 ' CG1' HH21 ' A' ' 90' ' ' ARG . 61.7 t -104.36 92.12 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.518 -0.738 . . . . 0.0 109.29 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.589 HH21 ' CG1' ' A' ' 89' ' ' VAL . 0.7 OUTLIER 49.93 -177.01 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.291 -0.881 . . . . 0.0 109.211 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.88 55.34 4.63 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -135.55 -29.23 1.07 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.552 -0.969 . . . . 0.0 109.651 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.91 -153.57 7.96 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.008 -1.568 . . . . 0.0 110.921 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.485 ' OH ' ' NH2' ' A' ' 78' ' ' ARG . 32.5 m-85 -148.57 169.94 19.19 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.6 ttp -164.09 130.28 3.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.166 -0.959 . . . . 0.0 109.969 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 9.8 mp -83.38 144.2 29.8 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.58 -0.7 . . . . 0.0 109.155 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.69 119.69 20.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.493 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -63.45 -16.75 61.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.182 -0.949 . . . . 0.0 109.453 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 102' ' ' THR . 1.2 p30 -171.93 128.05 0.61 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.386 -0.821 . . . . 0.0 109.372 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 11.8 mm -59.05 -14.93 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 108.864 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -82.51 -7.56 59.64 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.437 ' N ' ' OD1' ' A' ' 99' ' ' ASN . 9.5 t -52.43 142.3 17.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 109.668 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.52 179.961 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.412 ' H1 ' ' ND2' ' A' ' 1' ' ' ASN . 9.5 m-80 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.438 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 3.9 mp0 46.43 27.43 0.6 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.316 -0.865 . . . . 0.0 110.238 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.98 -36.32 7.77 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -104.14 98.08 7.95 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.507 -0.996 . . . . 0.0 109.537 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -169.59 101.29 0.33 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.182 -0.949 . . . . 0.0 109.247 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -162.29 155.76 20.68 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.153 -0.967 . . . . 0.0 109.93 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.5 pt -147.94 163.33 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.373 -0.83 . . . . 0.0 109.017 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.2 m -144.9 158.96 43.62 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.145 -0.972 . . . . 0.0 109.912 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.0 t -148.35 101.04 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.36 -108.4 2.48 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -109.05 4.6 23.29 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.541 -0.976 . . . . 0.0 109.589 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.516 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 7.0 mp -95.51 123.55 39.11 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.288 -0.882 . . . . 0.0 108.83 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -118.85 128.78 54.77 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.443 -0.786 . . . . 0.0 109.094 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.505 ' C ' HD21 ' A' ' 15' ' ' ASN . 51.5 tp -116.43 128.28 55.35 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.607 -0.683 . . . . 0.0 109.206 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.505 HD21 ' C ' ' A' ' 14' ' ' LEU . 1.3 m-80 -122.91 98.11 5.75 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.516 -0.74 . . . . 0.0 109.366 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.4 t -71.06 -27.0 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.47 -0.769 . . . . 0.0 109.23 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.405 HG23 ' H ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -64.7 -53.92 39.78 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.593 -0.692 . . . . 0.0 109.657 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.405 ' H ' HG23 ' A' ' 17' ' ' THR . 82.3 mtt180 -91.01 -12.83 34.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.249 -0.907 . . . . 0.0 108.862 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.479 ' NE ' ' CD1' ' A' ' 35' ' ' TYR . 9.5 tpt180 64.98 61.62 0.76 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -140.09 154.78 47.15 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.424 -0.798 . . . . 0.0 109.045 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.5 t -139.28 126.82 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.375 -0.828 . . . . 0.0 109.371 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 18.4 m-90 -103.44 148.18 26.24 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.223 -0.923 . . . . 0.0 109.128 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.425 ' O ' ' OG1' ' A' ' 26' ' ' THR . 24.4 tp -128.77 102.89 6.76 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.439 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 76.71 46.01 12.06 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 -178.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 61.91 -0.67 0.42 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 122.022 -0.693 . . . . 0.0 110.25 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.439 ' H ' ' C ' ' A' ' 24' ' ' GLY . 50.2 p -103.76 140.32 37.78 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.211 -0.931 . . . . 0.0 109.862 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.95 110.83 1.91 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 109.996 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.9 tp -76.9 134.89 38.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 108.622 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -101.77 111.45 23.71 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.315 -0.866 . . . . 0.0 109.615 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.499 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 1.1 pt? -140.51 150.86 44.26 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.327 -0.858 . . . . 0.0 109.853 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.4 p -58.07 152.85 37.92 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.361 -0.837 . . . . 0.0 109.239 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.21 -36.35 80.69 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.853 1.702 . . . . 0.0 111.188 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -55.84 -47.4 77.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 108.931 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -58.61 -39.62 80.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.319 -0.863 . . . . 0.0 108.893 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.479 ' CD1' ' NE ' ' A' ' 19' ' ' ARG . 16.7 t80 -52.89 -31.85 41.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.168 -0.958 . . . . 0.0 109.087 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.61 -52.76 10.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -0.87 . . . . 0.0 109.389 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.6 mp -58.59 -40.66 83.82 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tt -67.37 -43.89 80.29 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.602 0.715 . . . . 0.0 109.306 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.0 t -48.42 -41.64 29.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.127 -0.983 . . . . 0.0 111.134 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.8 ttt-85 -80.73 -35.06 33.97 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.533 -1.354 . . . . 0.0 109.485 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.5 tp -60.3 -36.73 78.56 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.34 -0.85 . . . . 0.0 109.34 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 41.0 tpp -75.22 -38.68 60.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 0.0 109.259 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 42.1 ttm -52.4 -27.05 14.26 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.6 mmtt -118.99 42.76 2.73 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.29 137.06 55.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 110.215 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.85 -14.31 65.56 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.5 p -117.42 151.85 48.63 Favored Pre-proline 0 N--CA 1.501 2.115 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -73.87 119.43 5.87 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.594 1.529 . . . . 0.0 111.999 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -103.99 135.95 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.518 -0.739 . . . . 0.0 109.475 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.774 ' HD1' ' H ' ' A' ' 52' ' ' GLU . 7.2 t-80 -72.87 125.77 28.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.059 -1.026 . . . . 0.0 108.647 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -58.4 -16.25 14.01 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.469 -0.77 . . . . 0.0 109.291 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.774 ' H ' ' HD1' ' A' ' 50' ' ' HIS . 34.1 tt0 -67.61 -50.4 58.33 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.499 -0.75 . . . . 0.0 109.363 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.5 mt -58.1 -25.0 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.36 -0.838 . . . . 0.0 110.381 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 38.1 mt -72.11 -48.16 45.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.038 -1.039 . . . . 0.0 108.356 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.413 ' O ' ' O ' ' A' ' 59' ' ' TYR . 23.6 m-85 -52.25 -34.59 46.76 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.568 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 30.4 m-80 -63.84 -21.13 66.3 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.967 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.17 -53.75 31.88 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.034 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 58' ' ' ILE . 21.7 mm -94.0 -37.68 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.142 -0.974 . . . . 0.0 110.782 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.413 ' O ' ' O ' ' A' ' 55' ' ' TYR . 38.5 p90 -169.09 176.42 5.31 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.828 -1.17 . . . . 0.0 110.5 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.5 t -168.09 -34.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.225 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 54.6 p-90 -83.34 -3.7 57.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.27 -0.894 . . . . 0.0 109.491 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.19 -80.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.196 -0.94 . . . . 0.0 109.449 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 63' ' ' ASN . 1.3 p-10 -155.95 96.33 1.71 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.459 -0.775 . . . . 0.0 109.112 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.581 ' N ' ' CD ' ' A' ' 65' ' ' PRO . 8.1 mt-10 -75.99 -34.79 1.53 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 111.162 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 64' ' ' GLU . 62.5 Cg_endo -90.37 47.2 0.78 Allowed 'Trans proline' 0 N--CA 1.487 1.133 0 C-N-CA 122.109 1.873 . . . . 0.0 112.097 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.8 8.67 7.65 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.213 -0.93 . . . . 0.0 109.458 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m 60.42 -127.63 1.01 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.47 -0.769 . . . . 0.0 109.465 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.403 ' O ' ' OG1' ' A' ' 69' ' ' THR . 18.1 t-20 -73.04 98.17 2.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.098 -1.001 . . . . 0.0 109.654 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 68' ' ' ASN . 25.4 m -165.67 -73.6 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.291 -0.88 . . . . 0.0 109.574 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.403 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 9.7 mp -56.0 -49.4 73.72 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.391 -0.818 . . . . 0.0 109.598 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -59.86 -30.02 68.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.156 -0.965 . . . . 0.0 109.729 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 t -70.41 -41.43 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.094 -1.004 . . . . 0.0 109.139 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.425 ' N ' ' HD1' ' A' ' 73' ' ' HIS . 1.8 m80 -54.56 -37.64 65.71 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 35.2 mm -65.63 -41.42 90.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.436 ' ND1' HH21 ' A' ' 78' ' ' ARG . 13.4 t60 -65.73 -41.55 92.09 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.36 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.575 ' N ' HD21 ' A' ' 76' ' ' ASN . 0.9 OUTLIER -67.88 -44.58 76.72 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.195 -0.941 . . . . 0.0 109.091 179.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 74.3 mt -70.34 -38.63 74.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.417 -0.802 . . . . 0.0 109.919 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.436 HH21 ' ND1' ' A' ' 75' ' ' HIS . 44.6 ttp85 -49.19 -48.6 45.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.13 -0.981 . . . . 0.0 109.786 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -57.24 -27.28 61.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.957 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -78.4 -40.68 35.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.938 -1.101 . . . . 0.0 110.636 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.7 pt -85.11 -39.56 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.885 -1.135 . . . . 0.0 110.313 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 91.18 106.76 1.42 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 107.386 -2.286 . . . . 0.0 107.386 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 86' ' ' ILE . 52.2 pttt -43.61 -18.15 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.678 -0.895 . . . . 0.0 110.467 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 82' ' ' GLY . 47.3 t -62.93 -54.86 31.98 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.825 -1.172 . . . . 0.0 108.708 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 54.8 ttp85 -54.94 -10.97 0.55 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.396 -0.815 . . . . 0.0 110.803 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' A' ' 83' ' ' LYS . 9.4 mt -143.4 119.35 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.394 0 O-C-N 120.891 -1.13 . . . . 0.0 110.646 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 63.4 mtp85 -86.95 130.35 34.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.3 -0.875 . . . . 0.0 108.711 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 p -80.94 128.76 34.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.051 -1.031 . . . . 0.0 109.491 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.408 ' O ' ' O ' ' A' ' 90' ' ' ARG . 21.0 t -104.17 92.12 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.539 -0.725 . . . . 0.0 109.181 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.408 ' O ' ' O ' ' A' ' 89' ' ' VAL . 79.6 mtt-85 52.15 177.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 109.554 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.96 55.04 4.97 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -138.33 -29.98 0.8 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.399 -1.06 . . . . 0.0 109.916 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -165.06 -155.72 8.67 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 118.997 -1.573 . . . . 0.0 110.826 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -146.16 171.09 15.44 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.467 ' SD ' ' O ' ' A' ' 96' ' ' LEU . 11.6 tmm? -163.57 142.86 8.23 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.85 -1.156 . . . . 0.0 110.704 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.467 ' O ' ' SD ' ' A' ' 95' ' ' MET . 11.1 mp -89.43 132.79 34.83 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' A' ' 99' ' ' ASN . . . -56.18 121.02 8.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.213 -0.929 . . . . 0.0 109.082 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -68.14 67.33 0.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 0.0 109.712 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 97' ' ' ALA . 61.7 t-20 49.39 41.06 20.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.188 -0.945 . . . . 0.0 109.874 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.8 mt -78.79 -2.51 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.287 -0.883 . . . . 0.0 108.825 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 102' ' ' THR . 3.2 p30 -65.11 -27.63 68.88 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.225 -0.922 . . . . 0.0 109.386 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.486 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 93.3 m -68.46 -87.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.383 -0.823 . . . . 0.0 109.452 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.419 -179.994 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -71.21 64.21 0.37 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.299 -0.876 . . . . 0.0 109.554 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -177.55 25.12 0.05 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 5.7 p-10 -175.33 107.72 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.29 -1.123 . . . . 0.0 109.229 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -160.43 121.02 2.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.135 -0.978 . . . . 0.0 109.38 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -158.91 156.24 29.17 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.479 -0.763 . . . . 0.0 109.364 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.4 pt -148.83 163.67 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.298 -0.876 . . . . 0.0 109.393 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.6 m -136.2 146.53 46.92 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.472 -0.768 . . . . 0.0 109.542 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -146.46 93.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.67 -114.09 3.91 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -106.06 6.27 30.97 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.492 -1.005 . . . . 0.0 109.66 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.4 mt -100.89 122.04 42.77 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.258 -0.901 . . . . 0.0 109.946 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -115.19 129.46 56.66 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.511 ' C ' HD21 ' A' ' 15' ' ' ASN . 46.9 tp -114.65 138.67 50.4 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.535 -0.728 . . . . 0.0 109.415 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.511 HD21 ' C ' ' A' ' 14' ' ' LEU . 2.1 m-80 -135.02 97.63 3.79 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.576 -0.702 . . . . 0.0 109.236 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.2 t -73.34 -28.51 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.376 -0.827 . . . . 0.0 109.282 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -63.13 -55.47 25.02 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.444 -0.785 . . . . 0.0 109.454 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.407 ' H ' HG23 ' A' ' 17' ' ' THR . 64.8 mtm180 -88.62 -16.02 33.54 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.307 -0.871 . . . . 0.0 108.847 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? 68.83 65.19 0.3 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.2 mt -143.93 142.32 30.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.303 -0.873 . . . . 0.0 108.724 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -129.61 127.57 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.5 -0.75 . . . . 0.0 108.977 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -103.72 142.21 34.73 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.269 -0.894 . . . . 0.0 109.173 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.423 ' O ' ' OG1' ' A' ' 26' ' ' THR . 28.0 tp -127.2 102.9 7.14 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 75.93 47.3 11.76 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.131 -1.988 . . . . 0.0 108.131 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 60.68 2.58 0.52 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.979 -0.718 . . . . 0.0 110.33 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.431 ' H ' ' C ' ' A' ' 24' ' ' GLY . 50.4 p -108.81 141.72 40.42 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.15 -0.969 . . . . 0.0 109.846 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.03 115.29 4.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.247 -0.908 . . . . 0.0 110.075 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.3 tp -81.73 132.99 35.3 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -101.34 111.81 24.15 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.305 -0.872 . . . . 0.0 109.483 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.46 147.51 47.23 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.453 -0.779 . . . . 0.0 109.274 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.1 p -57.9 152.15 39.92 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.89 -33.73 92.15 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.84 1.693 . . . . 0.0 111.359 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -57.52 -50.88 71.64 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.206 -0.934 . . . . 0.0 109.045 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -56.89 -35.58 69.14 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.151 -0.968 . . . . 0.0 109.032 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.4 ' OH ' ' O ' ' A' ' 15' ' ' ASN . 7.3 t80 -55.47 -33.9 64.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -0.888 . . . . 0.0 108.962 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.422 ' O ' ' OD2' ' A' ' 57' ' ' ASP . . . -67.89 -52.96 30.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 109.518 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.47 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 7.2 mp -60.75 -32.61 71.9 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 12.5 tp -63.31 -45.63 90.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.535 -0.728 . . . . 0.0 109.28 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.3 p -53.79 -32.66 53.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.902 . . . . 0.0 109.327 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -79.8 -45.42 18.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 109.549 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.0 mt -58.21 -46.65 85.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.925 . . . . 0.0 109.937 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.545 ' SD ' ' N ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -70.83 -36.15 72.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 110.047 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.545 ' N ' ' SD ' ' A' ' 42' ' ' MET . 22.3 ttt -52.9 -29.2 27.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.099 -1.001 . . . . 0.0 108.873 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -122.39 46.72 2.06 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.37 134.51 52.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.886 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.99 -8.86 78.85 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.3 t -118.46 115.1 35.93 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.61 119.95 4.16 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.038 1.159 . . . . 0.0 112.001 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -98.7 136.67 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.41 -0.806 . . . . 0.0 110.116 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.514 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 17.5 t-160 -71.18 124.25 24.05 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.241 -0.912 . . . . 0.0 108.931 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.469 ' NH1' ' OE1' ' A' ' 71' ' ' GLU . 53.3 ttp180 -51.35 -17.53 0.77 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.402 -0.811 . . . . 0.0 109.31 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.517 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 18.9 tt0 -68.01 -47.8 67.48 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.383 -0.823 . . . . 0.0 109.974 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.0 mt -57.45 -29.55 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.161 -0.962 . . . . 0.0 110.194 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.9 mt -68.58 -46.79 68.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.159 -0.963 . . . . 0.0 108.835 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -60.84 -34.47 74.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 70.3 m-80 -70.08 -21.67 63.12 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.443 -0.785 . . . . 0.0 110.145 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 36' ' ' ALA . 11.3 t0 -54.49 -52.52 61.68 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.0 -1.063 . . . . 0.0 109.414 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.8 mt -99.83 -37.12 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.487 -0.758 . . . . 0.0 110.172 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -99.79 78.77 2.16 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.275 -0.89 . . . . 0.0 109.956 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.3 p -61.44 -57.42 12.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 109.301 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 27.9 m0 -82.42 51.92 1.94 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.4 -0.812 . . . . 0.0 108.969 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -62.94 -120.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.465 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 53.12 60.26 3.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.057 -1.027 . . . . 0.0 109.587 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -169.68 61.77 0.43 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 109.422 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -77.64 103.51 1.73 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.584 2.19 . . . . 0.0 111.939 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.06 -50.07 21.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 109.459 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.528 ' HG1' ' N ' ' A' ' 68' ' ' ASN . 1.7 t -172.37 -173.98 1.14 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.528 ' N ' ' HG1' ' A' ' 67' ' ' THR . 8.6 t-20 -54.51 107.05 0.24 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.522 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 68' ' ' ASN . 15.5 m -165.55 -44.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.343 -0.848 . . . . 0.0 109.248 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.528 ' CD2' ' N ' ' A' ' 70' ' ' LEU . 1.6 mm? -66.1 -49.28 68.09 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.469 ' OE1' ' NH1' ' A' ' 51' ' ' ARG . 64.2 mm-40 -64.07 -24.99 67.91 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.34 -0.85 . . . . 0.0 108.793 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.0 t -74.83 -41.02 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.411 -0.806 . . . . 0.0 109.425 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -54.29 -39.33 66.85 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 35.6 mm -65.08 -40.21 88.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -67.18 -40.69 86.62 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.153 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -64.75 -44.49 89.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.26 -0.9 . . . . 0.0 109.311 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.7 mt -70.19 -34.19 72.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -0.876 . . . . 0.0 109.478 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -49.35 -49.35 44.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.252 -0.905 . . . . 0.0 109.765 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -58.01 -28.9 64.86 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.352 -0.842 . . . . 0.0 109.804 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -74.24 -43.19 58.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.138 -0.976 . . . . 0.0 110.445 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.5 pt -82.6 -36.95 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.935 -1.103 . . . . 0.0 110.171 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 93.12 103.45 1.6 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 107.161 -2.376 . . . . 0.0 107.161 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 86' ' ' ILE . 9.8 ptpp? -42.95 -19.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.791 -0.829 . . . . 0.0 110.724 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.595 ' HG ' ' H ' ' A' ' 85' ' ' ARG . 36.4 p -64.21 -55.35 22.26 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.966 -1.083 . . . . 0.0 108.905 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.595 ' H ' ' HG ' ' A' ' 84' ' ' SER . 66.9 ttt-85 -47.9 -14.07 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.307 -0.871 . . . . 0.0 110.793 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 84' ' ' SER . 12.8 pt -135.56 168.5 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.095 -1.003 . . . . 0.0 110.759 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -137.5 122.15 18.58 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 p -90.27 135.54 33.61 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.128 -0.982 . . . . 0.0 109.628 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.85 119.91 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.532 -0.73 . . . . 0.0 110.189 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 49.7 29.1 2.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.504 -0.748 . . . . 0.0 110.027 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.22 52.5 17.83 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.514 ' CZ ' ' CD2' ' A' ' 50' ' ' HIS . 26.1 t80 -138.25 -69.57 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.509 -0.995 . . . . 0.0 108.757 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.466 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . -99.92 -151.83 26.27 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.466 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 31.0 m-85 -151.06 162.16 41.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.475 -1.015 . . . . 0.0 108.445 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 55.8 ttp -163.02 127.55 3.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.061 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 9.4 mp -82.29 135.11 35.27 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.62 118.43 15.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.931 . . . . 0.0 109.695 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.59 ' N ' HD21 ' A' ' 98' ' ' ASN . 0.8 OUTLIER -82.0 103.08 11.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.261 -0.899 . . . . 0.0 109.433 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.414 ' O ' ' O ' ' A' ' 98' ' ' ASN . 2.9 m120 59.46 115.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.435 -0.79 . . . . 0.0 109.822 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.6 mt -75.43 -4.18 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.185 -0.947 . . . . 0.0 109.118 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -170.64 36.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.287 -0.883 . . . . 0.0 109.54 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.4 m 53.56 66.68 1.16 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 109.497 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.496 -179.971 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 58.33 41.48 23.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 109.308 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 50.28 32.73 22.24 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 26.6 p-10 -53.63 113.0 1.03 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.253 -1.145 . . . . 0.0 109.514 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -167.35 125.58 1.28 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.298 -0.876 . . . . 0.0 109.088 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -163.12 157.91 21.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.907 . . . . 0.0 109.892 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.9 pt -150.68 163.37 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.324 -0.86 . . . . 0.0 108.755 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.2 m -145.15 158.22 43.88 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.214 -0.929 . . . . 0.0 109.926 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.5 p -152.47 97.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.03 -118.17 4.65 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -101.56 8.99 41.67 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.402 -1.058 . . . . 0.0 110.207 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 17.2 mt -106.52 126.52 52.36 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.275 -0.891 . . . . 0.0 109.925 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -116.85 130.68 56.86 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.9 tp -115.05 116.96 29.28 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.455 -0.778 . . . . 0.0 110.109 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -111.32 97.69 6.95 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 121.506 -0.746 . . . . 0.0 109.027 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.3 t -69.35 -28.6 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 109.534 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.49 -53.14 52.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.467 -0.771 . . . . 0.0 109.478 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 -90.26 -8.54 50.72 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.181 -0.95 . . . . 0.0 108.803 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 56.45 67.63 0.97 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 98.6 mt -143.72 158.47 43.65 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.6 t -142.5 123.8 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.227 -0.921 . . . . 0.0 110.012 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 16.0 m-90 -99.42 153.39 19.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.367 -0.833 . . . . 0.0 109.121 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.415 ' O ' ' OG1' ' A' ' 26' ' ' THR . 1.2 tt -146.15 116.05 7.32 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 62.58 39.68 98.18 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 107.623 -2.191 . . . . 0.0 107.623 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 65.87 -4.6 0.61 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 122.263 -0.551 . . . . 0.0 109.875 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.44 ' H ' ' C ' ' A' ' 24' ' ' GLY . 73.7 p -100.27 139.87 35.32 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.082 -1.011 . . . . 0.0 109.535 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.11 115.24 3.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 0.0 110.041 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.1 tp -75.1 127.28 32.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.3 -0.875 . . . . 0.0 108.684 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.402 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 5.7 m-20 -94.16 101.24 13.24 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.242 -0.911 . . . . 0.0 110.303 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.495 ' H ' ' CD2' ' A' ' 30' ' ' LEU . 1.4 pt? -128.33 137.45 51.94 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.5 p -62.8 151.42 84.97 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.795 -1.191 . . . . 0.0 109.475 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -44.91 -46.94 12.44 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 121.792 1.662 . . . . 0.0 112.35 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -53.34 -42.17 66.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.7 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -63.23 -36.06 82.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.154 -0.966 . . . . 0.0 109.336 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -57.03 -30.65 64.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.295 -0.878 . . . . 0.0 109.243 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.401 ' O ' ' OG ' ' A' ' 39' ' ' SER . . . -74.43 -53.3 9.84 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.241 -0.912 . . . . 0.0 109.733 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.06 -39.48 92.52 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.6 tp -65.61 -46.12 80.52 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.61 -0.681 . . . . 0.0 109.678 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 36' ' ' ALA . 87.8 p -50.77 -29.84 12.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 110.378 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.488 ' NH2' ' CG2' ' A' ' 53' ' ' ILE . 6.3 tpt180 -79.18 -36.89 39.58 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.85 -1.157 . . . . 0.0 110.173 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.29 -38.57 91.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.962 -1.086 . . . . 0.0 110.261 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.4 ' SD ' ' CD2' ' A' ' 96' ' ' LEU . 13.0 mmt -65.39 -42.93 92.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.768 -1.207 . . . . 0.0 110.077 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 51.8 mtt -58.72 -32.25 69.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.223 -0.923 . . . . 0.0 109.505 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -106.19 35.34 2.96 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.637 -0.664 . . . . 0.0 109.44 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.1 103.16 2.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 109.885 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.26 -16.58 2.31 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.64 155.72 79.29 Favored Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.718 -0.872 . . . . 0.0 108.707 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.52 120.46 7.13 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.928 1.752 . . . . 0.0 111.554 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.5 t -91.57 136.6 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.8 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.477 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 19.7 t-160 -72.26 123.36 22.81 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.156 -0.965 . . . . 0.0 108.607 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -52.99 -15.57 0.82 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 0.0 109.082 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.555 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 36.1 tt0 -69.38 -48.24 61.81 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.601 -0.687 . . . . 0.0 109.764 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.488 ' CG2' ' NH2' ' A' ' 40' ' ' ARG . 77.9 mt -57.83 -30.04 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.048 -1.032 . . . . 0.0 110.099 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.1 mt -67.51 -48.67 66.38 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -54.96 -35.81 64.66 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.555 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 55.8 m-80 -67.3 -22.02 65.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.412 -0.805 . . . . 0.0 110.379 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.28 -51.12 60.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.56 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.9 mt -107.63 -34.58 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.553 -0.717 . . . . 0.0 110.853 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -96.98 90.98 5.38 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.023 -1.048 . . . . 0.0 110.175 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.1 m -74.28 56.28 0.63 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.359 -0.838 . . . . 0.0 108.991 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.492 ' NE1' ' OD1' ' A' ' 56' ' ' ASN . 2.2 m-90 61.13 46.75 7.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.594 -0.692 . . . . 0.0 109.616 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -79.42 -99.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.185 -0.947 . . . . 0.0 109.302 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -76.67 -40.56 48.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.108 -0.995 . . . . 0.0 109.424 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 53.2 69.86 2.09 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.906 . . . . 0.0 109.602 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -45.45 162.74 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.629 2.219 . . . . 0.0 112.284 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.64 -51.97 11.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 109.598 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -175.93 174.66 2.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.87 . . . . 0.0 109.457 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.406 ' O ' ' OG1' ' A' ' 69' ' ' THR . 26.7 t30 52.22 61.76 3.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 109.552 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.409 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 87.1 m -166.07 -76.9 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.905 . . . . 0.0 109.39 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 pp -67.37 -38.25 84.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.354 -0.841 . . . . 0.0 109.698 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -60.77 -32.79 72.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.032 -1.042 . . . . 0.0 109.877 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.2 t -70.88 -40.11 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.089 -1.007 . . . . 0.0 109.45 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.409 ' ND1' ' O ' ' A' ' 69' ' ' THR . 17.1 m80 -55.74 -37.93 69.12 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.3 mt -66.07 -39.5 84.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -59.05 -36.02 74.31 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.365 -0.934 . . . . 0.0 108.918 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -76.14 -40.24 53.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.447 -0.783 . . . . 0.0 109.088 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -44.07 82.83 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -50.73 -50.28 55.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.388 -0.82 . . . . 0.0 110.228 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -61.74 -27.98 69.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.168 -0.957 . . . . 0.0 110.616 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -74.36 -44.27 52.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.937 -1.102 . . . . 0.0 110.862 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.8 pt -74.43 -21.2 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.854 -1.154 . . . . 0.0 110.212 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 81.27 82.73 0.8 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.413 ' O ' ' O ' ' A' ' 86' ' ' ILE . 18.1 pttp -45.48 -16.57 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.673 -0.898 . . . . 0.0 110.442 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 82' ' ' GLY . 78.8 p -53.66 -49.76 67.24 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.985 -1.072 . . . . 0.0 109.752 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 25.3 mmt-85 -79.34 11.02 3.17 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.313 -0.867 . . . . 0.0 110.402 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 87' ' ' ARG . 4.7 mp -138.86 163.56 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.088 -1.007 . . . . 0.0 109.268 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.416 ' N ' ' CG2' ' A' ' 86' ' ' ILE . 76.6 ttt180 -138.13 127.41 24.52 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.361 -0.837 . . . . 0.0 109.72 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.9 p -93.24 142.41 27.34 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.306 -0.871 . . . . 0.0 109.202 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.5 t -101.78 115.39 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.412 -0.805 . . . . 0.0 110.119 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 48.39 29.61 2.05 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.443 -0.786 . . . . 0.0 110.374 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.0 56.55 11.84 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.477 ' CZ ' ' CD2' ' A' ' 50' ' ' HIS . 22.2 t80 -138.79 -67.23 0.46 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.555 -0.968 . . . . 0.0 108.701 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.473 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . -106.91 -151.94 18.48 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.473 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 23.8 m-85 -151.33 157.62 42.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.422 -1.046 . . . . 0.0 108.565 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.418 ' C ' ' SD ' ' A' ' 95' ' ' MET . 1.5 tmt? -157.75 123.01 4.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.347 -0.845 . . . . 0.0 109.523 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.434 ' CD1' ' N ' ' A' ' 96' ' ' LEU . 9.2 mp -82.43 139.09 34.2 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.406 -0.808 . . . . 0.0 108.848 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 99' ' ' ASN . . . -55.89 113.48 1.52 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.929 . . . . 0.0 109.501 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -69.2 66.78 0.17 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 0.0 109.54 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 97' ' ' ALA . 11.3 t-20 51.5 44.45 29.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.203 -0.936 . . . . 0.0 109.754 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.5 mt -74.45 -7.87 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.24 -0.913 . . . . 0.0 108.741 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -57.5 -30.05 64.81 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.436 -0.79 . . . . 0.0 109.398 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 74.3 p -68.61 132.63 47.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 0.0 109.484 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.434 -179.942 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.0 m120 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.354 0.597 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -146.77 48.09 1.16 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.196 -0.94 . . . . 0.0 109.337 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 56.89 31.65 61.4 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 10.8 p-10 -54.06 147.74 12.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.182 -1.187 . . . . 0.0 109.341 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -164.99 124.87 1.88 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.141 -0.975 . . . . 0.0 109.444 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -163.48 156.06 18.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.465 -0.772 . . . . 0.0 109.474 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.7 pt -147.84 163.97 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.357 -0.839 . . . . 0.0 109.167 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.4 m -133.99 145.43 49.49 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.533 -0.729 . . . . 0.0 109.558 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.4 t -141.44 93.4 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.87 -109.5 2.83 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.65 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -105.84 4.1 29.37 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.593 -0.945 . . . . 0.0 109.865 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.4 mp -98.68 117.63 33.58 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.234 -0.917 . . . . 0.0 109.602 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 59.9 mtp85 -108.46 116.06 31.27 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.2 mp -103.11 136.13 43.49 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.482 -0.761 . . . . 0.0 109.428 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -134.98 98.71 4.08 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.7 t -71.64 -29.39 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.498 -0.751 . . . . 0.0 109.449 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -56.88 -52.7 64.13 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.42 -0.8 . . . . 0.0 109.231 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.6 mtp180 -97.01 -6.71 34.74 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.485 ' NH2' ' O ' ' A' ' 30' ' ' LEU . 1.4 tmt_? 55.23 81.73 0.11 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.81 0.814 . . . . 0.0 109.248 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -167.76 132.34 1.82 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.2 t -117.44 132.75 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.587 -0.695 . . . . 0.0 109.816 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -103.97 124.67 49.42 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.425 -0.797 . . . . 0.0 108.967 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.407 ' O ' ' OG1' ' A' ' 26' ' ' THR . 20.4 tp -104.15 111.77 24.5 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.68 37.4 93.48 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 107.311 -2.315 . . . . 0.0 107.311 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 69.89 2.11 3.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 122.35 -0.5 . . . . 0.0 109.826 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 33.5 p -103.65 138.06 40.83 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.129 -0.982 . . . . 0.0 109.97 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.9 113.14 5.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 110.225 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.3 tp -81.56 136.12 35.58 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -93.06 102.76 15.09 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.023 -1.048 . . . . 0.0 110.464 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.487 ' H ' ' CD2' ' A' ' 30' ' ' LEU . 1.3 pt? -128.53 136.52 50.88 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 p -55.05 152.99 12.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 120.99 -1.068 . . . . 0.0 108.865 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.06 -40.93 47.58 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 122.054 1.836 . . . . 0.0 111.26 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -55.81 -41.91 74.86 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.188 -0.945 . . . . 0.0 108.509 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -63.32 -36.34 83.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.456 -0.778 . . . . 0.0 109.114 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -56.25 -28.22 57.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.161 -0.962 . . . . 0.0 108.633 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.24 -50.91 34.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.315 -0.866 . . . . 0.0 108.891 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.424 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 8.4 mp -58.22 -39.96 80.4 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 12.8 tp -58.45 -41.99 86.36 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.509 ' C ' ' HE ' ' A' ' 40' ' ' ARG . 15.7 m -51.7 -35.48 43.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 109.17 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.509 ' HE ' ' C ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -76.38 -43.26 41.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.466 -0.771 . . . . 0.0 109.031 179.307 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.6 mt -59.7 -50.84 72.3 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.219 -0.926 . . . . 0.0 110.018 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -67.65 -36.45 80.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.923 -1.11 . . . . 0.0 110.196 -179.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.548 ' N ' ' SD ' ' A' ' 42' ' ' MET . 10.8 ttt -54.04 -28.4 38.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.089 -1.007 . . . . 0.0 108.96 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -122.34 44.54 2.59 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.37 132.16 49.32 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.195 -0.941 . . . . 0.0 109.909 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.17 -6.09 57.92 Favored Glycine 0 N--CA 1.501 3.032 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.3 m -132.75 150.82 76.81 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.591 -0.946 . . . . 0.0 108.718 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.07 120.25 5.65 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.803 1.669 . . . . 0.0 112.189 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.0 t -93.38 138.33 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -0.838 . . . . 0.0 109.273 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.473 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 10.4 t-160 -68.85 122.27 18.27 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.185 -0.947 . . . . 0.0 108.759 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -52.33 -17.12 1.03 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 109.266 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.558 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 68.5 mm-40 -66.53 -50.24 63.84 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.401 -0.812 . . . . 0.0 109.361 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.4 mt -55.0 -29.77 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.271 -0.893 . . . . 0.0 109.784 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.9 mt -72.95 -30.32 63.77 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.211 -0.931 . . . . 0.0 109.385 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -71.4 -34.13 70.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.752 -1.217 . . . . 0.0 107.837 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 24.4 m-80 -62.89 -20.82 65.51 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.362 0.601 . . . . 0.0 109.767 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.09 -54.53 43.55 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.814 -1.179 . . . . 0.0 109.507 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.8 mt -80.26 -38.08 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.509 -0.744 . . . . 0.0 110.538 -178.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.452 ' O ' ' O ' ' A' ' 56' ' ' ASN . 96.7 m-85 -110.17 162.81 14.23 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.421 -0.8 . . . . 0.0 109.932 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.3 m -169.16 -37.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.135 -0.978 . . . . 0.0 109.397 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 58.9 m95 -81.72 -26.56 34.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.302 -0.874 . . . . 0.0 109.853 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -158.3 120.01 3.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.188 -0.945 . . . . 0.0 109.457 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -60.48 -47.25 86.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 109.592 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 53.39 64.14 7.29 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.266 -0.896 . . . . 0.0 109.399 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -77.11 104.68 1.94 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.519 2.146 . . . . 0.0 112.102 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.58 -13.09 60.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.238 -0.914 . . . . 0.0 109.511 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.5 m 60.17 24.86 14.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.402 -0.811 . . . . 0.0 109.581 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.44 HD21 ' C ' ' A' ' 68' ' ' ASN . 0.5 OUTLIER -171.63 42.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -0.978 . . . . 0.0 109.513 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 68' ' ' ASN . 33.3 m -167.35 -35.98 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.47 -0.769 . . . . 0.0 109.07 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.488 ' CD1' ' H ' ' A' ' 70' ' ' LEU . 6.8 mp -59.77 -50.48 73.66 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.449 -0.782 . . . . 0.0 109.855 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -69.7 -26.01 64.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.094 -1.004 . . . . 0.0 109.754 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.6 t -75.23 -45.66 40.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.294 -0.879 . . . . 0.0 109.477 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -55.14 -37.45 66.96 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 89.0 mt -67.35 -40.45 84.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -59.78 -37.37 78.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.194 -0.941 . . . . 0.0 108.681 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.489 ' N ' HD21 ' A' ' 76' ' ' ASN . 1.4 m120 -72.71 -42.12 64.52 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.418 ' CD1' ' C ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -64.42 -41.23 96.71 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -49.72 -50.39 44.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.334 -0.854 . . . . 0.0 109.815 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -59.52 -31.78 69.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.873 . . . . 0.0 110.803 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -68.32 -45.5 72.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.875 -1.141 . . . . 0.0 109.817 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.4 pt -74.88 -31.94 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.014 -1.054 . . . . 0.0 109.924 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 86.0 87.9 0.98 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.409 ' O ' ' O ' ' A' ' 86' ' ' ILE . 22.7 pttm -45.54 -17.33 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.573 -0.957 . . . . 0.0 110.31 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 82' ' ' GLY . 48.4 t -56.51 -52.06 66.15 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.185 -0.947 . . . . 0.0 109.897 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -87.75 10.06 19.6 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.179 -0.95 . . . . 0.0 110.942 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.409 ' O ' ' O ' ' A' ' 83' ' ' LYS . 5.1 mp -133.08 164.04 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -140.85 128.02 20.89 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.075 -1.016 . . . . 0.0 110.085 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.2 p -88.57 142.24 27.86 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.498 -0.751 . . . . 0.0 109.096 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.7 t -102.12 112.0 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.368 -0.832 . . . . 0.0 110.236 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 47.11 34.47 2.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.443 -0.785 . . . . 0.0 110.552 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.4 54.8 11.92 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.473 ' CZ ' ' CD2' ' A' ' 50' ' ' HIS . 58.3 t80 -135.8 -74.71 0.45 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.471 -1.017 . . . . 0.0 108.73 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.456 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . -103.1 -153.08 24.02 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 12.1 m-85 -151.29 149.98 30.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.388 -1.066 . . . . 0.0 108.335 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.477 ' SD ' ' O ' ' A' ' 95' ' ' MET . 3.4 ppp? -149.22 127.45 12.11 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.212 -0.93 . . . . 0.0 109.542 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.8 mp -79.87 132.74 36.16 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.08 132.1 46.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.347 -0.846 . . . . 0.0 109.615 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.455 ' O ' ' ND2' ' A' ' 99' ' ' ASN . 28.9 m120 -55.04 -85.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 109.456 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 33.5 m120 -156.67 49.42 0.47 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.325 -0.86 . . . . 0.0 109.305 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 45.5 mt -68.67 -11.74 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.919 . . . . 0.0 108.83 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 0.9 OUTLIER -75.28 -8.22 56.06 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.659 -0.65 . . . . 0.0 109.357 179.742 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.5 t -58.05 -173.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.397 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.516 -179.979 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.523 ' H3 ' ' NE2' ' A' ' 2' ' ' GLN . 34.1 t30 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.523 ' NE2' ' H3 ' ' A' ' 1' ' ' ASN . 3.1 pm0 -154.8 45.4 0.52 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.334 -0.854 . . . . 0.0 109.312 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 83.42 15.48 71.27 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -166.1 175.63 8.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -1.162 . . . . 0.0 109.381 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 17' ' ' THR . 4.1 p30 -178.09 111.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -163.24 156.01 18.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 109.863 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.2 pt -146.38 163.12 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.347 -0.846 . . . . 0.0 109.084 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.8 t -134.49 142.15 46.97 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.336 -0.852 . . . . 0.0 109.8 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.77 92.88 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.55 -119.79 5.38 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -101.09 10.84 40.53 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.407 -1.055 . . . . 0.0 109.794 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.4 mt -108.33 123.59 49.04 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.413 -0.805 . . . . 0.0 109.672 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -108.1 146.98 31.87 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.6 tp -130.84 120.97 24.48 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.482 -0.762 . . . . 0.0 109.176 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 19' ' ' ARG . 13.2 m-20 -118.55 97.85 5.95 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.531 -0.731 . . . . 0.0 109.525 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.94 -27.51 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.449 -0.782 . . . . 0.0 109.216 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.463 ' N ' ' OD1' ' A' ' 5' ' ' ASN . 0.1 OUTLIER -63.18 -53.83 47.19 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.508 -0.745 . . . . 0.0 109.645 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.401 ' H ' HG21 ' A' ' 17' ' ' THR . 73.1 mtm180 -92.73 -14.62 27.71 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.153 -0.967 . . . . 0.0 108.814 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 15' ' ' ASN . 5.6 tpt180 68.18 61.31 0.4 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.312 0.577 . . . . 0.0 109.604 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.9 mt -138.89 156.65 47.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.38 -0.825 . . . . 0.0 108.973 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 t -143.69 127.73 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.255 -0.903 . . . . 0.0 109.388 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 12.3 m-90 -102.38 154.87 18.66 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.247 -0.908 . . . . 0.0 108.898 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.433 ' O ' ' OG1' ' A' ' 26' ' ' THR . 1.1 tt -144.5 115.09 7.68 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.439 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 63.5 43.47 98.08 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 107.805 -2.118 . . . . 0.0 107.805 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 61.28 0.43 0.42 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 122.129 -0.63 . . . . 0.0 110.213 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.439 ' H ' ' C ' ' A' ' 24' ' ' GLY . 68.1 p -106.47 139.85 40.29 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.215 -0.928 . . . . 0.0 109.452 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.03 114.56 3.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.412 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 32.2 tp -75.27 128.75 36.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.252 -0.905 . . . . 0.0 108.657 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -97.39 104.8 16.86 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.164 -0.96 . . . . 0.0 109.657 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.47 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 1.4 pt? -131.32 141.83 50.0 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.67 -0.644 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.3 p -62.36 152.19 80.29 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.155 -0.966 . . . . 0.0 109.961 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.04 -45.23 14.5 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.779 1.653 . . . . 0.0 112.013 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -53.63 -48.62 69.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.357 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -56.43 -35.26 67.64 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.324 -0.86 . . . . 0.0 109.536 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.401 ' OH ' ' O ' ' A' ' 15' ' ' ASN . 11.7 t80 -60.19 -32.97 71.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 109.198 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.82 -53.45 9.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.155 -0.966 . . . . 0.0 108.583 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 tt -55.94 -45.0 78.91 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.9 tp -64.46 -45.74 86.08 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.3 0.572 . . . . 0.0 109.739 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.8 t -50.59 -39.45 49.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.364 -0.835 . . . . 0.0 110.635 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.36 -41.68 24.29 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.916 -1.115 . . . . 0.0 109.87 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.6 tp -60.69 -41.83 95.94 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 109.325 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.1 mtp -72.35 -37.3 68.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.058 -1.026 . . . . 0.0 109.296 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 13.5 ttt -51.85 -27.3 12.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.28 -0.888 . . . . 0.0 108.766 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm -119.37 46.05 1.99 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.66 141.58 49.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.33 -0.856 . . . . 0.0 110.512 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.54 -22.14 40.63 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 t -114.43 152.99 46.61 Favored Pre-proline 0 N--CA 1.502 2.134 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.77 119.43 6.08 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.557 1.505 . . . . 0.0 111.629 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.8 t -97.11 133.69 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.293 -0.879 . . . . 0.0 110.047 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.586 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 17.9 t-160 -68.44 124.75 24.4 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.184 -0.948 . . . . 0.0 108.673 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -52.31 -18.71 1.69 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.345 -0.847 . . . . 0.0 109.008 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.526 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 58.4 tt0 -60.74 -57.15 13.9 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.46 -0.775 . . . . 0.0 109.379 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.2 mt -56.46 -30.67 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.238 -0.914 . . . . 0.0 109.735 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 33.8 mt -68.55 -32.53 72.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.096 -1.002 . . . . 0.0 108.959 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -74.1 -35.52 64.18 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 32.8 m-80 -61.19 -22.05 64.37 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -71.33 -54.03 12.18 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.386 -0.821 . . . . 0.0 109.751 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.5 mt -77.93 -26.19 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.349 -0.845 . . . . 0.0 110.227 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 56' ' ' ASN . 82.0 m-85 -143.22 -164.98 1.97 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.177 -0.952 . . . . 0.0 109.605 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.9 t 175.58 -31.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.346 -0.846 . . . . 0.0 109.101 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.432 ' O ' ' O ' ' A' ' 62' ' ' ASP . 61.0 m95 -78.71 -14.84 59.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.276 -0.89 . . . . 0.0 109.685 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 61' ' ' TRP . 34.0 m-20 50.8 101.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.533 -0.73 . . . . 0.0 110.151 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -73.08 -92.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.675 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -165.4 62.57 0.86 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.332 -0.855 . . . . 0.0 109.515 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.9 112.61 3.3 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.593 2.195 . . . . 0.0 111.962 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.76 -47.28 40.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.883 . . . . 0.0 109.612 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.0 m -164.67 -87.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 109.43 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -62.11 101.99 0.26 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.108 -0.995 . . . . 0.0 109.299 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 98.3 m -165.59 -87.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -0.876 . . . . 0.0 109.352 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.5 pp -68.1 -33.0 73.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.733 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.455 ' O ' ' CD2' ' A' ' 75' ' ' HIS . 75.7 mm-40 -60.23 -32.09 70.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.022 -1.049 . . . . 0.0 110.026 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.1 t -73.84 -45.68 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.039 -1.038 . . . . 0.0 109.279 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.486 ' ND1' ' N ' ' A' ' 73' ' ' HIS . 1.5 m-70 -55.86 -37.49 68.84 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 86.8 mt -67.79 -39.79 82.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.455 ' CD2' ' O ' ' A' ' 71' ' ' GLU . 34.6 m170 -61.25 -35.84 78.38 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.969 -1.082 . . . . 0.0 108.752 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -74.49 -41.66 60.33 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.479 -0.763 . . . . 0.0 109.017 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.11 -42.83 75.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 0.0 108.85 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -50.82 -50.64 56.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -0.857 . . . . 0.0 110.726 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -64.71 -26.07 68.21 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.036 -1.04 . . . . 0.0 110.769 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -71.44 -45.35 62.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.856 -1.152 . . . . 0.0 110.077 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 21.7 pt -74.84 -22.29 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.122 -0.986 . . . . 0.0 110.09 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 81.6 84.39 0.76 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.576 -1.81 . . . . 0.0 108.576 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 86' ' ' ILE . 18.3 pttp -45.1 -17.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.658 -0.907 . . . . 0.0 110.425 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 82' ' ' GLY . 36.7 p -54.78 -48.73 72.31 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.168 -0.957 . . . . 0.0 109.751 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.83 9.58 4.09 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.056 -1.028 . . . . 0.0 109.893 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.407 ' O ' ' O ' ' A' ' 83' ' ' LYS . 5.2 mp -134.46 159.56 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.214 -0.929 . . . . 0.0 109.307 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -140.73 124.39 17.01 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.419 -0.8 . . . . 0.0 109.689 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.8 p -86.75 138.63 31.45 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.287 -0.883 . . . . 0.0 109.285 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.8 t -101.58 121.0 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.375 -0.828 . . . . 0.0 110.535 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 49.7 ttp85 47.87 28.38 1.36 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.569 -0.707 . . . . 0.0 110.343 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.37 49.18 26.4 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.586 ' CZ ' ' CD2' ' A' ' 50' ' ' HIS . 25.2 t80 -137.11 -69.37 0.46 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.578 -0.954 . . . . 0.0 108.432 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.433 ' N ' ' CD2' ' A' ' 92' ' ' PHE . . . -100.44 -151.39 25.5 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.428 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 22.7 m-85 -149.51 158.06 43.84 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 45.6 ttp -159.81 126.61 4.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.204 -0.935 . . . . 0.0 110.075 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.4 mp -84.3 131.88 34.68 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.02 127.14 27.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.189 -0.944 . . . . 0.0 109.215 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -51.47 -69.45 0.11 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.238 -0.913 . . . . 0.0 109.629 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -158.55 40.22 0.24 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.376 -0.827 . . . . 0.0 109.252 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 41.0 mt -84.85 -10.72 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 121.889 0.852 . . . . 0.0 108.821 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -61.24 -33.36 73.38 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.548 -0.72 . . . . 0.0 109.547 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.7 p -75.47 169.49 17.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.208 -0.932 . . . . 0.0 109.362 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.462 -179.995 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.686 ' H1 ' HD21 ' A' ' 1' ' ' ASN . 1.4 m120 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 67.7 58.48 0.5 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 4' ' ' ASP . . . 162.73 -37.94 0.35 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 3' ' ' GLY . 18.6 m-20 51.14 -179.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.451 -1.029 . . . . 0.0 109.768 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.469 ' C ' HD21 ' A' ' 5' ' ' ASN . 0.4 OUTLIER -161.92 125.01 3.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 108.952 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -150.26 146.5 26.83 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.554 -0.716 . . . . 0.0 109.492 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.3 pt -148.92 163.44 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.271 -0.893 . . . . 0.0 108.905 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.1 t -143.24 152.79 42.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.201 -0.937 . . . . 0.0 109.712 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.1 t -147.35 92.92 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.91 -114.84 4.08 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.7 m-20 -103.09 6.19 38.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.421 -1.046 . . . . 0.0 109.893 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.8 mt -101.78 118.31 36.66 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.351 -0.843 . . . . 0.0 109.887 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -110.84 118.97 37.56 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 mp -106.88 126.47 52.35 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.552 -0.717 . . . . 0.0 109.309 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -122.72 97.91 5.67 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.97 -27.34 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.432 -0.792 . . . . 0.0 109.576 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.404 HG21 ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -63.74 -49.11 74.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.273 -0.892 . . . . 0.0 109.867 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.404 ' H ' HG21 ' A' ' 17' ' ' THR . 47.2 mtp85 -97.14 -7.75 31.79 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.164 -0.96 . . . . 0.0 108.611 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? 56.0 73.35 0.44 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 tt -157.7 128.13 6.34 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 t -114.73 136.72 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.499 -0.75 . . . . 0.0 110.264 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 29.0 m-90 -108.18 133.16 52.83 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.411 ' O ' ' OG1' ' A' ' 26' ' ' THR . 1.2 tt -113.75 110.11 19.64 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.37 39.0 91.66 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 107.623 -2.191 . . . . 0.0 107.623 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 69.65 -0.45 2.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 122.324 -0.515 . . . . 0.0 110.025 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 60.7 p -101.93 138.99 38.16 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.064 -1.023 . . . . 0.0 109.789 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.98 112.46 1.34 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 110.012 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.4 tp -75.43 127.89 34.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 108.839 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -92.24 98.76 11.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.115 -0.991 . . . . 0.0 109.926 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.51 ' H ' ' CD2' ' A' ' 30' ' ' LEU . 1.3 pt? -123.84 134.28 53.62 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 121.509 0.671 . . . . 0.0 109.341 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.0 p -59.57 149.15 72.0 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.997 -1.065 . . . . 0.0 109.463 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -45.01 -48.37 11.05 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.719 1.613 . . . . 0.0 112.117 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -54.67 -37.43 65.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.419 -0.801 . . . . 0.0 109.882 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -67.55 -35.06 78.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.095 -1.003 . . . . 0.0 109.261 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -59.12 -33.4 70.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.042 -1.036 . . . . 0.0 108.72 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.53 -53.05 17.7 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.9 tt -52.16 -50.3 62.07 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 13.1 tp -56.09 -40.09 73.13 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.169 0.509 . . . . 0.0 109.854 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.8 m -52.42 -33.31 43.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 109.744 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.492 HH21 ' CE ' ' A' ' 43' ' ' MET . 10.5 mmp_? -78.55 -42.66 28.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.97 . . . . 0.0 109.456 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 17.9 mt -59.22 -48.05 83.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.959 -1.088 . . . . 0.0 110.011 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.417 ' SD ' ' C ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -70.36 -25.96 63.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.985 -1.072 . . . . 0.0 109.746 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.492 ' CE ' HH21 ' A' ' 40' ' ' ARG . 40.2 ttm -61.77 -32.67 72.95 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.161 -0.962 . . . . 0.0 108.872 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -118.13 38.91 3.54 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.79 121.3 9.53 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.262 -0.899 . . . . 0.0 109.753 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.32 -6.85 30.38 Favored Glycine 0 N--CA 1.503 3.14 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.3 m -130.28 151.68 78.9 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 121.535 -0.98 . . . . 0.0 108.771 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.72 120.4 5.51 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.859 1.706 . . . . 0.0 112.186 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.5 t -87.77 131.68 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.241 -0.912 . . . . 0.0 109.78 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.417 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 22.7 t-160 -67.15 129.34 39.57 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.309 -0.87 . . . . 0.0 108.675 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.446 ' NH2' ' OE1' ' A' ' 71' ' ' GLU . 13.0 ptm180 -54.04 -22.2 10.15 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.473 -0.767 . . . . 0.0 109.394 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.576 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 38.2 tt0 -72.79 -36.24 67.54 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.524 -0.735 . . . . 0.0 110.409 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.9 mt -75.64 -35.37 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.433 -0.792 . . . . 0.0 111.66 -178.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.401 ' CD1' ' C ' ' A' ' 54' ' ' LEU . 4.2 pp -76.34 -22.43 54.92 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.818 -1.176 . . . . 0.0 109.474 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.561 ' CZ ' ' CD1' ' A' ' 59' ' ' TYR . 63.4 t80 -64.88 -33.36 75.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.903 . . . . 0.0 109.521 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.662 ' ND2' ' H ' ' A' ' 56' ' ' ASN . 0.4 OUTLIER -61.54 -23.69 66.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 109.669 -179.495 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.17 -56.74 18.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.386 -0.822 . . . . 0.0 110.175 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.413 HG22 HD12 ' A' ' 58' ' ' ILE . 70.5 mt -73.63 -37.7 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.323 -0.861 . . . . 0.0 110.452 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.561 ' CD1' ' CZ ' ' A' ' 55' ' ' TYR . 88.9 m-85 -110.12 133.8 52.85 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.495 -0.753 . . . . 0.0 109.854 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.4 m -77.13 42.28 0.32 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.192 -0.943 . . . . 0.0 109.14 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.413 ' H ' ' C ' ' A' ' 59' ' ' TYR . 21.2 t90 53.88 44.1 29.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.344 -0.847 . . . . 0.0 109.432 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.419 ' O ' ' O ' ' A' ' 63' ' ' ASN . 12.7 t70 -80.87 -33.7 34.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.239 -0.913 . . . . 0.0 109.663 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 62' ' ' ASP . 2.2 m120 60.51 120.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.518 -0.739 . . . . 0.0 109.782 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.403 ' N ' ' CD ' ' A' ' 65' ' ' PRO . 0.9 OUTLIER -178.45 -51.16 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.298 -0.877 . . . . 0.0 109.546 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.403 ' CD ' ' N ' ' A' ' 64' ' ' GLU . 64.5 Cg_endo -85.44 81.98 1.69 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.066 1.844 . . . . 0.0 112.07 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.94 -19.15 59.0 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.883 . . . . 0.0 109.587 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 62.8 p -61.95 175.06 0.73 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.64 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.515 HD21 ' N ' ' A' ' 68' ' ' ASN . 1.5 m120 -76.16 110.25 10.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.895 . . . . 0.0 109.553 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.455 ' HG1' ' C ' ' A' ' 68' ' ' ASN . 23.7 m -165.93 -35.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.877 . . . . 0.0 109.353 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.432 ' CD2' ' H ' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -70.54 -49.28 49.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.373 -0.83 . . . . 0.0 108.892 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.446 ' OE1' ' NH2' ' A' ' 51' ' ' ARG . 29.8 tp10 -69.87 -31.23 68.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.574 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.9 t -72.4 -40.11 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.181 -0.95 . . . . 0.0 109.0 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -56.95 -39.3 74.31 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 89.9 mt -63.82 -35.9 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -61.97 -32.4 72.84 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.48 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -73.04 -41.78 63.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.505 -0.747 . . . . 0.0 109.255 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.8 mt -72.26 -39.39 68.43 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.227 -0.921 . . . . 0.0 109.544 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -50.32 -51.48 44.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.959 . . . . 0.0 110.181 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.43 -24.79 67.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.055 -1.028 . . . . 0.0 109.803 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -70.95 -45.92 63.31 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.984 -1.073 . . . . 0.0 110.135 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.3 pt -74.89 -19.29 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.104 -0.997 . . . . 0.0 110.121 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 84.19 83.07 0.98 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 86' ' ' ILE . 56.4 pttt -44.51 -17.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.721 -0.87 . . . . 0.0 110.59 -179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 82' ' ' GLY . 57.9 m -59.38 -48.42 81.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.138 -0.976 . . . . 0.0 110.777 -178.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.483 ' N ' ' CD ' ' A' ' 85' ' ' ARG . 10.6 mpt_? -72.72 9.42 1.12 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.025 -1.047 . . . . 0.0 111.003 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' A' ' 83' ' ' LYS . 9.0 tt -146.82 160.96 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 120.934 -1.104 . . . . 0.0 109.29 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -117.1 132.44 56.67 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.42 -0.8 . . . . 0.0 109.703 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.7 p -95.39 142.47 27.74 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.414 -0.804 . . . . 0.0 108.89 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.6 t -101.74 92.75 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.352 -0.843 . . . . 0.0 109.787 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.8 mtp85 47.52 32.31 2.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.317 -0.865 . . . . 0.0 110.461 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.22 0.99 6.41 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.491 ' CD2' ' N ' ' A' ' 93' ' ' GLY . 60.0 t80 -74.61 -81.73 0.07 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.078 -1.248 . . . . 0.0 108.536 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.491 ' N ' ' CD2' ' A' ' 92' ' ' PHE . . . -105.17 -150.41 19.8 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.472 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 26.0 m-85 -151.21 163.31 39.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.421 -1.046 . . . . 0.0 108.305 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.46 ' SD ' ' O ' ' A' ' 96' ' ' LEU . 1.2 tmt? -163.27 127.79 2.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.981 -1.074 . . . . 0.0 110.261 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.46 ' O ' ' SD ' ' A' ' 95' ' ' MET . 9.6 mp -78.49 142.02 37.77 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.7 120.73 20.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 109.486 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -53.29 -24.8 12.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 109.645 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.428 ' N ' ' OD1' ' A' ' 99' ' ' ASN . 12.6 p-10 -171.25 111.06 0.33 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.279 -0.888 . . . . 0.0 109.483 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.8 mt -70.39 -12.61 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 108.688 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 102' ' ' THR . 18.3 p30 -173.83 -17.97 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.414 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 8.5 m -74.01 56.47 0.6 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.239 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.545 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 20.2 m120 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.393 0.616 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 48.85 61.0 3.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.289 -0.882 . . . . 0.0 109.559 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 164.67 -36.49 0.29 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -77.81 142.56 38.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.295 -1.121 . . . . 0.0 109.297 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -158.26 120.27 3.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.241 -0.912 . . . . 0.0 109.321 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -162.44 154.57 18.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.333 -0.855 . . . . 0.0 109.706 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.8 pt -150.44 164.65 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.5 p -140.39 154.0 46.55 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.294 -0.879 . . . . 0.0 110.028 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.3 t -148.33 93.43 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.67 -115.19 4.19 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -101.44 5.35 41.99 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.396 -1.061 . . . . 0.0 109.837 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.2 mt -101.06 116.24 32.37 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.334 -0.854 . . . . 0.0 109.715 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -108.94 122.04 46.38 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.494 ' C ' HD21 ' A' ' 15' ' ' ASN . 37.1 tp -105.95 134.74 48.6 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.597 -0.69 . . . . 0.0 110.006 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.494 HD21 ' C ' ' A' ' 14' ' ' LEU . 0.9 OUTLIER -131.78 97.36 4.17 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.228 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.9 t -71.89 -27.9 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.317 -0.864 . . . . 0.0 109.403 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.404 HG21 ' H ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -63.7 -54.75 30.65 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.503 -0.748 . . . . 0.0 109.656 -179.93 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.404 ' H ' HG21 ' A' ' 17' ' ' THR . 74.2 mtp180 -86.9 -11.6 50.19 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.169 -0.957 . . . . 0.0 108.697 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 60.29 72.23 0.53 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.441 0.639 . . . . 0.0 109.329 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.5 tp -166.8 153.63 8.83 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.5 t -134.59 135.52 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.298 -0.876 . . . . 0.0 109.876 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 20.0 m-90 -100.0 120.37 39.72 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 26' ' ' THR . 1.2 tt -101.91 110.51 22.5 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.55 43.45 96.54 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 107.212 -2.355 . . . . 0.0 107.212 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 64.75 3.37 1.98 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 122.338 -0.507 . . . . 0.0 110.269 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 23' ' ' LEU . 43.8 p -106.03 138.48 42.14 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 120.95 -1.094 . . . . 0.0 109.711 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.71 113.31 2.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.973 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 29.1 tp -71.04 126.25 29.06 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -96.91 104.93 16.98 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.22 -0.925 . . . . 0.0 110.695 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.512 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 1.1 pt? -143.09 151.48 40.8 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.44 -0.788 . . . . 0.0 109.354 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.08 157.35 62.68 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.141 -0.975 . . . . 0.0 108.71 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -60.8 -39.77 59.72 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.457 2.105 . . . . 0.0 112.069 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -54.54 -36.27 64.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.073 -1.017 . . . . 0.0 109.102 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.486 ' OE2' ' NE2' ' A' ' 73' ' ' HIS . 20.5 mm-40 -70.18 -37.73 75.21 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.449 ' HH ' ' CD1' ' A' ' 14' ' ' LEU . 28.6 t80 -55.25 -27.86 49.28 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.421 ' O ' ' OD2' ' A' ' 57' ' ' ASP . . . -72.83 -50.49 23.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.383 -0.823 . . . . 0.0 109.002 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.471 ' CD2' ' O ' ' A' ' 54' ' ' LEU . 9.9 mt -65.71 -37.73 87.24 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tt -57.58 -42.44 83.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.511 -0.743 . . . . 0.0 109.446 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.5 p -60.78 -45.86 92.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.11 -0.994 . . . . 0.0 109.275 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -55.24 -48.06 74.49 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.368 -0.832 . . . . 0.0 109.29 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.1 mt -61.65 -39.29 90.83 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 109.991 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 8.1 mmt -74.7 -37.03 62.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.874 -1.141 . . . . 0.0 109.888 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 40.5 mtt -55.14 -29.31 57.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.119 -0.988 . . . . 0.0 108.699 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -120.81 47.85 1.73 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.86 129.97 39.89 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.197 -0.94 . . . . 0.0 110.064 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.33 -12.98 43.98 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.8 p -125.75 151.43 70.86 Favored Pre-proline 0 N--CA 1.502 2.165 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.1 119.74 6.2 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.637 1.558 . . . . 0.0 111.709 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.4 t -94.67 135.34 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.349 -0.845 . . . . 0.0 109.81 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.413 ' C ' ' N ' ' A' ' 52' ' ' GLU . 8.2 t-160 -72.72 125.12 26.76 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.044 -1.035 . . . . 0.0 108.492 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.482 ' N ' ' CD ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -50.83 -15.18 0.26 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.489 -0.757 . . . . 0.0 109.787 -179.281 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.544 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 17.2 tt0 -66.47 -49.12 67.69 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.498 -0.751 . . . . 0.0 109.866 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.2 mm -56.24 -33.14 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.034 -1.041 . . . . 0.0 109.93 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.471 ' O ' ' CD2' ' A' ' 37' ' ' LEU . 22.7 mt -65.93 -48.95 69.67 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.524 ' CE1' ' CD2' ' A' ' 59' ' ' TYR . 34.0 t80 -57.67 -35.98 71.29 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 68.7 m-80 -66.84 -21.79 66.01 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.528 -0.733 . . . . 0.0 110.693 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.421 ' OD2' ' O ' ' A' ' 36' ' ' ALA . 7.2 t0 -56.85 -54.7 43.46 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.764 -1.21 . . . . 0.0 109.347 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.8 mm -94.72 -36.46 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.348 -0.845 . . . . 0.0 110.081 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.524 ' CD2' ' CE1' ' A' ' 55' ' ' TYR . 74.9 m-85 -99.6 -174.59 2.76 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.199 -0.938 . . . . 0.0 109.638 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.3 p -173.57 -29.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.474 -0.766 . . . . 0.0 109.372 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.47 ' C ' ' H ' ' A' ' 63' ' ' ASN . 41.1 p-90 -157.58 -9.68 0.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 0.0 109.313 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -74.61 15.05 0.4 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.325 -0.859 . . . . 0.0 109.337 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.47 ' H ' ' C ' ' A' ' 61' ' ' TRP . 12.9 m-80 -50.16 -95.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.429 -0.795 . . . . 0.0 109.976 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.488 ' O ' ' N ' ' A' ' 66' ' ' ALA . 30.5 tt0 53.44 69.3 2.33 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.462 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -45.59 82.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.766 2.311 . . . . 0.0 112.5 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 64' ' ' GLU . . . -82.96 -37.08 24.56 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.02 -1.05 . . . . 0.0 109.348 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.7 m -165.13 161.12 19.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.337 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.401 ' O ' ' OG1' ' A' ' 69' ' ' THR . 45.1 m-80 -52.02 126.56 18.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -0.938 . . . . 0.0 109.6 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 68' ' ' ASN . 75.3 m -165.79 -46.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.417 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.456 ' CD1' ' H ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -55.49 -50.38 70.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.239 -0.913 . . . . 0.0 109.201 -179.684 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -71.57 -27.44 63.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 110.138 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.65 -48.24 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.105 -0.997 . . . . 0.0 109.413 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.486 ' NE2' ' OE2' ' A' ' 34' ' ' GLU . 81.4 t60 -54.73 -36.72 65.07 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 74' ' ' ILE . 90.5 mt -71.61 -42.45 71.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -61.39 -35.43 77.48 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.816 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -74.07 -40.86 62.48 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.512 -0.743 . . . . 0.0 109.402 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.428 ' CD1' ' C ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -67.71 -42.51 81.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 108.665 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.483 ' NH2' ' OH ' ' A' ' 94' ' ' TYR . 35.6 ttm180 -49.85 -51.29 41.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.524 -0.735 . . . . 0.0 110.448 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -62.16 -27.71 69.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 110.642 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -74.47 -45.04 48.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.981 -1.074 . . . . 0.0 110.94 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.7 pt -76.83 -22.23 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.821 -1.175 . . . . 0.0 110.638 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 83.93 82.12 0.99 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.2 pttt -45.07 -15.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.707 -0.878 . . . . 0.0 110.658 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 82' ' ' GLY . 65.1 p -49.44 -45.53 46.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.954 -1.091 . . . . 0.0 109.841 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.497 ' HE ' ' N ' ' A' ' 85' ' ' ARG . 5.4 mmp_? -84.25 9.5 12.79 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.189 -0.944 . . . . 0.0 110.295 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 37.2 mm -116.95 161.5 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 121.372 -0.83 . . . . 0.0 109.617 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 47.4 ttt85 -134.04 110.46 9.66 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.3 p -87.37 138.14 31.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.145 -0.972 . . . . 0.0 110.274 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.7 t -102.07 100.03 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.539 -0.726 . . . . 0.0 109.597 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.498 ' C ' ' H ' ' A' ' 92' ' ' PHE . 15.5 mmt85 52.24 28.01 5.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.306 -0.871 . . . . 0.0 109.726 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.65 0.98 2.26 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.539 ' CD2' ' N ' ' A' ' 93' ' ' GLY . 41.4 t80 -73.29 -87.79 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.309 -1.112 . . . . 0.0 108.761 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.539 ' N ' ' CD2' ' A' ' 92' ' ' PHE . . . -95.23 -149.52 25.82 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.483 ' OH ' ' NH2' ' A' ' 78' ' ' ARG . 28.0 m-85 -151.21 159.84 44.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.299 -1.118 . . . . 0.0 108.585 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 43.1 ttp -161.15 131.69 5.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 110.065 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.416 ' CD1' ' N ' ' A' ' 96' ' ' LEU . 9.3 mp -89.64 133.13 34.79 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.17 114.06 1.62 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 109.729 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -77.57 98.78 5.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.294 -0.878 . . . . 0.0 109.243 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.4 m120 50.85 94.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.227 -0.92 . . . . 0.0 109.689 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.3 mt -58.07 -12.38 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 108.873 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 0.7 OUTLIER -73.99 -37.33 64.47 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.641 -0.662 . . . . 0.0 109.444 179.739 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.5 m 52.24 81.74 0.08 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.315 -0.866 . . . . 0.0 109.658 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.489 -179.954 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -72.52 57.38 0.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.884 . . . . 0.0 109.533 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -157.15 19.54 0.4 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.6 p30 -172.08 172.74 4.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.322 -1.105 . . . . 0.0 109.394 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -158.83 123.93 4.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 108.924 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -161.32 152.36 18.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.394 -0.816 . . . . 0.0 109.546 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.5 mt -137.04 159.97 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.2 m -142.9 146.69 34.29 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.39 -0.819 . . . . 0.0 109.732 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.5 t -142.66 94.65 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.01 -119.41 4.95 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.555 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 0.8 OUTLIER -100.96 10.11 41.49 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.37 -1.076 . . . . 0.0 109.34 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 17.7 tp -104.45 127.85 52.23 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -123.53 135.65 54.13 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 tt -129.2 121.44 27.67 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.622 -0.674 . . . . 0.0 109.582 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -112.12 107.11 15.91 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.629 -0.669 . . . . 0.0 110.241 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.1 t -71.9 -28.58 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.284 -0.885 . . . . 0.0 109.561 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.69 -54.7 20.33 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.368 -0.832 . . . . 0.0 109.303 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -84.01 -18.78 35.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.115 -0.991 . . . . 0.0 108.665 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? 66.11 65.92 0.5 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.9 mt -148.01 158.23 43.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.236 -0.915 . . . . 0.0 108.661 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.7 t -140.35 128.63 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.324 -0.86 . . . . 0.0 109.58 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -103.86 148.0 26.65 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.415 -0.803 . . . . 0.0 109.35 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.9 tp -133.83 102.53 5.48 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.467 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 71.85 40.87 57.06 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.315 -1.914 . . . . 0.0 108.315 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 70.62 -10.86 0.67 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 122.034 -0.686 . . . . 0.0 109.695 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.467 ' H ' ' C ' ' A' ' 24' ' ' GLY . 44.3 p -92.85 142.81 26.91 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.077 -1.014 . . . . 0.0 109.638 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.71 116.68 7.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 110.121 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.3 tp -75.14 130.57 39.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.263 -0.898 . . . . 0.0 108.604 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 29' ' ' ASP . 9.5 p-10 -97.45 102.79 14.64 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.231 -0.918 . . . . 0.0 110.046 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 1.4 pt? -131.29 140.94 49.88 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.0 p -64.59 151.21 92.48 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.026 -1.046 . . . . 0.0 109.703 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -44.71 -44.58 14.03 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 121.734 1.623 . . . . 0.0 112.087 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -53.6 -46.22 70.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 109.325 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -55.55 -44.77 77.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.918 . . . . 0.0 109.786 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -56.29 -28.11 57.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.411 -0.805 . . . . 0.0 109.921 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.64 -54.12 8.04 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.908 -1.12 . . . . 0.0 109.681 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 tt -58.28 -42.73 87.2 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 22.4 tp -62.32 -43.08 99.66 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.291 0.567 . . . . 0.0 109.488 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.8 m -51.44 -36.14 42.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.78 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -77.14 -39.25 49.96 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.738 -1.226 . . . . 0.0 109.725 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.7 mt -57.4 -43.99 84.18 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.097 -1.002 . . . . 0.0 108.961 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.3 mmt -67.93 -28.91 67.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.053 -1.029 . . . . 0.0 109.66 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 24.6 ttt -61.59 -33.16 73.41 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.183 -0.948 . . . . 0.0 108.907 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -124.01 47.32 2.08 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.867 -0.521 . . . . 0.0 109.64 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.45 136.95 52.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.108 -0.995 . . . . 0.0 110.254 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.45 -13.99 61.04 Favored Glycine 0 N--CA 1.501 2.984 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.2 p -119.9 151.32 52.34 Favored Pre-proline 0 N--CA 1.502 2.162 0 O-C-N 121.56 -0.965 . . . . 0.0 108.566 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.03 120.2 5.96 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.639 1.559 . . . . 0.0 111.519 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.0 t -100.0 138.38 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.489 -0.757 . . . . 0.0 109.87 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.439 ' C ' ' N ' ' A' ' 52' ' ' GLU . 18.2 t-160 -79.56 126.35 30.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.344 -0.848 . . . . 0.0 108.764 178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.7 ttp-105 -51.06 -16.77 0.5 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 108.816 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.555 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 31.7 tt0 -65.05 -39.02 92.68 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.5 mt -73.54 -35.05 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.273 0.559 . . . . 0.0 109.529 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.9 mt -73.84 -25.03 59.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.174 -0.954 . . . . 0.0 108.906 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.57 ' HH ' ' CB ' ' A' ' 70' ' ' LEU . 2.6 t80 -60.21 -37.01 78.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.001 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.691 HD21 ' H ' ' A' ' 56' ' ' ASN . 0.6 OUTLIER -59.13 -28.07 66.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.519 -0.738 . . . . 0.0 109.918 -179.447 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.9 -54.39 19.2 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.341 -0.849 . . . . 0.0 110.047 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.6 mm -70.92 -28.8 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.244 -0.91 . . . . 0.0 110.239 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -49.95 -67.09 0.29 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.101 -1.0 . . . . 0.0 109.497 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.0 t 54.98 13.55 0.78 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.405 -0.809 . . . . 0.0 109.608 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 3.6 m0 52.8 50.04 18.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 109.658 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -157.2 -33.75 0.08 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.184 -0.947 . . . . 0.0 109.68 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -59.25 -35.24 73.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.209 -0.932 . . . . 0.0 109.55 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 52.76 76.37 0.54 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.174 -0.954 . . . . 0.0 109.585 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -46.43 105.04 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.597 2.198 . . . . 0.0 112.373 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.07 -52.2 7.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.272 -0.893 . . . . 0.0 109.654 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.4 ' OG1' ' N ' ' A' ' 68' ' ' ASN . 9.0 t -171.15 -153.69 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.256 -0.903 . . . . 0.0 109.516 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.411 ' O ' ' OG1' ' A' ' 69' ' ' THR . 30.4 m120 -57.7 98.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.444 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 68' ' ' ASN . 99.4 m -167.15 -36.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.462 -0.774 . . . . 0.0 109.074 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.57 ' CB ' ' HH ' ' A' ' 55' ' ' TYR . 2.1 mm? -64.49 -49.36 71.68 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.296 -0.878 . . . . 0.0 109.166 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.14 -34.68 78.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.896 -1.128 . . . . 0.0 108.781 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.6 t -69.1 -35.33 68.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.16 -38.57 80.04 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.96 -36.66 77.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -62.73 -34.22 76.74 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.789 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -77.37 -41.68 39.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.489 -0.757 . . . . 0.0 109.306 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.413 ' CD1' ' C ' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -71.73 -39.22 70.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.292 -0.88 . . . . 0.0 109.276 -179.065 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -56.46 -47.78 78.45 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.775 -0.578 . . . . 0.0 110.62 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -62.3 -15.2 46.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.076 -1.015 . . . . 0.0 110.847 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -88.2 -39.64 14.33 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.849 -1.157 . . . . 0.0 110.681 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.2 pt -81.52 -15.74 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.028 -1.045 . . . . 0.0 110.131 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 78.93 85.82 0.54 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -44.78 -16.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.638 -0.919 . . . . 0.0 110.539 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 82' ' ' GLY . 52.0 p -50.01 -44.74 51.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.601 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -75.29 8.79 2.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.18 -0.95 . . . . 0.0 109.971 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.1 mt -137.56 127.71 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.335 -0.853 . . . . 0.0 108.933 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -97.8 98.09 9.54 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.394 -0.816 . . . . 0.0 109.058 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.9 p -67.43 131.23 45.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -0.945 . . . . 0.0 109.336 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.1 t -101.01 110.85 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.487 -0.758 . . . . 0.0 110.246 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.512 ' C ' ' H ' ' A' ' 92' ' ' PHE . 65.4 mtp85 47.88 20.4 0.23 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.482 -0.761 . . . . 0.0 110.254 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.98 -2.2 2.2 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.546 ' CD2' ' N ' ' A' ' 93' ' ' GLY . 25.4 t80 -75.76 -77.36 0.13 Allowed 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.31 -1.112 . . . . 0.0 108.428 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.546 ' N ' ' CD2' ' A' ' 92' ' ' PHE . . . -98.84 -149.23 24.43 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.422 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 31.4 m-85 -151.98 159.74 43.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -1.131 . . . . 0.0 108.795 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 38.8 ttp -161.94 135.1 6.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.278 -0.889 . . . . 0.0 110.188 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.417 ' CD1' ' N ' ' A' ' 96' ' ' LEU . 9.3 mp -93.12 130.6 38.7 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.44 -0.788 . . . . 0.0 108.921 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.2 123.77 25.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 109.558 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -80.13 107.72 13.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.233 -0.917 . . . . 0.0 109.488 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.479 ' C ' ' H ' ' A' ' 101' ' ' ASP . 63.3 m-20 51.26 93.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.314 -0.866 . . . . 0.0 109.823 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.9 mt -69.05 1.84 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.479 ' H ' ' C ' ' A' ' 99' ' ' ASN . 4.0 t70 72.8 45.21 0.33 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.7 m -163.34 145.25 9.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.367 -0.833 . . . . 0.0 109.477 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.434 -179.992 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.324 0.583 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.412 ' N ' ' OD1' ' A' ' 5' ' ' ASN . 8.7 p30 -171.14 124.74 0.63 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 109.213 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 1.3 pm0 -160.64 155.98 24.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.392 -0.818 . . . . 0.0 109.831 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 7' ' ' ILE . 21.9 pt -147.17 163.03 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.338 -0.851 . . . . 0.0 109.012 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m -143.74 154.36 43.38 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.238 -0.914 . . . . 0.0 109.712 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.5 t -142.67 99.09 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.15 -119.69 5.69 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -99.29 11.37 39.27 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.455 -1.027 . . . . 0.0 109.738 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 29.6 mt -106.82 130.62 54.48 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.356 -0.84 . . . . 0.0 109.455 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -118.59 141.05 48.96 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.1 tt -129.05 143.53 50.9 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.618 -0.676 . . . . 0.0 109.525 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 19' ' ' ARG . 3.3 m-20 -135.48 100.7 4.58 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.622 -0.674 . . . . 0.0 109.721 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.85 -30.34 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.363 -0.835 . . . . 0.0 109.564 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.427 ' H ' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER -60.75 -49.32 77.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.444 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -93.73 -14.53 26.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.129 -0.982 . . . . 0.0 108.378 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 15' ' ' ASN . 5.7 tpt180 64.41 49.25 2.52 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.873 -0.517 . . . . 0.0 109.742 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.3 mt -133.69 153.08 51.96 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.9 t -133.87 134.27 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.422 -0.799 . . . . 0.0 109.319 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -103.17 158.68 16.15 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.429 ' O ' ' OG1' ' A' ' 26' ' ' THR . 1.9 tt -146.41 116.92 7.52 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.27 -0.894 . . . . 0.0 108.714 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.64 41.65 97.66 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 107.727 -2.149 . . . . 0.0 107.727 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 61.63 3.48 0.86 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 122.089 -0.654 . . . . 0.0 110.077 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 60.6 p -108.35 140.8 41.11 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 121.187 -0.946 . . . . 0.0 109.457 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.33 114.58 7.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 109.693 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 28' ' ' LEU . 12.1 tp -84.94 141.27 30.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 109.023 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -99.78 107.5 19.57 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.322 -0.861 . . . . 0.0 109.795 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.3 140.57 51.8 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.8 p -61.11 145.05 90.32 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.107 -0.996 . . . . 0.0 109.48 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -45.0 -42.72 15.76 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.709 1.606 . . . . 0.0 112.32 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -53.31 -48.24 68.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.885 . . . . 0.0 109.767 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -59.48 -33.37 71.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.973 . . . . 0.0 109.381 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.442 ' HH ' ' C ' ' A' ' 15' ' ' ASN . 20.3 t80 -60.04 -32.03 70.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.128 -0.982 . . . . 0.0 109.369 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.409 ' O ' ' OD2' ' A' ' 57' ' ' ASP . . . -74.27 -53.85 8.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.171 -0.956 . . . . 0.0 109.794 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 37' ' ' LEU . 8.5 mp -64.96 -38.47 91.07 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.8 tp -65.23 -46.27 81.3 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.5 m -50.46 -30.15 12.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 109.61 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -77.27 -37.81 52.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.156 -0.965 . . . . 0.0 109.082 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.4 mp -56.53 -47.28 79.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 108.998 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 54.8 mtt -72.28 -30.86 65.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.15 -0.969 . . . . 0.0 109.665 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 20.8 ttt -52.35 -36.03 52.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.159 -0.963 . . . . 0.0 109.443 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -120.92 53.96 1.11 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.64 104.2 3.83 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.305 -0.872 . . . . 0.0 109.919 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.61 -17.45 1.27 Allowed Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.06 159.98 59.72 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.578 -0.954 . . . . 0.0 108.85 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.12 119.97 6.9 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.121 1.88 . . . . 0.0 111.74 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.4 132.63 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.331 -0.856 . . . . 0.0 109.569 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -58.45 147.56 31.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.978 -1.076 . . . . 0.0 108.986 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.0 mtm180 -79.72 -20.94 45.25 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.144 -0.973 . . . . 0.0 110.13 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -72.24 -33.93 67.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.118 -0.989 . . . . 0.0 109.89 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.2 mt -67.16 -33.48 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.029 -1.044 . . . . 0.0 109.548 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.6 mt -64.63 -50.66 66.24 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -58.19 -34.34 70.25 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -70.66 -22.03 62.54 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.528 -0.732 . . . . 0.0 109.958 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.409 ' OD2' ' O ' ' A' ' 36' ' ' ALA . 12.3 t0 . . . . . 0 N--CA 1.487 1.383 0 O-C-N 120.982 -1.074 . . . . 0.0 109.679 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.404 0.621 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.579 ' N ' HD12 ' A' ' 70' ' ' LEU . 8.8 mp -62.68 -47.79 82.1 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.43 -0.794 . . . . 0.0 108.938 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -70.99 -31.42 67.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 109.293 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.1 t -73.12 -37.48 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.279 -0.888 . . . . 0.0 109.256 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -56.34 -41.09 75.51 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.49 -36.53 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -64.27 -37.17 86.52 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -68.22 -43.9 76.95 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.0 mt -71.95 -30.0 64.85 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -50.97 -49.25 60.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.665 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -63.87 -26.99 68.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.243 -0.911 . . . . 0.0 110.439 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -71.99 -44.15 63.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.959 -1.088 . . . . 0.0 110.309 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.413 ' H ' HG12 ' A' ' 81' ' ' ILE . 16.0 pt -72.51 -15.37 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.177 -0.952 . . . . 0.0 109.655 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 75.57 82.88 0.45 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -46.96 -17.74 0.06 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.476 -1.014 . . . . 0.0 109.902 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' GLY . 22.7 t -56.91 -51.89 67.33 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.446 -0.784 . . . . 0.0 110.23 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -86.56 9.17 19.26 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.0 -1.062 . . . . 0.0 110.603 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.1 mm -121.6 165.92 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -140.98 114.02 8.48 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.436 -0.79 . . . . 0.0 108.947 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.419 HG22 ' CE2' ' A' ' 94' ' ' TYR . 4.7 p -86.63 138.26 31.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.208 -0.932 . . . . 0.0 109.591 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.9 t . . . . . 0 N--CA 1.499 2.012 0 O-C-N 121.537 -0.727 . . . . 0.0 109.2 179.687 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.419 ' CE2' HG22 ' A' ' 88' ' ' THR . 14.2 m-85 -129.54 157.12 42.93 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 38.6 ttp -153.05 133.15 13.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.291 -0.881 . . . . 0.0 109.736 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.5 mp -91.0 145.49 24.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.567 -0.708 . . . . 0.0 109.092 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.75 105.78 0.87 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -0.878 . . . . 0.0 109.361 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.905 . . . . 0.0 109.433 -179.982 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.9 p30 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -164.53 125.86 2.17 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.261 -0.899 . . . . 0.0 108.962 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -163.5 158.31 20.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.458 -0.776 . . . . 0.0 109.75 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.9 pt -149.32 163.7 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 80.9 p -128.46 132.24 48.39 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.498 -0.751 . . . . 0.0 109.755 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.26 91.49 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.04 -120.3 8.52 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.746 -1.741 . . . . 0.0 108.746 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -95.46 11.84 31.48 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.311 -1.111 . . . . 0.0 109.26 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.541 HD12 ' N ' ' A' ' 12' ' ' LEU . 8.0 mp -104.43 125.77 50.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.492 -0.755 . . . . 0.0 108.988 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -108.7 118.91 38.02 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.476 HD23 ' N ' ' A' ' 15' ' ' ASN . 0.9 OUTLIER -102.3 133.87 46.51 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.486 -0.759 . . . . 0.0 109.366 -179.139 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.476 ' N ' HD23 ' A' ' 14' ' ' LEU . 4.7 m-20 -135.53 98.19 3.87 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.43 -0.794 . . . . 0.0 109.467 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.5 t -73.91 -26.32 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.435 -0.791 . . . . 0.0 109.482 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.42 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -58.37 -50.39 73.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.429 -0.795 . . . . 0.0 109.679 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -98.86 -3.72 34.72 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.42 ' NH1' ' O ' ' A' ' 17' ' ' THR . 6.9 mpt_? 56.44 75.33 0.35 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.423 0.63 . . . . 0.0 109.419 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.409 HD23 ' CZ2' ' A' ' 22' ' ' TRP . 61.8 tp -163.99 149.58 10.84 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.8 t -134.25 146.52 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.381 -0.824 . . . . 0.0 109.807 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.409 ' CZ2' HD23 ' A' ' 20' ' ' LEU . 28.5 m-90 -113.23 142.54 45.69 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.0 tp -121.86 105.47 10.39 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 71.3 40.55 60.63 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.132 -1.987 . . . . 0.0 108.132 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 70.91 -10.79 0.71 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.996 -0.708 . . . . 0.0 109.645 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.426 ' H ' ' C ' ' A' ' 24' ' ' GLY . 32.2 p -91.66 142.14 27.94 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.041 -1.037 . . . . 0.0 109.631 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.42 112.99 2.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 110.245 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.8 tp -74.66 128.38 35.42 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 3.1 m-20 -96.02 100.64 12.29 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.171 -0.956 . . . . 0.0 110.327 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.9 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.3 pt? -121.4 134.13 55.1 Favored 'General case' 0 N--CA 1.504 2.229 0 CA-C-O 121.588 0.709 . . . . 0.0 109.35 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.4 p -52.11 152.48 5.7 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.184 -0.948 . . . . 0.0 109.218 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.34 -45.22 27.98 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.622 1.548 . . . . 0.0 110.804 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -56.19 -47.29 78.64 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.189 -0.944 . . . . 0.0 108.487 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -55.16 -36.36 65.75 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.341 -0.849 . . . . 0.0 109.033 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -57.6 -32.28 67.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.268 -0.895 . . . . 0.0 108.982 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.9 -49.97 63.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 108.983 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 37' ' ' LEU . 7.4 mp -58.8 -39.05 79.98 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 12.8 tp -57.14 -42.6 81.26 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.1 t -54.11 -39.2 66.19 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.347 -0.845 . . . . 0.0 109.549 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.2 mmt-85 -76.37 -45.19 33.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.176 -0.953 . . . . 0.0 109.425 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.8 mt -59.46 -52.33 66.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 110.311 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.51 ' SD ' ' N ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -63.93 -38.07 89.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.089 -1.007 . . . . 0.0 110.429 -178.832 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.51 ' N ' ' SD ' ' A' ' 42' ' ' MET . 46.3 tpp -55.57 -29.6 59.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.062 -1.024 . . . . 0.0 108.762 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -119.36 42.15 2.93 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.89 132.68 51.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.221 -0.925 . . . . 0.0 109.956 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.4 ' C ' ' SD ' ' A' ' 95' ' ' MET . . . 90.35 -6.22 82.46 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.6 t -121.85 116.17 30.36 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.644 -0.915 . . . . 0.0 108.717 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -47.62 119.89 4.11 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.017 1.145 . . . . 0.0 111.676 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.5 t -97.59 137.23 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.46 -0.775 . . . . 0.0 110.376 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.459 ' CD2' ' HB3' ' A' ' 52' ' ' GLU . 0.8 OUTLIER -63.89 121.07 13.17 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.363 -0.836 . . . . 0.0 108.792 178.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.487 ' NH1' ' OE1' ' A' ' 71' ' ' GLU . 11.3 ttm180 -52.89 -18.42 1.92 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.389 -0.819 . . . . 0.0 108.937 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.459 ' HB3' ' CD2' ' A' ' 50' ' ' HIS . 34.2 tt0 -65.48 -48.87 71.13 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.567 -0.708 . . . . 0.0 109.563 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.1 mt -58.0 -31.75 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.08 -1.012 . . . . 0.0 110.177 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.06 -33.06 74.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.042 -1.036 . . . . 0.0 108.991 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -74.06 -33.23 63.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.999 -1.063 . . . . 0.0 108.43 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -64.82 -22.54 67.01 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.543 -0.723 . . . . 0.0 109.764 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.488 1.428 0 O-C-N 121.1 -1.0 . . . . 0.0 109.253 -179.777 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 120.887 0.375 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 71' ' ' GLU . 2.4 pp -70.47 -43.7 69.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.007 -1.058 . . . . 0.0 109.264 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.487 ' OE1' ' NH1' ' A' ' 51' ' ' ARG . 33.6 tt0 -71.75 -33.01 68.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 109.453 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.0 t -70.77 -38.71 73.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.255 -0.903 . . . . 0.0 108.977 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -56.32 -39.6 73.03 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.99 -37.03 79.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -62.49 -36.5 82.69 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -71.57 -41.88 68.49 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.67 -38.11 73.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 0.0 109.412 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -50.57 -47.84 57.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.927 . . . . 0.0 109.669 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -62.47 -24.93 67.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 110.496 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -75.68 -43.6 46.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.936 -1.102 . . . . 0.0 110.466 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.9 pt -76.61 -22.43 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.142 -0.974 . . . . 0.0 109.945 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 82.67 87.76 0.73 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -44.79 -17.17 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.722 -0.87 . . . . 0.0 110.422 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.533 ' C ' ' HE ' ' A' ' 85' ' ' ARG . 12.9 t -51.72 -47.59 63.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.219 -0.925 . . . . 0.0 109.701 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.563 ' HE ' ' N ' ' A' ' 85' ' ' ARG . 4.4 mmp_? -83.41 9.66 10.56 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.241 -0.912 . . . . 0.0 110.596 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 87' ' ' ARG . 5.1 mp -135.67 159.2 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.197 -0.939 . . . . 0.0 109.754 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.49 ' N ' HG22 ' A' ' 86' ' ' ILE . 39.4 ttm180 -123.09 128.01 49.53 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.4 p -94.09 141.03 29.0 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.082 -1.011 . . . . 0.0 109.778 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.423 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.468 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.496 2.667 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 40.7 m-85 -150.99 170.69 18.74 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.363 -1.08 . . . . 0.0 108.579 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.4 ' SD ' ' C ' ' A' ' 46' ' ' GLY . 50.4 ttp -162.5 136.66 6.45 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.142 -0.974 . . . . 0.0 110.469 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 96' ' ' LEU . 10.2 mp -88.69 139.04 30.87 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.07 133.48 44.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 109.473 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.7 m120 . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.571 -179.966 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.4 t70 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.187 0.517 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -158.72 122.05 3.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.336 -0.852 . . . . 0.0 108.877 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -161.36 155.59 22.65 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.348 -0.845 . . . . 0.0 109.746 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.8 pt -148.03 163.33 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.378 -0.826 . . . . 0.0 109.07 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -142.24 152.55 43.17 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.223 -0.923 . . . . 0.0 109.777 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.6 t -147.98 95.97 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.27 -116.38 4.3 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.061 -1.615 . . . . 0.0 109.061 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -103.5 7.63 37.83 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.49 -1.006 . . . . 0.0 109.697 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 12' ' ' LEU . 9.3 mp -102.35 125.4 49.04 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.346 -0.846 . . . . 0.0 109.224 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -118.07 124.31 47.76 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.446 HD12 ' N ' ' A' ' 14' ' ' LEU . 8.1 mp -107.37 140.24 40.61 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.531 -0.731 . . . . 0.0 109.153 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -135.6 97.37 3.65 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.554 -0.716 . . . . 0.0 109.184 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.1 t -69.87 -29.62 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.375 -0.828 . . . . 0.0 109.306 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.425 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -63.94 -55.17 24.56 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.44 -0.787 . . . . 0.0 109.266 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.7 mmt85 -82.68 -16.04 49.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.96 . . . . 0.0 108.481 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 63.36 70.69 0.53 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.609 0.718 . . . . 0.0 109.152 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.7 tp -163.78 154.15 15.42 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.7 t -136.21 143.08 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.297 -0.877 . . . . 0.0 109.853 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -107.93 145.18 34.16 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 67.1 tp -128.75 104.03 7.4 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.7 44.68 38.33 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 64.36 -3.17 0.53 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 122.175 -0.603 . . . . 0.0 110.282 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.4 p -99.31 139.92 34.26 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 120.995 -1.066 . . . . 0.0 109.612 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.3 116.79 5.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.227 -0.921 . . . . 0.0 110.58 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.9 tp -85.0 128.95 34.85 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -103.93 120.84 41.87 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.347 -0.846 . . . . 0.0 109.825 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.834 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.1 pt? -140.51 148.66 41.41 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.398 0.618 . . . . 0.0 109.453 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.3 p -67.32 151.22 97.37 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.057 -1.027 . . . . 0.0 109.83 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -45.19 -41.01 16.65 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 121.928 1.752 . . . . 0.0 112.366 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -53.25 -50.65 64.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.763 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -60.13 -27.62 67.2 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.293 -0.879 . . . . 0.0 109.273 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -71.21 -31.05 67.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.114 -0.991 . . . . 0.0 109.145 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.99 -52.56 10.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.179 -0.95 . . . . 0.0 109.259 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 mt -59.27 -37.08 76.75 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 23.2 tp -63.19 -43.96 96.72 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.712 -0.618 . . . . 0.0 109.706 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.8 m -53.25 -37.75 62.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.225 -0.922 . . . . 0.0 110.158 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -80.35 -43.4 21.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 0.0 109.373 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 27.7 tp -63.73 -40.03 95.75 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.285 -0.885 . . . . 0.0 110.212 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -72.47 -38.95 68.08 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.77 -1.206 . . . . 0.0 109.544 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.468 ' O ' ' SD ' ' A' ' 43' ' ' MET . 1.3 tmt? -53.91 -28.78 38.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.304 -0.872 . . . . 0.0 108.71 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -115.7 43.67 2.04 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.06 140.22 48.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.253 -0.904 . . . . 0.0 110.347 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.09 -17.57 59.0 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.4 m -119.63 151.87 52.49 Favored Pre-proline 0 N--CA 1.501 2.113 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -71.88 119.46 6.21 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.56 1.507 . . . . 0.0 111.519 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.1 t -98.9 136.09 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.399 -0.813 . . . . 0.0 110.209 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -73.7 125.66 28.56 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.276 -0.89 . . . . 0.0 108.619 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.417 ' NH1' ' OE2' ' A' ' 71' ' ' GLU . 13.1 ptp180 -55.24 -15.86 2.77 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.223 -0.923 . . . . 0.0 108.779 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.425 ' O ' ' OD1' ' A' ' 56' ' ' ASN . 41.2 tt0 -61.82 -56.82 15.43 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.623 -0.673 . . . . 0.0 109.481 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.6 mt -54.64 -29.28 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.254 -0.904 . . . . 0.0 110.33 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.8 mt -71.24 -46.72 60.41 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 108.609 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -51.96 -36.05 48.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.957 -1.089 . . . . 0.0 108.957 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 16.3 m120 -65.18 -20.86 66.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.663 -0.648 . . . . 0.0 110.476 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.488 1.456 0 O-C-N 120.694 -1.254 . . . . 0.0 109.895 -179.282 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.1 m . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 pp -56.08 -37.79 69.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.353 -0.842 . . . . 0.0 109.644 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.417 ' OE2' ' NH1' ' A' ' 51' ' ' ARG . 7.2 tp10 -67.03 -31.19 71.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.169 -0.957 . . . . 0.0 109.456 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.3 t -73.33 -41.31 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.139 -0.976 . . . . 0.0 109.115 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -56.99 -38.22 72.74 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.0 mm -64.14 -36.91 78.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -67.65 -33.45 74.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.23 -0.919 . . . . 0.0 109.4 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -71.05 -41.9 70.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.34 -0.85 . . . . 0.0 109.802 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.0 mt -71.44 -42.23 68.48 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.291 -0.881 . . . . 0.0 109.892 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -49.7 -44.4 48.14 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.084 -1.01 . . . . 0.0 109.247 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -62.83 -26.8 68.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 110.045 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -75.78 -43.22 47.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.987 -1.071 . . . . 0.0 110.508 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 pt -82.21 -30.26 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.023 -1.048 . . . . 0.0 109.575 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 97.39 85.02 1.77 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -44.48 -16.68 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.545 -0.974 . . . . 0.0 110.396 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 82' ' ' GLY . 56.2 m -51.82 -44.8 63.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.083 -1.011 . . . . 0.0 109.381 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -73.71 8.75 1.74 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.296 -0.878 . . . . 0.0 109.481 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 87' ' ' ARG . 96.6 mt -136.37 159.76 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.288 -0.882 . . . . 0.0 109.159 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.49 HH21 ' CE ' ' A' ' 95' ' ' MET . 39.1 ttp180 -137.28 124.2 21.38 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.555 -0.716 . . . . 0.0 109.271 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.3 p -88.87 141.66 28.31 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.142 -0.974 . . . . 0.0 109.386 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.4 t . . . . . 0 N--CA 1.501 2.08 0 O-C-N 121.479 -0.763 . . . . 0.0 110.377 -178.785 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.644 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -150.98 162.34 41.02 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.357 -1.084 . . . . 0.0 108.407 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.49 ' CE ' HH21 ' A' ' 87' ' ' ARG . 43.9 ttp -163.55 136.16 5.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.179 -0.951 . . . . 0.0 110.548 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.3 mp -91.48 127.32 36.87 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.77 99.69 2.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.318 -0.863 . . . . 0.0 109.42 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.329 -0.857 . . . . 0.0 109.539 179.994 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.266 0.555 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -155.87 119.86 4.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.15 -0.969 . . . . 0.0 108.947 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -162.09 157.42 23.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.326 -0.859 . . . . 0.0 109.713 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.4 pt -147.27 162.54 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.297 -0.877 . . . . 0.0 109.163 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.8 t -145.25 156.11 43.64 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.19 -0.944 . . . . 0.0 109.741 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 9' ' ' VAL . 5.1 p -152.72 101.85 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.15 -109.64 2.84 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -112.07 4.88 18.31 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.506 -0.996 . . . . 0.0 110.093 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 12' ' ' LEU . 10.4 mp -99.07 124.9 44.41 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.151 -0.968 . . . . 0.0 109.083 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -118.53 126.13 51.35 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.528 ' C ' HD22 ' A' ' 15' ' ' ASN . 5.7 tt -114.15 115.19 27.12 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.528 HD22 ' C ' ' A' ' 14' ' ' LEU . 1.7 m120 -113.2 102.21 10.15 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.573 -0.705 . . . . 0.0 109.313 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.3 t -74.9 -27.44 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.439 -0.788 . . . . 0.0 109.454 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.44 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -60.42 -54.1 49.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.536 -0.728 . . . . 0.0 109.507 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.499 ' NH2' ' OD1' ' A' ' 15' ' ' ASN . 89.2 mtm-85 -92.21 -13.43 30.54 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.12 -0.987 . . . . 0.0 108.714 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.5 tpp85 66.31 67.14 0.46 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.419 0.628 . . . . 0.0 109.393 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.5 mt -143.47 158.47 43.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.228 -0.92 . . . . 0.0 108.812 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 t -142.38 120.75 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.283 -0.885 . . . . 0.0 109.757 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 17.8 m-90 -98.93 150.87 21.49 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.175 -0.953 . . . . 0.0 108.812 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.9 tp -136.94 107.05 6.33 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.84 43.59 73.58 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 64.24 -1.65 0.69 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 122.169 -0.606 . . . . 0.0 110.346 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.4 p -100.58 139.9 35.6 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 120.973 -1.079 . . . . 0.0 109.383 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.04 115.54 6.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 0.0 110.161 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.9 tp -78.82 132.31 36.81 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -102.86 112.59 25.46 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.312 -0.868 . . . . 0.0 109.972 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.837 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.2 pt? -139.63 148.9 43.1 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.364 -0.835 . . . . 0.0 109.28 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.407 ' OG1' ' OE2' ' A' ' 34' ' ' GLU . 4.1 p -60.52 152.98 63.47 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.056 -1.027 . . . . 0.0 108.881 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -58.95 -41.67 59.65 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.0 1.8 . . . . 0.0 111.735 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -53.97 -45.66 71.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.027 -1.046 . . . . 0.0 109.252 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.407 ' OE2' ' OG1' ' A' ' 31' ' ' THR . 69.8 mt-10 -60.71 -34.61 74.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.322 -0.861 . . . . 0.0 109.223 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.4 ' OH ' ' O ' ' A' ' 15' ' ' ASN . 15.9 t80 -55.62 -34.1 64.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 108.706 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.05 -53.12 28.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 109.303 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 37' ' ' LEU . 8.3 mp -60.3 -39.42 86.88 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.9 tp -59.57 -43.74 93.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.606 -0.684 . . . . 0.0 109.546 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.502 ' C ' ' HE ' ' A' ' 40' ' ' ARG . 33.8 t -52.91 -34.28 54.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.153 -0.967 . . . . 0.0 109.458 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.502 ' HE ' ' C ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -79.44 -45.29 19.72 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 0.0 109.181 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.3 mt -56.72 -40.66 76.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.045 -1.034 . . . . 0.0 109.285 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.7 tpp -75.44 -35.0 61.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 109.56 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.46 ' SD ' ' NH2' ' A' ' 40' ' ' ARG . 24.7 ttt -53.92 -25.93 22.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.327 -0.858 . . . . 0.0 109.229 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -129.08 43.17 3.19 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.74 -0.6 . . . . 0.0 109.678 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.81 143.8 55.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.025 -1.047 . . . . 0.0 109.958 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.462 ' O ' ' SD ' ' A' ' 95' ' ' MET . . . 101.02 -22.75 38.18 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.08 154.55 64.82 Favored Pre-proline 0 N--CA 1.503 2.206 0 O-C-N 121.599 -0.942 . . . . 0.0 108.676 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.42 120.91 7.83 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.826 1.684 . . . . 0.0 111.083 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 80.5 t -92.77 137.04 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 0.0 110.326 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.458 ' CE1' ' HG3' ' A' ' 52' ' ' GLU . 0.8 OUTLIER -68.83 121.03 15.71 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.381 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -51.21 -16.82 0.56 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 0.0 109.792 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.458 ' HG3' ' CE1' ' A' ' 50' ' ' HIS . 80.8 mt-10 -65.97 -48.39 71.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.342 -0.849 . . . . 0.0 109.801 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.2 mt -54.65 -30.87 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.19 -0.944 . . . . 0.0 109.949 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.0 mt -70.58 -34.13 71.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.932 . . . . 0.0 109.199 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -70.93 -35.44 72.24 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -59.39 -20.8 57.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.545 -0.722 . . . . 0.0 110.051 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--N 1.306 -1.312 0 O-C-N 121.074 -1.016 . . . . 0.0 109.89 -179.353 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.0 m . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.465 0.65 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.7 mt -70.12 -37.46 75.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.298 -0.876 . . . . 0.0 109.658 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -60.3 -32.43 71.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.081 -1.012 . . . . 0.0 109.504 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.85 -38.92 74.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.214 -0.929 . . . . 0.0 109.096 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.22 -38.01 73.1 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.2 mt -63.81 -38.93 83.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.418 ' CE1' HH21 ' A' ' 78' ' ' ARG . 1.2 t60 -60.17 -36.55 77.84 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.511 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.576 ' ND2' ' NZ ' ' A' ' 80' ' ' LYS . 3.2 t-20 -73.34 -41.61 63.26 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.689 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -66.41 -42.93 87.06 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.661 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.418 HH21 ' CE1' ' A' ' 75' ' ' HIS . 52.6 ttp180 -50.15 -50.99 47.07 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.513 -0.742 . . . . 0.0 110.936 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -65.24 -29.27 70.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.963 -1.086 . . . . 0.0 110.613 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.576 ' NZ ' ' ND2' ' A' ' 76' ' ' ASN . 61.7 mttp -66.44 -47.94 71.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.9 -1.125 . . . . 0.0 110.2 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 21.6 pt -74.83 -24.6 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.979 -1.075 . . . . 0.0 110.17 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 84.3 84.37 0.95 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -45.05 -17.01 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.689 -0.889 . . . . 0.0 110.484 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 82' ' ' GLY . 59.5 m -55.12 -48.9 73.0 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.243 -0.911 . . . . 0.0 110.069 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.702 ' C ' HD12 ' A' ' 86' ' ' ILE . 8.5 mpt_? -81.48 9.78 6.86 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.972 -1.08 . . . . 0.0 110.473 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.702 HD12 ' C ' ' A' ' 85' ' ' ARG . 3.6 mp -130.67 162.63 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.5 ' N ' HG22 ' A' ' 86' ' ' ILE . 40.3 ttm180 -118.75 93.61 4.16 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.443 -0.786 . . . . 0.0 109.478 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.0 p -66.1 134.77 53.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.315 -0.866 . . . . 0.0 109.511 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 N--CA 1.497 1.904 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.759 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.442 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -146.04 170.06 17.42 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.462 ' SD ' ' O ' ' A' ' 46' ' ' GLY . 6.1 ttt -161.1 127.81 4.02 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.932 -1.105 . . . . 0.0 110.133 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 96' ' ' LEU . 9.4 mp -81.27 139.98 35.12 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.13 106.19 5.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 109.455 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.451 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 29.4 p-10 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -172.37 107.97 0.2 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.024 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -161.55 154.29 20.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.114 -0.991 . . . . 0.0 109.911 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.7 pt -145.86 163.29 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.476 -0.765 . . . . 0.0 108.983 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.8 p -139.88 151.99 46.08 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.304 -0.873 . . . . 0.0 109.623 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.1 t -146.79 97.6 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.61 -113.68 4.0 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -105.52 5.92 31.86 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.457 -1.025 . . . . 0.0 110.079 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.5 mt -100.69 126.46 47.21 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.129 -0.982 . . . . 0.0 109.186 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -118.05 124.84 49.08 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.475 HD12 HG22 ' A' ' 21' ' ' VAL . 5.6 tp -106.87 141.4 38.15 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.737 -0.602 . . . . 0.0 109.579 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.638 ' ND2' ' CZ3' ' A' ' 22' ' ' TRP . 20.7 m-80 -135.57 97.69 3.74 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.325 -0.859 . . . . 0.0 109.143 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.1 t -76.63 -28.93 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.297 -0.877 . . . . 0.0 109.97 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.406 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -57.65 -53.44 58.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 0.0 109.405 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.434 ' NH2' ' OD1' ' A' ' 15' ' ' ASN . 12.7 ptt-85 -96.5 -10.32 27.66 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.277 -0.889 . . . . 0.0 108.807 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 64.81 73.66 0.41 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.456 0.646 . . . . 0.0 109.3 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.0 tp -156.98 154.42 29.62 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.475 HG22 HD12 ' A' ' 14' ' ' LEU . 12.3 t -140.1 133.54 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.273 -0.892 . . . . 0.0 109.773 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.638 ' CZ3' ' ND2' ' A' ' 15' ' ' ASN . 8.5 m-90 -100.34 144.26 29.56 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.345 -0.847 . . . . 0.0 109.238 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 25' ' ' GLU . 10.7 tp -117.96 100.24 7.43 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.67 -73.2 0.25 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 23' ' ' LEU . 74.0 mt-10 -154.45 23.13 0.47 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.219 -1.165 . . . . 0.0 109.406 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.3 p -138.83 141.82 38.67 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.455 -0.778 . . . . 0.0 110.07 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.9 121.92 16.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.502 -0.749 . . . . 0.0 109.538 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.5 tp -78.48 128.45 33.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 108.614 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -101.4 110.59 22.61 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.328 -0.858 . . . . 0.0 109.923 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.75 145.75 48.74 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.2 p -58.33 140.26 83.91 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.1 -1.0 . . . . 0.0 109.455 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -44.68 -43.99 14.26 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.526 1.484 . . . . 0.0 112.052 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.446 ' CD ' ' H ' ' A' ' 33' ' ' LYS . 2.4 mptp? -53.54 -46.43 70.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 108.99 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -59.49 -35.07 73.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.348 -0.845 . . . . 0.0 109.213 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.464 ' HH ' ' C ' ' A' ' 15' ' ' ASN . 15.0 t80 -56.66 -33.16 66.09 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.916 . . . . 0.0 109.066 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.422 ' O ' ' OD2' ' A' ' 57' ' ' ASP . . . -68.62 -52.82 27.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.431 -0.793 . . . . 0.0 109.524 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.611 HD12 ' N ' ' A' ' 37' ' ' LEU . 7.7 mp -63.54 -36.59 84.27 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.3 tp -64.46 -46.98 80.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.55 -0.719 . . . . 0.0 109.329 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.8 m -53.28 -29.68 34.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.321 -0.862 . . . . 0.0 109.956 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -75.73 -40.57 55.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.065 -1.022 . . . . 0.0 110.018 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.8 mt -61.04 -44.39 97.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.975 -1.078 . . . . 0.0 110.179 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.7 mmm -65.87 -37.07 85.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.819 -1.176 . . . . 0.0 109.739 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 18.1 ttt -57.41 -32.36 66.77 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 108.994 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -116.05 43.46 2.14 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.06 129.12 39.0 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.245 -0.909 . . . . 0.0 110.165 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.89 -11.93 52.87 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 p -124.71 151.89 68.51 Favored Pre-proline 0 N--CA 1.504 2.242 0 O-C-N 121.529 -0.983 . . . . 0.0 108.652 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.18 120.46 6.59 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.781 1.654 . . . . 0.0 111.634 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.5 t -95.69 132.87 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.263 -0.898 . . . . 0.0 109.95 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.411 ' C ' ' N ' ' A' ' 52' ' ' GLU . 0.8 OUTLIER -73.04 126.19 29.41 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.19 -0.944 . . . . 0.0 108.545 178.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -50.36 -15.07 0.21 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.223 -0.923 . . . . 0.0 109.836 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.411 ' N ' ' C ' ' A' ' 50' ' ' HIS . 77.4 mt-10 -66.87 -46.35 75.23 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.319 -0.863 . . . . 0.0 109.881 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.5 mm -57.56 -32.36 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.083 -1.011 . . . . 0.0 109.923 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.42 -45.3 69.5 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.241 -0.912 . . . . 0.0 108.746 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -62.33 -36.86 83.52 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -70.33 -21.77 62.87 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.641 -0.662 . . . . 0.0 109.993 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 36' ' ' ALA . 5.2 t0 . . . . . 0 N--CA 1.485 1.318 0 O-C-N 120.81 -1.181 . . . . 0.0 109.271 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 13.9 mt -70.64 -33.49 71.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 109.403 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -60.36 -35.59 76.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.009 . . . . 0.0 109.385 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.2 t -73.82 -38.95 51.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.166 -0.959 . . . . 0.0 108.827 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -58.71 -40.38 83.53 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 62.7 mt -62.98 -31.48 52.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -72.28 -22.38 61.21 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 118.947 -1.101 . . . . 0.0 108.086 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -77.43 -45.43 25.8 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.6 -0.687 . . . . 0.0 110.337 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 pp -74.58 -43.98 53.0 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.813 -1.179 . . . . 0.0 109.747 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -50.59 -46.12 57.68 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.554 -0.717 . . . . 0.0 110.144 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -65.65 -13.8 59.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.167 -0.958 . . . . 0.0 110.118 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -81.43 -40.23 23.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.084 -1.01 . . . . 0.0 110.02 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 11.0 pt -78.56 -14.94 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 109.777 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 85.68 81.41 1.12 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -44.42 -16.41 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.779 -0.836 . . . . 0.0 110.583 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 82' ' ' GLY . 44.5 t -50.17 -43.95 52.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.144 -0.973 . . . . 0.0 109.612 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -77.52 9.05 3.59 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.234 -0.916 . . . . 0.0 109.937 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 87' ' ' ARG . 82.0 mt -137.97 158.12 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.2 -0.937 . . . . 0.0 109.1 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.422 ' N ' HG22 ' A' ' 86' ' ' ILE . 65.7 ttt-85 -141.04 122.62 15.12 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.598 -0.689 . . . . 0.0 109.212 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.7 p -89.36 142.51 27.6 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.302 -0.874 . . . . 0.0 109.282 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 89' ' ' VAL . 8.1 p . . . . . 0 N--CA 1.5 2.069 0 O-C-N 121.405 -0.809 . . . . 0.0 110.171 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.8 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -150.76 159.24 44.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.452 -1.028 . . . . 0.0 108.257 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 43.1 ttp -163.82 127.61 2.7 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.131 -0.981 . . . . 0.0 110.391 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.476 HD12 ' N ' ' A' ' 96' ' ' LEU . 9.6 mp -90.2 133.22 35.05 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.88 137.2 50.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -0.931 . . . . 0.0 109.498 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.4 m120 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.618 179.997 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.6 t70 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.311 0.577 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -165.71 113.54 0.95 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.266 -0.896 . . . . 0.0 108.975 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -162.36 157.44 22.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.109 -0.994 . . . . 0.0 110.008 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.4 pt -144.78 162.91 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.309 -0.869 . . . . 0.0 109.008 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 m -143.05 152.92 42.41 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.284 -0.885 . . . . 0.0 109.699 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 9' ' ' VAL . 2.9 p -149.41 99.2 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.54 -116.64 4.74 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -104.06 6.95 36.31 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.439 -1.036 . . . . 0.0 109.622 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.7 mt -100.68 122.08 42.73 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.274 -0.891 . . . . 0.0 109.602 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -114.84 134.44 55.13 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.4 tt -126.55 127.9 46.01 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.553 -0.717 . . . . 0.0 109.823 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 19' ' ' ARG . 5.3 m-20 -121.44 104.41 9.66 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.757 -0.59 . . . . 0.0 109.62 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.2 t -68.77 -30.31 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.264 -0.898 . . . . 0.0 109.44 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.74 -53.98 38.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.908 . . . . 0.0 109.16 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.2 mtp-105 -83.72 -16.52 44.56 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 15' ' ' ASN . 15.1 tpp180 58.78 75.73 0.38 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.449 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 23.9 tp -170.33 127.35 0.81 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.359 -0.838 . . . . 0.0 108.964 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.1 t -104.33 138.21 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.509 -0.745 . . . . 0.0 109.682 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.449 ' CZ3' ' O ' ' A' ' 20' ' ' LEU . 28.5 m-90 -105.6 142.26 35.64 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.454 -0.779 . . . . 0.0 109.225 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.7 tp -118.11 102.26 8.88 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.94 44.95 54.3 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 107.946 -2.062 . . . . 0.0 107.946 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 65.65 -1.23 1.07 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 122.132 -0.628 . . . . 0.0 110.218 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.0 p -99.23 140.94 32.65 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.042 -1.036 . . . . 0.0 109.699 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.53 110.47 1.99 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.921 . . . . 0.0 109.862 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.9 tp -71.43 133.37 45.86 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -91.01 94.06 9.47 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.051 -1.031 . . . . 0.0 110.267 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.902 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.4 pt? -127.45 135.54 50.56 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.1 p -63.81 152.98 85.51 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 120.978 -1.076 . . . . 0.0 109.567 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -44.9 -48.13 11.13 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.848 1.698 . . . . 0.0 112.433 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -53.25 -47.99 68.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.446 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -55.24 -45.16 76.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.249 -0.907 . . . . 0.0 109.289 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -50.2 -30.04 10.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.229 -0.919 . . . . 0.0 109.701 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.8 -49.38 47.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.352 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.594 HD12 ' N ' ' A' ' 37' ' ' LEU . 8.1 mp -59.2 -44.5 92.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.093 -1.004 . . . . 0.0 108.785 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.6 mp -58.01 -42.06 84.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.919 . . . . 0.0 108.521 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.1 m -50.73 -37.08 39.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.229 -0.919 . . . . 0.0 109.653 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -80.22 -43.58 21.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.031 -1.043 . . . . 0.0 109.911 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.7 mt -59.34 -49.07 79.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.12 -0.988 . . . . 0.0 109.961 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 42.2 mtt -66.83 -35.46 80.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.991 -1.068 . . . . 0.0 109.645 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 25.7 ttt -56.05 -29.21 60.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.201 -0.937 . . . . 0.0 108.833 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -116.68 40.69 2.87 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.22 103.15 1.5 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.135 -0.978 . . . . 0.0 109.802 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.402 ' CA ' ' OD1' ' A' ' 98' ' ' ASN . . . 137.85 -13.36 3.64 Favored Glycine 0 N--CA 1.502 3.062 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.9 m -132.56 152.54 80.17 Favored Pre-proline 0 N--CA 1.502 2.131 0 O-C-N 121.697 -0.884 . . . . 0.0 108.806 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -71.73 120.19 6.72 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 121.774 1.649 . . . . 0.0 111.544 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.0 t -91.11 133.72 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.883 . . . . 0.0 109.612 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.413 ' C ' ' N ' ' A' ' 52' ' ' GLU . 10.3 t-160 -65.54 122.5 17.35 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -50.65 -15.94 0.33 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.166 -0.959 . . . . 0.0 109.6 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.413 ' N ' ' C ' ' A' ' 50' ' ' HIS . 17.0 mm-40 -65.78 -50.5 64.48 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.313 -0.867 . . . . 0.0 109.875 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.9 mt -57.07 -31.92 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.131 -0.98 . . . . 0.0 110.044 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.7 mt -66.47 -33.31 75.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.996 -1.065 . . . . 0.0 108.307 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -73.51 -35.69 65.65 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -63.53 -22.07 66.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.848 -0.533 . . . . 0.0 110.039 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.486 1.374 0 O-C-N 121.027 -1.046 . . . . 0.0 109.243 -179.835 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 90.0 m . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.603 ' H ' HD23 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -70.61 -48.93 52.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 108.88 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -70.3 -25.39 63.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 109.44 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.4 t -75.3 -43.55 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.176 -0.952 . . . . 0.0 109.505 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -54.55 -39.05 67.33 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.3 mt -67.38 -39.55 82.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -60.67 -34.67 74.67 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.122 -0.986 . . . . 0.0 109.072 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -76.73 -40.9 47.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.397 -0.814 . . . . 0.0 108.993 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.648 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -67.71 -43.36 80.24 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -51.76 -50.09 61.34 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.464 -0.772 . . . . 0.0 110.243 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -64.98 -27.37 68.79 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.252 -0.905 . . . . 0.0 110.834 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -71.01 -45.35 64.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.985 -1.072 . . . . 0.0 110.439 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.7 pt -75.04 -18.69 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.977 -1.077 . . . . 0.0 110.718 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 81.28 79.53 0.92 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -46.63 -15.9 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.688 -0.89 . . . . 0.0 110.662 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.514 ' CB ' HH11 ' A' ' 85' ' ' ARG . 10.5 t -48.2 -43.39 31.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.16 -0.962 . . . . 0.0 110.443 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.514 HH11 ' CB ' ' A' ' 84' ' ' SER . 12.5 mpt_? -91.48 11.03 25.33 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.164 -0.96 . . . . 0.0 110.163 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 87' ' ' ARG . 30.2 mm -115.75 164.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 O-C-N 121.35 -0.844 . . . . 0.0 108.98 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.435 ' N ' HG22 ' A' ' 86' ' ' ILE . 61.5 ttt-85 -135.69 118.56 16.24 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.399 -0.813 . . . . 0.0 108.898 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.5 p -94.93 137.64 33.73 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.235 -0.916 . . . . 0.0 109.766 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.5 2.052 0 O-C-N 121.569 -0.707 . . . . 0.0 109.756 -179.868 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.486 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.494 2.516 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 27.3 m-85 -151.44 157.44 42.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.385 -1.068 . . . . 0.0 108.87 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.6 ttp -157.7 128.89 6.66 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.36 -0.837 . . . . 0.0 109.675 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.487 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 9.2 mp -85.47 136.54 33.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.357 -0.839 . . . . 0.0 108.891 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.13 112.54 1.56 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 109.681 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.663 ' N ' HD22 ' A' ' 98' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.29 -0.882 . . . . 0.0 109.414 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.2 t0 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -156.67 119.77 4.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 0.0 109.081 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -164.94 158.5 17.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.377 -0.827 . . . . 0.0 109.737 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.2 pt -149.94 164.0 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.378 -0.826 . . . . 0.0 108.943 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.1 t -136.96 150.36 48.12 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.392 -0.818 . . . . 0.0 109.283 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.2 t -143.13 93.8 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.27 -108.4 2.48 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -104.88 3.51 31.02 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.48 -1.011 . . . . 0.0 109.863 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.1 mt -97.8 115.1 27.37 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.215 -0.928 . . . . 0.0 109.849 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -106.98 115.54 30.36 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.524 HD12 ' N ' ' A' ' 14' ' ' LEU . 8.2 mp -104.94 138.44 41.16 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.502 -0.749 . . . . 0.0 109.873 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -136.24 101.87 4.82 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.723 -0.611 . . . . 0.0 109.355 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.4 t -76.73 -28.88 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.84 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.415 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -55.97 -54.3 46.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.237 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -93.86 -9.57 36.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.131 -0.981 . . . . 0.0 108.665 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 63.35 78.35 0.29 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.341 0.591 . . . . 0.0 110.017 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.41 HD23 ' CZ2' ' A' ' 22' ' ' TRP . 62.1 tp -166.89 153.25 8.38 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.087 -1.008 . . . . 0.0 108.822 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.9 t -137.5 147.7 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.331 -0.856 . . . . 0.0 109.957 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.41 ' CZ2' HD23 ' A' ' 20' ' ' LEU . 31.2 m-90 -115.84 137.1 52.42 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.5 tp -112.4 105.73 14.06 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.47 39.9 68.62 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 107.578 -2.209 . . . . 0.0 107.578 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 69.06 -3.4 1.51 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 122.197 -0.59 . . . . 0.0 109.924 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.7 p -98.22 139.54 33.85 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.078 -1.014 . . . . 0.0 109.893 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.23 115.05 7.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 110.012 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.0 tp -85.94 138.85 31.7 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 27.0 p-10 -93.81 103.8 15.91 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.101 -0.999 . . . . 0.0 110.732 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.91 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.3 pt? -126.22 135.06 51.14 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.1 p -62.84 151.91 83.98 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.856 -1.153 . . . . 0.0 109.379 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -44.8 -44.12 14.54 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.784 1.656 . . . . 0.0 112.142 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -53.75 -50.54 65.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.272 -0.892 . . . . 0.0 109.686 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.65 ' HG3' HD13 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -54.08 -41.43 68.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.389 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -56.75 -30.33 63.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.101 -1.0 . . . . 0.0 109.289 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.19 -52.53 26.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.079 -1.013 . . . . 0.0 109.77 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.616 HD12 ' H ' ' A' ' 37' ' ' LEU . 7.2 mp -55.87 -39.32 71.33 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.4 tp -58.36 -43.21 88.31 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.5 p -50.72 -39.32 51.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.417 -0.802 . . . . 0.0 110.229 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -79.76 -42.58 24.22 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.855 -1.153 . . . . 0.0 109.828 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 26.3 mt -58.88 -47.75 83.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.155 -0.966 . . . . 0.0 109.897 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.1 ptt? -67.91 -36.0 79.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.022 -1.049 . . . . 0.0 109.975 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 21.7 ttt -54.26 -29.05 45.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -0.885 . . . . 0.0 108.763 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -124.04 45.02 2.58 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.6 133.66 51.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.104 -0.998 . . . . 0.0 110.095 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.485 ' HA3' HD22 ' A' ' 98' ' ' ASN . . . 100.53 -10.47 59.36 Favored Glycine 0 N--CA 1.501 3.004 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 p -127.11 151.9 75.03 Favored Pre-proline 0 N--CA 1.504 2.25 0 O-C-N 121.537 -0.978 . . . . 0.0 108.696 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.22 120.15 6.4 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 121.749 1.633 . . . . 0.0 111.652 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.9 t -96.2 136.67 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.412 -0.805 . . . . 0.0 109.736 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.495 ' CE1' ' HB2' ' A' ' 52' ' ' GLU . 0.8 OUTLIER -62.09 120.13 10.26 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.211 -0.931 . . . . 0.0 108.725 179.33 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -57.24 -18.76 17.63 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.339 -0.851 . . . . 0.0 109.178 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.495 ' HB2' ' CE1' ' A' ' 50' ' ' HIS . 0.2 OUTLIER -65.39 -48.81 71.59 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.378 -0.826 . . . . 0.0 108.981 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.5 mt -58.76 -30.23 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.25 -0.906 . . . . 0.0 110.324 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.3 mt -69.61 -29.77 67.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.922 -1.111 . . . . 0.0 108.976 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -71.57 -33.09 68.79 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -65.33 -22.21 66.79 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.655 -0.653 . . . . 0.0 109.941 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 O-C-N 120.902 -1.124 . . . . 0.0 109.403 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.741 ' H ' HD23 ' A' ' 70' ' ' LEU . 1.9 pt? -69.09 -38.9 79.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.041 -1.037 . . . . 0.0 109.76 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -71.23 -26.55 62.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.988 -1.07 . . . . 0.0 109.563 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 49.1 t -75.43 -47.85 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.19 -0.943 . . . . 0.0 109.303 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -55.85 -37.18 68.4 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.2 mt -67.51 -39.95 83.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -60.95 -35.96 78.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.082 -1.011 . . . . 0.0 108.861 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -74.44 -41.73 60.34 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.734 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -67.86 -42.46 81.31 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.485 ' NH2' ' OH ' ' A' ' 94' ' ' TYR . 41.0 ttm180 -49.9 -50.7 45.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.216 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -62.31 -27.08 68.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.241 -0.912 . . . . 0.0 110.817 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -73.22 -43.83 60.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.947 -1.096 . . . . 0.0 110.424 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.0 pt -73.76 -18.53 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.073 -1.017 . . . . 0.0 109.884 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.57 82.12 0.6 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -52.56 -18.23 1.63 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.515 -0.991 . . . . 0.0 110.111 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.9 m -52.37 -46.4 66.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.267 -0.896 . . . . 0.0 109.924 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -87.97 10.69 18.05 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.209 -0.932 . . . . 0.0 110.025 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.7 mm -119.58 168.07 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.461 -0.775 . . . . 0.0 108.962 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 61.3 mtp85 -140.19 114.05 8.86 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.0 p -81.82 138.05 35.18 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.267 -0.896 . . . . 0.0 109.768 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 N--CA 1.5 2.05 0 O-C-N 121.518 -0.738 . . . . 0.0 109.29 179.607 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.485 ' OH ' ' NH2' ' A' ' 78' ' ' ARG . 32.5 m-85 -148.57 169.94 19.19 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.6 ttp -164.09 130.28 3.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.166 -0.959 . . . . 0.0 109.969 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.47 HD12 ' N ' ' A' ' 96' ' ' LEU . 9.8 mp -83.38 144.2 29.8 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.58 -0.7 . . . . 0.0 109.155 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.69 119.69 20.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.493 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.485 HD22 ' HA3' ' A' ' 46' ' ' GLY . 55.5 m-20 . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.182 -0.949 . . . . 0.0 109.453 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 . . . . . 0 N--CA 1.501 2.087 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -169.59 101.29 0.33 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.182 -0.949 . . . . 0.0 109.247 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -162.29 155.76 20.68 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.153 -0.967 . . . . 0.0 109.93 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 7' ' ' ILE . 16.5 pt -147.94 163.33 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.373 -0.83 . . . . 0.0 109.017 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.2 m -144.9 158.96 43.62 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.145 -0.972 . . . . 0.0 109.912 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.0 t -148.35 101.04 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.36 -108.4 2.48 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -109.05 4.6 23.29 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.541 -0.976 . . . . 0.0 109.589 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.58 HD12 ' N ' ' A' ' 12' ' ' LEU . 7.0 mp -95.51 123.55 39.11 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.288 -0.882 . . . . 0.0 108.83 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -118.85 128.78 54.77 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.443 -0.786 . . . . 0.0 109.094 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.454 HD11 ' CZ ' ' A' ' 35' ' ' TYR . 51.5 tp -116.43 128.28 55.35 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.607 -0.683 . . . . 0.0 109.206 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -122.91 98.11 5.75 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.516 -0.74 . . . . 0.0 109.366 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.4 t -71.06 -27.0 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.47 -0.769 . . . . 0.0 109.23 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.7 -53.92 39.78 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.593 -0.692 . . . . 0.0 109.657 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -91.01 -12.83 34.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.249 -0.907 . . . . 0.0 108.862 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.479 ' NE ' ' CD1' ' A' ' 35' ' ' TYR . 9.5 tpt180 64.98 61.62 0.76 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -140.09 154.78 47.15 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.424 -0.798 . . . . 0.0 109.045 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.5 t -139.28 126.82 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.375 -0.828 . . . . 0.0 109.371 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 18.4 m-90 -103.44 148.18 26.24 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.223 -0.923 . . . . 0.0 109.128 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.425 ' O ' ' OG1' ' A' ' 26' ' ' THR . 24.4 tp -128.77 102.89 6.76 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 76.71 46.01 12.06 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 -178.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 61.91 -0.67 0.42 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 122.022 -0.693 . . . . 0.0 110.25 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 50.2 p -103.76 140.32 37.78 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.211 -0.931 . . . . 0.0 109.862 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.95 110.83 1.91 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 109.996 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.9 tp -76.9 134.89 38.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 108.622 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -101.77 111.45 23.71 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.315 -0.866 . . . . 0.0 109.615 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.812 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.1 pt? -140.51 150.86 44.26 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.327 -0.858 . . . . 0.0 109.853 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.4 p -58.07 152.85 37.92 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.361 -0.837 . . . . 0.0 109.239 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.21 -36.35 80.69 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.853 1.702 . . . . 0.0 111.188 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -55.84 -47.4 77.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 108.931 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -58.61 -39.62 80.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.319 -0.863 . . . . 0.0 108.893 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.479 ' CD1' ' NE ' ' A' ' 19' ' ' ARG . 16.7 t80 -52.89 -31.85 41.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.168 -0.958 . . . . 0.0 109.087 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.61 -52.76 10.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -0.87 . . . . 0.0 109.389 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 37' ' ' LEU . 8.6 mp -58.59 -40.66 83.82 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.506 HD23 ' O ' ' A' ' 38' ' ' LEU . 2.3 tt -67.37 -43.89 80.29 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.602 0.715 . . . . 0.0 109.306 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.0 t -48.42 -41.64 29.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.127 -0.983 . . . . 0.0 111.134 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.8 ttt-85 -80.73 -35.06 33.97 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.533 -1.354 . . . . 0.0 109.485 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.5 tp -60.3 -36.73 78.56 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.34 -0.85 . . . . 0.0 109.34 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 41.0 tpp -75.22 -38.68 60.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 0.0 109.259 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 42.1 ttm -52.4 -27.05 14.26 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.6 mmtt -118.99 42.76 2.73 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.29 137.06 55.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 110.215 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.85 -14.31 65.56 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.5 p -117.42 151.85 48.63 Favored Pre-proline 0 N--CA 1.501 2.115 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -73.87 119.43 5.87 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.594 1.529 . . . . 0.0 111.999 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -103.99 135.95 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.518 -0.739 . . . . 0.0 109.475 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -72.87 125.77 28.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.059 -1.026 . . . . 0.0 108.647 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -58.4 -16.25 14.01 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.469 -0.77 . . . . 0.0 109.291 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.418 ' O ' ' OD1' ' A' ' 56' ' ' ASN . 34.1 tt0 -67.61 -50.4 58.33 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.499 -0.75 . . . . 0.0 109.363 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.5 mt -58.1 -25.0 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.36 -0.838 . . . . 0.0 110.381 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 38.1 mt -72.11 -48.16 45.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.038 -1.039 . . . . 0.0 108.356 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -52.25 -34.59 46.76 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 16.1 m120 -63.84 -21.13 66.3 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.967 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.493 1.707 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.034 -179.492 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.4 m . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.417 0.627 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.556 HD12 ' N ' ' A' ' 70' ' ' LEU . 9.7 mp -56.0 -49.4 73.72 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.391 -0.818 . . . . 0.0 109.598 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -59.86 -30.02 68.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.156 -0.965 . . . . 0.0 109.729 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 t -70.41 -41.43 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.094 -1.004 . . . . 0.0 109.139 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -54.56 -37.64 65.71 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 35.2 mm -65.63 -41.42 90.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -65.73 -41.55 92.09 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.36 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -67.88 -44.58 76.72 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.195 -0.941 . . . . 0.0 109.091 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 74.3 mt -70.34 -38.63 74.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.417 -0.802 . . . . 0.0 109.919 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.6 ttp85 -49.19 -48.6 45.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.13 -0.981 . . . . 0.0 109.786 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -57.24 -27.28 61.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.957 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -78.4 -40.68 35.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.938 -1.101 . . . . 0.0 110.636 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.411 HD12 HD12 ' A' ' 86' ' ' ILE . 5.7 pt -85.11 -39.56 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.885 -1.135 . . . . 0.0 110.313 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 91.18 106.76 1.42 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 107.386 -2.286 . . . . 0.0 107.386 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 86' ' ' ILE . 52.2 pttt -43.61 -18.15 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.678 -0.895 . . . . 0.0 110.467 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 82' ' ' GLY . 47.3 t -62.93 -54.86 31.98 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.825 -1.172 . . . . 0.0 108.708 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.469 ' NH2' HD11 ' A' ' 86' ' ' ILE . 54.8 ttp85 -54.94 -10.97 0.55 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.396 -0.815 . . . . 0.0 110.803 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.469 HD11 ' NH2' ' A' ' 85' ' ' ARG . 9.4 mt -143.4 119.35 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.394 0 O-C-N 120.891 -1.13 . . . . 0.0 110.646 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 63.4 mtp85 -86.95 130.35 34.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.3 -0.875 . . . . 0.0 108.711 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 p -80.94 128.76 34.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.051 -1.031 . . . . 0.0 109.491 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.0 t . . . . . 0 N--CA 1.5 2.061 0 O-C-N 121.539 -0.725 . . . . 0.0 109.181 179.552 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.391 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -146.16 171.09 15.44 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.467 ' SD ' ' O ' ' A' ' 96' ' ' LEU . 11.6 tmm? -163.57 142.86 8.23 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.85 -1.156 . . . . 0.0 110.704 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.467 ' O ' ' SD ' ' A' ' 95' ' ' MET . 11.1 mp -89.43 132.79 34.83 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.18 121.02 8.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.213 -0.929 . . . . 0.0 109.082 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 0.0 109.712 -179.684 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 5.7 p-10 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -160.43 121.02 2.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.135 -0.978 . . . . 0.0 109.38 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -158.91 156.24 29.17 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.479 -0.763 . . . . 0.0 109.364 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.4 pt -148.83 163.67 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.298 -0.876 . . . . 0.0 109.393 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.6 m -136.2 146.53 46.92 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.472 -0.768 . . . . 0.0 109.542 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -146.46 93.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.67 -114.09 3.91 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -106.06 6.27 30.97 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.492 -1.005 . . . . 0.0 109.66 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.4 mt -100.89 122.04 42.77 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.258 -0.901 . . . . 0.0 109.946 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -115.19 129.46 56.66 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.438 HD11 ' CZ ' ' A' ' 35' ' ' TYR . 46.9 tp -114.65 138.67 50.4 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.535 -0.728 . . . . 0.0 109.415 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.519 ' ND2' HH21 ' A' ' 18' ' ' ARG . 4.1 m120 -135.02 97.63 3.79 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.576 -0.702 . . . . 0.0 109.236 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.2 t -73.34 -28.51 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.376 -0.827 . . . . 0.0 109.282 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -63.13 -55.47 25.02 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.444 -0.785 . . . . 0.0 109.454 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.519 HH21 ' ND2' ' A' ' 15' ' ' ASN . 64.8 mtm180 -88.62 -16.02 33.54 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.307 -0.871 . . . . 0.0 108.847 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? 68.83 65.19 0.3 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.2 mt -143.93 142.32 30.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.303 -0.873 . . . . 0.0 108.724 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -129.61 127.57 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.5 -0.75 . . . . 0.0 108.977 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -103.72 142.21 34.73 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.269 -0.894 . . . . 0.0 109.173 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.422 ' O ' ' OG1' ' A' ' 26' ' ' THR . 28.0 tp -127.2 102.9 7.14 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.93 47.3 11.76 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.131 -1.988 . . . . 0.0 108.131 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 60.68 2.58 0.52 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.979 -0.718 . . . . 0.0 110.33 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 50.4 p -108.81 141.72 40.42 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.15 -0.969 . . . . 0.0 109.846 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.03 115.29 4.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.247 -0.908 . . . . 0.0 110.075 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.3 tp -81.73 132.99 35.3 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -101.34 111.81 24.15 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.305 -0.872 . . . . 0.0 109.483 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.46 147.51 47.23 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.453 -0.779 . . . . 0.0 109.274 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.1 p -57.9 152.15 39.92 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.89 -33.73 92.15 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.84 1.693 . . . . 0.0 111.359 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -57.52 -50.88 71.64 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.206 -0.934 . . . . 0.0 109.045 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -56.89 -35.58 69.14 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.151 -0.968 . . . . 0.0 109.032 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.438 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 7.3 t80 -55.47 -33.9 64.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -0.888 . . . . 0.0 108.962 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.422 ' O ' ' OD2' ' A' ' 57' ' ' ASP . . . -67.89 -52.96 30.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 109.518 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 37' ' ' LEU . 7.2 mp -60.75 -32.61 71.9 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 12.5 tp -63.31 -45.63 90.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.535 -0.728 . . . . 0.0 109.28 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.3 p -53.79 -32.66 53.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.902 . . . . 0.0 109.327 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -79.8 -45.42 18.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 109.549 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.0 mt -58.21 -46.65 85.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.925 . . . . 0.0 109.937 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.545 ' SD ' ' N ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -70.83 -36.15 72.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 110.047 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.545 ' N ' ' SD ' ' A' ' 42' ' ' MET . 22.3 ttt -52.9 -29.2 27.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.099 -1.001 . . . . 0.0 108.873 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -122.39 46.72 2.06 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.37 134.51 52.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.886 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.99 -8.86 78.85 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.3 t -118.46 115.1 35.93 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.61 119.95 4.16 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.038 1.159 . . . . 0.0 112.001 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -98.7 136.67 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.41 -0.806 . . . . 0.0 110.116 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -71.18 124.25 24.05 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.241 -0.912 . . . . 0.0 108.931 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.469 ' NH1' ' OE1' ' A' ' 71' ' ' GLU . 53.3 ttp180 -51.35 -17.53 0.77 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.402 -0.811 . . . . 0.0 109.31 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -68.01 -47.8 67.48 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.383 -0.823 . . . . 0.0 109.974 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.0 mt -57.45 -29.55 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.161 -0.962 . . . . 0.0 110.194 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.9 mt -68.58 -46.79 68.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.159 -0.963 . . . . 0.0 108.835 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -60.84 -34.47 74.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -70.08 -21.67 63.12 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.443 -0.785 . . . . 0.0 110.145 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 36' ' ' ALA . 11.3 t0 . . . . . 0 N--CA 1.485 1.304 0 O-C-N 121.0 -1.063 . . . . 0.0 109.414 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.528 ' CD2' ' N ' ' A' ' 70' ' ' LEU . 1.6 mm? -66.1 -49.28 68.09 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.469 ' OE1' ' NH1' ' A' ' 51' ' ' ARG . 64.2 mm-40 -64.07 -24.99 67.91 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.34 -0.85 . . . . 0.0 108.793 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.0 t -74.83 -41.02 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.411 -0.806 . . . . 0.0 109.425 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -54.29 -39.33 66.85 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 35.6 mm -65.08 -40.21 88.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -67.18 -40.69 86.62 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.153 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -64.75 -44.49 89.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.26 -0.9 . . . . 0.0 109.311 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.7 mt -70.19 -34.19 72.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -0.876 . . . . 0.0 109.478 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -49.35 -49.35 44.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.252 -0.905 . . . . 0.0 109.765 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -58.01 -28.9 64.86 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.352 -0.842 . . . . 0.0 109.804 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -74.24 -43.19 58.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.138 -0.976 . . . . 0.0 110.445 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.5 pt -82.6 -36.95 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.935 -1.103 . . . . 0.0 110.171 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 93.12 103.45 1.6 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 107.161 -2.376 . . . . 0.0 107.161 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 86' ' ' ILE . 9.8 ptpp? -42.95 -19.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.791 -0.829 . . . . 0.0 110.724 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 82' ' ' GLY . 36.4 p -64.21 -55.35 22.26 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.966 -1.083 . . . . 0.0 108.905 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -47.9 -14.07 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.307 -0.871 . . . . 0.0 110.793 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 84' ' ' SER . 12.8 pt -135.56 168.5 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.095 -1.003 . . . . 0.0 110.759 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -137.5 122.15 18.58 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 p -90.27 135.54 33.61 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.128 -0.982 . . . . 0.0 109.628 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.501 2.086 0 O-C-N 121.532 -0.73 . . . . 0.0 110.189 -179.343 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.466 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.496 2.662 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.466 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 31.0 m-85 -151.06 162.16 41.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.475 -1.015 . . . . 0.0 108.445 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 55.8 ttp -163.02 127.55 3.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.061 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 96' ' ' LEU . 9.4 mp -82.29 135.11 35.27 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.62 118.43 15.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.931 . . . . 0.0 109.695 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.2 m120 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.261 -0.899 . . . . 0.0 109.433 179.878 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 26.6 p-10 . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -167.35 125.58 1.28 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.298 -0.876 . . . . 0.0 109.088 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -163.12 157.91 21.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.907 . . . . 0.0 109.892 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.9 pt -150.68 163.37 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.324 -0.86 . . . . 0.0 108.755 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.2 m -145.15 158.22 43.88 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.214 -0.929 . . . . 0.0 109.926 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 9' ' ' VAL . 3.5 p -152.47 97.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.03 -118.17 4.65 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -101.56 8.99 41.67 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.402 -1.058 . . . . 0.0 110.207 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 17.2 mt -106.52 126.52 52.36 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.275 -0.891 . . . . 0.0 109.925 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -116.85 130.68 56.86 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.462 HD12 HG22 ' A' ' 21' ' ' VAL . 5.9 tp -115.05 116.96 29.28 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.455 -0.778 . . . . 0.0 110.109 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.454 ' C ' ' HH ' ' A' ' 35' ' ' TYR . 7.4 m-20 -111.32 97.69 6.95 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 121.506 -0.746 . . . . 0.0 109.027 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.3 t -69.35 -28.6 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 109.534 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.439 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -64.49 -53.14 52.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.467 -0.771 . . . . 0.0 109.478 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 -90.26 -8.54 50.72 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.181 -0.95 . . . . 0.0 108.803 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 56.45 67.63 0.97 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 98.6 mt -143.72 158.47 43.65 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.462 HG22 HD12 ' A' ' 14' ' ' LEU . 16.6 t -142.5 123.8 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.227 -0.921 . . . . 0.0 110.012 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 16.0 m-90 -99.42 153.39 19.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.367 -0.833 . . . . 0.0 109.121 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tt -146.15 116.05 7.32 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 62.58 39.68 98.18 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 107.623 -2.191 . . . . 0.0 107.623 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 65.87 -4.6 0.61 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 122.263 -0.551 . . . . 0.0 109.875 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.41 ' H ' ' C ' ' A' ' 24' ' ' GLY . 73.7 p -100.27 139.87 35.32 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.082 -1.011 . . . . 0.0 109.535 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.11 115.24 3.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 0.0 110.041 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.1 tp -75.1 127.28 32.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.3 -0.875 . . . . 0.0 108.684 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.402 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 5.7 m-20 -94.16 101.24 13.24 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.242 -0.911 . . . . 0.0 110.303 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.909 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.4 pt? -128.33 137.45 51.94 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.5 p -62.8 151.42 84.97 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.795 -1.191 . . . . 0.0 109.475 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -44.91 -46.94 12.44 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 121.792 1.662 . . . . 0.0 112.35 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -53.34 -42.17 66.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.7 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -63.23 -36.06 82.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.154 -0.966 . . . . 0.0 109.336 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.454 ' HH ' ' C ' ' A' ' 15' ' ' ASN . 13.0 t80 -57.03 -30.65 64.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.295 -0.878 . . . . 0.0 109.243 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.43 -53.3 9.84 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.241 -0.912 . . . . 0.0 109.733 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 37' ' ' LEU . 9.2 mp -62.06 -39.48 92.52 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.6 tp -65.61 -46.12 80.52 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.61 -0.681 . . . . 0.0 109.678 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -50.77 -29.84 12.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 110.378 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.488 ' NH2' ' CG2' ' A' ' 53' ' ' ILE . 6.3 tpt180 -79.18 -36.89 39.58 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.85 -1.157 . . . . 0.0 110.173 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.29 -38.57 91.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.962 -1.086 . . . . 0.0 110.261 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.4 ' SD ' ' CD2' ' A' ' 96' ' ' LEU . 13.0 mmt -65.39 -42.93 92.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.768 -1.207 . . . . 0.0 110.077 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 51.8 mtt -58.72 -32.25 69.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.223 -0.923 . . . . 0.0 109.505 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -106.19 35.34 2.96 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.637 -0.664 . . . . 0.0 109.44 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.1 103.16 2.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 109.885 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.26 -16.58 2.31 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.64 155.72 79.29 Favored Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.718 -0.872 . . . . 0.0 108.707 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.52 120.46 7.13 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.928 1.752 . . . . 0.0 111.554 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.5 t -91.57 136.6 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.8 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.413 ' C ' ' N ' ' A' ' 52' ' ' GLU . 19.7 t-160 -72.26 123.36 22.81 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.156 -0.965 . . . . 0.0 108.607 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -52.99 -15.57 0.82 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 0.0 109.082 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.413 ' N ' ' C ' ' A' ' 50' ' ' HIS . 36.1 tt0 -69.38 -48.24 61.81 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.601 -0.687 . . . . 0.0 109.764 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.488 ' CG2' ' NH2' ' A' ' 40' ' ' ARG . 77.9 mt -57.83 -30.04 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.048 -1.032 . . . . 0.0 110.099 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.1 mt -67.51 -48.67 66.38 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -54.96 -35.81 64.66 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 22.7 m120 -67.3 -22.02 65.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.412 -0.805 . . . . 0.0 110.379 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.56 -179.631 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.409 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 87.1 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.377 0.608 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 pp -67.37 -38.25 84.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.354 -0.841 . . . . 0.0 109.698 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -60.77 -32.79 72.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.032 -1.042 . . . . 0.0 109.877 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.2 t -70.88 -40.11 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.089 -1.007 . . . . 0.0 109.45 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.409 ' ND1' ' O ' ' A' ' 69' ' ' THR . 17.1 m80 -55.74 -37.93 69.12 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.3 mt -66.07 -39.5 84.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -59.05 -36.02 74.31 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.365 -0.934 . . . . 0.0 108.918 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -76.14 -40.24 53.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.447 -0.783 . . . . 0.0 109.088 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.658 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -66.67 -44.07 82.83 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -50.73 -50.28 55.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.388 -0.82 . . . . 0.0 110.228 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -61.74 -27.98 69.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.168 -0.957 . . . . 0.0 110.616 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -74.36 -44.27 52.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.937 -1.102 . . . . 0.0 110.862 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.8 pt -74.43 -21.2 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.854 -1.154 . . . . 0.0 110.212 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 81.27 82.73 0.8 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.413 ' O ' ' O ' ' A' ' 86' ' ' ILE . 18.1 pttp -45.48 -16.57 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.673 -0.898 . . . . 0.0 110.442 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 82' ' ' GLY . 78.8 p -53.66 -49.76 67.24 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.985 -1.072 . . . . 0.0 109.752 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.601 ' C ' HD12 ' A' ' 86' ' ' ILE . 25.3 mmt-85 -79.34 11.02 3.17 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.313 -0.867 . . . . 0.0 110.402 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.601 HD12 ' C ' ' A' ' 85' ' ' ARG . 4.7 mp -138.86 163.56 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.088 -1.007 . . . . 0.0 109.268 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.546 ' N ' HG22 ' A' ' 86' ' ' ILE . 76.6 ttt180 -138.13 127.41 24.52 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.361 -0.837 . . . . 0.0 109.72 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.419 HG22 ' CE2' ' A' ' 94' ' ' TYR . 2.9 p -93.24 142.41 27.34 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.306 -0.871 . . . . 0.0 109.202 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.5 t . . . . . 0 N--CA 1.501 2.088 0 O-C-N 121.412 -0.805 . . . . 0.0 110.119 -179.365 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.473 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.497 2.755 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.473 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 23.8 m-85 -151.33 157.62 42.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.422 -1.046 . . . . 0.0 108.565 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.418 ' C ' ' SD ' ' A' ' 95' ' ' MET . 1.5 tmt? -157.75 123.01 4.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.347 -0.845 . . . . 0.0 109.523 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 96' ' ' LEU . 9.2 mp -82.43 139.09 34.2 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.406 -0.808 . . . . 0.0 108.848 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.89 113.48 1.52 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.929 . . . . 0.0 109.501 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 0.0 109.54 -179.965 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 10.8 p-10 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -164.99 124.87 1.88 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.141 -0.975 . . . . 0.0 109.444 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -163.48 156.06 18.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.465 -0.772 . . . . 0.0 109.474 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.7 pt -147.84 163.97 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.357 -0.839 . . . . 0.0 109.167 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.4 m -133.99 145.43 49.49 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.533 -0.729 . . . . 0.0 109.558 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.4 t -141.44 93.4 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.87 -109.5 2.83 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -105.84 4.1 29.37 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.593 -0.945 . . . . 0.0 109.865 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.508 HD12 ' N ' ' A' ' 12' ' ' LEU . 10.4 mp -98.68 117.63 33.58 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.234 -0.917 . . . . 0.0 109.602 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 59.9 mtp85 -108.46 116.06 31.27 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 14' ' ' LEU . 9.2 mp -103.11 136.13 43.49 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.482 -0.761 . . . . 0.0 109.428 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -134.98 98.71 4.08 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.7 t -71.64 -29.39 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.498 -0.751 . . . . 0.0 109.449 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.41 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -56.88 -52.7 64.13 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.42 -0.8 . . . . 0.0 109.231 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.6 mtp180 -97.01 -6.71 34.74 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.485 ' NH2' ' O ' ' A' ' 30' ' ' LEU . 1.4 tmt_? 55.23 81.73 0.11 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.81 0.814 . . . . 0.0 109.248 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.409 HD23 ' N ' ' A' ' 21' ' ' VAL . 0.8 OUTLIER -167.76 132.34 1.82 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.409 ' N ' HD23 ' A' ' 20' ' ' LEU . 15.2 t -117.44 132.75 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.587 -0.695 . . . . 0.0 109.816 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -103.97 124.67 49.42 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.425 -0.797 . . . . 0.0 108.967 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 20.4 tp -104.15 111.77 24.5 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.68 37.4 93.48 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 107.311 -2.315 . . . . 0.0 107.311 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 69.89 2.11 3.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 122.35 -0.5 . . . . 0.0 109.826 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.5 p -103.65 138.06 40.83 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.129 -0.982 . . . . 0.0 109.97 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.9 113.14 5.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 110.225 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.3 tp -81.56 136.12 35.58 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -93.06 102.76 15.09 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.023 -1.048 . . . . 0.0 110.464 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.874 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.3 pt? -128.53 136.52 50.88 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 p -55.05 152.99 12.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 120.99 -1.068 . . . . 0.0 108.865 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.06 -40.93 47.58 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 122.054 1.836 . . . . 0.0 111.26 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -55.81 -41.91 74.86 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.188 -0.945 . . . . 0.0 108.509 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -63.32 -36.34 83.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.456 -0.778 . . . . 0.0 109.114 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -56.25 -28.22 57.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.161 -0.962 . . . . 0.0 108.633 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.24 -50.91 34.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.315 -0.866 . . . . 0.0 108.891 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.594 HD12 ' N ' ' A' ' 37' ' ' LEU . 8.4 mp -58.22 -39.96 80.4 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 12.8 tp -58.45 -41.99 86.36 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.543 ' C ' ' HE ' ' A' ' 40' ' ' ARG . 15.7 m -51.7 -35.48 43.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 109.17 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.543 ' HE ' ' C ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -76.38 -43.26 41.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.466 -0.771 . . . . 0.0 109.031 179.307 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.453 HD21 HD11 ' A' ' 54' ' ' LEU . 96.6 mt -59.7 -50.84 72.3 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.219 -0.926 . . . . 0.0 110.018 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -67.65 -36.45 80.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.923 -1.11 . . . . 0.0 110.196 -179.233 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.548 ' N ' ' SD ' ' A' ' 42' ' ' MET . 10.8 ttt -54.04 -28.4 38.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.089 -1.007 . . . . 0.0 108.96 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -122.34 44.54 2.59 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.37 132.16 49.32 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.195 -0.941 . . . . 0.0 109.909 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.17 -6.09 57.92 Favored Glycine 0 N--CA 1.501 3.032 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.3 m -132.75 150.82 76.81 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.591 -0.946 . . . . 0.0 108.718 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.07 120.25 5.65 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.803 1.669 . . . . 0.0 112.189 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.0 t -93.38 138.33 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -0.838 . . . . 0.0 109.273 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -68.85 122.27 18.27 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.185 -0.947 . . . . 0.0 108.759 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -52.33 -17.12 1.03 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 109.266 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.405 ' O ' ' OD1' ' A' ' 56' ' ' ASN . 68.5 mm-40 -66.53 -50.24 63.84 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.401 -0.812 . . . . 0.0 109.361 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.4 mt -55.0 -29.77 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.271 -0.893 . . . . 0.0 109.784 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.453 HD11 HD21 ' A' ' 41' ' ' LEU . 17.9 mt -72.95 -30.32 63.77 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.211 -0.931 . . . . 0.0 109.385 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -71.4 -34.13 70.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.752 -1.217 . . . . 0.0 107.837 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 14.7 m120 -62.89 -20.82 65.51 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.362 0.601 . . . . 0.0 109.767 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.305 -1.359 0 O-C-N 120.814 -1.179 . . . . 0.0 109.507 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.66 HD12 ' N ' ' A' ' 70' ' ' LEU . 6.8 mp -59.77 -50.48 73.66 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.449 -0.782 . . . . 0.0 109.855 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -69.7 -26.01 64.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.094 -1.004 . . . . 0.0 109.754 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.6 t -75.23 -45.66 40.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.294 -0.879 . . . . 0.0 109.477 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -55.14 -37.45 66.96 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 89.0 mt -67.35 -40.45 84.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -59.78 -37.37 78.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.194 -0.941 . . . . 0.0 108.681 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -72.71 -42.12 64.52 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.723 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -64.42 -41.23 96.71 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -49.72 -50.39 44.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.334 -0.854 . . . . 0.0 109.815 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -59.52 -31.78 69.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.873 . . . . 0.0 110.803 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -68.32 -45.5 72.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.875 -1.141 . . . . 0.0 109.817 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.4 pt -74.88 -31.94 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.014 -1.054 . . . . 0.0 109.924 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 86.0 87.9 0.98 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.409 ' O ' ' O ' ' A' ' 86' ' ' ILE . 22.7 pttm -45.54 -17.33 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.573 -0.957 . . . . 0.0 110.31 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 82' ' ' GLY . 48.4 t -56.51 -52.06 66.15 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.185 -0.947 . . . . 0.0 109.897 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -87.75 10.06 19.6 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.179 -0.95 . . . . 0.0 110.942 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.546 HG22 ' N ' ' A' ' 87' ' ' ARG . 5.1 mp -133.08 164.04 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.546 ' N ' HG22 ' A' ' 86' ' ' ILE . 56.4 ttm-85 -140.85 128.02 20.89 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.075 -1.016 . . . . 0.0 110.085 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.435 HG22 ' CE2' ' A' ' 94' ' ' TYR . 2.2 p -88.57 142.24 27.86 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.498 -0.751 . . . . 0.0 109.096 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.7 t . . . . . 0 N--CA 1.502 2.151 0 O-C-N 121.368 -0.832 . . . . 0.0 110.236 -179.318 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.456 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.497 2.736 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 12.1 m-85 -151.29 149.98 30.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.388 -1.066 . . . . 0.0 108.335 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.477 ' SD ' ' O ' ' A' ' 95' ' ' MET . 3.4 ppp? -149.22 127.45 12.11 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.212 -0.93 . . . . 0.0 109.542 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.427 HD12 ' N ' ' A' ' 96' ' ' LEU . 9.8 mp -79.87 132.74 36.16 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.08 132.1 46.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.347 -0.846 . . . . 0.0 109.615 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 109.456 179.92 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.4 p30 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 17' ' ' THR . 4.1 p30 -178.09 111.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -163.24 156.01 18.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 109.863 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.2 pt -146.38 163.12 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.347 -0.846 . . . . 0.0 109.084 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.8 t -134.49 142.15 46.97 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.336 -0.852 . . . . 0.0 109.8 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.77 92.88 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.55 -119.79 5.38 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -101.09 10.84 40.53 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.407 -1.055 . . . . 0.0 109.794 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.4 mt -108.33 123.59 49.04 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.413 -0.805 . . . . 0.0 109.672 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -108.1 146.98 31.87 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.6 tp -130.84 120.97 24.48 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.482 -0.762 . . . . 0.0 109.176 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 19' ' ' ARG . 13.2 m-20 -118.55 97.85 5.95 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.531 -0.731 . . . . 0.0 109.525 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.94 -27.51 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.449 -0.782 . . . . 0.0 109.216 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.463 ' N ' ' OD1' ' A' ' 5' ' ' ASN . 0.1 OUTLIER -63.18 -53.83 47.19 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.508 -0.745 . . . . 0.0 109.645 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -92.73 -14.62 27.71 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.153 -0.967 . . . . 0.0 108.814 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 15' ' ' ASN . 5.6 tpt180 68.18 61.31 0.4 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.312 0.577 . . . . 0.0 109.604 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.9 mt -138.89 156.65 47.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.38 -0.825 . . . . 0.0 108.973 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 t -143.69 127.73 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.255 -0.903 . . . . 0.0 109.388 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 12.3 m-90 -102.38 154.87 18.66 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.247 -0.908 . . . . 0.0 108.898 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.404 ' O ' ' OG1' ' A' ' 26' ' ' THR . 1.1 tt -144.5 115.09 7.68 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 63.5 43.47 98.08 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 107.805 -2.118 . . . . 0.0 107.805 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 61.28 0.43 0.42 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 122.129 -0.63 . . . . 0.0 110.213 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 68.1 p -106.47 139.85 40.29 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.215 -0.928 . . . . 0.0 109.452 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.03 114.56 3.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.412 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 32.2 tp -75.27 128.75 36.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.252 -0.905 . . . . 0.0 108.657 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -97.39 104.8 16.86 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.164 -0.96 . . . . 0.0 109.657 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.854 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.4 pt? -131.32 141.83 50.0 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.67 -0.644 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.3 p -62.36 152.19 80.29 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.155 -0.966 . . . . 0.0 109.961 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.04 -45.23 14.5 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.779 1.653 . . . . 0.0 112.013 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -53.63 -48.62 69.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.357 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.46 ' HG2' HD13 ' A' ' 77' ' ' LEU . 37.2 mt-10 -56.43 -35.26 67.64 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.324 -0.86 . . . . 0.0 109.536 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -60.19 -32.97 71.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 109.198 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.82 -53.45 9.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.155 -0.966 . . . . 0.0 108.583 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 tt -55.94 -45.0 78.91 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.9 tp -64.46 -45.74 86.08 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.3 0.572 . . . . 0.0 109.739 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.8 t -50.59 -39.45 49.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.364 -0.835 . . . . 0.0 110.635 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.416 ' CA ' ' HE ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -80.36 -41.68 24.29 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.916 -1.115 . . . . 0.0 109.87 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.6 tp -60.69 -41.83 95.94 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 109.325 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.1 mtp -72.35 -37.3 68.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.058 -1.026 . . . . 0.0 109.296 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 13.5 ttt -51.85 -27.3 12.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.28 -0.888 . . . . 0.0 108.766 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm -119.37 46.05 1.99 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.66 141.58 49.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.33 -0.856 . . . . 0.0 110.512 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.54 -22.14 40.63 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 t -114.43 152.99 46.61 Favored Pre-proline 0 N--CA 1.502 2.134 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.77 119.43 6.08 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.557 1.505 . . . . 0.0 111.629 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.439 HG11 HD21 ' A' ' 54' ' ' LEU . 78.8 t -97.11 133.69 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.293 -0.879 . . . . 0.0 110.047 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -68.44 124.75 24.4 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.184 -0.948 . . . . 0.0 108.673 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -52.31 -18.71 1.69 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.345 -0.847 . . . . 0.0 109.008 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -60.74 -57.15 13.9 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.46 -0.775 . . . . 0.0 109.379 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.2 mt -56.46 -30.67 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.238 -0.914 . . . . 0.0 109.735 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.439 HD21 HG11 ' A' ' 49' ' ' VAL . 33.8 mt -68.55 -32.53 72.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.096 -1.002 . . . . 0.0 108.959 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -74.1 -35.52 64.18 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -61.19 -22.05 64.37 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 . . . . . 0 C--N 1.304 -1.394 0 O-C-N 121.386 -0.821 . . . . 0.0 109.751 -179.759 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 98.3 m . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.5 pp -68.1 -33.0 73.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.733 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.23 -32.09 70.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.022 -1.049 . . . . 0.0 110.026 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.1 t -73.84 -45.68 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.039 -1.038 . . . . 0.0 109.279 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.486 ' ND1' ' N ' ' A' ' 73' ' ' HIS . 1.5 m-70 -55.86 -37.49 68.84 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 86.8 mt -67.79 -39.79 82.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -61.25 -35.84 78.38 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.969 -1.082 . . . . 0.0 108.752 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -74.49 -41.66 60.33 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.479 -0.763 . . . . 0.0 109.017 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.665 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -69.11 -42.83 75.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 0.0 108.85 -179.231 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -50.82 -50.64 56.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -0.857 . . . . 0.0 110.726 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -64.71 -26.07 68.21 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.036 -1.04 . . . . 0.0 110.769 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -71.44 -45.35 62.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.856 -1.152 . . . . 0.0 110.077 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 21.7 pt -74.84 -22.29 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.122 -0.986 . . . . 0.0 110.09 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 81.6 84.39 0.76 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.576 -1.81 . . . . 0.0 108.576 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 86' ' ' ILE . 18.3 pttp -45.1 -17.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.658 -0.907 . . . . 0.0 110.425 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 82' ' ' GLY . 36.7 p -54.78 -48.73 72.31 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.168 -0.957 . . . . 0.0 109.751 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.83 9.58 4.09 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.056 -1.028 . . . . 0.0 109.893 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 87' ' ' ARG . 5.2 mp -134.46 159.56 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.214 -0.929 . . . . 0.0 109.307 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.49 ' N ' HG22 ' A' ' 86' ' ' ILE . 95.3 mtt180 -140.73 124.39 17.01 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.419 -0.8 . . . . 0.0 109.689 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.8 p -86.75 138.63 31.45 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.287 -0.883 . . . . 0.0 109.285 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.501 2.117 0 O-C-N 121.375 -0.828 . . . . 0.0 110.535 -179.092 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.428 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.495 2.631 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.428 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 22.7 m-85 -149.51 158.06 43.84 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 45.6 ttp -159.81 126.61 4.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.204 -0.935 . . . . 0.0 110.075 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.404 HD12 ' N ' ' A' ' 96' ' ' LEU . 9.4 mp -84.3 131.88 34.68 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.02 127.14 27.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.189 -0.944 . . . . 0.0 109.215 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.4 m120 . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.238 -0.913 . . . . 0.0 109.629 -179.855 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.348 0.594 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -161.92 125.01 3.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 108.952 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -150.26 146.5 26.83 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.554 -0.716 . . . . 0.0 109.492 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.3 pt -148.92 163.44 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.271 -0.893 . . . . 0.0 108.905 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.1 t -143.24 152.79 42.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.201 -0.937 . . . . 0.0 109.712 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.1 t -147.35 92.92 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.91 -114.84 4.08 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.7 m-20 -103.09 6.19 38.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.421 -1.046 . . . . 0.0 109.893 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.8 mt -101.78 118.31 36.66 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.351 -0.843 . . . . 0.0 109.887 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -110.84 118.97 37.56 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 mp -106.88 126.47 52.35 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.552 -0.717 . . . . 0.0 109.309 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -122.72 97.91 5.67 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.97 -27.34 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.432 -0.792 . . . . 0.0 109.576 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.412 ' H ' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER -63.74 -49.11 74.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.273 -0.892 . . . . 0.0 109.867 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.2 mtp85 -97.14 -7.75 31.79 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.164 -0.96 . . . . 0.0 108.611 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? 56.0 73.35 0.44 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 21' ' ' VAL . 1.1 tt -157.7 128.13 6.34 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.43 ' N ' HD23 ' A' ' 20' ' ' LEU . 12.6 t -114.73 136.72 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.499 -0.75 . . . . 0.0 110.264 -179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 29.0 m-90 -108.18 133.16 52.83 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tt -113.75 110.11 19.64 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.37 39.0 91.66 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 107.623 -2.191 . . . . 0.0 107.623 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 69.65 -0.45 2.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 122.324 -0.515 . . . . 0.0 110.025 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.7 p -101.93 138.99 38.16 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.064 -1.023 . . . . 0.0 109.789 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.98 112.46 1.34 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 110.012 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.4 tp -75.43 127.89 34.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 108.839 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -92.24 98.76 11.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.115 -0.991 . . . . 0.0 109.926 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.907 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.3 pt? -123.84 134.28 53.62 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 121.509 0.671 . . . . 0.0 109.341 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.0 p -59.57 149.15 72.0 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.997 -1.065 . . . . 0.0 109.463 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -45.01 -48.37 11.05 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.719 1.613 . . . . 0.0 112.117 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -54.67 -37.43 65.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.419 -0.801 . . . . 0.0 109.882 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -67.55 -35.06 78.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.095 -1.003 . . . . 0.0 109.261 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -59.12 -33.4 70.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.042 -1.036 . . . . 0.0 108.72 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.53 -53.05 17.7 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.535 HD11 HD13 ' A' ' 54' ' ' LEU . 4.9 tt -52.16 -50.3 62.07 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 13.1 tp -56.09 -40.09 73.13 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.169 0.509 . . . . 0.0 109.854 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.8 m -52.42 -33.31 43.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 109.744 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.51 HH21 ' CE ' ' A' ' 43' ' ' MET . 10.5 mmp_? -78.55 -42.66 28.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.97 . . . . 0.0 109.456 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 17.9 mt -59.22 -48.05 83.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.959 -1.088 . . . . 0.0 110.011 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.417 ' SD ' ' C ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -70.36 -25.96 63.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.985 -1.072 . . . . 0.0 109.746 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.51 ' CE ' HH21 ' A' ' 40' ' ' ARG . 40.2 ttm -61.77 -32.67 72.95 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.161 -0.962 . . . . 0.0 108.872 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -118.13 38.91 3.54 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.79 121.3 9.53 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.262 -0.899 . . . . 0.0 109.753 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.32 -6.85 30.38 Favored Glycine 0 N--CA 1.503 3.14 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.3 m -130.28 151.68 78.9 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 121.535 -0.98 . . . . 0.0 108.771 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.72 120.4 5.51 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.859 1.706 . . . . 0.0 112.186 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.5 t -87.77 131.68 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.241 -0.912 . . . . 0.0 109.78 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -67.15 129.34 39.57 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.309 -0.87 . . . . 0.0 108.675 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.446 ' NH2' ' OE1' ' A' ' 71' ' ' GLU . 13.0 ptm180 -54.04 -22.2 10.15 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.473 -0.767 . . . . 0.0 109.394 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.425 ' O ' ' OD1' ' A' ' 56' ' ' ASN . 38.2 tt0 -72.79 -36.24 67.54 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.524 -0.735 . . . . 0.0 110.409 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.9 mt -75.64 -35.37 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.433 -0.792 . . . . 0.0 111.66 -178.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.639 ' C ' HD12 ' A' ' 54' ' ' LEU . 4.2 pp -76.34 -22.43 54.92 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.818 -1.176 . . . . 0.0 109.474 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.61 ' N ' HD12 ' A' ' 54' ' ' LEU . 63.4 t80 -64.88 -33.36 75.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.903 . . . . 0.0 109.521 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 2.1 m120 -61.54 -23.69 66.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 109.669 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.386 -0.822 . . . . 0.0 110.175 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.423 0.63 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.597 ' H ' HD23 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -70.54 -49.28 49.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.373 -0.83 . . . . 0.0 108.892 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.446 ' OE1' ' NH2' ' A' ' 51' ' ' ARG . 29.8 tp10 -69.87 -31.23 68.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.574 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.9 t -72.4 -40.11 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.181 -0.95 . . . . 0.0 109.0 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -56.95 -39.3 74.31 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 89.9 mt -63.82 -35.9 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -61.97 -32.4 72.84 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.48 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -73.04 -41.78 63.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.505 -0.747 . . . . 0.0 109.255 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.8 mt -72.26 -39.39 68.43 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.227 -0.921 . . . . 0.0 109.544 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -50.32 -51.48 44.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.959 . . . . 0.0 110.181 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.43 -24.79 67.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.055 -1.028 . . . . 0.0 109.803 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -70.95 -45.92 63.31 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.984 -1.073 . . . . 0.0 110.135 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.408 HG12 ' H ' ' A' ' 81' ' ' ILE . 16.3 pt -74.89 -19.29 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.104 -0.997 . . . . 0.0 110.121 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 84.19 83.07 0.98 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 86' ' ' ILE . 56.4 pttt -44.51 -17.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.721 -0.87 . . . . 0.0 110.59 -179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 82' ' ' GLY . 57.9 m -59.38 -48.42 81.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.138 -0.976 . . . . 0.0 110.777 -178.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.483 ' N ' ' CD ' ' A' ' 85' ' ' ARG . 10.6 mpt_? -72.72 9.42 1.12 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.025 -1.047 . . . . 0.0 111.003 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' A' ' 83' ' ' LYS . 9.0 tt -146.82 160.96 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 120.934 -1.104 . . . . 0.0 109.29 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -117.1 132.44 56.67 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.42 -0.8 . . . . 0.0 109.703 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.7 p -95.39 142.47 27.74 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.414 -0.804 . . . . 0.0 108.89 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.6 t . . . . . 0 N--CA 1.499 2.002 0 O-C-N 121.352 -0.843 . . . . 0.0 109.787 -179.599 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.472 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.497 2.715 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.472 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 26.0 m-85 -151.21 163.31 39.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.421 -1.046 . . . . 0.0 108.305 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.46 ' SD ' ' O ' ' A' ' 96' ' ' LEU . 1.2 tmt? -163.27 127.79 2.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.981 -1.074 . . . . 0.0 110.261 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.46 ' O ' ' SD ' ' A' ' 95' ' ' MET . 9.6 mp -78.49 142.02 37.77 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.7 120.73 20.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 109.486 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 109.645 -180.0 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -158.26 120.27 3.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.241 -0.912 . . . . 0.0 109.321 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -162.44 154.57 18.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.333 -0.855 . . . . 0.0 109.706 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.8 pt -150.44 164.65 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.5 p -140.39 154.0 46.55 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.294 -0.879 . . . . 0.0 110.028 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.3 t -148.33 93.43 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.67 -115.19 4.19 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -101.44 5.35 41.99 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.396 -1.061 . . . . 0.0 109.837 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.2 mt -101.06 116.24 32.37 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.334 -0.854 . . . . 0.0 109.715 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -108.94 122.04 46.38 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 37.1 tp -105.95 134.74 48.6 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.597 -0.69 . . . . 0.0 110.006 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -131.78 97.36 4.17 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.9 t -71.89 -27.9 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.317 -0.864 . . . . 0.0 109.403 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.7 -54.75 30.65 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.503 -0.748 . . . . 0.0 109.656 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -86.9 -11.6 50.19 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.169 -0.957 . . . . 0.0 108.697 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 60.29 72.23 0.53 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.441 0.639 . . . . 0.0 109.329 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.5 tp -166.8 153.63 8.83 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.5 t -134.59 135.52 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.298 -0.876 . . . . 0.0 109.876 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 20.0 m-90 -100.0 120.37 39.72 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 26' ' ' THR . 1.2 tt -101.91 110.51 22.5 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.55 43.45 96.54 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 107.212 -2.355 . . . . 0.0 107.212 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 64.75 3.37 1.98 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 122.338 -0.507 . . . . 0.0 110.269 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 23' ' ' LEU . 43.8 p -106.03 138.48 42.14 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 120.95 -1.094 . . . . 0.0 109.711 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.71 113.31 2.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.973 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 28' ' ' LEU . 29.1 tp -71.04 126.25 29.06 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -96.91 104.93 16.98 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.22 -0.925 . . . . 0.0 110.695 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.779 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.1 pt? -143.09 151.48 40.8 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.44 -0.788 . . . . 0.0 109.354 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.08 157.35 62.68 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.141 -0.975 . . . . 0.0 108.71 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -60.8 -39.77 59.72 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.457 2.105 . . . . 0.0 112.069 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -54.54 -36.27 64.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.073 -1.017 . . . . 0.0 109.102 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.486 ' OE2' ' NE2' ' A' ' 73' ' ' HIS . 20.5 mm-40 -70.18 -37.73 75.21 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -55.25 -27.86 49.28 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.421 ' O ' ' OD2' ' A' ' 57' ' ' ASP . . . -72.83 -50.49 23.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.383 -0.823 . . . . 0.0 109.002 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.471 ' CD2' ' O ' ' A' ' 54' ' ' LEU . 9.9 mt -65.71 -37.73 87.24 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 38' ' ' LEU . 1.6 tt -57.58 -42.44 83.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.511 -0.743 . . . . 0.0 109.446 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.5 p -60.78 -45.86 92.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.11 -0.994 . . . . 0.0 109.275 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -55.24 -48.06 74.49 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.368 -0.832 . . . . 0.0 109.29 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.1 mt -61.65 -39.29 90.83 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 109.991 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 8.1 mmt -74.7 -37.03 62.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.874 -1.141 . . . . 0.0 109.888 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 40.5 mtt -55.14 -29.31 57.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.119 -0.988 . . . . 0.0 108.699 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -120.81 47.85 1.73 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.86 129.97 39.89 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.197 -0.94 . . . . 0.0 110.064 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.33 -12.98 43.98 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.8 p -125.75 151.43 70.86 Favored Pre-proline 0 N--CA 1.502 2.165 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.1 119.74 6.2 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.637 1.558 . . . . 0.0 111.709 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.4 t -94.67 135.34 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.349 -0.845 . . . . 0.0 109.81 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.413 ' C ' ' N ' ' A' ' 52' ' ' GLU . 8.2 t-160 -72.72 125.12 26.76 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.044 -1.035 . . . . 0.0 108.492 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.482 ' N ' ' CD ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -50.83 -15.18 0.26 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.489 -0.757 . . . . 0.0 109.787 -179.281 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.413 ' N ' ' C ' ' A' ' 50' ' ' HIS . 17.2 tt0 -66.47 -49.12 67.69 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.498 -0.751 . . . . 0.0 109.866 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.2 mm -56.24 -33.14 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.034 -1.041 . . . . 0.0 109.93 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.471 ' O ' ' CD2' ' A' ' 37' ' ' LEU . 22.7 mt -65.93 -48.95 69.67 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -57.67 -35.98 71.29 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -66.84 -21.79 66.01 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.528 -0.733 . . . . 0.0 110.693 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.421 ' OD2' ' O ' ' A' ' 36' ' ' ALA . 7.2 t0 . . . . . 0 N--CA 1.485 1.305 0 O-C-N 120.764 -1.21 . . . . 0.0 109.347 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.426 0.631 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.632 ' H ' HD12 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -55.49 -50.38 70.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.239 -0.913 . . . . 0.0 109.201 -179.684 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -71.57 -27.44 63.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 110.138 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.65 -48.24 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.105 -0.997 . . . . 0.0 109.413 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.486 ' NE2' ' OE2' ' A' ' 34' ' ' GLU . 81.4 t60 -54.73 -36.72 65.07 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 90.5 mt -71.61 -42.45 71.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -61.39 -35.43 77.48 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.816 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -74.07 -40.86 62.48 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.512 -0.743 . . . . 0.0 109.402 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.673 ' C ' HD12 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -67.71 -42.51 81.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 108.665 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.483 ' NH2' ' OH ' ' A' ' 94' ' ' TYR . 35.6 ttm180 -49.85 -51.29 41.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.524 -0.735 . . . . 0.0 110.448 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -62.16 -27.71 69.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 110.642 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -74.47 -45.04 48.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.981 -1.074 . . . . 0.0 110.94 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.7 pt -76.83 -22.23 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.821 -1.175 . . . . 0.0 110.638 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 83.93 82.12 0.99 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.2 pttt -45.07 -15.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.707 -0.878 . . . . 0.0 110.658 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 82' ' ' GLY . 65.1 p -49.44 -45.53 46.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.954 -1.091 . . . . 0.0 109.841 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.521 ' HE ' ' N ' ' A' ' 85' ' ' ARG . 5.4 mmp_? -84.25 9.5 12.79 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.189 -0.944 . . . . 0.0 110.295 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 87' ' ' ARG . 37.2 mm -116.95 161.5 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 121.372 -0.83 . . . . 0.0 109.617 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.463 ' N ' HG22 ' A' ' 86' ' ' ILE . 47.4 ttt85 -134.04 110.46 9.66 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.3 p -87.37 138.14 31.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.145 -0.972 . . . . 0.0 110.274 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.499 1.991 0 O-C-N 121.539 -0.726 . . . . 0.0 109.597 -179.947 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.496 2.643 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.483 ' OH ' ' NH2' ' A' ' 78' ' ' ARG . 28.0 m-85 -151.21 159.84 44.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.299 -1.118 . . . . 0.0 108.585 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 43.1 ttp -161.15 131.69 5.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 110.065 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.451 HD12 ' N ' ' A' ' 96' ' ' LEU . 9.3 mp -89.64 133.13 34.79 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.17 114.06 1.62 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 109.729 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.294 -0.878 . . . . 0.0 109.243 179.796 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.6 p30 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -158.83 123.93 4.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 108.924 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -161.32 152.36 18.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.394 -0.816 . . . . 0.0 109.546 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.458 HG22 ' N ' ' A' ' 8' ' ' SER . 58.5 mt -137.04 159.97 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.458 ' N ' HG22 ' A' ' 7' ' ' ILE . 72.2 m -142.9 146.69 34.29 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.39 -0.819 . . . . 0.0 109.732 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.5 t -142.66 94.65 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.01 -119.41 4.95 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -100.96 10.11 41.49 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.37 -1.076 . . . . 0.0 109.34 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 17.7 tp -104.45 127.85 52.23 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -123.53 135.65 54.13 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 tt -129.2 121.44 27.67 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.622 -0.674 . . . . 0.0 109.582 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.513 ' C ' ' HH ' ' A' ' 35' ' ' TYR . 3.4 m-20 -112.12 107.11 15.91 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.629 -0.669 . . . . 0.0 110.241 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.1 t -71.9 -28.58 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.284 -0.885 . . . . 0.0 109.561 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 17' ' ' THR . 0.1 OUTLIER -66.69 -54.7 20.33 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.368 -0.832 . . . . 0.0 109.303 -179.722 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -84.01 -18.78 35.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.115 -0.991 . . . . 0.0 108.665 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? 66.11 65.92 0.5 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.9 mt -148.01 158.23 43.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.236 -0.915 . . . . 0.0 108.661 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.7 t -140.35 128.63 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.324 -0.86 . . . . 0.0 109.58 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -103.86 148.0 26.65 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.415 -0.803 . . . . 0.0 109.35 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.9 tp -133.83 102.53 5.48 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 71.85 40.87 57.06 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.315 -1.914 . . . . 0.0 108.315 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 70.62 -10.86 0.67 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 122.034 -0.686 . . . . 0.0 109.695 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.431 ' H ' ' C ' ' A' ' 24' ' ' GLY . 44.3 p -92.85 142.81 26.91 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.077 -1.014 . . . . 0.0 109.638 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.71 116.68 7.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 110.121 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.3 tp -75.14 130.57 39.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.263 -0.898 . . . . 0.0 108.604 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 29' ' ' ASP . 9.5 p-10 -97.45 102.79 14.64 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.231 -0.918 . . . . 0.0 110.046 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.861 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.4 pt? -131.29 140.94 49.88 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.0 p -64.59 151.21 92.48 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.026 -1.046 . . . . 0.0 109.703 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -44.71 -44.58 14.03 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 121.734 1.623 . . . . 0.0 112.087 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -53.6 -46.22 70.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 109.325 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.512 ' HG2' HD13 ' A' ' 77' ' ' LEU . 45.6 mt-10 -55.55 -44.77 77.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.918 . . . . 0.0 109.786 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.513 ' HH ' ' C ' ' A' ' 15' ' ' ASN . 12.5 t80 -56.29 -28.11 57.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.411 -0.805 . . . . 0.0 109.921 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.64 -54.12 8.04 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.908 -1.12 . . . . 0.0 109.681 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 tt -58.28 -42.73 87.2 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 22.4 tp -62.32 -43.08 99.66 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.291 0.567 . . . . 0.0 109.488 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.8 m -51.44 -36.14 42.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.78 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -77.14 -39.25 49.96 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.738 -1.226 . . . . 0.0 109.725 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.7 mt -57.4 -43.99 84.18 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.097 -1.002 . . . . 0.0 108.961 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.3 mmt -67.93 -28.91 67.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.053 -1.029 . . . . 0.0 109.66 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 24.6 ttt -61.59 -33.16 73.41 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.183 -0.948 . . . . 0.0 108.907 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -124.01 47.32 2.08 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.867 -0.521 . . . . 0.0 109.64 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.45 136.95 52.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.108 -0.995 . . . . 0.0 110.254 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.45 -13.99 61.04 Favored Glycine 0 N--CA 1.501 2.984 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.2 p -119.9 151.32 52.34 Favored Pre-proline 0 N--CA 1.502 2.162 0 O-C-N 121.56 -0.965 . . . . 0.0 108.566 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.03 120.2 5.96 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.639 1.559 . . . . 0.0 111.519 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.0 t -100.0 138.38 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.489 -0.757 . . . . 0.0 109.87 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.439 ' C ' ' N ' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -79.56 126.35 30.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.344 -0.848 . . . . 0.0 108.764 178.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.7 ttp-105 -51.06 -16.77 0.5 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 108.816 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.439 ' N ' ' C ' ' A' ' 50' ' ' HIS . 31.7 tt0 -65.05 -39.02 92.68 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.5 mt -73.54 -35.05 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.273 0.559 . . . . 0.0 109.529 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.9 mt -73.84 -25.03 59.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.174 -0.954 . . . . 0.0 108.906 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -60.21 -37.01 78.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.001 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.403 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 3.3 m120 -59.13 -28.07 66.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.519 -0.738 . . . . 0.0 109.918 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--N 1.301 -1.521 0 O-C-N 121.341 -0.849 . . . . 0.0 110.047 -179.573 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.4 m . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' A' ' 70' ' ' LEU . 2.1 mm? -64.49 -49.36 71.68 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.296 -0.878 . . . . 0.0 109.166 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.14 -34.68 78.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.896 -1.128 . . . . 0.0 108.781 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.6 t -69.1 -35.33 68.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.16 -38.57 80.04 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.423 ' HA ' HD23 ' A' ' 77' ' ' LEU . 94.1 mt -63.96 -36.66 77.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -62.73 -34.22 76.74 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.789 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -77.37 -41.68 39.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.489 -0.757 . . . . 0.0 109.306 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.63 ' C ' HD12 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -71.73 -39.22 70.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.292 -0.88 . . . . 0.0 109.276 -179.065 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -56.46 -47.78 78.45 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.775 -0.578 . . . . 0.0 110.62 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -62.3 -15.2 46.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.076 -1.015 . . . . 0.0 110.847 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -88.2 -39.64 14.33 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.849 -1.157 . . . . 0.0 110.681 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.2 pt -81.52 -15.74 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.028 -1.045 . . . . 0.0 110.131 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 78.93 85.82 0.54 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -44.78 -16.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.638 -0.919 . . . . 0.0 110.539 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 82' ' ' GLY . 52.0 p -50.01 -44.74 51.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.601 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -75.29 8.79 2.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.18 -0.95 . . . . 0.0 109.971 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.1 mt -137.56 127.71 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.335 -0.853 . . . . 0.0 108.933 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -97.8 98.09 9.54 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.394 -0.816 . . . . 0.0 109.058 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.405 HG23 ' H ' ' A' ' 88' ' ' THR . 2.9 p -67.43 131.23 45.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -0.945 . . . . 0.0 109.336 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.501 2.094 0 O-C-N 121.487 -0.758 . . . . 0.0 110.246 -179.0 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.422 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.493 2.449 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.422 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 31.4 m-85 -151.98 159.74 43.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -1.131 . . . . 0.0 108.795 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 38.8 ttp -161.94 135.1 6.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.278 -0.889 . . . . 0.0 110.188 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 96' ' ' LEU . 9.3 mp -93.12 130.6 38.7 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.44 -0.788 . . . . 0.0 108.921 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.2 123.77 25.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 109.558 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.233 -0.917 . . . . 0.0 109.488 179.997 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -74.16 54.02 0.52 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.345 -0.847 . . . . 0.0 109.462 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 71.07 17.74 75.89 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -167.62 138.48 2.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.306 -1.114 . . . . 0.0 109.501 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.412 ' N ' ' OD1' ' A' ' 5' ' ' ASN . 8.7 p30 -171.14 124.74 0.63 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 109.213 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 1.3 pm0 -160.64 155.98 24.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.392 -0.818 . . . . 0.0 109.831 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 7' ' ' ILE . 21.9 pt -147.17 163.03 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.338 -0.851 . . . . 0.0 109.012 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m -143.74 154.36 43.38 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.238 -0.914 . . . . 0.0 109.712 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.5 t -142.67 99.09 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.15 -119.69 5.69 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -99.29 11.37 39.27 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.455 -1.027 . . . . 0.0 109.738 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 29.6 mt -106.82 130.62 54.48 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.356 -0.84 . . . . 0.0 109.455 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -118.59 141.05 48.96 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.1 tt -129.05 143.53 50.9 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.618 -0.676 . . . . 0.0 109.525 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 19' ' ' ARG . 3.3 m-20 -135.48 100.7 4.58 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.622 -0.674 . . . . 0.0 109.721 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.85 -30.34 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.363 -0.835 . . . . 0.0 109.564 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.427 ' H ' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER -60.75 -49.32 77.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.444 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -93.73 -14.53 26.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.129 -0.982 . . . . 0.0 108.378 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 15' ' ' ASN . 5.7 tpt180 64.41 49.25 2.52 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.873 -0.517 . . . . 0.0 109.742 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.3 mt -133.69 153.08 51.96 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.9 t -133.87 134.27 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.422 -0.799 . . . . 0.0 109.319 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -103.17 158.68 16.15 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.429 ' O ' ' OG1' ' A' ' 26' ' ' THR . 1.9 tt -146.41 116.92 7.52 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.27 -0.894 . . . . 0.0 108.714 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.64 41.65 97.66 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 107.727 -2.149 . . . . 0.0 107.727 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 61.63 3.48 0.86 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 122.089 -0.654 . . . . 0.0 110.077 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 60.6 p -108.35 140.8 41.11 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 121.187 -0.946 . . . . 0.0 109.457 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.33 114.58 7.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 109.693 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 28' ' ' LEU . 12.1 tp -84.94 141.27 30.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 109.023 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -99.78 107.5 19.57 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.322 -0.861 . . . . 0.0 109.795 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.3 140.57 51.8 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.8 p -61.11 145.05 90.32 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.107 -0.996 . . . . 0.0 109.48 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -45.0 -42.72 15.76 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.709 1.606 . . . . 0.0 112.32 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -53.31 -48.24 68.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.885 . . . . 0.0 109.767 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -59.48 -33.37 71.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.973 . . . . 0.0 109.381 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.442 ' HH ' ' C ' ' A' ' 15' ' ' ASN . 20.3 t80 -60.04 -32.03 70.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.128 -0.982 . . . . 0.0 109.369 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.409 ' O ' ' OD2' ' A' ' 57' ' ' ASP . . . -74.27 -53.85 8.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.171 -0.956 . . . . 0.0 109.794 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 37' ' ' LEU . 8.5 mp -64.96 -38.47 91.07 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.8 tp -65.23 -46.27 81.3 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.5 m -50.46 -30.15 12.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 109.61 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -77.27 -37.81 52.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.156 -0.965 . . . . 0.0 109.082 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.4 mp -56.53 -47.28 79.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 108.998 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 54.8 mtt -72.28 -30.86 65.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.15 -0.969 . . . . 0.0 109.665 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 20.8 ttt -52.35 -36.03 52.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.159 -0.963 . . . . 0.0 109.443 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -120.92 53.96 1.11 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.64 104.2 3.83 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.305 -0.872 . . . . 0.0 109.919 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.61 -17.45 1.27 Allowed Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.06 159.98 59.72 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.578 -0.954 . . . . 0.0 108.85 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.12 119.97 6.9 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.121 1.88 . . . . 0.0 111.74 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.4 132.63 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.331 -0.856 . . . . 0.0 109.569 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -58.45 147.56 31.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.978 -1.076 . . . . 0.0 108.986 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.0 mtm180 -79.72 -20.94 45.25 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.144 -0.973 . . . . 0.0 110.13 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -72.24 -33.93 67.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.118 -0.989 . . . . 0.0 109.89 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.2 mt -67.16 -33.48 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.029 -1.044 . . . . 0.0 109.548 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.6 mt -64.63 -50.66 66.24 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.403 ' O ' ' O ' ' A' ' 59' ' ' TYR . 32.2 m-85 -58.19 -34.34 70.25 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -70.66 -22.03 62.54 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.528 -0.732 . . . . 0.0 109.958 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.409 ' OD2' ' O ' ' A' ' 36' ' ' ALA . 12.3 t0 -54.58 -54.7 37.86 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.982 -1.074 . . . . 0.0 109.679 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 65.3 mt -83.39 -37.15 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.113 -0.992 . . . . 0.0 109.908 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.458 ' CD1' ' O ' ' A' ' 59' ' ' TYR . 43.0 p90 -163.27 138.57 6.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.057 -1.027 . . . . 0.0 110.094 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.9 t -120.11 20.71 12.02 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.429 ' CD1' ' C ' ' A' ' 61' ' ' TRP . 10.0 t-105 -77.52 -24.8 49.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.337 -0.852 . . . . 0.0 108.939 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 61' ' ' TRP . 16.8 m-20 45.64 97.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.548 -0.72 . . . . 0.0 110.479 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.546 ' ND2' ' H ' ' A' ' 64' ' ' GLU . 8.0 p-10 -78.85 -113.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.93 . . . . 0.0 109.308 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.546 ' H ' ' ND2' ' A' ' 63' ' ' ASN . 59.0 mt-10 -150.78 61.61 4.73 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.065 -1.022 . . . . 0.0 109.272 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.54 83.88 2.08 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.552 2.168 . . . . 0.0 112.026 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.64 -33.67 64.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.223 -0.923 . . . . 0.0 109.438 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -74.27 150.13 40.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.501 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -75.01 125.05 28.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 109.454 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 85.7 m -165.89 -41.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.334 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.579 ' N ' HD12 ' A' ' 70' ' ' LEU . 8.8 mp -62.68 -47.79 82.1 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.43 -0.794 . . . . 0.0 108.938 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -70.99 -31.42 67.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 109.293 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.1 t -73.12 -37.48 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.279 -0.888 . . . . 0.0 109.256 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -56.34 -41.09 75.51 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.49 -36.53 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -64.27 -37.17 86.52 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -68.22 -43.9 76.95 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.0 mt -71.95 -30.0 64.85 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -50.97 -49.25 60.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.665 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -63.87 -26.99 68.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.243 -0.911 . . . . 0.0 110.439 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -71.99 -44.15 63.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.959 -1.088 . . . . 0.0 110.309 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.413 ' H ' HG12 ' A' ' 81' ' ' ILE . 16.0 pt -72.51 -15.37 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.177 -0.952 . . . . 0.0 109.655 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 75.57 82.88 0.45 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -46.96 -17.74 0.06 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.476 -1.014 . . . . 0.0 109.902 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' GLY . 22.7 t -56.91 -51.89 67.33 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.446 -0.784 . . . . 0.0 110.23 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -86.56 9.17 19.26 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.0 -1.062 . . . . 0.0 110.603 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.1 mm -121.6 165.92 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -140.98 114.02 8.48 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.436 -0.79 . . . . 0.0 108.947 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.419 HG22 ' CE2' ' A' ' 94' ' ' TYR . 4.7 p -86.63 138.26 31.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.208 -0.932 . . . . 0.0 109.591 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.9 t -106.1 92.31 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.537 -0.727 . . . . 0.0 109.2 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 50.41 -178.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.293 -0.88 . . . . 0.0 109.732 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.78 55.98 5.0 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -134.74 -31.94 1.02 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.567 -0.96 . . . . 0.0 109.626 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -169.02 -171.73 35.06 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.04 -1.552 . . . . 0.0 110.83 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.419 ' CE2' HG22 ' A' ' 88' ' ' THR . 14.2 m-85 -129.54 157.12 42.93 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 38.6 ttp -153.05 133.15 13.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.291 -0.881 . . . . 0.0 109.736 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.5 mp -91.0 145.49 24.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.567 -0.708 . . . . 0.0 109.092 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 99' ' ' ASN . . . -63.75 105.78 0.87 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -0.878 . . . . 0.0 109.361 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -67.65 68.74 0.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.905 . . . . 0.0 109.433 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 97' ' ' ALA . 8.0 m120 51.22 42.16 28.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.3 -0.875 . . . . 0.0 109.654 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 47.9 mt -77.07 -12.06 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.316 -0.865 . . . . 0.0 108.817 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.16 -43.85 90.44 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.407 0.622 . . . . 0.0 109.404 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.6 p -79.29 48.92 0.92 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.339 -0.851 . . . . 0.0 109.389 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.574 179.984 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.6 m120 . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 51.39 42.24 29.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.196 -0.94 . . . . 0.0 109.522 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -165.11 23.26 0.15 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -52.38 164.71 0.3 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -1.173 . . . . 0.0 109.519 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -164.53 125.86 2.17 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.261 -0.899 . . . . 0.0 108.962 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -163.5 158.31 20.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.458 -0.776 . . . . 0.0 109.75 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.9 pt -149.32 163.7 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 80.9 p -128.46 132.24 48.39 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.498 -0.751 . . . . 0.0 109.755 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.26 91.49 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.04 -120.3 8.52 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.746 -1.741 . . . . 0.0 108.746 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -95.46 11.84 31.48 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.311 -1.111 . . . . 0.0 109.26 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.541 HD12 ' N ' ' A' ' 12' ' ' LEU . 8.0 mp -104.43 125.77 50.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.492 -0.755 . . . . 0.0 108.988 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -108.7 118.91 38.02 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.476 HD23 ' N ' ' A' ' 15' ' ' ASN . 0.9 OUTLIER -102.3 133.87 46.51 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.486 -0.759 . . . . 0.0 109.366 -179.139 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.476 ' N ' HD23 ' A' ' 14' ' ' LEU . 4.7 m-20 -135.53 98.19 3.87 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.43 -0.794 . . . . 0.0 109.467 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.5 t -73.91 -26.32 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.435 -0.791 . . . . 0.0 109.482 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.42 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -58.37 -50.39 73.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.429 -0.795 . . . . 0.0 109.679 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -98.86 -3.72 34.72 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.42 ' NH1' ' O ' ' A' ' 17' ' ' THR . 6.9 mpt_? 56.44 75.33 0.35 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.423 0.63 . . . . 0.0 109.419 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.409 HD23 ' CZ2' ' A' ' 22' ' ' TRP . 61.8 tp -163.99 149.58 10.84 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.8 t -134.25 146.52 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.381 -0.824 . . . . 0.0 109.807 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.409 ' CZ2' HD23 ' A' ' 20' ' ' LEU . 28.5 m-90 -113.23 142.54 45.69 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.0 tp -121.86 105.47 10.39 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 71.3 40.55 60.63 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.132 -1.987 . . . . 0.0 108.132 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 70.91 -10.79 0.71 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.996 -0.708 . . . . 0.0 109.645 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.426 ' H ' ' C ' ' A' ' 24' ' ' GLY . 32.2 p -91.66 142.14 27.94 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.041 -1.037 . . . . 0.0 109.631 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.42 112.99 2.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 110.245 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.8 tp -74.66 128.38 35.42 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 3.1 m-20 -96.02 100.64 12.29 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.171 -0.956 . . . . 0.0 110.327 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.9 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.3 pt? -121.4 134.13 55.1 Favored 'General case' 0 N--CA 1.504 2.229 0 CA-C-O 121.588 0.709 . . . . 0.0 109.35 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.4 p -52.11 152.48 5.7 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.184 -0.948 . . . . 0.0 109.218 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.34 -45.22 27.98 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.622 1.548 . . . . 0.0 110.804 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -56.19 -47.29 78.64 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.189 -0.944 . . . . 0.0 108.487 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -55.16 -36.36 65.75 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.341 -0.849 . . . . 0.0 109.033 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -57.6 -32.28 67.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.268 -0.895 . . . . 0.0 108.982 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.9 -49.97 63.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 108.983 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 37' ' ' LEU . 7.4 mp -58.8 -39.05 79.98 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 12.8 tp -57.14 -42.6 81.26 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.1 t -54.11 -39.2 66.19 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.347 -0.845 . . . . 0.0 109.549 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.2 mmt-85 -76.37 -45.19 33.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.176 -0.953 . . . . 0.0 109.425 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.8 mt -59.46 -52.33 66.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 110.311 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.51 ' SD ' ' N ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -63.93 -38.07 89.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.089 -1.007 . . . . 0.0 110.429 -178.832 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.51 ' N ' ' SD ' ' A' ' 42' ' ' MET . 46.3 tpp -55.57 -29.6 59.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.062 -1.024 . . . . 0.0 108.762 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -119.36 42.15 2.93 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.89 132.68 51.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.221 -0.925 . . . . 0.0 109.956 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.4 ' C ' ' SD ' ' A' ' 95' ' ' MET . . . 90.35 -6.22 82.46 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.6 t -121.85 116.17 30.36 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.644 -0.915 . . . . 0.0 108.717 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -47.62 119.89 4.11 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.017 1.145 . . . . 0.0 111.676 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.5 t -97.59 137.23 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.46 -0.775 . . . . 0.0 110.376 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.459 ' CD2' ' HB3' ' A' ' 52' ' ' GLU . 0.8 OUTLIER -63.89 121.07 13.17 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.363 -0.836 . . . . 0.0 108.792 178.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.487 ' NH1' ' OE1' ' A' ' 71' ' ' GLU . 11.3 ttm180 -52.89 -18.42 1.92 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.389 -0.819 . . . . 0.0 108.937 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.518 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 34.2 tt0 -65.48 -48.87 71.13 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.567 -0.708 . . . . 0.0 109.563 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.1 mt -58.0 -31.75 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.08 -1.012 . . . . 0.0 110.177 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.06 -33.06 74.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.042 -1.036 . . . . 0.0 108.991 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -74.06 -33.23 63.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.999 -1.063 . . . . 0.0 108.43 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 44.0 m-80 -64.82 -22.54 67.01 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.543 -0.723 . . . . 0.0 109.764 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.87 -55.54 31.27 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.1 -1.0 . . . . 0.0 109.253 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.6 mt -77.7 -12.86 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.263 -0.898 . . . . 0.0 109.436 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -145.2 70.61 1.27 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.22 -0.925 . . . . 0.0 109.251 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.9 t -83.06 -48.52 10.5 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.228 -0.92 . . . . 0.0 109.798 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -87.23 41.86 1.0 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.206 -0.934 . . . . 0.0 109.674 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 63' ' ' ASN . 54.2 m-20 -158.31 -55.85 0.07 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.197 -0.939 . . . . 0.0 109.733 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.466 ' ND2' ' OD1' ' A' ' 56' ' ' ASN . 2.8 m120 54.14 102.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.502 -0.749 . . . . 0.0 109.699 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -157.1 62.74 2.79 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.191 -0.943 . . . . 0.0 109.351 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -78.43 12.79 2.01 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.627 2.218 . . . . 0.0 111.989 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.12 -29.02 66.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 109.472 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 57.2 p -63.86 -141.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 109.527 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.495 ' C ' ' H ' ' A' ' 70' ' ' LEU . 32.4 m120 -156.88 -162.47 1.24 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.277 -0.889 . . . . 0.0 109.33 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.5 m 63.06 -7.47 0.15 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.605 -0.684 . . . . 0.0 110.114 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.495 ' H ' ' C ' ' A' ' 68' ' ' ASN . 2.4 pp -70.47 -43.7 69.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.007 -1.058 . . . . 0.0 109.264 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.487 ' OE1' ' NH1' ' A' ' 51' ' ' ARG . 33.6 tt0 -71.75 -33.01 68.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 109.453 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.0 t -70.77 -38.71 73.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.255 -0.903 . . . . 0.0 108.977 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -56.32 -39.6 73.03 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.99 -37.03 79.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -62.49 -36.5 82.69 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -71.57 -41.88 68.49 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.67 -38.11 73.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 0.0 109.412 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -50.57 -47.84 57.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.927 . . . . 0.0 109.669 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -62.47 -24.93 67.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 110.496 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -75.68 -43.6 46.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.936 -1.102 . . . . 0.0 110.466 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.9 pt -76.61 -22.43 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.142 -0.974 . . . . 0.0 109.945 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 82.67 87.76 0.73 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -44.79 -17.17 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.722 -0.87 . . . . 0.0 110.422 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.533 ' C ' ' HE ' ' A' ' 85' ' ' ARG . 12.9 t -51.72 -47.59 63.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.219 -0.925 . . . . 0.0 109.701 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.563 ' HE ' ' N ' ' A' ' 85' ' ' ARG . 4.4 mmp_? -83.41 9.66 10.56 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.241 -0.912 . . . . 0.0 110.596 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 87' ' ' ARG . 5.1 mp -135.67 159.2 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.197 -0.939 . . . . 0.0 109.754 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.49 ' N ' HG22 ' A' ' 86' ' ' ILE . 39.4 ttm180 -123.09 128.01 49.53 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.4 p -94.09 141.03 29.0 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.082 -1.011 . . . . 0.0 109.778 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.508 HG12 ' H ' ' A' ' 91' ' ' GLY . 22.2 t -107.5 104.49 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -50.5 -11.0 0.07 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.217 -0.927 . . . . 0.0 109.792 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.508 ' H ' HG12 ' A' ' 89' ' ' VAL . . . -64.2 -85.07 0.07 OUTLIER Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -170.47 23.46 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.384 -1.068 . . . . 0.0 109.539 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.468 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . -146.23 -163.43 10.34 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 40.7 m-85 -150.99 170.69 18.74 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.363 -1.08 . . . . 0.0 108.579 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.4 ' SD ' ' C ' ' A' ' 46' ' ' GLY . 50.4 ttp -162.5 136.66 6.45 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.142 -0.974 . . . . 0.0 110.469 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 96' ' ' LEU . 10.2 mp -88.69 139.04 30.87 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.07 133.48 44.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 109.473 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -53.05 -80.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.571 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -163.76 91.08 0.64 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.473 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.2 mm -73.67 -11.48 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 109.067 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -66.43 -27.85 68.16 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.712 -0.618 . . . . 0.0 109.501 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.9 p -63.74 -15.27 58.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.522 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.228 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -73.78 56.93 0.57 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 109.508 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 60.58 30.07 71.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -170.13 141.05 2.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -1.17 . . . . 0.0 109.613 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -158.72 122.05 3.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.336 -0.852 . . . . 0.0 108.877 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -161.36 155.59 22.65 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.348 -0.845 . . . . 0.0 109.746 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.8 pt -148.03 163.33 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.378 -0.826 . . . . 0.0 109.07 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -142.24 152.55 43.17 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.223 -0.923 . . . . 0.0 109.777 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.6 t -147.98 95.97 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.27 -116.38 4.3 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.061 -1.615 . . . . 0.0 109.061 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -103.5 7.63 37.83 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.49 -1.006 . . . . 0.0 109.697 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.503 HD12 ' N ' ' A' ' 12' ' ' LEU . 9.3 mp -102.35 125.4 49.04 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.346 -0.846 . . . . 0.0 109.224 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -118.07 124.31 47.76 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.446 HD12 ' N ' ' A' ' 14' ' ' LEU . 8.1 mp -107.37 140.24 40.61 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.531 -0.731 . . . . 0.0 109.153 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -135.6 97.37 3.65 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.554 -0.716 . . . . 0.0 109.184 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.1 t -69.87 -29.62 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.375 -0.828 . . . . 0.0 109.306 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.425 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -63.94 -55.17 24.56 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.44 -0.787 . . . . 0.0 109.266 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.7 mmt85 -82.68 -16.04 49.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.96 . . . . 0.0 108.481 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 63.36 70.69 0.53 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.609 0.718 . . . . 0.0 109.152 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.7 tp -163.78 154.15 15.42 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.7 t -136.21 143.08 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.297 -0.877 . . . . 0.0 109.853 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -107.93 145.18 34.16 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 67.1 tp -128.75 104.03 7.4 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.7 44.68 38.33 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 64.36 -3.17 0.53 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 122.175 -0.603 . . . . 0.0 110.282 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.4 p -99.31 139.92 34.26 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 120.995 -1.066 . . . . 0.0 109.612 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.3 116.79 5.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.227 -0.921 . . . . 0.0 110.58 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.9 tp -85.0 128.95 34.85 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -103.93 120.84 41.87 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.347 -0.846 . . . . 0.0 109.825 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.834 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.1 pt? -140.51 148.66 41.41 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.398 0.618 . . . . 0.0 109.453 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.3 p -67.32 151.22 97.37 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.057 -1.027 . . . . 0.0 109.83 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -45.19 -41.01 16.65 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 121.928 1.752 . . . . 0.0 112.366 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -53.25 -50.65 64.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.763 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -60.13 -27.62 67.2 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.293 -0.879 . . . . 0.0 109.273 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -71.21 -31.05 67.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.114 -0.991 . . . . 0.0 109.145 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.99 -52.56 10.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.179 -0.95 . . . . 0.0 109.259 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 mt -59.27 -37.08 76.75 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 23.2 tp -63.19 -43.96 96.72 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.712 -0.618 . . . . 0.0 109.706 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.8 m -53.25 -37.75 62.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.225 -0.922 . . . . 0.0 110.158 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -80.35 -43.4 21.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 0.0 109.373 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 27.7 tp -63.73 -40.03 95.75 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.285 -0.885 . . . . 0.0 110.212 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -72.47 -38.95 68.08 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.77 -1.206 . . . . 0.0 109.544 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.468 ' O ' ' SD ' ' A' ' 43' ' ' MET . 1.3 tmt? -53.91 -28.78 38.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.304 -0.872 . . . . 0.0 108.71 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -115.7 43.67 2.04 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.06 140.22 48.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.253 -0.904 . . . . 0.0 110.347 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.09 -17.57 59.0 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.4 m -119.63 151.87 52.49 Favored Pre-proline 0 N--CA 1.501 2.113 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -71.88 119.46 6.21 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.56 1.507 . . . . 0.0 111.519 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.1 t -98.9 136.09 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.399 -0.813 . . . . 0.0 110.209 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -73.7 125.66 28.56 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.276 -0.89 . . . . 0.0 108.619 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.495 ' NE ' ' O ' ' A' ' 92' ' ' PHE . 13.1 ptp180 -55.24 -15.86 2.77 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.223 -0.923 . . . . 0.0 108.779 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.425 ' O ' ' OD1' ' A' ' 56' ' ' ASN . 41.2 tt0 -61.82 -56.82 15.43 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.623 -0.673 . . . . 0.0 109.481 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.6 mt -54.64 -29.28 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.254 -0.904 . . . . 0.0 110.33 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.8 mt -71.24 -46.72 60.41 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 108.609 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.577 ' CE1' ' CD2' ' A' ' 59' ' ' TYR . 57.3 t80 -51.96 -36.05 48.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.957 -1.089 . . . . 0.0 108.957 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.442 ' O ' ' O ' ' A' ' 59' ' ' TYR . 16.3 m120 -65.18 -20.86 66.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.663 -0.648 . . . . 0.0 110.476 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.3 -55.48 34.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.694 -1.254 . . . . 0.0 109.895 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.0 mm -82.35 -37.84 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.234 -0.916 . . . . 0.0 110.544 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.577 ' CD2' ' CE1' ' A' ' 55' ' ' TYR . 97.7 m-85 -102.89 152.85 20.81 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.362 -0.836 . . . . 0.0 109.791 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.5 t -165.44 21.19 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.057 -1.027 . . . . 0.0 109.617 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.435 ' H ' ' H ' ' A' ' 62' ' ' ASP . 41.3 p-90 -167.35 0.25 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.274 -0.892 . . . . 0.0 109.014 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 63' ' ' ASN . 11.4 p-10 -60.65 -112.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.412 -0.805 . . . . 0.0 109.432 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.453 ' H ' ' CG ' ' A' ' 62' ' ' ASP . 19.7 m120 -158.23 -90.48 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.15 -0.969 . . . . 0.0 109.346 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -168.46 61.9 0.51 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.404 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.93 77.22 3.83 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.489 2.126 . . . . 0.0 111.852 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.64 -8.46 55.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 109.542 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 t -54.73 163.63 0.92 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.347 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -68.81 107.72 3.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.921 . . . . 0.0 109.34 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.1 m -165.58 -75.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.366 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 pp -56.08 -37.79 69.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.353 -0.842 . . . . 0.0 109.644 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.417 ' OE2' ' NH1' ' A' ' 51' ' ' ARG . 7.2 tp10 -67.03 -31.19 71.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.169 -0.957 . . . . 0.0 109.456 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.3 t -73.33 -41.31 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.139 -0.976 . . . . 0.0 109.115 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -56.99 -38.22 72.74 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.0 mm -64.14 -36.91 78.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -67.65 -33.45 74.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.23 -0.919 . . . . 0.0 109.4 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -71.05 -41.9 70.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.34 -0.85 . . . . 0.0 109.802 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.0 mt -71.44 -42.23 68.48 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.291 -0.881 . . . . 0.0 109.892 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -49.7 -44.4 48.14 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.084 -1.01 . . . . 0.0 109.247 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -62.83 -26.8 68.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 110.045 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -75.78 -43.22 47.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.987 -1.071 . . . . 0.0 110.508 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 pt -82.21 -30.26 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.023 -1.048 . . . . 0.0 109.575 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 97.39 85.02 1.77 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -44.48 -16.68 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.545 -0.974 . . . . 0.0 110.396 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 82' ' ' GLY . 56.2 m -51.82 -44.8 63.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.083 -1.011 . . . . 0.0 109.381 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -73.71 8.75 1.74 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.296 -0.878 . . . . 0.0 109.481 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 87' ' ' ARG . 96.6 mt -136.37 159.76 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.288 -0.882 . . . . 0.0 109.159 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.49 HH21 ' CE ' ' A' ' 95' ' ' MET . 39.1 ttp180 -137.28 124.2 21.38 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.555 -0.716 . . . . 0.0 109.271 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.3 p -88.87 141.66 28.31 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.142 -0.974 . . . . 0.0 109.386 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.4 t -100.7 106.92 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.479 -0.763 . . . . 0.0 110.377 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.51 ' N ' ' CD ' ' A' ' 90' ' ' ARG . 0.4 OUTLIER 48.72 37.76 10.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.512 -0.743 . . . . 0.0 110.1 179.206 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.63 52.41 20.12 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.539 ' CD2' ' N ' ' A' ' 93' ' ' GLY . 43.9 t80 -132.56 -81.93 0.49 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.627 -0.925 . . . . 0.0 108.611 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.539 ' N ' ' CD2' ' A' ' 92' ' ' PHE . . . -98.78 -147.57 22.23 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -150.98 162.34 41.02 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.357 -1.084 . . . . 0.0 108.407 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.49 ' CE ' HH21 ' A' ' 87' ' ' ARG . 43.9 ttp -163.55 136.16 5.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.179 -0.951 . . . . 0.0 110.548 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.3 mp -91.48 127.32 36.87 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.77 99.69 2.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.318 -0.863 . . . . 0.0 109.42 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -54.11 117.21 3.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.329 -0.857 . . . . 0.0 109.539 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 21.2 m120 53.22 97.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.333 -0.855 . . . . 0.0 109.584 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.4 mt -72.31 -11.94 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.251 -0.906 . . . . 0.0 108.776 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -173.52 -24.38 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.709 -0.619 . . . . 0.0 109.437 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.6 p -59.1 173.0 0.51 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.566 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.462 179.976 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -87.72 50.69 2.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 162.95 -28.79 0.25 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.1 t70 51.7 66.41 1.2 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -1.126 . . . . 0.0 109.754 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -155.87 119.86 4.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.15 -0.969 . . . . 0.0 108.947 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -162.09 157.42 23.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.326 -0.859 . . . . 0.0 109.713 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.4 pt -147.27 162.54 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.297 -0.877 . . . . 0.0 109.163 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.8 t -145.25 156.11 43.64 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.19 -0.944 . . . . 0.0 109.741 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 9' ' ' VAL . 5.1 p -152.72 101.85 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.15 -109.64 2.84 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -112.07 4.88 18.31 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.506 -0.996 . . . . 0.0 110.093 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 12' ' ' LEU . 10.4 mp -99.07 124.9 44.41 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.151 -0.968 . . . . 0.0 109.083 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -118.53 126.13 51.35 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.528 ' C ' HD22 ' A' ' 15' ' ' ASN . 5.7 tt -114.15 115.19 27.12 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.528 HD22 ' C ' ' A' ' 14' ' ' LEU . 1.7 m120 -113.2 102.21 10.15 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.573 -0.705 . . . . 0.0 109.313 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.3 t -74.9 -27.44 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.439 -0.788 . . . . 0.0 109.454 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.44 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -60.42 -54.1 49.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.536 -0.728 . . . . 0.0 109.507 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.499 ' NH2' ' OD1' ' A' ' 15' ' ' ASN . 89.2 mtm-85 -92.21 -13.43 30.54 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.12 -0.987 . . . . 0.0 108.714 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.5 tpp85 66.31 67.14 0.46 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.419 0.628 . . . . 0.0 109.393 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.5 mt -143.47 158.47 43.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.228 -0.92 . . . . 0.0 108.812 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 t -142.38 120.75 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.283 -0.885 . . . . 0.0 109.757 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 17.8 m-90 -98.93 150.87 21.49 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.175 -0.953 . . . . 0.0 108.812 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.9 tp -136.94 107.05 6.33 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.84 43.59 73.58 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 64.24 -1.65 0.69 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 122.169 -0.606 . . . . 0.0 110.346 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.4 p -100.58 139.9 35.6 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 120.973 -1.079 . . . . 0.0 109.383 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.04 115.54 6.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 0.0 110.161 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.9 tp -78.82 132.31 36.81 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -102.86 112.59 25.46 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.312 -0.868 . . . . 0.0 109.972 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.837 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.2 pt? -139.63 148.9 43.1 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.364 -0.835 . . . . 0.0 109.28 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.407 ' OG1' ' OE2' ' A' ' 34' ' ' GLU . 4.1 p -60.52 152.98 63.47 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.056 -1.027 . . . . 0.0 108.881 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -58.95 -41.67 59.65 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.0 1.8 . . . . 0.0 111.735 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -53.97 -45.66 71.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.027 -1.046 . . . . 0.0 109.252 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.407 ' OE2' ' OG1' ' A' ' 31' ' ' THR . 69.8 mt-10 -60.71 -34.61 74.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.322 -0.861 . . . . 0.0 109.223 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.4 ' OH ' ' O ' ' A' ' 15' ' ' ASN . 15.9 t80 -55.62 -34.1 64.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 108.706 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.05 -53.12 28.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 109.303 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 37' ' ' LEU . 8.3 mp -60.3 -39.42 86.88 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.9 tp -59.57 -43.74 93.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.606 -0.684 . . . . 0.0 109.546 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.502 ' C ' ' HE ' ' A' ' 40' ' ' ARG . 33.8 t -52.91 -34.28 54.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.153 -0.967 . . . . 0.0 109.458 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.502 ' HE ' ' C ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -79.44 -45.29 19.72 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 0.0 109.181 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.3 mt -56.72 -40.66 76.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.045 -1.034 . . . . 0.0 109.285 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.7 tpp -75.44 -35.0 61.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 109.56 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.46 ' SD ' ' NH2' ' A' ' 40' ' ' ARG . 24.7 ttt -53.92 -25.93 22.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.327 -0.858 . . . . 0.0 109.229 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -129.08 43.17 3.19 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.74 -0.6 . . . . 0.0 109.678 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.81 143.8 55.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.025 -1.047 . . . . 0.0 109.958 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.462 ' O ' ' SD ' ' A' ' 95' ' ' MET . . . 101.02 -22.75 38.18 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.08 154.55 64.82 Favored Pre-proline 0 N--CA 1.503 2.206 0 O-C-N 121.599 -0.942 . . . . 0.0 108.676 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.42 120.91 7.83 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.826 1.684 . . . . 0.0 111.083 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 80.5 t -92.77 137.04 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 0.0 110.326 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.458 ' CE1' ' HG3' ' A' ' 52' ' ' GLU . 0.8 OUTLIER -68.83 121.03 15.71 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.381 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -51.21 -16.82 0.56 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 0.0 109.792 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.458 ' HG3' ' CE1' ' A' ' 50' ' ' HIS . 80.8 mt-10 -65.97 -48.39 71.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.342 -0.849 . . . . 0.0 109.801 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.2 mt -54.65 -30.87 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.19 -0.944 . . . . 0.0 109.949 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.0 mt -70.58 -34.13 71.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.932 . . . . 0.0 109.199 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.497 ' O ' ' N ' ' A' ' 59' ' ' TYR . 3.0 m-85 -70.93 -35.44 72.24 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -59.39 -20.8 57.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.545 -0.722 . . . . 0.0 110.051 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.06 -53.63 52.82 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.074 -1.016 . . . . 0.0 109.89 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.49 ' O ' ' CG ' ' A' ' 59' ' ' TYR . 4.1 mt -125.92 15.91 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-O 121.508 0.67 . . . . 0.0 109.555 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.497 ' N ' ' O ' ' A' ' 55' ' ' TYR . 78.4 m-85 -156.26 98.26 1.84 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.945 -1.097 . . . . 0.0 109.674 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.7 t -89.91 -18.56 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.293 -0.879 . . . . 0.0 109.367 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.405 ' C ' ' N ' ' A' ' 63' ' ' ASN . 91.3 m95 -54.11 -26.89 29.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.0 109.603 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.9 t70 53.3 11.6 0.27 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 109.625 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' A' ' 63' ' ' ASN . 20.3 p-10 -53.69 -41.07 66.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.502 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 52.13 71.84 1.36 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.345 -0.847 . . . . 0.0 109.809 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -48.0 129.86 18.93 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.64 2.227 . . . . 0.0 112.082 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.32 -27.74 68.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.14 -0.975 . . . . 0.0 109.634 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.8 p -71.58 142.23 50.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.564 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.0 m-20 -58.8 128.04 35.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.403 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.0 m -165.92 -74.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 109.419 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.7 mt -70.12 -37.46 75.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.298 -0.876 . . . . 0.0 109.658 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -60.3 -32.43 71.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.081 -1.012 . . . . 0.0 109.504 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.85 -38.92 74.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.214 -0.929 . . . . 0.0 109.096 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.22 -38.01 73.1 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.2 mt -63.81 -38.93 83.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.418 ' CE1' HH21 ' A' ' 78' ' ' ARG . 1.2 t60 -60.17 -36.55 77.84 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.511 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.576 ' ND2' ' NZ ' ' A' ' 80' ' ' LYS . 3.2 t-20 -73.34 -41.61 63.26 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.689 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -66.41 -42.93 87.06 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.661 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.418 HH21 ' CE1' ' A' ' 75' ' ' HIS . 52.6 ttp180 -50.15 -50.99 47.07 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.513 -0.742 . . . . 0.0 110.936 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -65.24 -29.27 70.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.963 -1.086 . . . . 0.0 110.613 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.576 ' NZ ' ' ND2' ' A' ' 76' ' ' ASN . 61.7 mttp -66.44 -47.94 71.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.9 -1.125 . . . . 0.0 110.2 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 21.6 pt -74.83 -24.6 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.979 -1.075 . . . . 0.0 110.17 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 84.3 84.37 0.95 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -45.05 -17.01 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.689 -0.889 . . . . 0.0 110.484 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 82' ' ' GLY . 59.5 m -55.12 -48.9 73.0 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.243 -0.911 . . . . 0.0 110.069 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.702 ' C ' HD12 ' A' ' 86' ' ' ILE . 8.5 mpt_? -81.48 9.78 6.86 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.972 -1.08 . . . . 0.0 110.473 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.702 HD12 ' C ' ' A' ' 85' ' ' ARG . 3.6 mp -130.67 162.63 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.5 ' N ' HG22 ' A' ' 86' ' ' ILE . 40.3 ttm180 -118.75 93.61 4.16 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.443 -0.786 . . . . 0.0 109.478 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.0 p -66.1 134.77 53.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.315 -0.866 . . . . 0.0 109.511 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 91' ' ' GLY . 59.2 t -102.3 98.34 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.6 mtm-85 -61.61 78.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.407 -0.808 . . . . 0.0 109.122 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 89' ' ' VAL . . . -164.29 -69.34 0.02 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -170.87 19.36 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.209 -1.171 . . . . 0.0 109.583 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.46 -167.3 19.08 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.455 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -146.04 170.06 17.42 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.462 ' SD ' ' O ' ' A' ' 46' ' ' GLY . 6.1 ttt -161.1 127.81 4.02 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.932 -1.105 . . . . 0.0 110.133 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 96' ' ' LEU . 9.4 mp -81.27 139.98 35.12 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.13 106.19 5.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 109.455 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 0.7 OUTLIER -70.18 124.37 23.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.451 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.408 ' O ' ' O ' ' A' ' 98' ' ' ASN . 5.9 m120 51.1 97.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.324 -0.86 . . . . 0.0 109.773 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.2 mm -68.43 -13.04 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.173 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -76.6 -14.95 59.95 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.708 -0.62 . . . . 0.0 109.497 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.1 t -167.77 152.18 6.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.207 -0.933 . . . . 0.0 109.499 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.412 179.973 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -71.72 65.29 0.49 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.359 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 65.35 32.32 83.27 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 29.4 p-10 -164.13 179.13 7.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -1.169 . . . . 0.0 109.468 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -172.37 107.97 0.2 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.024 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -161.55 154.29 20.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.114 -0.991 . . . . 0.0 109.911 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.7 pt -145.86 163.29 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.476 -0.765 . . . . 0.0 108.983 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.8 p -139.88 151.99 46.08 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.304 -0.873 . . . . 0.0 109.623 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.1 t -146.79 97.6 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.61 -113.68 4.0 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -105.52 5.92 31.86 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.457 -1.025 . . . . 0.0 110.079 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.5 mt -100.69 126.46 47.21 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.129 -0.982 . . . . 0.0 109.186 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -118.05 124.84 49.08 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.475 HD12 HG22 ' A' ' 21' ' ' VAL . 5.6 tp -106.87 141.4 38.15 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.737 -0.602 . . . . 0.0 109.579 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.638 ' ND2' ' CZ3' ' A' ' 22' ' ' TRP . 20.7 m-80 -135.57 97.69 3.74 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.325 -0.859 . . . . 0.0 109.143 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.1 t -76.63 -28.93 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.297 -0.877 . . . . 0.0 109.97 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.406 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -57.65 -53.44 58.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 0.0 109.405 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.434 ' NH2' ' OD1' ' A' ' 15' ' ' ASN . 12.7 ptt-85 -96.5 -10.32 27.66 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.277 -0.889 . . . . 0.0 108.807 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 64.81 73.66 0.41 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.456 0.646 . . . . 0.0 109.3 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.0 tp -156.98 154.42 29.62 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.475 HG22 HD12 ' A' ' 14' ' ' LEU . 12.3 t -140.1 133.54 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.273 -0.892 . . . . 0.0 109.773 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.638 ' CZ3' ' ND2' ' A' ' 15' ' ' ASN . 8.5 m-90 -100.34 144.26 29.56 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.345 -0.847 . . . . 0.0 109.238 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 25' ' ' GLU . 10.7 tp -117.96 100.24 7.43 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.67 -73.2 0.25 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 23' ' ' LEU . 74.0 mt-10 -154.45 23.13 0.47 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.219 -1.165 . . . . 0.0 109.406 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.3 p -138.83 141.82 38.67 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.455 -0.778 . . . . 0.0 110.07 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.9 121.92 16.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.502 -0.749 . . . . 0.0 109.538 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.5 tp -78.48 128.45 33.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 108.614 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -101.4 110.59 22.61 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.328 -0.858 . . . . 0.0 109.923 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.75 145.75 48.74 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.2 p -58.33 140.26 83.91 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.1 -1.0 . . . . 0.0 109.455 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -44.68 -43.99 14.26 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.526 1.484 . . . . 0.0 112.052 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.446 ' CD ' ' H ' ' A' ' 33' ' ' LYS . 2.4 mptp? -53.54 -46.43 70.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 108.99 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -59.49 -35.07 73.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.348 -0.845 . . . . 0.0 109.213 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.464 ' HH ' ' C ' ' A' ' 15' ' ' ASN . 15.0 t80 -56.66 -33.16 66.09 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.916 . . . . 0.0 109.066 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.422 ' O ' ' OD2' ' A' ' 57' ' ' ASP . . . -68.62 -52.82 27.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.431 -0.793 . . . . 0.0 109.524 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.611 HD12 ' N ' ' A' ' 37' ' ' LEU . 7.7 mp -63.54 -36.59 84.27 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.3 tp -64.46 -46.98 80.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.55 -0.719 . . . . 0.0 109.329 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.8 m -53.28 -29.68 34.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.321 -0.862 . . . . 0.0 109.956 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -75.73 -40.57 55.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.065 -1.022 . . . . 0.0 110.018 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.8 mt -61.04 -44.39 97.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.975 -1.078 . . . . 0.0 110.179 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.7 mmm -65.87 -37.07 85.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.819 -1.176 . . . . 0.0 109.739 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 18.1 ttt -57.41 -32.36 66.77 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 108.994 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -116.05 43.46 2.14 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.06 129.12 39.0 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.245 -0.909 . . . . 0.0 110.165 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.89 -11.93 52.87 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 p -124.71 151.89 68.51 Favored Pre-proline 0 N--CA 1.504 2.242 0 O-C-N 121.529 -0.983 . . . . 0.0 108.652 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.18 120.46 6.59 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.781 1.654 . . . . 0.0 111.634 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.5 t -95.69 132.87 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.263 -0.898 . . . . 0.0 109.95 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.538 ' CE1' ' CE1' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -73.04 126.19 29.41 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.19 -0.944 . . . . 0.0 108.545 178.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -50.36 -15.07 0.21 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.223 -0.923 . . . . 0.0 109.836 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.411 ' N ' ' C ' ' A' ' 50' ' ' HIS . 77.4 mt-10 -66.87 -46.35 75.23 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.319 -0.863 . . . . 0.0 109.881 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.5 mm -57.56 -32.36 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.083 -1.011 . . . . 0.0 109.923 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.42 -45.3 69.5 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.241 -0.912 . . . . 0.0 108.746 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -62.33 -36.86 83.52 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.403 HD21 ' HA ' ' A' ' 60' ' ' SER . 35.6 m120 -70.33 -21.77 62.87 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.641 -0.662 . . . . 0.0 109.993 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 36' ' ' ALA . 5.2 t0 -55.27 -54.31 45.15 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 120.81 -1.181 . . . . 0.0 109.271 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 68.2 mt -93.94 -37.64 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.276 -0.89 . . . . 0.0 109.504 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -103.86 -163.24 0.96 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.763 0.792 . . . . 0.0 109.792 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.403 ' HA ' HD21 ' A' ' 56' ' ' ASN . 24.7 m -171.57 -31.97 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.506 ' O ' ' CD2' ' A' ' 61' ' ' TRP . 31.7 p-90 -75.89 82.02 2.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.0 108.973 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 25.8 p-10 -61.73 -125.03 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.354 -0.841 . . . . 0.0 109.792 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 52.51 16.31 0.61 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.916 -1.115 . . . . 0.0 109.354 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -70.1 150.71 96.13 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.145 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.68 145.22 41.07 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.111 1.874 . . . . 0.0 111.819 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.5 8.35 1.86 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 109.565 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.2 m -57.93 141.85 48.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -0.931 . . . . 0.0 109.611 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 68' ' ' ASN . 2.6 p-10 -65.39 117.64 8.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.882 . . . . 0.0 109.474 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.6 m -165.75 -75.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.923 . . . . 0.0 109.334 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 13.9 mt -70.64 -33.49 71.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 109.403 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -60.36 -35.59 76.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.009 . . . . 0.0 109.385 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.2 t -73.82 -38.95 51.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.166 -0.959 . . . . 0.0 108.827 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -58.71 -40.38 83.53 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 62.7 mt -62.98 -31.48 52.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -72.28 -22.38 61.21 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 118.947 -1.101 . . . . 0.0 108.086 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -77.43 -45.43 25.8 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.6 -0.687 . . . . 0.0 110.337 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 pp -74.58 -43.98 53.0 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.813 -1.179 . . . . 0.0 109.747 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -50.59 -46.12 57.68 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.554 -0.717 . . . . 0.0 110.144 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -65.65 -13.8 59.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.167 -0.958 . . . . 0.0 110.118 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -81.43 -40.23 23.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.084 -1.01 . . . . 0.0 110.02 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 11.0 pt -78.56 -14.94 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 109.777 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 85.68 81.41 1.12 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -44.42 -16.41 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.779 -0.836 . . . . 0.0 110.583 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 82' ' ' GLY . 44.5 t -50.17 -43.95 52.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.144 -0.973 . . . . 0.0 109.612 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -77.52 9.05 3.59 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.234 -0.916 . . . . 0.0 109.937 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 87' ' ' ARG . 82.0 mt -137.97 158.12 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.2 -0.937 . . . . 0.0 109.1 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.422 ' N ' HG22 ' A' ' 86' ' ' ILE . 65.7 ttt-85 -141.04 122.62 15.12 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.598 -0.689 . . . . 0.0 109.212 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.7 p -89.36 142.51 27.6 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.302 -0.874 . . . . 0.0 109.282 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 89' ' ' VAL . 8.1 p -101.62 124.37 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.405 -0.809 . . . . 0.0 110.171 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.5 ttp85 45.0 28.88 0.41 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.513 -0.742 . . . . 0.0 110.204 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.44 55.66 12.73 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.538 ' CE1' ' CE1' ' A' ' 50' ' ' HIS . 16.7 t80 -138.53 -68.66 0.45 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.524 -0.986 . . . . 0.0 108.829 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.46 ' N ' ' CD2' ' A' ' 92' ' ' PHE . . . -102.08 -147.8 20.14 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -150.76 159.24 44.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.452 -1.028 . . . . 0.0 108.257 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 43.1 ttp -163.82 127.61 2.7 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.131 -0.981 . . . . 0.0 110.391 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.476 HD12 ' N ' ' A' ' 96' ' ' LEU . 9.6 mp -90.2 133.22 35.05 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.88 137.2 50.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -0.931 . . . . 0.0 109.498 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -51.63 -75.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.618 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -158.12 41.71 0.28 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.388 -0.82 . . . . 0.0 109.551 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.3 mt -80.71 -2.06 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.274 -0.891 . . . . 0.0 108.858 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -75.82 -30.09 58.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 76.4 p -58.17 96.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.408 -0.808 . . . . 0.0 109.376 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.576 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.458 ' C ' ' H ' ' A' ' 3' ' ' GLY . 11.9 m120 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -71.0 40.67 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 0.0 109.795 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 1' ' ' ASN . . . -160.85 19.62 0.21 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -164.05 78.66 0.39 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.312 -1.11 . . . . 0.0 109.444 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -165.71 113.54 0.95 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.266 -0.896 . . . . 0.0 108.975 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -162.36 157.44 22.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.109 -0.994 . . . . 0.0 110.008 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.4 pt -144.78 162.91 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.309 -0.869 . . . . 0.0 109.008 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 m -143.05 152.92 42.41 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.284 -0.885 . . . . 0.0 109.699 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 9' ' ' VAL . 2.9 p -149.41 99.2 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.54 -116.64 4.74 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -104.06 6.95 36.31 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.439 -1.036 . . . . 0.0 109.622 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.7 mt -100.68 122.08 42.73 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.274 -0.891 . . . . 0.0 109.602 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -114.84 134.44 55.13 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.4 tt -126.55 127.9 46.01 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.553 -0.717 . . . . 0.0 109.823 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 19' ' ' ARG . 5.3 m-20 -121.44 104.41 9.66 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.757 -0.59 . . . . 0.0 109.62 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.2 t -68.77 -30.31 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.264 -0.898 . . . . 0.0 109.44 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.74 -53.98 38.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.908 . . . . 0.0 109.16 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.2 mtp-105 -83.72 -16.52 44.56 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 15' ' ' ASN . 15.1 tpp180 58.78 75.73 0.38 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.449 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 23.9 tp -170.33 127.35 0.81 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.359 -0.838 . . . . 0.0 108.964 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.1 t -104.33 138.21 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.509 -0.745 . . . . 0.0 109.682 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.449 ' CZ3' ' O ' ' A' ' 20' ' ' LEU . 28.5 m-90 -105.6 142.26 35.64 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.454 -0.779 . . . . 0.0 109.225 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.7 tp -118.11 102.26 8.88 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.94 44.95 54.3 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 107.946 -2.062 . . . . 0.0 107.946 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 65.65 -1.23 1.07 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 122.132 -0.628 . . . . 0.0 110.218 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.0 p -99.23 140.94 32.65 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.042 -1.036 . . . . 0.0 109.699 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.53 110.47 1.99 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.921 . . . . 0.0 109.862 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.9 tp -71.43 133.37 45.86 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -91.01 94.06 9.47 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.051 -1.031 . . . . 0.0 110.267 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.902 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.4 pt? -127.45 135.54 50.56 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.1 p -63.81 152.98 85.51 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 120.978 -1.076 . . . . 0.0 109.567 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -44.9 -48.13 11.13 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.848 1.698 . . . . 0.0 112.433 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -53.25 -47.99 68.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.446 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -55.24 -45.16 76.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.249 -0.907 . . . . 0.0 109.289 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -50.2 -30.04 10.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.229 -0.919 . . . . 0.0 109.701 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.8 -49.38 47.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.352 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.594 HD12 ' N ' ' A' ' 37' ' ' LEU . 8.1 mp -59.2 -44.5 92.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.093 -1.004 . . . . 0.0 108.785 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.6 mp -58.01 -42.06 84.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.919 . . . . 0.0 108.521 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.1 m -50.73 -37.08 39.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.229 -0.919 . . . . 0.0 109.653 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -80.22 -43.58 21.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.031 -1.043 . . . . 0.0 109.911 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.7 mt -59.34 -49.07 79.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.12 -0.988 . . . . 0.0 109.961 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 42.2 mtt -66.83 -35.46 80.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.991 -1.068 . . . . 0.0 109.645 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 25.7 ttt -56.05 -29.21 60.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.201 -0.937 . . . . 0.0 108.833 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -116.68 40.69 2.87 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.22 103.15 1.5 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.135 -0.978 . . . . 0.0 109.802 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.402 ' CA ' ' OD1' ' A' ' 98' ' ' ASN . . . 137.85 -13.36 3.64 Favored Glycine 0 N--CA 1.502 3.062 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.9 m -132.56 152.54 80.17 Favored Pre-proline 0 N--CA 1.502 2.131 0 O-C-N 121.697 -0.884 . . . . 0.0 108.806 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -71.73 120.19 6.72 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 121.774 1.649 . . . . 0.0 111.544 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.0 t -91.11 133.72 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.883 . . . . 0.0 109.612 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.413 ' C ' ' N ' ' A' ' 52' ' ' GLU . 10.3 t-160 -65.54 122.5 17.35 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -50.65 -15.94 0.33 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.166 -0.959 . . . . 0.0 109.6 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.531 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 17.0 mm-40 -65.78 -50.5 64.48 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.313 -0.867 . . . . 0.0 109.875 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.9 mt -57.07 -31.92 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.131 -0.98 . . . . 0.0 110.044 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.7 mt -66.47 -33.31 75.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.996 -1.065 . . . . 0.0 108.307 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 59' ' ' TYR . 22.4 t80 -73.51 -35.69 65.65 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 41.4 m-80 -63.53 -22.07 66.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.848 -0.533 . . . . 0.0 110.039 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.09 -54.23 42.32 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.027 -1.046 . . . . 0.0 109.243 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.439 HG22 ' CD2' ' A' ' 59' ' ' TYR . 5.6 mm -85.83 -37.46 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.22 -0.925 . . . . 0.0 109.872 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.439 ' CD2' HG22 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -179.94 168.25 1.29 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.047 -1.033 . . . . 0.0 110.158 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.43 ' C ' ' N ' ' A' ' 62' ' ' ASP . 1.7 t -173.81 -31.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.336 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -54.06 -10.56 0.35 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -0.905 . . . . 0.0 109.38 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.43 ' N ' ' C ' ' A' ' 60' ' ' SER . 28.0 m-20 -156.42 -137.35 0.06 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.378 -0.826 . . . . 0.0 109.057 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 62' ' ' ASP . 13.5 m120 53.01 97.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.931 . . . . 0.0 109.614 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -165.29 61.97 0.82 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.339 -0.85 . . . . 0.0 109.31 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.7 157.97 31.8 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.614 2.209 . . . . 0.0 111.902 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.96 -51.65 30.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 0.0 109.496 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.6 m -55.53 150.31 12.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.225 -0.922 . . . . 0.0 109.554 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -73.27 139.08 45.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 109.497 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 90.0 m -165.79 -36.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.317 -0.864 . . . . 0.0 109.452 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.603 ' H ' HD23 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -70.61 -48.93 52.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 108.88 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -70.3 -25.39 63.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 109.44 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.4 t -75.3 -43.55 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.176 -0.952 . . . . 0.0 109.505 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -54.55 -39.05 67.33 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.3 mt -67.38 -39.55 82.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -60.67 -34.67 74.67 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.122 -0.986 . . . . 0.0 109.072 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -76.73 -40.9 47.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.397 -0.814 . . . . 0.0 108.993 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.648 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -67.71 -43.36 80.24 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -51.76 -50.09 61.34 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.464 -0.772 . . . . 0.0 110.243 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -64.98 -27.37 68.79 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.252 -0.905 . . . . 0.0 110.834 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -71.01 -45.35 64.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.985 -1.072 . . . . 0.0 110.439 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.7 pt -75.04 -18.69 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.977 -1.077 . . . . 0.0 110.718 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 81.28 79.53 0.92 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -46.63 -15.9 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.688 -0.89 . . . . 0.0 110.662 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.514 ' CB ' HH11 ' A' ' 85' ' ' ARG . 10.5 t -48.2 -43.39 31.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.16 -0.962 . . . . 0.0 110.443 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.514 HH11 ' CB ' ' A' ' 84' ' ' SER . 12.5 mpt_? -91.48 11.03 25.33 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.164 -0.96 . . . . 0.0 110.163 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 87' ' ' ARG . 30.2 mm -115.75 164.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 O-C-N 121.35 -0.844 . . . . 0.0 108.98 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.435 ' N ' HG22 ' A' ' 86' ' ' ILE . 61.5 ttt-85 -135.69 118.56 16.24 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.399 -0.813 . . . . 0.0 108.898 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.5 p -94.93 137.64 33.73 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.235 -0.916 . . . . 0.0 109.766 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.8 t -102.14 102.25 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.569 -0.707 . . . . 0.0 109.756 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.479 ' C ' ' H ' ' A' ' 92' ' ' PHE . 40.9 ttt85 52.47 27.12 4.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 109.542 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.78 1.85 1.54 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.519 ' CD2' ' N ' ' A' ' 93' ' ' GLY . 53.6 t80 -75.34 -81.89 0.07 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.233 -1.157 . . . . 0.0 108.756 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.519 ' N ' ' CD2' ' A' ' 92' ' ' PHE . . . -98.36 -150.63 26.31 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 27.3 m-85 -151.44 157.44 42.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.385 -1.068 . . . . 0.0 108.87 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.6 ttp -157.7 128.89 6.66 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.36 -0.837 . . . . 0.0 109.675 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.487 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 9.2 mp -85.47 136.54 33.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.357 -0.839 . . . . 0.0 108.891 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.13 112.54 1.56 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 109.681 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.663 ' N ' HD22 ' A' ' 98' ' ' ASN . 0.9 OUTLIER -75.89 81.0 2.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -0.882 . . . . 0.0 109.414 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 53.43 88.58 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.567 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.2 mt -145.05 -2.02 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.293 -0.879 . . . . 0.0 108.66 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.07 -35.48 61.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.367 -0.833 . . . . 0.0 109.36 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.1 m -78.22 111.03 13.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.869 . . . . 0.0 109.433 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.417 179.964 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -75.93 62.22 1.57 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.28 -0.888 . . . . 0.0 109.554 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.12 18.99 79.84 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.437 ' C ' ' ND2' ' A' ' 5' ' ' ASN . 33.2 t0 -170.2 155.09 5.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.24 -1.153 . . . . 0.0 109.471 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.437 ' ND2' ' C ' ' A' ' 4' ' ' ASP . 14.9 m-80 -156.67 119.77 4.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 0.0 109.081 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -164.94 158.5 17.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.377 -0.827 . . . . 0.0 109.737 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.2 pt -149.94 164.0 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.378 -0.826 . . . . 0.0 108.943 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.1 t -136.96 150.36 48.12 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.392 -0.818 . . . . 0.0 109.283 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.2 t -143.13 93.8 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.27 -108.4 2.48 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -104.88 3.51 31.02 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.48 -1.011 . . . . 0.0 109.863 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.1 mt -97.8 115.1 27.37 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.215 -0.928 . . . . 0.0 109.849 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -106.98 115.54 30.36 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.524 HD12 ' N ' ' A' ' 14' ' ' LEU . 8.2 mp -104.94 138.44 41.16 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.502 -0.749 . . . . 0.0 109.873 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -136.24 101.87 4.82 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.723 -0.611 . . . . 0.0 109.355 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.4 t -76.73 -28.88 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.84 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.415 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -55.97 -54.3 46.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.237 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -93.86 -9.57 36.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.131 -0.981 . . . . 0.0 108.665 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 63.35 78.35 0.29 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.341 0.591 . . . . 0.0 110.017 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.41 HD23 ' CZ2' ' A' ' 22' ' ' TRP . 62.1 tp -166.89 153.25 8.38 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.087 -1.008 . . . . 0.0 108.822 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.9 t -137.5 147.7 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.331 -0.856 . . . . 0.0 109.957 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.41 ' CZ2' HD23 ' A' ' 20' ' ' LEU . 31.2 m-90 -115.84 137.1 52.42 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.5 tp -112.4 105.73 14.06 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.47 39.9 68.62 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 107.578 -2.209 . . . . 0.0 107.578 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 69.06 -3.4 1.51 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 122.197 -0.59 . . . . 0.0 109.924 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.7 p -98.22 139.54 33.85 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.078 -1.014 . . . . 0.0 109.893 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.23 115.05 7.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 110.012 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.0 tp -85.94 138.85 31.7 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 27.0 p-10 -93.81 103.8 15.91 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.101 -0.999 . . . . 0.0 110.732 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.91 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.3 pt? -126.22 135.06 51.14 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.1 p -62.84 151.91 83.98 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.856 -1.153 . . . . 0.0 109.379 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -44.8 -44.12 14.54 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.784 1.656 . . . . 0.0 112.142 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -53.75 -50.54 65.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.272 -0.892 . . . . 0.0 109.686 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.65 ' HG3' HD13 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -54.08 -41.43 68.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.389 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -56.75 -30.33 63.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.101 -1.0 . . . . 0.0 109.289 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.19 -52.53 26.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.079 -1.013 . . . . 0.0 109.77 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.616 HD12 ' H ' ' A' ' 37' ' ' LEU . 7.2 mp -55.87 -39.32 71.33 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.4 tp -58.36 -43.21 88.31 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.5 p -50.72 -39.32 51.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.417 -0.802 . . . . 0.0 110.229 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -79.76 -42.58 24.22 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.855 -1.153 . . . . 0.0 109.828 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 26.3 mt -58.88 -47.75 83.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.155 -0.966 . . . . 0.0 109.897 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.1 ptt? -67.91 -36.0 79.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.022 -1.049 . . . . 0.0 109.975 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 21.7 ttt -54.26 -29.05 45.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -0.885 . . . . 0.0 108.763 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -124.04 45.02 2.58 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.6 133.66 51.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.104 -0.998 . . . . 0.0 110.095 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.485 ' HA3' HD22 ' A' ' 98' ' ' ASN . . . 100.53 -10.47 59.36 Favored Glycine 0 N--CA 1.501 3.004 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 p -127.11 151.9 75.03 Favored Pre-proline 0 N--CA 1.504 2.25 0 O-C-N 121.537 -0.978 . . . . 0.0 108.696 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.22 120.15 6.4 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 121.749 1.633 . . . . 0.0 111.652 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.9 t -96.2 136.67 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.412 -0.805 . . . . 0.0 109.736 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.495 ' CE1' ' HB2' ' A' ' 52' ' ' GLU . 0.8 OUTLIER -62.09 120.13 10.26 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.211 -0.931 . . . . 0.0 108.725 179.33 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -57.24 -18.76 17.63 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.339 -0.851 . . . . 0.0 109.178 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.495 ' HB2' ' CE1' ' A' ' 50' ' ' HIS . 0.2 OUTLIER -65.39 -48.81 71.59 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.378 -0.826 . . . . 0.0 108.981 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.5 mt -58.76 -30.23 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.25 -0.906 . . . . 0.0 110.324 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.3 mt -69.61 -29.77 67.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.922 -1.111 . . . . 0.0 108.976 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -71.57 -33.09 68.79 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.413 ' O ' ' O ' ' A' ' 59' ' ' TYR . 13.7 m120 -65.33 -22.21 66.79 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.655 -0.653 . . . . 0.0 109.941 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.76 -55.45 32.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.902 -1.124 . . . . 0.0 109.403 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.5 mt -74.01 -37.76 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.224 -0.923 . . . . 0.0 110.291 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.413 ' O ' ' O ' ' A' ' 56' ' ' ASN . 87.6 m-85 -105.36 125.46 51.01 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.404 -0.81 . . . . 0.0 109.792 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.6 m -146.13 20.46 1.41 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.092 -1.005 . . . . 0.0 109.454 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.4 ' H ' ' H ' ' A' ' 62' ' ' ASP . 66.5 p-90 -169.46 -17.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.155 -0.966 . . . . 0.0 109.532 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.4 ' H ' ' H ' ' A' ' 61' ' ' TRP . 24.0 t70 -75.68 -48.7 20.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.28 -0.888 . . . . 0.0 109.435 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 51.18 96.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.425 -0.797 . . . . 0.0 109.72 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -166.87 71.45 1.06 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.453 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -47.11 95.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.669 2.246 . . . . 0.0 112.311 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.38 -18.81 60.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.257 -0.902 . . . . 0.0 109.463 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.3 m 57.31 11.65 1.18 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.16 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.474 ' C ' ' H ' ' A' ' 70' ' ' LEU . 63.7 t30 -162.82 163.65 26.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.175 -0.953 . . . . 0.0 109.471 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 m 72.36 -28.6 0.19 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.605 -0.684 . . . . 0.0 109.795 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.741 ' H ' HD23 ' A' ' 70' ' ' LEU . 1.9 pt? -69.09 -38.9 79.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.041 -1.037 . . . . 0.0 109.76 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -71.23 -26.55 62.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.988 -1.07 . . . . 0.0 109.563 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 49.1 t -75.43 -47.85 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.19 -0.943 . . . . 0.0 109.303 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -55.85 -37.18 68.4 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.2 mt -67.51 -39.95 83.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -60.95 -35.96 78.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.082 -1.011 . . . . 0.0 108.861 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -74.44 -41.73 60.34 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.734 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -67.86 -42.46 81.31 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.485 ' NH2' ' OH ' ' A' ' 94' ' ' TYR . 41.0 ttm180 -49.9 -50.7 45.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.216 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -62.31 -27.08 68.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.241 -0.912 . . . . 0.0 110.817 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -73.22 -43.83 60.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.947 -1.096 . . . . 0.0 110.424 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.0 pt -73.76 -18.53 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.073 -1.017 . . . . 0.0 109.884 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.57 82.12 0.6 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -52.56 -18.23 1.63 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.515 -0.991 . . . . 0.0 110.111 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.9 m -52.37 -46.4 66.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.267 -0.896 . . . . 0.0 109.924 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -87.97 10.69 18.05 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.209 -0.932 . . . . 0.0 110.025 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.7 mm -119.58 168.07 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.461 -0.775 . . . . 0.0 108.962 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 61.3 mtp85 -140.19 114.05 8.86 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.0 p -81.82 138.05 35.18 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.267 -0.896 . . . . 0.0 109.768 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.606 ' CG1' HH21 ' A' ' 90' ' ' ARG . 61.7 t -104.36 92.12 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.518 -0.738 . . . . 0.0 109.29 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.606 HH21 ' CG1' ' A' ' 89' ' ' VAL . 0.7 OUTLIER 49.93 -177.01 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.291 -0.881 . . . . 0.0 109.211 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.88 55.34 4.63 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -135.55 -29.23 1.07 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.552 -0.969 . . . . 0.0 109.651 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.91 -153.57 7.96 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.008 -1.568 . . . . 0.0 110.921 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.485 ' OH ' ' NH2' ' A' ' 78' ' ' ARG . 32.5 m-85 -148.57 169.94 19.19 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.6 ttp -164.09 130.28 3.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.166 -0.959 . . . . 0.0 109.969 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.47 HD12 ' N ' ' A' ' 96' ' ' LEU . 9.8 mp -83.38 144.2 29.8 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.58 -0.7 . . . . 0.0 109.155 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.69 119.69 20.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.493 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.485 HD22 ' HA3' ' A' ' 46' ' ' GLY . 55.5 m-20 -63.45 -16.75 61.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.182 -0.949 . . . . 0.0 109.453 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 102' ' ' THR . 1.2 p30 -171.93 128.05 0.61 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.386 -0.821 . . . . 0.0 109.372 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 11.8 mm -59.05 -14.93 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 108.864 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -82.51 -7.56 59.64 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.437 ' N ' ' OD1' ' A' ' 99' ' ' ASN . 9.5 t -52.43 142.3 17.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 109.668 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.52 179.961 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 11.0 m120 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.438 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 3.9 mp0 46.43 27.43 0.6 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.316 -0.865 . . . . 0.0 110.238 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.98 -36.32 7.77 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -104.14 98.08 7.95 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.507 -0.996 . . . . 0.0 109.537 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -169.59 101.29 0.33 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.182 -0.949 . . . . 0.0 109.247 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -162.29 155.76 20.68 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.153 -0.967 . . . . 0.0 109.93 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 7' ' ' ILE . 16.5 pt -147.94 163.33 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.373 -0.83 . . . . 0.0 109.017 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.2 m -144.9 158.96 43.62 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.145 -0.972 . . . . 0.0 109.912 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.0 t -148.35 101.04 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.36 -108.4 2.48 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -109.05 4.6 23.29 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.541 -0.976 . . . . 0.0 109.589 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.58 HD12 ' N ' ' A' ' 12' ' ' LEU . 7.0 mp -95.51 123.55 39.11 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.288 -0.882 . . . . 0.0 108.83 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -118.85 128.78 54.77 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.443 -0.786 . . . . 0.0 109.094 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.454 HD11 ' CZ ' ' A' ' 35' ' ' TYR . 51.5 tp -116.43 128.28 55.35 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.607 -0.683 . . . . 0.0 109.206 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -122.91 98.11 5.75 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.516 -0.74 . . . . 0.0 109.366 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.4 t -71.06 -27.0 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.47 -0.769 . . . . 0.0 109.23 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.7 -53.92 39.78 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.593 -0.692 . . . . 0.0 109.657 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -91.01 -12.83 34.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.249 -0.907 . . . . 0.0 108.862 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.479 ' NE ' ' CD1' ' A' ' 35' ' ' TYR . 9.5 tpt180 64.98 61.62 0.76 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -140.09 154.78 47.15 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.424 -0.798 . . . . 0.0 109.045 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.5 t -139.28 126.82 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.375 -0.828 . . . . 0.0 109.371 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 18.4 m-90 -103.44 148.18 26.24 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.223 -0.923 . . . . 0.0 109.128 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.425 ' O ' ' OG1' ' A' ' 26' ' ' THR . 24.4 tp -128.77 102.89 6.76 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 76.71 46.01 12.06 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 -178.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 61.91 -0.67 0.42 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 122.022 -0.693 . . . . 0.0 110.25 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 50.2 p -103.76 140.32 37.78 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.211 -0.931 . . . . 0.0 109.862 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.95 110.83 1.91 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 109.996 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.9 tp -76.9 134.89 38.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 108.622 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -101.77 111.45 23.71 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.315 -0.866 . . . . 0.0 109.615 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.812 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.1 pt? -140.51 150.86 44.26 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.327 -0.858 . . . . 0.0 109.853 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.4 p -58.07 152.85 37.92 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.361 -0.837 . . . . 0.0 109.239 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.21 -36.35 80.69 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.853 1.702 . . . . 0.0 111.188 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -55.84 -47.4 77.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 108.931 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -58.61 -39.62 80.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.319 -0.863 . . . . 0.0 108.893 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.479 ' CD1' ' NE ' ' A' ' 19' ' ' ARG . 16.7 t80 -52.89 -31.85 41.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.168 -0.958 . . . . 0.0 109.087 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.61 -52.76 10.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -0.87 . . . . 0.0 109.389 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 37' ' ' LEU . 8.6 mp -58.59 -40.66 83.82 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.506 HD23 ' O ' ' A' ' 38' ' ' LEU . 2.3 tt -67.37 -43.89 80.29 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.602 0.715 . . . . 0.0 109.306 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.0 t -48.42 -41.64 29.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.127 -0.983 . . . . 0.0 111.134 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.8 ttt-85 -80.73 -35.06 33.97 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.533 -1.354 . . . . 0.0 109.485 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.5 tp -60.3 -36.73 78.56 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.34 -0.85 . . . . 0.0 109.34 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 41.0 tpp -75.22 -38.68 60.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 0.0 109.259 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 42.1 ttm -52.4 -27.05 14.26 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.6 mmtt -118.99 42.76 2.73 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.29 137.06 55.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 110.215 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.85 -14.31 65.56 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.5 p -117.42 151.85 48.63 Favored Pre-proline 0 N--CA 1.501 2.115 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -73.87 119.43 5.87 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.594 1.529 . . . . 0.0 111.999 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -103.99 135.95 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.518 -0.739 . . . . 0.0 109.475 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -72.87 125.77 28.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.059 -1.026 . . . . 0.0 108.647 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -58.4 -16.25 14.01 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.469 -0.77 . . . . 0.0 109.291 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.418 ' O ' ' OD1' ' A' ' 56' ' ' ASN . 34.1 tt0 -67.61 -50.4 58.33 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.499 -0.75 . . . . 0.0 109.363 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.5 mt -58.1 -25.0 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.36 -0.838 . . . . 0.0 110.381 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 38.1 mt -72.11 -48.16 45.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.038 -1.039 . . . . 0.0 108.356 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.413 ' O ' ' O ' ' A' ' 59' ' ' TYR . 23.6 m-85 -52.25 -34.59 46.76 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 16.1 m120 -63.84 -21.13 66.3 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.967 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.17 -53.75 31.88 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.034 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.7 mm -94.0 -37.68 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.142 -0.974 . . . . 0.0 110.782 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.413 ' O ' ' O ' ' A' ' 55' ' ' TYR . 38.5 p90 -169.09 176.42 5.31 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.828 -1.17 . . . . 0.0 110.5 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.5 t -168.09 -34.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.225 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 54.6 p-90 -83.34 -3.7 57.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.27 -0.894 . . . . 0.0 109.491 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.19 -80.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.196 -0.94 . . . . 0.0 109.449 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -155.95 96.33 1.71 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.459 -0.775 . . . . 0.0 109.112 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.581 ' N ' ' CD ' ' A' ' 65' ' ' PRO . 8.1 mt-10 -75.99 -34.79 1.53 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 111.162 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 64' ' ' GLU . 62.5 Cg_endo -90.37 47.2 0.78 Allowed 'Trans proline' 0 N--CA 1.487 1.133 0 C-N-CA 122.109 1.873 . . . . 0.0 112.097 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.8 8.67 7.65 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.213 -0.93 . . . . 0.0 109.458 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m 60.42 -127.63 1.01 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.47 -0.769 . . . . 0.0 109.465 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -73.04 98.17 2.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.098 -1.001 . . . . 0.0 109.654 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.4 m -165.67 -73.6 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.291 -0.88 . . . . 0.0 109.574 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.556 HD12 ' N ' ' A' ' 70' ' ' LEU . 9.7 mp -56.0 -49.4 73.72 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.391 -0.818 . . . . 0.0 109.598 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -59.86 -30.02 68.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.156 -0.965 . . . . 0.0 109.729 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 t -70.41 -41.43 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.094 -1.004 . . . . 0.0 109.139 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -54.56 -37.64 65.71 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 35.2 mm -65.63 -41.42 90.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -65.73 -41.55 92.09 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.36 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -67.88 -44.58 76.72 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.195 -0.941 . . . . 0.0 109.091 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 74.3 mt -70.34 -38.63 74.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.417 -0.802 . . . . 0.0 109.919 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.6 ttp85 -49.19 -48.6 45.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.13 -0.981 . . . . 0.0 109.786 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -57.24 -27.28 61.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.957 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -78.4 -40.68 35.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.938 -1.101 . . . . 0.0 110.636 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.411 HD12 HD12 ' A' ' 86' ' ' ILE . 5.7 pt -85.11 -39.56 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.885 -1.135 . . . . 0.0 110.313 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 91.18 106.76 1.42 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 107.386 -2.286 . . . . 0.0 107.386 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 86' ' ' ILE . 52.2 pttt -43.61 -18.15 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.678 -0.895 . . . . 0.0 110.467 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 82' ' ' GLY . 47.3 t -62.93 -54.86 31.98 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.825 -1.172 . . . . 0.0 108.708 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.469 ' NH2' HD11 ' A' ' 86' ' ' ILE . 54.8 ttp85 -54.94 -10.97 0.55 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.396 -0.815 . . . . 0.0 110.803 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.469 HD11 ' NH2' ' A' ' 85' ' ' ARG . 9.4 mt -143.4 119.35 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.394 0 O-C-N 120.891 -1.13 . . . . 0.0 110.646 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 63.4 mtp85 -86.95 130.35 34.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.3 -0.875 . . . . 0.0 108.711 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 p -80.94 128.76 34.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.051 -1.031 . . . . 0.0 109.491 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.408 ' O ' ' O ' ' A' ' 90' ' ' ARG . 21.0 t -104.17 92.12 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.539 -0.725 . . . . 0.0 109.181 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.408 ' O ' ' O ' ' A' ' 89' ' ' VAL . 79.6 mtt-85 52.15 177.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 109.554 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.96 55.04 4.97 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -138.33 -29.98 0.8 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.399 -1.06 . . . . 0.0 109.916 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -165.06 -155.72 8.67 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 118.997 -1.573 . . . . 0.0 110.826 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -146.16 171.09 15.44 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.467 ' SD ' ' O ' ' A' ' 96' ' ' LEU . 11.6 tmm? -163.57 142.86 8.23 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.85 -1.156 . . . . 0.0 110.704 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.467 ' O ' ' SD ' ' A' ' 95' ' ' MET . 11.1 mp -89.43 132.79 34.83 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' A' ' 99' ' ' ASN . . . -56.18 121.02 8.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.213 -0.929 . . . . 0.0 109.082 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -68.14 67.33 0.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 0.0 109.712 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 97' ' ' ALA . 61.7 t-20 49.39 41.06 20.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.188 -0.945 . . . . 0.0 109.874 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.8 mt -78.79 -2.51 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.287 -0.883 . . . . 0.0 108.825 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 102' ' ' THR . 3.2 p30 -65.11 -27.63 68.88 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.225 -0.922 . . . . 0.0 109.386 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.486 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 93.3 m -68.46 -87.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.383 -0.823 . . . . 0.0 109.452 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.419 -179.994 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.6 m120 . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -71.21 64.21 0.37 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.299 -0.876 . . . . 0.0 109.554 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -177.55 25.12 0.05 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 5.7 p-10 -175.33 107.72 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.29 -1.123 . . . . 0.0 109.229 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -160.43 121.02 2.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.135 -0.978 . . . . 0.0 109.38 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -158.91 156.24 29.17 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.479 -0.763 . . . . 0.0 109.364 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.4 pt -148.83 163.67 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.298 -0.876 . . . . 0.0 109.393 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.6 m -136.2 146.53 46.92 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.472 -0.768 . . . . 0.0 109.542 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -146.46 93.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.67 -114.09 3.91 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -106.06 6.27 30.97 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.492 -1.005 . . . . 0.0 109.66 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.4 mt -100.89 122.04 42.77 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.258 -0.901 . . . . 0.0 109.946 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -115.19 129.46 56.66 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.438 HD11 ' CZ ' ' A' ' 35' ' ' TYR . 46.9 tp -114.65 138.67 50.4 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.535 -0.728 . . . . 0.0 109.415 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.519 ' ND2' HH21 ' A' ' 18' ' ' ARG . 4.1 m120 -135.02 97.63 3.79 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.576 -0.702 . . . . 0.0 109.236 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.2 t -73.34 -28.51 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.376 -0.827 . . . . 0.0 109.282 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -63.13 -55.47 25.02 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.444 -0.785 . . . . 0.0 109.454 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.519 HH21 ' ND2' ' A' ' 15' ' ' ASN . 64.8 mtm180 -88.62 -16.02 33.54 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.307 -0.871 . . . . 0.0 108.847 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? 68.83 65.19 0.3 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.2 mt -143.93 142.32 30.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.303 -0.873 . . . . 0.0 108.724 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -129.61 127.57 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.5 -0.75 . . . . 0.0 108.977 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -103.72 142.21 34.73 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.269 -0.894 . . . . 0.0 109.173 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.422 ' O ' ' OG1' ' A' ' 26' ' ' THR . 28.0 tp -127.2 102.9 7.14 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.93 47.3 11.76 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.131 -1.988 . . . . 0.0 108.131 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 60.68 2.58 0.52 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.979 -0.718 . . . . 0.0 110.33 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 50.4 p -108.81 141.72 40.42 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.15 -0.969 . . . . 0.0 109.846 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.03 115.29 4.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.247 -0.908 . . . . 0.0 110.075 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.3 tp -81.73 132.99 35.3 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -101.34 111.81 24.15 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.305 -0.872 . . . . 0.0 109.483 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.46 147.51 47.23 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.453 -0.779 . . . . 0.0 109.274 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.1 p -57.9 152.15 39.92 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.89 -33.73 92.15 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.84 1.693 . . . . 0.0 111.359 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -57.52 -50.88 71.64 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.206 -0.934 . . . . 0.0 109.045 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -56.89 -35.58 69.14 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.151 -0.968 . . . . 0.0 109.032 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.438 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 7.3 t80 -55.47 -33.9 64.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -0.888 . . . . 0.0 108.962 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.422 ' O ' ' OD2' ' A' ' 57' ' ' ASP . . . -67.89 -52.96 30.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 109.518 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 37' ' ' LEU . 7.2 mp -60.75 -32.61 71.9 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 12.5 tp -63.31 -45.63 90.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.535 -0.728 . . . . 0.0 109.28 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.3 p -53.79 -32.66 53.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.902 . . . . 0.0 109.327 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -79.8 -45.42 18.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 109.549 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.0 mt -58.21 -46.65 85.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.925 . . . . 0.0 109.937 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.545 ' SD ' ' N ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -70.83 -36.15 72.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 110.047 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.545 ' N ' ' SD ' ' A' ' 42' ' ' MET . 22.3 ttt -52.9 -29.2 27.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.099 -1.001 . . . . 0.0 108.873 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -122.39 46.72 2.06 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.37 134.51 52.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.886 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.99 -8.86 78.85 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.3 t -118.46 115.1 35.93 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.61 119.95 4.16 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.038 1.159 . . . . 0.0 112.001 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -98.7 136.67 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.41 -0.806 . . . . 0.0 110.116 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -71.18 124.25 24.05 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.241 -0.912 . . . . 0.0 108.931 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.469 ' NH1' ' OE1' ' A' ' 71' ' ' GLU . 53.3 ttp180 -51.35 -17.53 0.77 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.402 -0.811 . . . . 0.0 109.31 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -68.01 -47.8 67.48 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.383 -0.823 . . . . 0.0 109.974 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.0 mt -57.45 -29.55 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.161 -0.962 . . . . 0.0 110.194 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.9 mt -68.58 -46.79 68.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.159 -0.963 . . . . 0.0 108.835 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -60.84 -34.47 74.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -70.08 -21.67 63.12 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.443 -0.785 . . . . 0.0 110.145 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 36' ' ' ALA . 11.3 t0 -54.49 -52.52 61.68 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.0 -1.063 . . . . 0.0 109.414 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.8 mt -99.83 -37.12 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.487 -0.758 . . . . 0.0 110.172 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -99.79 78.77 2.16 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.275 -0.89 . . . . 0.0 109.956 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.3 p -61.44 -57.42 12.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 109.301 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 27.9 m0 -82.42 51.92 1.94 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.4 -0.812 . . . . 0.0 108.969 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -62.94 -120.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.465 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 53.12 60.26 3.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.057 -1.027 . . . . 0.0 109.587 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -169.68 61.77 0.43 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 109.422 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -77.64 103.51 1.73 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.584 2.19 . . . . 0.0 111.939 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.06 -50.07 21.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 109.459 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.453 ' OG1' ' N ' ' A' ' 68' ' ' ASN . 1.7 t -172.37 -173.98 1.14 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.453 ' N ' ' OG1' ' A' ' 67' ' ' THR . 8.6 t-20 -54.51 107.05 0.24 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.522 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.5 m -165.55 -44.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.343 -0.848 . . . . 0.0 109.248 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.528 ' CD2' ' N ' ' A' ' 70' ' ' LEU . 1.6 mm? -66.1 -49.28 68.09 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.469 ' OE1' ' NH1' ' A' ' 51' ' ' ARG . 64.2 mm-40 -64.07 -24.99 67.91 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.34 -0.85 . . . . 0.0 108.793 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.0 t -74.83 -41.02 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.411 -0.806 . . . . 0.0 109.425 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -54.29 -39.33 66.85 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 35.6 mm -65.08 -40.21 88.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -67.18 -40.69 86.62 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.153 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -64.75 -44.49 89.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.26 -0.9 . . . . 0.0 109.311 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.7 mt -70.19 -34.19 72.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -0.876 . . . . 0.0 109.478 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -49.35 -49.35 44.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.252 -0.905 . . . . 0.0 109.765 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -58.01 -28.9 64.86 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.352 -0.842 . . . . 0.0 109.804 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -74.24 -43.19 58.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.138 -0.976 . . . . 0.0 110.445 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.5 pt -82.6 -36.95 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.935 -1.103 . . . . 0.0 110.171 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 93.12 103.45 1.6 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 107.161 -2.376 . . . . 0.0 107.161 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 86' ' ' ILE . 9.8 ptpp? -42.95 -19.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.791 -0.829 . . . . 0.0 110.724 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 82' ' ' GLY . 36.4 p -64.21 -55.35 22.26 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.966 -1.083 . . . . 0.0 108.905 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -47.9 -14.07 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.307 -0.871 . . . . 0.0 110.793 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 84' ' ' SER . 12.8 pt -135.56 168.5 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.095 -1.003 . . . . 0.0 110.759 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -137.5 122.15 18.58 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 p -90.27 135.54 33.61 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.128 -0.982 . . . . 0.0 109.628 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.85 119.91 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.532 -0.73 . . . . 0.0 110.189 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 49.7 29.1 2.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.504 -0.748 . . . . 0.0 110.027 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.22 52.5 17.83 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.442 ' CD2' ' N ' ' A' ' 93' ' ' GLY . 26.1 t80 -138.25 -69.57 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.509 -0.995 . . . . 0.0 108.757 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.466 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . -99.92 -151.83 26.27 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.466 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 31.0 m-85 -151.06 162.16 41.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.475 -1.015 . . . . 0.0 108.445 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 55.8 ttp -163.02 127.55 3.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.061 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 96' ' ' LEU . 9.4 mp -82.29 135.11 35.27 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.62 118.43 15.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.931 . . . . 0.0 109.695 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.414 ' O ' ' O ' ' A' ' 99' ' ' ASN . 3.2 m120 -82.0 103.08 11.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.261 -0.899 . . . . 0.0 109.433 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.414 ' O ' ' O ' ' A' ' 98' ' ' ASN . 2.9 m120 59.46 115.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.435 -0.79 . . . . 0.0 109.822 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.6 mt -75.43 -4.18 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.185 -0.947 . . . . 0.0 109.118 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -170.64 36.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.287 -0.883 . . . . 0.0 109.54 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.4 m 53.56 66.68 1.16 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 109.497 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.496 -179.971 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 58.33 41.48 23.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 109.308 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 50.28 32.73 22.24 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 26.6 p-10 -53.63 113.0 1.03 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.253 -1.145 . . . . 0.0 109.514 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -167.35 125.58 1.28 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.298 -0.876 . . . . 0.0 109.088 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -163.12 157.91 21.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.907 . . . . 0.0 109.892 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.9 pt -150.68 163.37 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.324 -0.86 . . . . 0.0 108.755 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.2 m -145.15 158.22 43.88 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.214 -0.929 . . . . 0.0 109.926 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 9' ' ' VAL . 3.5 p -152.47 97.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.03 -118.17 4.65 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -101.56 8.99 41.67 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.402 -1.058 . . . . 0.0 110.207 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 17.2 mt -106.52 126.52 52.36 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.275 -0.891 . . . . 0.0 109.925 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -116.85 130.68 56.86 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.462 HD12 HG22 ' A' ' 21' ' ' VAL . 5.9 tp -115.05 116.96 29.28 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.455 -0.778 . . . . 0.0 110.109 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.454 ' C ' ' HH ' ' A' ' 35' ' ' TYR . 7.4 m-20 -111.32 97.69 6.95 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 121.506 -0.746 . . . . 0.0 109.027 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.3 t -69.35 -28.6 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 109.534 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.439 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -64.49 -53.14 52.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.467 -0.771 . . . . 0.0 109.478 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 -90.26 -8.54 50.72 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.181 -0.95 . . . . 0.0 108.803 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 56.45 67.63 0.97 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 98.6 mt -143.72 158.47 43.65 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.462 HG22 HD12 ' A' ' 14' ' ' LEU . 16.6 t -142.5 123.8 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.227 -0.921 . . . . 0.0 110.012 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 16.0 m-90 -99.42 153.39 19.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.367 -0.833 . . . . 0.0 109.121 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tt -146.15 116.05 7.32 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 62.58 39.68 98.18 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 107.623 -2.191 . . . . 0.0 107.623 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 65.87 -4.6 0.61 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 122.263 -0.551 . . . . 0.0 109.875 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.41 ' H ' ' C ' ' A' ' 24' ' ' GLY . 73.7 p -100.27 139.87 35.32 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.082 -1.011 . . . . 0.0 109.535 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.11 115.24 3.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 0.0 110.041 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.1 tp -75.1 127.28 32.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.3 -0.875 . . . . 0.0 108.684 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.402 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 5.7 m-20 -94.16 101.24 13.24 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.242 -0.911 . . . . 0.0 110.303 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.909 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.4 pt? -128.33 137.45 51.94 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.5 p -62.8 151.42 84.97 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.795 -1.191 . . . . 0.0 109.475 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -44.91 -46.94 12.44 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 121.792 1.662 . . . . 0.0 112.35 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -53.34 -42.17 66.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.7 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -63.23 -36.06 82.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.154 -0.966 . . . . 0.0 109.336 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.454 ' HH ' ' C ' ' A' ' 15' ' ' ASN . 13.0 t80 -57.03 -30.65 64.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.295 -0.878 . . . . 0.0 109.243 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.43 -53.3 9.84 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.241 -0.912 . . . . 0.0 109.733 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 37' ' ' LEU . 9.2 mp -62.06 -39.48 92.52 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.6 tp -65.61 -46.12 80.52 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.61 -0.681 . . . . 0.0 109.678 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -50.77 -29.84 12.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 110.378 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.488 ' NH2' ' CG2' ' A' ' 53' ' ' ILE . 6.3 tpt180 -79.18 -36.89 39.58 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.85 -1.157 . . . . 0.0 110.173 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.29 -38.57 91.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.962 -1.086 . . . . 0.0 110.261 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.4 ' SD ' ' CD2' ' A' ' 96' ' ' LEU . 13.0 mmt -65.39 -42.93 92.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.768 -1.207 . . . . 0.0 110.077 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 51.8 mtt -58.72 -32.25 69.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.223 -0.923 . . . . 0.0 109.505 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -106.19 35.34 2.96 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.637 -0.664 . . . . 0.0 109.44 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.1 103.16 2.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 109.885 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.26 -16.58 2.31 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.64 155.72 79.29 Favored Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.718 -0.872 . . . . 0.0 108.707 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.52 120.46 7.13 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.928 1.752 . . . . 0.0 111.554 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.5 t -91.57 136.6 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.8 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.413 ' C ' ' N ' ' A' ' 52' ' ' GLU . 1.3 t60 -72.26 123.36 22.81 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.156 -0.965 . . . . 0.0 108.607 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -52.99 -15.57 0.82 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 0.0 109.082 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.555 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 36.1 tt0 -69.38 -48.24 61.81 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.601 -0.687 . . . . 0.0 109.764 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.488 ' CG2' ' NH2' ' A' ' 40' ' ' ARG . 77.9 mt -57.83 -30.04 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.048 -1.032 . . . . 0.0 110.099 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.1 mt -67.51 -48.67 66.38 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -54.96 -35.81 64.66 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.555 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 55.8 m-80 -67.3 -22.02 65.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.412 -0.805 . . . . 0.0 110.379 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.28 -51.12 60.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.56 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.9 mt -107.63 -34.58 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.553 -0.717 . . . . 0.0 110.853 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -96.98 90.98 5.38 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.023 -1.048 . . . . 0.0 110.175 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.1 m -74.28 56.28 0.63 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.359 -0.838 . . . . 0.0 108.991 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.492 ' NE1' ' OD1' ' A' ' 56' ' ' ASN . 2.2 m-90 61.13 46.75 7.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.594 -0.692 . . . . 0.0 109.616 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -79.42 -99.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.185 -0.947 . . . . 0.0 109.302 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -76.67 -40.56 48.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.108 -0.995 . . . . 0.0 109.424 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 53.2 69.86 2.09 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.906 . . . . 0.0 109.602 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -45.45 162.74 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.629 2.219 . . . . 0.0 112.284 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.64 -51.97 11.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 109.598 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -175.93 174.66 2.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.87 . . . . 0.0 109.457 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.7 t30 52.22 61.76 3.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 109.552 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.409 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 87.1 m -166.07 -76.9 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.905 . . . . 0.0 109.39 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 pp -67.37 -38.25 84.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.354 -0.841 . . . . 0.0 109.698 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -60.77 -32.79 72.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.032 -1.042 . . . . 0.0 109.877 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.2 t -70.88 -40.11 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.089 -1.007 . . . . 0.0 109.45 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.409 ' ND1' ' O ' ' A' ' 69' ' ' THR . 17.1 m80 -55.74 -37.93 69.12 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.3 mt -66.07 -39.5 84.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -59.05 -36.02 74.31 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.365 -0.934 . . . . 0.0 108.918 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -76.14 -40.24 53.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.447 -0.783 . . . . 0.0 109.088 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.658 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -66.67 -44.07 82.83 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -50.73 -50.28 55.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.388 -0.82 . . . . 0.0 110.228 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -61.74 -27.98 69.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.168 -0.957 . . . . 0.0 110.616 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -74.36 -44.27 52.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.937 -1.102 . . . . 0.0 110.862 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.8 pt -74.43 -21.2 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.854 -1.154 . . . . 0.0 110.212 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 81.27 82.73 0.8 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.413 ' O ' ' O ' ' A' ' 86' ' ' ILE . 18.1 pttp -45.48 -16.57 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.673 -0.898 . . . . 0.0 110.442 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 82' ' ' GLY . 78.8 p -53.66 -49.76 67.24 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.985 -1.072 . . . . 0.0 109.752 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.601 ' C ' HD12 ' A' ' 86' ' ' ILE . 25.3 mmt-85 -79.34 11.02 3.17 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.313 -0.867 . . . . 0.0 110.402 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.601 HD12 ' C ' ' A' ' 85' ' ' ARG . 4.7 mp -138.86 163.56 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.088 -1.007 . . . . 0.0 109.268 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.546 ' N ' HG22 ' A' ' 86' ' ' ILE . 76.6 ttt180 -138.13 127.41 24.52 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.361 -0.837 . . . . 0.0 109.72 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.419 HG22 ' CE2' ' A' ' 94' ' ' TYR . 2.9 p -93.24 142.41 27.34 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.306 -0.871 . . . . 0.0 109.202 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.5 t -101.78 115.39 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.412 -0.805 . . . . 0.0 110.119 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 48.39 29.61 2.05 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.443 -0.786 . . . . 0.0 110.374 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.0 56.55 11.84 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.423 ' CD2' ' N ' ' A' ' 93' ' ' GLY . 22.2 t80 -138.79 -67.23 0.46 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.555 -0.968 . . . . 0.0 108.701 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.473 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . -106.91 -151.94 18.48 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.473 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 23.8 m-85 -151.33 157.62 42.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.422 -1.046 . . . . 0.0 108.565 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.418 ' C ' ' SD ' ' A' ' 95' ' ' MET . 1.5 tmt? -157.75 123.01 4.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.347 -0.845 . . . . 0.0 109.523 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 96' ' ' LEU . 9.2 mp -82.43 139.09 34.2 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.406 -0.808 . . . . 0.0 108.848 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 99' ' ' ASN . . . -55.89 113.48 1.52 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.929 . . . . 0.0 109.501 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -69.2 66.78 0.17 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 0.0 109.54 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 97' ' ' ALA . 11.3 t-20 51.5 44.45 29.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.203 -0.936 . . . . 0.0 109.754 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.5 mt -74.45 -7.87 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.24 -0.913 . . . . 0.0 108.741 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -57.5 -30.05 64.81 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.436 -0.79 . . . . 0.0 109.398 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 74.3 p -68.61 132.63 47.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 0.0 109.484 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.434 -179.942 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.354 0.597 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -146.77 48.09 1.16 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.196 -0.94 . . . . 0.0 109.337 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 56.89 31.65 61.4 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 10.8 p-10 -54.06 147.74 12.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.182 -1.187 . . . . 0.0 109.341 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -164.99 124.87 1.88 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.141 -0.975 . . . . 0.0 109.444 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -163.48 156.06 18.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.465 -0.772 . . . . 0.0 109.474 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.7 pt -147.84 163.97 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.357 -0.839 . . . . 0.0 109.167 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.4 m -133.99 145.43 49.49 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.533 -0.729 . . . . 0.0 109.558 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.4 t -141.44 93.4 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.87 -109.5 2.83 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -105.84 4.1 29.37 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.593 -0.945 . . . . 0.0 109.865 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.508 HD12 ' N ' ' A' ' 12' ' ' LEU . 10.4 mp -98.68 117.63 33.58 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.234 -0.917 . . . . 0.0 109.602 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 59.9 mtp85 -108.46 116.06 31.27 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 14' ' ' LEU . 9.2 mp -103.11 136.13 43.49 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.482 -0.761 . . . . 0.0 109.428 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -134.98 98.71 4.08 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.7 t -71.64 -29.39 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.498 -0.751 . . . . 0.0 109.449 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.41 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -56.88 -52.7 64.13 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.42 -0.8 . . . . 0.0 109.231 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.6 mtp180 -97.01 -6.71 34.74 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.485 ' NH2' ' O ' ' A' ' 30' ' ' LEU . 1.4 tmt_? 55.23 81.73 0.11 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.81 0.814 . . . . 0.0 109.248 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.409 HD23 ' N ' ' A' ' 21' ' ' VAL . 0.8 OUTLIER -167.76 132.34 1.82 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.409 ' N ' HD23 ' A' ' 20' ' ' LEU . 15.2 t -117.44 132.75 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.587 -0.695 . . . . 0.0 109.816 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -103.97 124.67 49.42 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.425 -0.797 . . . . 0.0 108.967 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 20.4 tp -104.15 111.77 24.5 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.68 37.4 93.48 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 107.311 -2.315 . . . . 0.0 107.311 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 69.89 2.11 3.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 122.35 -0.5 . . . . 0.0 109.826 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.5 p -103.65 138.06 40.83 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.129 -0.982 . . . . 0.0 109.97 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.9 113.14 5.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 110.225 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.3 tp -81.56 136.12 35.58 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -93.06 102.76 15.09 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.023 -1.048 . . . . 0.0 110.464 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.874 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.3 pt? -128.53 136.52 50.88 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 p -55.05 152.99 12.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 120.99 -1.068 . . . . 0.0 108.865 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.06 -40.93 47.58 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 122.054 1.836 . . . . 0.0 111.26 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -55.81 -41.91 74.86 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.188 -0.945 . . . . 0.0 108.509 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -63.32 -36.34 83.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.456 -0.778 . . . . 0.0 109.114 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -56.25 -28.22 57.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.161 -0.962 . . . . 0.0 108.633 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.24 -50.91 34.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.315 -0.866 . . . . 0.0 108.891 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.594 HD12 ' N ' ' A' ' 37' ' ' LEU . 8.4 mp -58.22 -39.96 80.4 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 12.8 tp -58.45 -41.99 86.36 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.543 ' C ' ' HE ' ' A' ' 40' ' ' ARG . 15.7 m -51.7 -35.48 43.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 109.17 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.543 ' HE ' ' C ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -76.38 -43.26 41.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.466 -0.771 . . . . 0.0 109.031 179.307 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.453 HD21 HD11 ' A' ' 54' ' ' LEU . 96.6 mt -59.7 -50.84 72.3 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.219 -0.926 . . . . 0.0 110.018 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -67.65 -36.45 80.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.923 -1.11 . . . . 0.0 110.196 -179.233 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.548 ' N ' ' SD ' ' A' ' 42' ' ' MET . 10.8 ttt -54.04 -28.4 38.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.089 -1.007 . . . . 0.0 108.96 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -122.34 44.54 2.59 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.37 132.16 49.32 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.195 -0.941 . . . . 0.0 109.909 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.17 -6.09 57.92 Favored Glycine 0 N--CA 1.501 3.032 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.3 m -132.75 150.82 76.81 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.591 -0.946 . . . . 0.0 108.718 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.07 120.25 5.65 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.803 1.669 . . . . 0.0 112.189 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.0 t -93.38 138.33 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -0.838 . . . . 0.0 109.273 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.473 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 10.4 t-160 -68.85 122.27 18.27 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.185 -0.947 . . . . 0.0 108.759 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -52.33 -17.12 1.03 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 109.266 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.405 ' O ' ' OD1' ' A' ' 56' ' ' ASN . 68.5 mm-40 -66.53 -50.24 63.84 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.401 -0.812 . . . . 0.0 109.361 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.4 mt -55.0 -29.77 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.271 -0.893 . . . . 0.0 109.784 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.453 HD11 HD21 ' A' ' 41' ' ' LEU . 17.9 mt -72.95 -30.32 63.77 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.211 -0.931 . . . . 0.0 109.385 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -71.4 -34.13 70.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.752 -1.217 . . . . 0.0 107.837 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.452 ' O ' ' O ' ' A' ' 59' ' ' TYR . 14.7 m120 -62.89 -20.82 65.51 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.362 0.601 . . . . 0.0 109.767 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.09 -54.53 43.55 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.814 -1.179 . . . . 0.0 109.507 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.8 mt -80.26 -38.08 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.509 -0.744 . . . . 0.0 110.538 -178.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.452 ' O ' ' O ' ' A' ' 56' ' ' ASN . 96.7 m-85 -110.17 162.81 14.23 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.421 -0.8 . . . . 0.0 109.932 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.3 m -169.16 -37.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.135 -0.978 . . . . 0.0 109.397 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 58.9 m95 -81.72 -26.56 34.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.302 -0.874 . . . . 0.0 109.853 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -158.3 120.01 3.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.188 -0.945 . . . . 0.0 109.457 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -60.48 -47.25 86.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 109.592 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 53.39 64.14 7.29 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.266 -0.896 . . . . 0.0 109.399 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -77.11 104.68 1.94 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.519 2.146 . . . . 0.0 112.102 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.58 -13.09 60.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.238 -0.914 . . . . 0.0 109.511 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.5 m 60.17 24.86 14.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.402 -0.811 . . . . 0.0 109.581 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.45 HD22 ' C ' ' A' ' 68' ' ' ASN . 0.5 OUTLIER -171.63 42.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -0.978 . . . . 0.0 109.513 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 68' ' ' ASN . 33.3 m -167.35 -35.98 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.47 -0.769 . . . . 0.0 109.07 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.66 HD12 ' N ' ' A' ' 70' ' ' LEU . 6.8 mp -59.77 -50.48 73.66 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.449 -0.782 . . . . 0.0 109.855 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -69.7 -26.01 64.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.094 -1.004 . . . . 0.0 109.754 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.6 t -75.23 -45.66 40.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.294 -0.879 . . . . 0.0 109.477 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -55.14 -37.45 66.96 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 89.0 mt -67.35 -40.45 84.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -59.78 -37.37 78.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.194 -0.941 . . . . 0.0 108.681 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -72.71 -42.12 64.52 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.723 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -64.42 -41.23 96.71 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -49.72 -50.39 44.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.334 -0.854 . . . . 0.0 109.815 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -59.52 -31.78 69.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.873 . . . . 0.0 110.803 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -68.32 -45.5 72.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.875 -1.141 . . . . 0.0 109.817 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.4 pt -74.88 -31.94 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.014 -1.054 . . . . 0.0 109.924 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 86.0 87.9 0.98 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.409 ' O ' ' O ' ' A' ' 86' ' ' ILE . 22.7 pttm -45.54 -17.33 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.573 -0.957 . . . . 0.0 110.31 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 82' ' ' GLY . 48.4 t -56.51 -52.06 66.15 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.185 -0.947 . . . . 0.0 109.897 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -87.75 10.06 19.6 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.179 -0.95 . . . . 0.0 110.942 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.546 HG22 ' N ' ' A' ' 87' ' ' ARG . 5.1 mp -133.08 164.04 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.546 ' N ' HG22 ' A' ' 86' ' ' ILE . 56.4 ttm-85 -140.85 128.02 20.89 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.075 -1.016 . . . . 0.0 110.085 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.435 HG22 ' CE2' ' A' ' 94' ' ' TYR . 2.2 p -88.57 142.24 27.86 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.498 -0.751 . . . . 0.0 109.096 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.7 t -102.12 112.0 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.368 -0.832 . . . . 0.0 110.236 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 47.11 34.47 2.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.443 -0.785 . . . . 0.0 110.552 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.4 54.8 11.92 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.473 ' CZ ' ' CD2' ' A' ' 50' ' ' HIS . 58.3 t80 -135.8 -74.71 0.45 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.471 -1.017 . . . . 0.0 108.73 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.456 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . -103.1 -153.08 24.02 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 12.1 m-85 -151.29 149.98 30.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.388 -1.066 . . . . 0.0 108.335 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.477 ' SD ' ' O ' ' A' ' 95' ' ' MET . 3.4 ppp? -149.22 127.45 12.11 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.212 -0.93 . . . . 0.0 109.542 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.427 HD12 ' N ' ' A' ' 96' ' ' LEU . 9.8 mp -79.87 132.74 36.16 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.08 132.1 46.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.347 -0.846 . . . . 0.0 109.615 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -55.04 -85.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 109.456 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -156.67 49.42 0.47 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.325 -0.86 . . . . 0.0 109.305 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 45.5 mt -68.67 -11.74 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.919 . . . . 0.0 108.83 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 0.9 OUTLIER -75.28 -8.22 56.06 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.659 -0.65 . . . . 0.0 109.357 179.742 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.5 t -58.05 -173.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.397 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.516 -179.979 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 34.1 t30 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.438 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 3.1 pm0 -154.8 45.4 0.52 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.334 -0.854 . . . . 0.0 109.312 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 83.42 15.48 71.27 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -166.1 175.63 8.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -1.162 . . . . 0.0 109.381 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 17' ' ' THR . 4.1 p30 -178.09 111.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -163.24 156.01 18.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 109.863 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.2 pt -146.38 163.12 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.347 -0.846 . . . . 0.0 109.084 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.8 t -134.49 142.15 46.97 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.336 -0.852 . . . . 0.0 109.8 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.77 92.88 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.55 -119.79 5.38 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -101.09 10.84 40.53 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.407 -1.055 . . . . 0.0 109.794 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.4 mt -108.33 123.59 49.04 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.413 -0.805 . . . . 0.0 109.672 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -108.1 146.98 31.87 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.6 tp -130.84 120.97 24.48 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.482 -0.762 . . . . 0.0 109.176 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 19' ' ' ARG . 13.2 m-20 -118.55 97.85 5.95 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.531 -0.731 . . . . 0.0 109.525 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.94 -27.51 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.449 -0.782 . . . . 0.0 109.216 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.463 ' N ' ' OD1' ' A' ' 5' ' ' ASN . 0.1 OUTLIER -63.18 -53.83 47.19 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.508 -0.745 . . . . 0.0 109.645 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -92.73 -14.62 27.71 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.153 -0.967 . . . . 0.0 108.814 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 15' ' ' ASN . 5.6 tpt180 68.18 61.31 0.4 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.312 0.577 . . . . 0.0 109.604 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.9 mt -138.89 156.65 47.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.38 -0.825 . . . . 0.0 108.973 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 t -143.69 127.73 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.255 -0.903 . . . . 0.0 109.388 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 12.3 m-90 -102.38 154.87 18.66 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.247 -0.908 . . . . 0.0 108.898 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.404 ' O ' ' OG1' ' A' ' 26' ' ' THR . 1.1 tt -144.5 115.09 7.68 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 63.5 43.47 98.08 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 107.805 -2.118 . . . . 0.0 107.805 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 61.28 0.43 0.42 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 122.129 -0.63 . . . . 0.0 110.213 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 68.1 p -106.47 139.85 40.29 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.215 -0.928 . . . . 0.0 109.452 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.03 114.56 3.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.412 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 32.2 tp -75.27 128.75 36.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.252 -0.905 . . . . 0.0 108.657 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -97.39 104.8 16.86 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.164 -0.96 . . . . 0.0 109.657 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.854 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.4 pt? -131.32 141.83 50.0 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.67 -0.644 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.3 p -62.36 152.19 80.29 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.155 -0.966 . . . . 0.0 109.961 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.04 -45.23 14.5 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.779 1.653 . . . . 0.0 112.013 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -53.63 -48.62 69.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.357 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.46 ' HG2' HD13 ' A' ' 77' ' ' LEU . 37.2 mt-10 -56.43 -35.26 67.64 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.324 -0.86 . . . . 0.0 109.536 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -60.19 -32.97 71.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 109.198 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.82 -53.45 9.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.155 -0.966 . . . . 0.0 108.583 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 tt -55.94 -45.0 78.91 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.9 tp -64.46 -45.74 86.08 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.3 0.572 . . . . 0.0 109.739 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.8 t -50.59 -39.45 49.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.364 -0.835 . . . . 0.0 110.635 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.416 ' CA ' ' HE ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -80.36 -41.68 24.29 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.916 -1.115 . . . . 0.0 109.87 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.6 tp -60.69 -41.83 95.94 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 109.325 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.1 mtp -72.35 -37.3 68.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.058 -1.026 . . . . 0.0 109.296 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 13.5 ttt -51.85 -27.3 12.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.28 -0.888 . . . . 0.0 108.766 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm -119.37 46.05 1.99 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.66 141.58 49.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.33 -0.856 . . . . 0.0 110.512 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.54 -22.14 40.63 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 t -114.43 152.99 46.61 Favored Pre-proline 0 N--CA 1.502 2.134 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.77 119.43 6.08 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.557 1.505 . . . . 0.0 111.629 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.439 HG11 HD21 ' A' ' 54' ' ' LEU . 78.8 t -97.11 133.69 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.293 -0.879 . . . . 0.0 110.047 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.402 ' CE1' ' CE1' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -68.44 124.75 24.4 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.184 -0.948 . . . . 0.0 108.673 178.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -52.31 -18.71 1.69 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.345 -0.847 . . . . 0.0 109.008 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -60.74 -57.15 13.9 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.46 -0.775 . . . . 0.0 109.379 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.2 mt -56.46 -30.67 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.238 -0.914 . . . . 0.0 109.735 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.439 HD21 HG11 ' A' ' 49' ' ' VAL . 33.8 mt -68.55 -32.53 72.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.096 -1.002 . . . . 0.0 108.959 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -74.1 -35.52 64.18 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 59' ' ' TYR . 16.4 m120 -61.19 -22.05 64.37 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -71.33 -54.03 12.18 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.386 -0.821 . . . . 0.0 109.751 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.5 mt -77.93 -26.19 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.349 -0.845 . . . . 0.0 110.227 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 56' ' ' ASN . 82.0 m-85 -143.22 -164.98 1.97 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.177 -0.952 . . . . 0.0 109.605 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.9 t 175.58 -31.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.346 -0.846 . . . . 0.0 109.101 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.432 ' O ' ' O ' ' A' ' 62' ' ' ASP . 61.0 m95 -78.71 -14.84 59.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.276 -0.89 . . . . 0.0 109.685 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 61' ' ' TRP . 34.0 m-20 50.8 101.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.533 -0.73 . . . . 0.0 110.151 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -73.08 -92.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.675 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -165.4 62.57 0.86 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.332 -0.855 . . . . 0.0 109.515 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.9 112.61 3.3 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.593 2.195 . . . . 0.0 111.962 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.76 -47.28 40.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.883 . . . . 0.0 109.612 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.0 m -164.67 -87.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 109.43 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -62.11 101.99 0.26 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.108 -0.995 . . . . 0.0 109.299 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 98.3 m -165.59 -87.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -0.876 . . . . 0.0 109.352 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.5 pp -68.1 -33.0 73.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.733 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.23 -32.09 70.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.022 -1.049 . . . . 0.0 110.026 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.1 t -73.84 -45.68 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.039 -1.038 . . . . 0.0 109.279 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.486 ' ND1' ' N ' ' A' ' 73' ' ' HIS . 1.5 m-70 -55.86 -37.49 68.84 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 86.8 mt -67.79 -39.79 82.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -61.25 -35.84 78.38 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.969 -1.082 . . . . 0.0 108.752 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -74.49 -41.66 60.33 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.479 -0.763 . . . . 0.0 109.017 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.665 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -69.11 -42.83 75.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 0.0 108.85 -179.231 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -50.82 -50.64 56.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -0.857 . . . . 0.0 110.726 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -64.71 -26.07 68.21 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.036 -1.04 . . . . 0.0 110.769 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -71.44 -45.35 62.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.856 -1.152 . . . . 0.0 110.077 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 21.7 pt -74.84 -22.29 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.122 -0.986 . . . . 0.0 110.09 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 81.6 84.39 0.76 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.576 -1.81 . . . . 0.0 108.576 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 86' ' ' ILE . 18.3 pttp -45.1 -17.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.658 -0.907 . . . . 0.0 110.425 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 82' ' ' GLY . 36.7 p -54.78 -48.73 72.31 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.168 -0.957 . . . . 0.0 109.751 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.83 9.58 4.09 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.056 -1.028 . . . . 0.0 109.893 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 87' ' ' ARG . 5.2 mp -134.46 159.56 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.214 -0.929 . . . . 0.0 109.307 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.49 ' N ' HG22 ' A' ' 86' ' ' ILE . 95.3 mtt180 -140.73 124.39 17.01 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.419 -0.8 . . . . 0.0 109.689 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.8 p -86.75 138.63 31.45 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.287 -0.883 . . . . 0.0 109.285 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.8 t -101.58 121.0 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.375 -0.828 . . . . 0.0 110.535 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 49.7 ttp85 47.87 28.38 1.36 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.569 -0.707 . . . . 0.0 110.343 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.37 49.18 26.4 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.433 ' CD2' ' N ' ' A' ' 93' ' ' GLY . 25.2 t80 -137.11 -69.37 0.46 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.578 -0.954 . . . . 0.0 108.432 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.433 ' N ' ' CD2' ' A' ' 92' ' ' PHE . . . -100.44 -151.39 25.5 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.428 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 22.7 m-85 -149.51 158.06 43.84 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 45.6 ttp -159.81 126.61 4.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.204 -0.935 . . . . 0.0 110.075 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.404 HD12 ' N ' ' A' ' 96' ' ' LEU . 9.4 mp -84.3 131.88 34.68 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.02 127.14 27.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.189 -0.944 . . . . 0.0 109.215 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -51.47 -69.45 0.11 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.238 -0.913 . . . . 0.0 109.629 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -158.55 40.22 0.24 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.376 -0.827 . . . . 0.0 109.252 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 41.0 mt -84.85 -10.72 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 121.889 0.852 . . . . 0.0 108.821 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -61.24 -33.36 73.38 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.548 -0.72 . . . . 0.0 109.547 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.7 p -75.47 169.49 17.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.208 -0.932 . . . . 0.0 109.362 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.462 -179.995 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 67.7 58.48 0.5 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 4' ' ' ASP . . . 162.73 -37.94 0.35 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 3' ' ' GLY . 18.6 m-20 51.14 -179.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.451 -1.029 . . . . 0.0 109.768 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -161.92 125.01 3.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 108.952 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -150.26 146.5 26.83 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.554 -0.716 . . . . 0.0 109.492 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.3 pt -148.92 163.44 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.271 -0.893 . . . . 0.0 108.905 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.1 t -143.24 152.79 42.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.201 -0.937 . . . . 0.0 109.712 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.1 t -147.35 92.92 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.91 -114.84 4.08 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.7 m-20 -103.09 6.19 38.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.421 -1.046 . . . . 0.0 109.893 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.8 mt -101.78 118.31 36.66 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.351 -0.843 . . . . 0.0 109.887 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -110.84 118.97 37.56 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 mp -106.88 126.47 52.35 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.552 -0.717 . . . . 0.0 109.309 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -122.72 97.91 5.67 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.97 -27.34 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.432 -0.792 . . . . 0.0 109.576 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.412 ' H ' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER -63.74 -49.11 74.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.273 -0.892 . . . . 0.0 109.867 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.2 mtp85 -97.14 -7.75 31.79 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.164 -0.96 . . . . 0.0 108.611 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? 56.0 73.35 0.44 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 21' ' ' VAL . 1.1 tt -157.7 128.13 6.34 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.43 ' N ' HD23 ' A' ' 20' ' ' LEU . 12.6 t -114.73 136.72 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.499 -0.75 . . . . 0.0 110.264 -179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 29.0 m-90 -108.18 133.16 52.83 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tt -113.75 110.11 19.64 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.37 39.0 91.66 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 107.623 -2.191 . . . . 0.0 107.623 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 69.65 -0.45 2.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 122.324 -0.515 . . . . 0.0 110.025 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.7 p -101.93 138.99 38.16 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.064 -1.023 . . . . 0.0 109.789 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.98 112.46 1.34 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 110.012 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.4 tp -75.43 127.89 34.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 108.839 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -92.24 98.76 11.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.115 -0.991 . . . . 0.0 109.926 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.907 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.3 pt? -123.84 134.28 53.62 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 121.509 0.671 . . . . 0.0 109.341 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.0 p -59.57 149.15 72.0 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.997 -1.065 . . . . 0.0 109.463 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -45.01 -48.37 11.05 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.719 1.613 . . . . 0.0 112.117 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -54.67 -37.43 65.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.419 -0.801 . . . . 0.0 109.882 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -67.55 -35.06 78.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.095 -1.003 . . . . 0.0 109.261 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -59.12 -33.4 70.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.042 -1.036 . . . . 0.0 108.72 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.53 -53.05 17.7 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.535 HD11 HD13 ' A' ' 54' ' ' LEU . 4.9 tt -52.16 -50.3 62.07 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 13.1 tp -56.09 -40.09 73.13 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.169 0.509 . . . . 0.0 109.854 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.8 m -52.42 -33.31 43.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 109.744 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.51 HH21 ' CE ' ' A' ' 43' ' ' MET . 10.5 mmp_? -78.55 -42.66 28.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.97 . . . . 0.0 109.456 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 17.9 mt -59.22 -48.05 83.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.959 -1.088 . . . . 0.0 110.011 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.417 ' SD ' ' C ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -70.36 -25.96 63.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.985 -1.072 . . . . 0.0 109.746 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.51 ' CE ' HH21 ' A' ' 40' ' ' ARG . 40.2 ttm -61.77 -32.67 72.95 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.161 -0.962 . . . . 0.0 108.872 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -118.13 38.91 3.54 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.79 121.3 9.53 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.262 -0.899 . . . . 0.0 109.753 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.32 -6.85 30.38 Favored Glycine 0 N--CA 1.503 3.14 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.3 m -130.28 151.68 78.9 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 121.535 -0.98 . . . . 0.0 108.771 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.72 120.4 5.51 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.859 1.706 . . . . 0.0 112.186 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.5 t -87.77 131.68 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.241 -0.912 . . . . 0.0 109.78 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.45 ' CD2' ' HB3' ' A' ' 52' ' ' GLU . 2.2 t60 -67.15 129.34 39.57 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.309 -0.87 . . . . 0.0 108.675 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.446 ' NH2' ' OE1' ' A' ' 71' ' ' GLU . 13.0 ptm180 -54.04 -22.2 10.15 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.473 -0.767 . . . . 0.0 109.394 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.45 ' HB3' ' CD2' ' A' ' 50' ' ' HIS . 38.2 tt0 -72.79 -36.24 67.54 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.524 -0.735 . . . . 0.0 110.409 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.9 mt -75.64 -35.37 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.433 -0.792 . . . . 0.0 111.66 -178.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.639 ' C ' HD12 ' A' ' 54' ' ' LEU . 4.2 pp -76.34 -22.43 54.92 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.818 -1.176 . . . . 0.0 109.474 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.61 ' N ' HD12 ' A' ' 54' ' ' LEU . 63.4 t80 -64.88 -33.36 75.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.903 . . . . 0.0 109.521 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 2.1 m120 -61.54 -23.69 66.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 109.669 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.17 -56.74 18.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.386 -0.822 . . . . 0.0 110.175 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.5 mt -73.63 -37.7 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.323 -0.861 . . . . 0.0 110.452 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.561 ' CD1' ' CZ ' ' A' ' 55' ' ' TYR . 88.9 m-85 -110.12 133.8 52.85 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.495 -0.753 . . . . 0.0 109.854 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.4 m -77.13 42.28 0.32 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.192 -0.943 . . . . 0.0 109.14 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 21.2 t90 53.88 44.1 29.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.344 -0.847 . . . . 0.0 109.432 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.419 ' O ' ' O ' ' A' ' 63' ' ' ASN . 12.7 t70 -80.87 -33.7 34.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.239 -0.913 . . . . 0.0 109.663 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 62' ' ' ASP . 6.3 m-20 60.51 120.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.518 -0.739 . . . . 0.0 109.782 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.454 ' H ' ' HD2' ' A' ' 65' ' ' PRO . 0.9 OUTLIER -178.45 -51.16 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.298 -0.877 . . . . 0.0 109.546 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.454 ' HD2' ' H ' ' A' ' 64' ' ' GLU . 64.5 Cg_endo -85.44 81.98 1.69 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.066 1.844 . . . . 0.0 112.07 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.94 -19.15 59.0 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.883 . . . . 0.0 109.587 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 62.8 p -61.95 175.06 0.73 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.64 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -76.16 110.25 10.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.895 . . . . 0.0 109.553 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.7 m -165.93 -35.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.877 . . . . 0.0 109.353 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.597 ' H ' HD23 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -70.54 -49.28 49.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.373 -0.83 . . . . 0.0 108.892 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.446 ' OE1' ' NH2' ' A' ' 51' ' ' ARG . 29.8 tp10 -69.87 -31.23 68.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.574 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.9 t -72.4 -40.11 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.181 -0.95 . . . . 0.0 109.0 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -56.95 -39.3 74.31 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 89.9 mt -63.82 -35.9 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -61.97 -32.4 72.84 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.48 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -73.04 -41.78 63.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.505 -0.747 . . . . 0.0 109.255 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.8 mt -72.26 -39.39 68.43 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.227 -0.921 . . . . 0.0 109.544 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -50.32 -51.48 44.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.959 . . . . 0.0 110.181 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.43 -24.79 67.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.055 -1.028 . . . . 0.0 109.803 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -70.95 -45.92 63.31 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.984 -1.073 . . . . 0.0 110.135 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.408 HG12 ' H ' ' A' ' 81' ' ' ILE . 16.3 pt -74.89 -19.29 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.104 -0.997 . . . . 0.0 110.121 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 84.19 83.07 0.98 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 86' ' ' ILE . 56.4 pttt -44.51 -17.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.721 -0.87 . . . . 0.0 110.59 -179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 82' ' ' GLY . 57.9 m -59.38 -48.42 81.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.138 -0.976 . . . . 0.0 110.777 -178.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.483 ' N ' ' CD ' ' A' ' 85' ' ' ARG . 10.6 mpt_? -72.72 9.42 1.12 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.025 -1.047 . . . . 0.0 111.003 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' A' ' 83' ' ' LYS . 9.0 tt -146.82 160.96 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 120.934 -1.104 . . . . 0.0 109.29 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -117.1 132.44 56.67 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.42 -0.8 . . . . 0.0 109.703 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.7 p -95.39 142.47 27.74 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.414 -0.804 . . . . 0.0 108.89 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.6 t -101.74 92.75 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.352 -0.843 . . . . 0.0 109.787 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.8 mtp85 47.52 32.31 2.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.317 -0.865 . . . . 0.0 110.461 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.22 0.99 6.41 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.491 ' CD2' ' N ' ' A' ' 93' ' ' GLY . 60.0 t80 -74.61 -81.73 0.07 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.078 -1.248 . . . . 0.0 108.536 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.491 ' N ' ' CD2' ' A' ' 92' ' ' PHE . . . -105.17 -150.41 19.8 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.472 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 26.0 m-85 -151.21 163.31 39.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.421 -1.046 . . . . 0.0 108.305 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.46 ' SD ' ' O ' ' A' ' 96' ' ' LEU . 1.2 tmt? -163.27 127.79 2.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.981 -1.074 . . . . 0.0 110.261 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.46 ' O ' ' SD ' ' A' ' 95' ' ' MET . 9.6 mp -78.49 142.02 37.77 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.7 120.73 20.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 109.486 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -53.29 -24.8 12.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 109.645 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.428 ' N ' ' OD1' ' A' ' 99' ' ' ASN . 12.6 p-10 -171.25 111.06 0.33 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.279 -0.888 . . . . 0.0 109.483 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.8 mt -70.39 -12.61 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 108.688 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 102' ' ' THR . 18.3 p30 -173.83 -17.97 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.414 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 8.5 m -74.01 56.47 0.6 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.239 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.545 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.393 0.616 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 48.85 61.0 3.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.289 -0.882 . . . . 0.0 109.559 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 164.67 -36.49 0.29 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -77.81 142.56 38.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.295 -1.121 . . . . 0.0 109.297 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -158.26 120.27 3.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.241 -0.912 . . . . 0.0 109.321 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -162.44 154.57 18.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.333 -0.855 . . . . 0.0 109.706 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.8 pt -150.44 164.65 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.5 p -140.39 154.0 46.55 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.294 -0.879 . . . . 0.0 110.028 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.3 t -148.33 93.43 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.67 -115.19 4.19 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -101.44 5.35 41.99 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.396 -1.061 . . . . 0.0 109.837 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.2 mt -101.06 116.24 32.37 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.334 -0.854 . . . . 0.0 109.715 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -108.94 122.04 46.38 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 37.1 tp -105.95 134.74 48.6 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.597 -0.69 . . . . 0.0 110.006 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -131.78 97.36 4.17 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.9 t -71.89 -27.9 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.317 -0.864 . . . . 0.0 109.403 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.7 -54.75 30.65 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.503 -0.748 . . . . 0.0 109.656 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -86.9 -11.6 50.19 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.169 -0.957 . . . . 0.0 108.697 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 60.29 72.23 0.53 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.441 0.639 . . . . 0.0 109.329 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.5 tp -166.8 153.63 8.83 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.5 t -134.59 135.52 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.298 -0.876 . . . . 0.0 109.876 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 20.0 m-90 -100.0 120.37 39.72 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 26' ' ' THR . 1.2 tt -101.91 110.51 22.5 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.55 43.45 96.54 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 107.212 -2.355 . . . . 0.0 107.212 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 64.75 3.37 1.98 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 122.338 -0.507 . . . . 0.0 110.269 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 23' ' ' LEU . 43.8 p -106.03 138.48 42.14 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 120.95 -1.094 . . . . 0.0 109.711 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.71 113.31 2.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.973 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 28' ' ' LEU . 29.1 tp -71.04 126.25 29.06 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -96.91 104.93 16.98 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.22 -0.925 . . . . 0.0 110.695 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.779 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.1 pt? -143.09 151.48 40.8 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.44 -0.788 . . . . 0.0 109.354 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.08 157.35 62.68 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.141 -0.975 . . . . 0.0 108.71 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -60.8 -39.77 59.72 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.457 2.105 . . . . 0.0 112.069 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -54.54 -36.27 64.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.073 -1.017 . . . . 0.0 109.102 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.486 ' OE2' ' NE2' ' A' ' 73' ' ' HIS . 20.5 mm-40 -70.18 -37.73 75.21 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -55.25 -27.86 49.28 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.421 ' O ' ' OD2' ' A' ' 57' ' ' ASP . . . -72.83 -50.49 23.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.383 -0.823 . . . . 0.0 109.002 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.471 ' CD2' ' O ' ' A' ' 54' ' ' LEU . 9.9 mt -65.71 -37.73 87.24 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 38' ' ' LEU . 1.6 tt -57.58 -42.44 83.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.511 -0.743 . . . . 0.0 109.446 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.5 p -60.78 -45.86 92.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.11 -0.994 . . . . 0.0 109.275 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -55.24 -48.06 74.49 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.368 -0.832 . . . . 0.0 109.29 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.1 mt -61.65 -39.29 90.83 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 109.991 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 8.1 mmt -74.7 -37.03 62.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.874 -1.141 . . . . 0.0 109.888 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 40.5 mtt -55.14 -29.31 57.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.119 -0.988 . . . . 0.0 108.699 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -120.81 47.85 1.73 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.86 129.97 39.89 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.197 -0.94 . . . . 0.0 110.064 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.33 -12.98 43.98 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.8 p -125.75 151.43 70.86 Favored Pre-proline 0 N--CA 1.502 2.165 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.1 119.74 6.2 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.637 1.558 . . . . 0.0 111.709 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.4 t -94.67 135.34 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.349 -0.845 . . . . 0.0 109.81 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.413 ' C ' ' N ' ' A' ' 52' ' ' GLU . 8.2 t-160 -72.72 125.12 26.76 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.044 -1.035 . . . . 0.0 108.492 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.482 ' N ' ' CD ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -50.83 -15.18 0.26 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.489 -0.757 . . . . 0.0 109.787 -179.281 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.413 ' N ' ' C ' ' A' ' 50' ' ' HIS . 17.2 tt0 -66.47 -49.12 67.69 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.498 -0.751 . . . . 0.0 109.866 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.2 mm -56.24 -33.14 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.034 -1.041 . . . . 0.0 109.93 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.471 ' O ' ' CD2' ' A' ' 37' ' ' LEU . 22.7 mt -65.93 -48.95 69.67 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.524 ' CE1' ' CD2' ' A' ' 59' ' ' TYR . 34.0 t80 -57.67 -35.98 71.29 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -66.84 -21.79 66.01 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.528 -0.733 . . . . 0.0 110.693 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.421 ' OD2' ' O ' ' A' ' 36' ' ' ALA . 7.2 t0 -56.85 -54.7 43.46 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.764 -1.21 . . . . 0.0 109.347 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.8 mm -94.72 -36.46 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.348 -0.845 . . . . 0.0 110.081 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.524 ' CD2' ' CE1' ' A' ' 55' ' ' TYR . 74.9 m-85 -99.6 -174.59 2.76 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.199 -0.938 . . . . 0.0 109.638 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.3 p -173.57 -29.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.474 -0.766 . . . . 0.0 109.372 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.447 ' C ' ' H ' ' A' ' 63' ' ' ASN . 41.1 p-90 -157.58 -9.68 0.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 0.0 109.313 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -74.61 15.05 0.4 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.325 -0.859 . . . . 0.0 109.337 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.447 ' H ' ' C ' ' A' ' 61' ' ' TRP . 12.0 m120 -50.16 -95.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.429 -0.795 . . . . 0.0 109.976 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.488 ' O ' ' N ' ' A' ' 66' ' ' ALA . 30.5 tt0 53.44 69.3 2.33 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.462 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -45.59 82.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.766 2.311 . . . . 0.0 112.5 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 64' ' ' GLU . . . -82.96 -37.08 24.56 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.02 -1.05 . . . . 0.0 109.348 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.463 HG22 ' N ' ' A' ' 68' ' ' ASN . 85.7 m -165.13 161.12 19.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.337 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.463 ' N ' HG22 ' A' ' 67' ' ' THR . 45.1 m-80 -52.02 126.56 18.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -0.938 . . . . 0.0 109.6 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 75.3 m -165.79 -46.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.417 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.632 ' H ' HD12 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -55.49 -50.38 70.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.239 -0.913 . . . . 0.0 109.201 -179.684 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -71.57 -27.44 63.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 110.138 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.65 -48.24 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.105 -0.997 . . . . 0.0 109.413 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.486 ' NE2' ' OE2' ' A' ' 34' ' ' GLU . 81.4 t60 -54.73 -36.72 65.07 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 90.5 mt -71.61 -42.45 71.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -61.39 -35.43 77.48 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.816 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -74.07 -40.86 62.48 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.512 -0.743 . . . . 0.0 109.402 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.673 ' C ' HD12 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -67.71 -42.51 81.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 108.665 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.483 ' NH2' ' OH ' ' A' ' 94' ' ' TYR . 35.6 ttm180 -49.85 -51.29 41.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.524 -0.735 . . . . 0.0 110.448 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -62.16 -27.71 69.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 110.642 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -74.47 -45.04 48.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.981 -1.074 . . . . 0.0 110.94 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.7 pt -76.83 -22.23 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.821 -1.175 . . . . 0.0 110.638 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 83.93 82.12 0.99 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.2 pttt -45.07 -15.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.707 -0.878 . . . . 0.0 110.658 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 82' ' ' GLY . 65.1 p -49.44 -45.53 46.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.954 -1.091 . . . . 0.0 109.841 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.521 ' HE ' ' N ' ' A' ' 85' ' ' ARG . 5.4 mmp_? -84.25 9.5 12.79 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.189 -0.944 . . . . 0.0 110.295 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 87' ' ' ARG . 37.2 mm -116.95 161.5 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 121.372 -0.83 . . . . 0.0 109.617 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.463 ' N ' HG22 ' A' ' 86' ' ' ILE . 47.4 ttt85 -134.04 110.46 9.66 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.3 p -87.37 138.14 31.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.145 -0.972 . . . . 0.0 110.274 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.7 t -102.07 100.03 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.539 -0.726 . . . . 0.0 109.597 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.47 ' C ' ' H ' ' A' ' 92' ' ' PHE . 15.5 mmt85 52.24 28.01 5.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.306 -0.871 . . . . 0.0 109.726 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.65 0.98 2.26 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.539 ' CD2' ' N ' ' A' ' 93' ' ' GLY . 41.4 t80 -73.29 -87.79 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.309 -1.112 . . . . 0.0 108.761 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.539 ' N ' ' CD2' ' A' ' 92' ' ' PHE . . . -95.23 -149.52 25.82 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.483 ' OH ' ' NH2' ' A' ' 78' ' ' ARG . 28.0 m-85 -151.21 159.84 44.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.299 -1.118 . . . . 0.0 108.585 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 43.1 ttp -161.15 131.69 5.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 110.065 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.451 HD12 ' N ' ' A' ' 96' ' ' LEU . 9.3 mp -89.64 133.13 34.79 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.17 114.06 1.62 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 109.729 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -77.57 98.78 5.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.294 -0.878 . . . . 0.0 109.243 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 50.85 94.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.227 -0.92 . . . . 0.0 109.689 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.3 mt -58.07 -12.38 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 108.873 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 0.7 OUTLIER -73.99 -37.33 64.47 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.641 -0.662 . . . . 0.0 109.444 179.739 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.5 m 52.24 81.74 0.08 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.315 -0.866 . . . . 0.0 109.658 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.489 -179.954 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.7 m120 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -72.52 57.38 0.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.884 . . . . 0.0 109.533 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -157.15 19.54 0.4 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.6 p30 -172.08 172.74 4.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.322 -1.105 . . . . 0.0 109.394 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -158.83 123.93 4.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 108.924 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -161.32 152.36 18.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.394 -0.816 . . . . 0.0 109.546 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.458 HG22 ' N ' ' A' ' 8' ' ' SER . 58.5 mt -137.04 159.97 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.458 ' N ' HG22 ' A' ' 7' ' ' ILE . 72.2 m -142.9 146.69 34.29 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.39 -0.819 . . . . 0.0 109.732 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.5 t -142.66 94.65 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.01 -119.41 4.95 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -100.96 10.11 41.49 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.37 -1.076 . . . . 0.0 109.34 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 17.7 tp -104.45 127.85 52.23 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -123.53 135.65 54.13 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 tt -129.2 121.44 27.67 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.622 -0.674 . . . . 0.0 109.582 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.513 ' C ' ' HH ' ' A' ' 35' ' ' TYR . 3.4 m-20 -112.12 107.11 15.91 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.629 -0.669 . . . . 0.0 110.241 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.1 t -71.9 -28.58 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.284 -0.885 . . . . 0.0 109.561 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 17' ' ' THR . 0.1 OUTLIER -66.69 -54.7 20.33 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.368 -0.832 . . . . 0.0 109.303 -179.722 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -84.01 -18.78 35.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.115 -0.991 . . . . 0.0 108.665 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? 66.11 65.92 0.5 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.9 mt -148.01 158.23 43.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.236 -0.915 . . . . 0.0 108.661 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.7 t -140.35 128.63 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.324 -0.86 . . . . 0.0 109.58 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -103.86 148.0 26.65 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.415 -0.803 . . . . 0.0 109.35 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.9 tp -133.83 102.53 5.48 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 71.85 40.87 57.06 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.315 -1.914 . . . . 0.0 108.315 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 70.62 -10.86 0.67 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 122.034 -0.686 . . . . 0.0 109.695 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.431 ' H ' ' C ' ' A' ' 24' ' ' GLY . 44.3 p -92.85 142.81 26.91 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.077 -1.014 . . . . 0.0 109.638 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.71 116.68 7.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 110.121 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.3 tp -75.14 130.57 39.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.263 -0.898 . . . . 0.0 108.604 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 29' ' ' ASP . 9.5 p-10 -97.45 102.79 14.64 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.231 -0.918 . . . . 0.0 110.046 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.861 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.4 pt? -131.29 140.94 49.88 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.0 p -64.59 151.21 92.48 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.026 -1.046 . . . . 0.0 109.703 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -44.71 -44.58 14.03 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 121.734 1.623 . . . . 0.0 112.087 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -53.6 -46.22 70.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 109.325 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.512 ' HG2' HD13 ' A' ' 77' ' ' LEU . 45.6 mt-10 -55.55 -44.77 77.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.918 . . . . 0.0 109.786 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.513 ' HH ' ' C ' ' A' ' 15' ' ' ASN . 12.5 t80 -56.29 -28.11 57.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.411 -0.805 . . . . 0.0 109.921 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.64 -54.12 8.04 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.908 -1.12 . . . . 0.0 109.681 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 tt -58.28 -42.73 87.2 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 22.4 tp -62.32 -43.08 99.66 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.291 0.567 . . . . 0.0 109.488 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.8 m -51.44 -36.14 42.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.78 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -77.14 -39.25 49.96 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.738 -1.226 . . . . 0.0 109.725 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.7 mt -57.4 -43.99 84.18 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.097 -1.002 . . . . 0.0 108.961 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.3 mmt -67.93 -28.91 67.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.053 -1.029 . . . . 0.0 109.66 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 24.6 ttt -61.59 -33.16 73.41 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.183 -0.948 . . . . 0.0 108.907 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -124.01 47.32 2.08 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.867 -0.521 . . . . 0.0 109.64 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.45 136.95 52.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.108 -0.995 . . . . 0.0 110.254 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.45 -13.99 61.04 Favored Glycine 0 N--CA 1.501 2.984 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.2 p -119.9 151.32 52.34 Favored Pre-proline 0 N--CA 1.502 2.162 0 O-C-N 121.56 -0.965 . . . . 0.0 108.566 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.03 120.2 5.96 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.639 1.559 . . . . 0.0 111.519 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.0 t -100.0 138.38 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.489 -0.757 . . . . 0.0 109.87 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.439 ' C ' ' N ' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -79.56 126.35 30.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.344 -0.848 . . . . 0.0 108.764 178.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.7 ttp-105 -51.06 -16.77 0.5 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 108.816 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.439 ' N ' ' C ' ' A' ' 50' ' ' HIS . 31.7 tt0 -65.05 -39.02 92.68 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.5 mt -73.54 -35.05 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.273 0.559 . . . . 0.0 109.529 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.9 mt -73.84 -25.03 59.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.174 -0.954 . . . . 0.0 108.906 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -60.21 -37.01 78.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.001 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.403 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 3.3 m120 -59.13 -28.07 66.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.519 -0.738 . . . . 0.0 109.918 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.9 -54.39 19.2 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.341 -0.849 . . . . 0.0 110.047 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.6 mm -70.92 -28.8 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.244 -0.91 . . . . 0.0 110.239 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -49.95 -67.09 0.29 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.101 -1.0 . . . . 0.0 109.497 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.0 t 54.98 13.55 0.78 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.405 -0.809 . . . . 0.0 109.608 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 3.6 m0 52.8 50.04 18.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 109.658 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -157.2 -33.75 0.08 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.184 -0.947 . . . . 0.0 109.68 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -59.25 -35.24 73.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.209 -0.932 . . . . 0.0 109.55 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 52.76 76.37 0.54 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.174 -0.954 . . . . 0.0 109.585 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -46.43 105.04 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.597 2.198 . . . . 0.0 112.373 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.07 -52.2 7.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.272 -0.893 . . . . 0.0 109.654 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.429 ' OG1' ' N ' ' A' ' 68' ' ' ASN . 9.0 t -171.15 -153.69 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.256 -0.903 . . . . 0.0 109.516 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.429 ' N ' ' OG1' ' A' ' 67' ' ' THR . 30.4 m120 -57.7 98.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.444 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.4 m -167.15 -36.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.462 -0.774 . . . . 0.0 109.074 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' A' ' 70' ' ' LEU . 2.1 mm? -64.49 -49.36 71.68 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.296 -0.878 . . . . 0.0 109.166 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.14 -34.68 78.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.896 -1.128 . . . . 0.0 108.781 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.6 t -69.1 -35.33 68.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.16 -38.57 80.04 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.423 ' HA ' HD23 ' A' ' 77' ' ' LEU . 94.1 mt -63.96 -36.66 77.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -62.73 -34.22 76.74 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.789 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -77.37 -41.68 39.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.489 -0.757 . . . . 0.0 109.306 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.63 ' C ' HD12 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -71.73 -39.22 70.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.292 -0.88 . . . . 0.0 109.276 -179.065 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -56.46 -47.78 78.45 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.775 -0.578 . . . . 0.0 110.62 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -62.3 -15.2 46.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.076 -1.015 . . . . 0.0 110.847 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -88.2 -39.64 14.33 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.849 -1.157 . . . . 0.0 110.681 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.2 pt -81.52 -15.74 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.028 -1.045 . . . . 0.0 110.131 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 78.93 85.82 0.54 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -44.78 -16.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.638 -0.919 . . . . 0.0 110.539 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 82' ' ' GLY . 52.0 p -50.01 -44.74 51.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.601 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -75.29 8.79 2.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.18 -0.95 . . . . 0.0 109.971 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.1 mt -137.56 127.71 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.335 -0.853 . . . . 0.0 108.933 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -97.8 98.09 9.54 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.394 -0.816 . . . . 0.0 109.058 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.405 HG23 ' H ' ' A' ' 88' ' ' THR . 2.9 p -67.43 131.23 45.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -0.945 . . . . 0.0 109.336 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.1 t -101.01 110.85 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.487 -0.758 . . . . 0.0 110.246 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.479 ' C ' ' H ' ' A' ' 92' ' ' PHE . 65.4 mtp85 47.88 20.4 0.23 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.482 -0.761 . . . . 0.0 110.254 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.98 -2.2 2.2 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.546 ' CD2' ' N ' ' A' ' 93' ' ' GLY . 25.4 t80 -75.76 -77.36 0.13 Allowed 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.31 -1.112 . . . . 0.0 108.428 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.546 ' N ' ' CD2' ' A' ' 92' ' ' PHE . . . -98.84 -149.23 24.43 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.422 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 31.4 m-85 -151.98 159.74 43.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -1.131 . . . . 0.0 108.795 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 38.8 ttp -161.94 135.1 6.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.278 -0.889 . . . . 0.0 110.188 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 96' ' ' LEU . 9.3 mp -93.12 130.6 38.7 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.44 -0.788 . . . . 0.0 108.921 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.2 123.77 25.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 109.558 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -80.13 107.72 13.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.233 -0.917 . . . . 0.0 109.488 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.436 ' C ' ' H ' ' A' ' 101' ' ' ASP . 63.3 m-20 51.26 93.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.314 -0.866 . . . . 0.0 109.823 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.9 mt -69.05 1.84 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.436 ' H ' ' C ' ' A' ' 99' ' ' ASN . 4.0 t70 72.8 45.21 0.33 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.7 m -163.34 145.25 9.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.367 -0.833 . . . . 0.0 109.477 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.434 -179.992 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.324 0.583 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.583 HD22 ' N ' ' A' ' 5' ' ' ASN . 0.1 OUTLIER -171.14 124.74 0.63 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 109.213 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.452 ' CD ' ' N ' ' A' ' 6' ' ' GLU . 1.3 pm0 -160.64 155.98 24.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.392 -0.818 . . . . 0.0 109.831 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 7' ' ' ILE . 21.9 pt -147.17 163.03 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.338 -0.851 . . . . 0.0 109.012 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m -143.74 154.36 43.38 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.238 -0.914 . . . . 0.0 109.712 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.5 t -142.67 99.09 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.15 -119.69 5.69 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -99.29 11.37 39.27 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.455 -1.027 . . . . 0.0 109.738 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 29.6 mt -106.82 130.62 54.48 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.356 -0.84 . . . . 0.0 109.455 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -118.59 141.05 48.96 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.1 tt -129.05 143.53 50.9 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.618 -0.676 . . . . 0.0 109.525 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 19' ' ' ARG . 3.3 m-20 -135.48 100.7 4.58 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.622 -0.674 . . . . 0.0 109.721 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.85 -30.34 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.363 -0.835 . . . . 0.0 109.564 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.522 ' N ' HD21 ' A' ' 5' ' ' ASN . 0.0 OUTLIER -60.75 -49.32 77.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.444 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -93.73 -14.53 26.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.129 -0.982 . . . . 0.0 108.378 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 15' ' ' ASN . 5.7 tpt180 64.41 49.25 2.52 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.873 -0.517 . . . . 0.0 109.742 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.3 mt -133.69 153.08 51.96 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.9 t -133.87 134.27 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.422 -0.799 . . . . 0.0 109.319 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -103.17 158.68 16.15 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.429 ' O ' ' OG1' ' A' ' 26' ' ' THR . 1.9 tt -146.41 116.92 7.52 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.27 -0.894 . . . . 0.0 108.714 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.64 41.65 97.66 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 107.727 -2.149 . . . . 0.0 107.727 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 61.63 3.48 0.86 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 122.089 -0.654 . . . . 0.0 110.077 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 60.6 p -108.35 140.8 41.11 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 121.187 -0.946 . . . . 0.0 109.457 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.33 114.58 7.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 109.693 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 28' ' ' LEU . 12.1 tp -84.94 141.27 30.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 109.023 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -99.78 107.5 19.57 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.322 -0.861 . . . . 0.0 109.795 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.3 140.57 51.8 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.8 p -61.11 145.05 90.32 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.107 -0.996 . . . . 0.0 109.48 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -45.0 -42.72 15.76 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.709 1.606 . . . . 0.0 112.32 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -53.31 -48.24 68.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.885 . . . . 0.0 109.767 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -59.48 -33.37 71.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.973 . . . . 0.0 109.381 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.442 ' HH ' ' C ' ' A' ' 15' ' ' ASN . 20.3 t80 -60.04 -32.03 70.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.128 -0.982 . . . . 0.0 109.369 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.409 ' O ' ' OD2' ' A' ' 57' ' ' ASP . . . -74.27 -53.85 8.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.171 -0.956 . . . . 0.0 109.794 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 37' ' ' LEU . 8.5 mp -64.96 -38.47 91.07 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.8 tp -65.23 -46.27 81.3 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.5 m -50.46 -30.15 12.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 109.61 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -77.27 -37.81 52.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.156 -0.965 . . . . 0.0 109.082 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.4 mp -56.53 -47.28 79.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 108.998 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 54.8 mtt -72.28 -30.86 65.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.15 -0.969 . . . . 0.0 109.665 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 20.8 ttt -52.35 -36.03 52.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.159 -0.963 . . . . 0.0 109.443 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -120.92 53.96 1.11 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.64 104.2 3.83 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.305 -0.872 . . . . 0.0 109.919 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.61 -17.45 1.27 Allowed Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.06 159.98 59.72 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.578 -0.954 . . . . 0.0 108.85 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.12 119.97 6.9 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.121 1.88 . . . . 0.0 111.74 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.4 132.63 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.331 -0.856 . . . . 0.0 109.569 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -58.45 147.56 31.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.978 -1.076 . . . . 0.0 108.986 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.0 mtm180 -79.72 -20.94 45.25 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.144 -0.973 . . . . 0.0 110.13 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -72.24 -33.93 67.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.118 -0.989 . . . . 0.0 109.89 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.2 mt -67.16 -33.48 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.029 -1.044 . . . . 0.0 109.548 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.6 mt -64.63 -50.66 66.24 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -58.19 -34.34 70.25 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -70.66 -22.03 62.54 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.528 -0.732 . . . . 0.0 109.958 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.409 ' OD2' ' O ' ' A' ' 36' ' ' ALA . 12.3 t0 . . . . . 0 N--CA 1.487 1.383 0 O-C-N 120.982 -1.074 . . . . 0.0 109.679 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.404 0.621 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.579 ' N ' HD12 ' A' ' 70' ' ' LEU . 8.8 mp -62.68 -47.79 82.1 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.43 -0.794 . . . . 0.0 108.938 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -70.99 -31.42 67.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 109.293 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.1 t -73.12 -37.48 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.279 -0.888 . . . . 0.0 109.256 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -56.34 -41.09 75.51 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.49 -36.53 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -64.27 -37.17 86.52 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -68.22 -43.9 76.95 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.0 mt -71.95 -30.0 64.85 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -50.97 -49.25 60.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.665 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -63.87 -26.99 68.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.243 -0.911 . . . . 0.0 110.439 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -71.99 -44.15 63.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.959 -1.088 . . . . 0.0 110.309 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.413 ' H ' HG12 ' A' ' 81' ' ' ILE . 16.0 pt -72.51 -15.37 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.177 -0.952 . . . . 0.0 109.655 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 75.57 82.88 0.45 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -46.96 -17.74 0.06 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.476 -1.014 . . . . 0.0 109.902 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' GLY . 22.7 t -56.91 -51.89 67.33 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.446 -0.784 . . . . 0.0 110.23 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -86.56 9.17 19.26 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.0 -1.062 . . . . 0.0 110.603 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.1 mm -121.6 165.92 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -140.98 114.02 8.48 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.436 -0.79 . . . . 0.0 108.947 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.419 HG22 ' CE2' ' A' ' 94' ' ' TYR . 4.7 p -86.63 138.26 31.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.208 -0.932 . . . . 0.0 109.591 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.9 t . . . . . 0 N--CA 1.499 2.012 0 O-C-N 121.537 -0.727 . . . . 0.0 109.2 179.687 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.419 ' CE2' HG22 ' A' ' 88' ' ' THR . 14.2 m-85 -129.54 157.12 42.93 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 38.6 ttp -153.05 133.15 13.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.291 -0.881 . . . . 0.0 109.736 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.5 mp -91.0 145.49 24.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.567 -0.708 . . . . 0.0 109.092 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.75 105.78 0.87 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -0.878 . . . . 0.0 109.361 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.905 . . . . 0.0 109.433 -179.982 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.9 p30 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.541 ' N ' ' ND2' ' A' ' 5' ' ' ASN . 0.1 OUTLIER -164.53 125.86 2.17 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.261 -0.899 . . . . 0.0 108.962 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -163.5 158.31 20.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.458 -0.776 . . . . 0.0 109.75 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.9 pt -149.32 163.7 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 80.9 p -128.46 132.24 48.39 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.498 -0.751 . . . . 0.0 109.755 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.26 91.49 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.04 -120.3 8.52 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.746 -1.741 . . . . 0.0 108.746 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -95.46 11.84 31.48 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.311 -1.111 . . . . 0.0 109.26 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.541 ' N ' HD12 ' A' ' 12' ' ' LEU . 8.0 mp -104.43 125.77 50.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.492 -0.755 . . . . 0.0 108.988 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -108.7 118.91 38.02 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.476 HD23 ' N ' ' A' ' 15' ' ' ASN . 0.9 OUTLIER -102.3 133.87 46.51 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.486 -0.759 . . . . 0.0 109.366 -179.139 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.476 ' N ' HD23 ' A' ' 14' ' ' LEU . 4.7 m-20 -135.53 98.19 3.87 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.43 -0.794 . . . . 0.0 109.467 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.5 t -73.91 -26.32 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.435 -0.791 . . . . 0.0 109.482 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.433 ' N ' HD21 ' A' ' 5' ' ' ASN . 0.1 OUTLIER -58.37 -50.39 73.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.429 -0.795 . . . . 0.0 109.679 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -98.86 -3.72 34.72 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.42 ' NH1' ' O ' ' A' ' 17' ' ' THR . 6.9 mpt_? 56.44 75.33 0.35 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.423 0.63 . . . . 0.0 109.419 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.409 HD23 ' CZ2' ' A' ' 22' ' ' TRP . 61.8 tp -163.99 149.58 10.84 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.8 t -134.25 146.52 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.381 -0.824 . . . . 0.0 109.807 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.409 ' CZ2' HD23 ' A' ' 20' ' ' LEU . 28.5 m-90 -113.23 142.54 45.69 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.0 tp -121.86 105.47 10.39 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 71.3 40.55 60.63 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.132 -1.987 . . . . 0.0 108.132 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 70.91 -10.79 0.71 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.996 -0.708 . . . . 0.0 109.645 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.426 ' H ' ' C ' ' A' ' 24' ' ' GLY . 32.2 p -91.66 142.14 27.94 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.041 -1.037 . . . . 0.0 109.631 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.42 112.99 2.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 110.245 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.8 tp -74.66 128.38 35.42 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 3.1 m-20 -96.02 100.64 12.29 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.171 -0.956 . . . . 0.0 110.327 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.9 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.3 pt? -121.4 134.13 55.1 Favored 'General case' 0 N--CA 1.504 2.229 0 CA-C-O 121.588 0.709 . . . . 0.0 109.35 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.4 p -52.11 152.48 5.7 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.184 -0.948 . . . . 0.0 109.218 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.34 -45.22 27.98 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.622 1.548 . . . . 0.0 110.804 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -56.19 -47.29 78.64 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.189 -0.944 . . . . 0.0 108.487 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -55.16 -36.36 65.75 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.341 -0.849 . . . . 0.0 109.033 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -57.6 -32.28 67.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.268 -0.895 . . . . 0.0 108.982 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.9 -49.97 63.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 108.983 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.64 ' N ' HD12 ' A' ' 37' ' ' LEU . 7.4 mp -58.8 -39.05 79.98 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 12.8 tp -57.14 -42.6 81.26 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.1 t -54.11 -39.2 66.19 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.347 -0.845 . . . . 0.0 109.549 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.2 mmt-85 -76.37 -45.19 33.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.176 -0.953 . . . . 0.0 109.425 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.8 mt -59.46 -52.33 66.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 110.311 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.51 ' SD ' ' N ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -63.93 -38.07 89.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.089 -1.007 . . . . 0.0 110.429 -178.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.51 ' N ' ' SD ' ' A' ' 42' ' ' MET . 46.3 tpp -55.57 -29.6 59.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.062 -1.024 . . . . 0.0 108.762 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -119.36 42.15 2.93 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.89 132.68 51.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.221 -0.925 . . . . 0.0 109.956 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.4 ' C ' ' SD ' ' A' ' 95' ' ' MET . . . 90.35 -6.22 82.46 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.6 t -121.85 116.17 30.36 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.644 -0.915 . . . . 0.0 108.717 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -47.62 119.89 4.11 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.017 1.145 . . . . 0.0 111.676 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.5 t -97.59 137.23 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.46 -0.775 . . . . 0.0 110.376 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.47 ' CD2' ' H ' ' A' ' 52' ' ' GLU . 17.6 t-160 -63.89 121.07 13.17 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.363 -0.836 . . . . 0.0 108.792 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.487 ' NH1' ' OE1' ' A' ' 71' ' ' GLU . 11.3 ttm180 -52.89 -18.42 1.92 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.389 -0.819 . . . . 0.0 108.937 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.518 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 34.2 tt0 -65.48 -48.87 71.13 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.567 -0.708 . . . . 0.0 109.563 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.1 mt -58.0 -31.75 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.08 -1.012 . . . . 0.0 110.177 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.06 -33.06 74.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.042 -1.036 . . . . 0.0 108.991 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -74.06 -33.23 63.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.999 -1.063 . . . . 0.0 108.43 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 44.0 m-80 -64.82 -22.54 67.01 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.543 -0.723 . . . . 0.0 109.764 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.488 1.428 0 O-C-N 121.1 -1.0 . . . . 0.0 109.253 -179.777 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 120.887 0.375 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 71' ' ' GLU . 2.4 pp -70.47 -43.7 69.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.007 -1.058 . . . . 0.0 109.264 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.487 ' OE1' ' NH1' ' A' ' 51' ' ' ARG . 33.6 tt0 -71.75 -33.01 68.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 109.453 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.0 t -70.77 -38.71 73.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.255 -0.903 . . . . 0.0 108.977 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -56.32 -39.6 73.03 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.99 -37.03 79.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -62.49 -36.5 82.69 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -71.57 -41.88 68.49 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.67 -38.11 73.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 0.0 109.412 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -50.57 -47.84 57.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.927 . . . . 0.0 109.669 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -62.47 -24.93 67.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 110.496 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -75.68 -43.6 46.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.936 -1.102 . . . . 0.0 110.466 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.9 pt -76.61 -22.43 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.142 -0.974 . . . . 0.0 109.945 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 82.67 87.76 0.73 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -44.79 -17.17 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.722 -0.87 . . . . 0.0 110.422 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.533 ' C ' ' HE ' ' A' ' 85' ' ' ARG . 12.9 t -51.72 -47.59 63.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.219 -0.925 . . . . 0.0 109.701 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.563 ' HE ' ' N ' ' A' ' 85' ' ' ARG . 4.4 mmp_? -83.41 9.66 10.56 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.241 -0.912 . . . . 0.0 110.596 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 87' ' ' ARG . 5.1 mp -135.67 159.2 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.197 -0.939 . . . . 0.0 109.754 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.49 ' N ' HG22 ' A' ' 86' ' ' ILE . 39.4 ttm180 -123.09 128.01 49.53 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.4 p -94.09 141.03 29.0 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.082 -1.011 . . . . 0.0 109.778 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.423 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.468 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.496 2.667 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 40.7 m-85 -150.99 170.69 18.74 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.363 -1.08 . . . . 0.0 108.579 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.4 ' SD ' ' C ' ' A' ' 46' ' ' GLY . 50.4 ttp -162.5 136.66 6.45 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.142 -0.974 . . . . 0.0 110.469 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 96' ' ' LEU . 10.2 mp -88.69 139.04 30.87 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.07 133.48 44.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 109.473 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.7 m120 . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.571 -179.966 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.4 t70 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.187 0.517 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -158.72 122.05 3.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.336 -0.852 . . . . 0.0 108.877 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -161.36 155.59 22.65 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.348 -0.845 . . . . 0.0 109.746 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.8 pt -148.03 163.33 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.378 -0.826 . . . . 0.0 109.07 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -142.24 152.55 43.17 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.223 -0.923 . . . . 0.0 109.777 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.6 t -147.98 95.97 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.27 -116.38 4.3 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.061 -1.615 . . . . 0.0 109.061 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -103.5 7.63 37.83 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.49 -1.006 . . . . 0.0 109.697 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 12' ' ' LEU . 9.3 mp -102.35 125.4 49.04 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.346 -0.846 . . . . 0.0 109.224 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -118.07 124.31 47.76 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.537 ' C ' HD22 ' A' ' 15' ' ' ASN . 8.1 mp -107.37 140.24 40.61 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.531 -0.731 . . . . 0.0 109.153 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.537 HD22 ' C ' ' A' ' 14' ' ' LEU . 2.1 m-80 -135.6 97.37 3.65 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.554 -0.716 . . . . 0.0 109.184 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.1 t -69.87 -29.62 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.375 -0.828 . . . . 0.0 109.306 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.425 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -63.94 -55.17 24.56 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.44 -0.787 . . . . 0.0 109.266 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.7 mmt85 -82.68 -16.04 49.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.96 . . . . 0.0 108.481 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 63.36 70.69 0.53 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.609 0.718 . . . . 0.0 109.152 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.7 tp -163.78 154.15 15.42 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.7 t -136.21 143.08 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.297 -0.877 . . . . 0.0 109.853 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -107.93 145.18 34.16 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 67.1 tp -128.75 104.03 7.4 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.7 44.68 38.33 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 64.36 -3.17 0.53 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 122.175 -0.603 . . . . 0.0 110.282 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.4 p -99.31 139.92 34.26 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 120.995 -1.066 . . . . 0.0 109.612 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.3 116.79 5.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.227 -0.921 . . . . 0.0 110.58 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.9 tp -85.0 128.95 34.85 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -103.93 120.84 41.87 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.347 -0.846 . . . . 0.0 109.825 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.834 HD23 ' H ' ' A' ' 30' ' ' LEU . 1.1 pt? -140.51 148.66 41.41 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.398 0.618 . . . . 0.0 109.453 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.3 p -67.32 151.22 97.37 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.057 -1.027 . . . . 0.0 109.83 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -45.19 -41.01 16.65 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 121.928 1.752 . . . . 0.0 112.366 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -53.25 -50.65 64.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.763 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -60.13 -27.62 67.2 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.293 -0.879 . . . . 0.0 109.273 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -71.21 -31.05 67.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.114 -0.991 . . . . 0.0 109.145 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.99 -52.56 10.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.179 -0.95 . . . . 0.0 109.259 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 mt -59.27 -37.08 76.75 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 23.2 tp -63.19 -43.96 96.72 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.712 -0.618 . . . . 0.0 109.706 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.8 m -53.25 -37.75 62.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.225 -0.922 . . . . 0.0 110.158 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -80.35 -43.4 21.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 0.0 109.373 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 27.7 tp -63.73 -40.03 95.75 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.285 -0.885 . . . . 0.0 110.212 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -72.47 -38.95 68.08 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.77 -1.206 . . . . 0.0 109.544 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.468 ' SD ' ' O ' ' A' ' 43' ' ' MET . 1.3 tmt? -53.91 -28.78 38.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.304 -0.872 . . . . 0.0 108.71 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -115.7 43.67 2.04 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.06 140.22 48.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.253 -0.904 . . . . 0.0 110.347 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.09 -17.57 59.0 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.4 m -119.63 151.87 52.49 Favored Pre-proline 0 N--CA 1.501 2.113 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -71.88 119.46 6.21 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.56 1.507 . . . . 0.0 111.519 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.1 t -98.9 136.09 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.399 -0.813 . . . . 0.0 110.209 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -73.7 125.66 28.56 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.276 -0.89 . . . . 0.0 108.619 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.417 ' NH1' ' OE2' ' A' ' 71' ' ' GLU . 13.1 ptp180 -55.24 -15.86 2.77 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.223 -0.923 . . . . 0.0 108.779 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.571 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 41.2 tt0 -61.82 -56.82 15.43 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.623 -0.673 . . . . 0.0 109.481 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.6 mt -54.64 -29.28 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.254 -0.904 . . . . 0.0 110.33 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.8 mt -71.24 -46.72 60.41 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 108.609 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -51.96 -36.05 48.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.957 -1.089 . . . . 0.0 108.957 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.571 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 31.6 m-80 -65.18 -20.86 66.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.663 -0.648 . . . . 0.0 110.476 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.488 1.456 0 O-C-N 120.694 -1.254 . . . . 0.0 109.895 -179.282 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.1 m . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 pp -56.08 -37.79 69.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.353 -0.842 . . . . 0.0 109.644 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.417 ' OE2' ' NH1' ' A' ' 51' ' ' ARG . 7.2 tp10 -67.03 -31.19 71.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.169 -0.957 . . . . 0.0 109.456 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.3 t -73.33 -41.31 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.139 -0.976 . . . . 0.0 109.115 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -56.99 -38.22 72.74 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.0 mm -64.14 -36.91 78.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -67.65 -33.45 74.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.23 -0.919 . . . . 0.0 109.4 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -71.05 -41.9 70.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.34 -0.85 . . . . 0.0 109.802 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.0 mt -71.44 -42.23 68.48 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.291 -0.881 . . . . 0.0 109.892 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -49.7 -44.4 48.14 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.084 -1.01 . . . . 0.0 109.247 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -62.83 -26.8 68.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 110.045 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -75.78 -43.22 47.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.987 -1.071 . . . . 0.0 110.508 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 pt -82.21 -30.26 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.023 -1.048 . . . . 0.0 109.575 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 97.39 85.02 1.77 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -44.48 -16.68 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.545 -0.974 . . . . 0.0 110.396 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 82' ' ' GLY . 56.2 m -51.82 -44.8 63.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.083 -1.011 . . . . 0.0 109.381 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -73.71 8.75 1.74 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.296 -0.878 . . . . 0.0 109.481 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 87' ' ' ARG . 96.6 mt -136.37 159.76 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.288 -0.882 . . . . 0.0 109.159 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.49 HH21 ' CE ' ' A' ' 95' ' ' MET . 39.1 ttp180 -137.28 124.2 21.38 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.555 -0.716 . . . . 0.0 109.271 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.3 p -88.87 141.66 28.31 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.142 -0.974 . . . . 0.0 109.386 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.4 t . . . . . 0 N--CA 1.501 2.08 0 O-C-N 121.479 -0.763 . . . . 0.0 110.377 -178.785 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.644 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -150.98 162.34 41.02 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.357 -1.084 . . . . 0.0 108.407 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.49 ' CE ' HH21 ' A' ' 87' ' ' ARG . 43.9 ttp -163.55 136.16 5.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.179 -0.951 . . . . 0.0 110.548 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.3 mp -91.48 127.32 36.87 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.77 99.69 2.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.318 -0.863 . . . . 0.0 109.42 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.329 -0.857 . . . . 0.0 109.539 179.994 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.266 0.555 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -155.87 119.86 4.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.15 -0.969 . . . . 0.0 108.947 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -162.09 157.42 23.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.326 -0.859 . . . . 0.0 109.713 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.4 pt -147.27 162.54 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.297 -0.877 . . . . 0.0 109.163 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.8 t -145.25 156.11 43.64 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.19 -0.944 . . . . 0.0 109.741 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 9' ' ' VAL . 5.1 p -152.72 101.85 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.15 -109.64 2.84 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.666 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -112.07 4.88 18.31 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.506 -0.996 . . . . 0.0 110.093 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 12' ' ' LEU . 10.4 mp -99.07 124.9 44.41 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.151 -0.968 . . . . 0.0 109.083 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -118.53 126.13 51.35 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.528 ' C ' HD22 ' A' ' 15' ' ' ASN . 5.7 tt -114.15 115.19 27.12 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.528 HD22 ' C ' ' A' ' 14' ' ' LEU . 1.7 m120 -113.2 102.21 10.15 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.573 -0.705 . . . . 0.0 109.313 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.3 t -74.9 -27.44 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.439 -0.788 . . . . 0.0 109.454 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.44 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -60.42 -54.1 49.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.536 -0.728 . . . . 0.0 109.507 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.499 ' NH2' ' OD1' ' A' ' 15' ' ' ASN . 89.2 mtm-85 -92.21 -13.43 30.54 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.12 -0.987 . . . . 0.0 108.714 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.5 tpp85 66.31 67.14 0.46 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.419 0.628 . . . . 0.0 109.393 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.5 mt -143.47 158.47 43.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.228 -0.92 . . . . 0.0 108.812 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 t -142.38 120.75 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.283 -0.885 . . . . 0.0 109.757 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 17.8 m-90 -98.93 150.87 21.49 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.175 -0.953 . . . . 0.0 108.812 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.9 tp -136.94 107.05 6.33 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.84 43.59 73.58 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 64.24 -1.65 0.69 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 122.169 -0.606 . . . . 0.0 110.346 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.4 p -100.58 139.9 35.6 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 120.973 -1.079 . . . . 0.0 109.383 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.04 115.54 6.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 0.0 110.161 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.9 tp -78.82 132.31 36.81 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -102.86 112.59 25.46 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.312 -0.868 . . . . 0.0 109.972 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.837 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.2 pt? -139.63 148.9 43.1 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.364 -0.835 . . . . 0.0 109.28 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.407 ' OG1' ' OE2' ' A' ' 34' ' ' GLU . 4.1 p -60.52 152.98 63.47 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.056 -1.027 . . . . 0.0 108.881 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -58.95 -41.67 59.65 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.0 1.8 . . . . 0.0 111.735 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -53.97 -45.66 71.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.027 -1.046 . . . . 0.0 109.252 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.407 ' OE2' ' OG1' ' A' ' 31' ' ' THR . 69.8 mt-10 -60.71 -34.61 74.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.322 -0.861 . . . . 0.0 109.223 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.4 ' OH ' ' O ' ' A' ' 15' ' ' ASN . 15.9 t80 -55.62 -34.1 64.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 108.706 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.05 -53.12 28.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 109.303 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 37' ' ' LEU . 8.3 mp -60.3 -39.42 86.88 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.9 tp -59.57 -43.74 93.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.606 -0.684 . . . . 0.0 109.546 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.502 ' C ' ' HE ' ' A' ' 40' ' ' ARG . 33.8 t -52.91 -34.28 54.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.153 -0.967 . . . . 0.0 109.458 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.502 ' HE ' ' C ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -79.44 -45.29 19.72 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 0.0 109.181 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.3 mt -56.72 -40.66 76.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.045 -1.034 . . . . 0.0 109.285 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.7 tpp -75.44 -35.0 61.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 109.56 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.46 ' SD ' ' NH2' ' A' ' 40' ' ' ARG . 24.7 ttt -53.92 -25.93 22.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.327 -0.858 . . . . 0.0 109.229 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -129.08 43.17 3.19 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.74 -0.6 . . . . 0.0 109.678 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.81 143.8 55.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.025 -1.047 . . . . 0.0 109.958 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.462 ' O ' ' SD ' ' A' ' 95' ' ' MET . . . 101.02 -22.75 38.18 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.08 154.55 64.82 Favored Pre-proline 0 N--CA 1.503 2.206 0 O-C-N 121.599 -0.942 . . . . 0.0 108.676 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.42 120.91 7.83 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.826 1.684 . . . . 0.0 111.083 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 80.5 t -92.77 137.04 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 0.0 110.326 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.437 ' CE1' ' CD ' ' A' ' 52' ' ' GLU . 9.0 t-160 -68.83 121.03 15.71 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -51.21 -16.82 0.56 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 0.0 109.792 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.522 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 80.8 mt-10 -65.97 -48.39 71.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.342 -0.849 . . . . 0.0 109.801 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.2 mt -54.65 -30.87 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.19 -0.944 . . . . 0.0 109.949 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.0 mt -70.58 -34.13 71.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.932 . . . . 0.0 109.199 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -70.93 -35.44 72.24 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 41.3 m-80 -59.39 -20.8 57.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.545 -0.722 . . . . 0.0 110.051 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--N 1.306 -1.312 0 O-C-N 121.074 -1.016 . . . . 0.0 109.89 -179.353 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.0 m . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.465 0.65 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.7 mt -70.12 -37.46 75.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.298 -0.876 . . . . 0.0 109.658 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -60.3 -32.43 71.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.081 -1.012 . . . . 0.0 109.504 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.85 -38.92 74.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.214 -0.929 . . . . 0.0 109.096 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -57.22 -38.01 73.1 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.2 mt -63.81 -38.93 83.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.418 ' CE1' HH21 ' A' ' 78' ' ' ARG . 1.2 t60 -60.17 -36.55 77.84 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.511 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.576 ' ND2' ' NZ ' ' A' ' 80' ' ' LYS . 3.2 t-20 -73.34 -41.61 63.26 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.689 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -66.41 -42.93 87.06 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.418 HH21 ' CE1' ' A' ' 75' ' ' HIS . 52.6 ttp180 -50.15 -50.99 47.07 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.513 -0.742 . . . . 0.0 110.936 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -65.24 -29.27 70.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.963 -1.086 . . . . 0.0 110.613 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.576 ' NZ ' ' ND2' ' A' ' 76' ' ' ASN . 61.7 mttp -66.44 -47.94 71.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.9 -1.125 . . . . 0.0 110.2 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 21.6 pt -74.83 -24.6 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.979 -1.075 . . . . 0.0 110.17 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 84.3 84.37 0.95 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -45.05 -17.01 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.689 -0.889 . . . . 0.0 110.484 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 82' ' ' GLY . 59.5 m -55.12 -48.9 73.0 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.243 -0.911 . . . . 0.0 110.069 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.702 ' C ' HD12 ' A' ' 86' ' ' ILE . 8.5 mpt_? -81.48 9.78 6.86 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.972 -1.08 . . . . 0.0 110.473 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.702 HD12 ' C ' ' A' ' 85' ' ' ARG . 3.6 mp -130.67 162.63 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.5 ' N ' HG22 ' A' ' 86' ' ' ILE . 40.3 ttm180 -118.75 93.61 4.16 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.443 -0.786 . . . . 0.0 109.478 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.0 p -66.1 134.77 53.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.315 -0.866 . . . . 0.0 109.511 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 N--CA 1.497 1.904 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.759 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.442 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -146.04 170.06 17.42 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.462 ' SD ' ' O ' ' A' ' 46' ' ' GLY . 6.1 ttt -161.1 127.81 4.02 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.932 -1.105 . . . . 0.0 110.133 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 96' ' ' LEU . 9.4 mp -81.27 139.98 35.12 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.13 106.19 5.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 109.455 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.2 p30 . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.451 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 29.4 p-10 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -172.37 107.97 0.2 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.024 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -161.55 154.29 20.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.114 -0.991 . . . . 0.0 109.911 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.7 pt -145.86 163.29 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.476 -0.765 . . . . 0.0 108.983 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.8 p -139.88 151.99 46.08 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.304 -0.873 . . . . 0.0 109.623 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.1 t -146.79 97.6 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.61 -113.68 4.0 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -105.52 5.92 31.86 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.457 -1.025 . . . . 0.0 110.079 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.5 mt -100.69 126.46 47.21 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.129 -0.982 . . . . 0.0 109.186 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -118.05 124.84 49.08 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.475 HD12 HG22 ' A' ' 21' ' ' VAL . 5.6 tp -106.87 141.4 38.15 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.737 -0.602 . . . . 0.0 109.579 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.59 ' ND2' ' NH2' ' A' ' 18' ' ' ARG . 14.8 m120 -135.57 97.69 3.74 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.325 -0.859 . . . . 0.0 109.143 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.1 t -76.63 -28.93 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.297 -0.877 . . . . 0.0 109.97 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.406 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -57.65 -53.44 58.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 0.0 109.405 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.59 ' NH2' ' ND2' ' A' ' 15' ' ' ASN . 12.7 ptt-85 -96.5 -10.32 27.66 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.277 -0.889 . . . . 0.0 108.807 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 64.81 73.66 0.41 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.456 0.646 . . . . 0.0 109.3 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.0 tp -156.98 154.42 29.62 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.475 HG22 HD12 ' A' ' 14' ' ' LEU . 12.3 t -140.1 133.54 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.273 -0.892 . . . . 0.0 109.773 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.488 ' CZ3' ' OD1' ' A' ' 15' ' ' ASN . 8.5 m-90 -100.34 144.26 29.56 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.345 -0.847 . . . . 0.0 109.238 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 25' ' ' GLU . 10.7 tp -117.96 100.24 7.43 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.67 -73.2 0.25 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 23' ' ' LEU . 74.0 mt-10 -154.45 23.13 0.47 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.219 -1.165 . . . . 0.0 109.406 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.3 p -138.83 141.82 38.67 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.455 -0.778 . . . . 0.0 110.07 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.9 121.92 16.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.502 -0.749 . . . . 0.0 109.538 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.5 tp -78.48 128.45 33.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 108.614 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -101.4 110.59 22.61 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.328 -0.858 . . . . 0.0 109.923 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.75 145.75 48.74 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.2 p -58.33 140.26 83.91 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.1 -1.0 . . . . 0.0 109.455 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -44.68 -43.99 14.26 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.526 1.484 . . . . 0.0 112.052 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.446 ' CD ' ' H ' ' A' ' 33' ' ' LYS . 2.4 mptp? -53.54 -46.43 70.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 108.99 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -59.49 -35.07 73.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.348 -0.845 . . . . 0.0 109.213 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.464 ' HH ' ' C ' ' A' ' 15' ' ' ASN . 15.0 t80 -56.66 -33.16 66.09 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.916 . . . . 0.0 109.066 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.422 ' O ' ' OD2' ' A' ' 57' ' ' ASP . . . -68.62 -52.82 27.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.431 -0.793 . . . . 0.0 109.524 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.611 ' N ' HD12 ' A' ' 37' ' ' LEU . 7.7 mp -63.54 -36.59 84.27 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.3 tp -64.46 -46.98 80.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.55 -0.719 . . . . 0.0 109.329 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.8 m -53.28 -29.68 34.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.321 -0.862 . . . . 0.0 109.956 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -75.73 -40.57 55.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.065 -1.022 . . . . 0.0 110.018 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.8 mt -61.04 -44.39 97.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.975 -1.078 . . . . 0.0 110.179 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.7 mmm -65.87 -37.07 85.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.819 -1.176 . . . . 0.0 109.739 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 18.1 ttt -57.41 -32.36 66.77 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 108.994 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -116.05 43.46 2.14 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.06 129.12 39.0 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.245 -0.909 . . . . 0.0 110.165 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.89 -11.93 52.87 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 p -124.71 151.89 68.51 Favored Pre-proline 0 N--CA 1.504 2.242 0 O-C-N 121.529 -0.983 . . . . 0.0 108.652 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.18 120.46 6.59 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.781 1.654 . . . . 0.0 111.634 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.5 t -95.69 132.87 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.263 -0.898 . . . . 0.0 109.95 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.435 ' CE1' ' CD ' ' A' ' 52' ' ' GLU . 15.2 t-160 -73.04 126.19 29.41 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.19 -0.944 . . . . 0.0 108.545 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -50.36 -15.07 0.21 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.223 -0.923 . . . . 0.0 109.836 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.527 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 77.4 mt-10 -66.87 -46.35 75.23 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.319 -0.863 . . . . 0.0 109.881 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.5 mm -57.56 -32.36 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.083 -1.011 . . . . 0.0 109.923 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.42 -45.3 69.5 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.241 -0.912 . . . . 0.0 108.746 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -62.33 -36.86 83.52 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 74.1 m-80 -70.33 -21.77 62.87 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.641 -0.662 . . . . 0.0 109.993 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 36' ' ' ALA . 5.2 t0 . . . . . 0 N--CA 1.485 1.318 0 O-C-N 120.81 -1.181 . . . . 0.0 109.271 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 13.9 mt -70.64 -33.49 71.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 109.403 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -60.36 -35.59 76.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.009 . . . . 0.0 109.385 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.2 t -73.82 -38.95 51.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.166 -0.959 . . . . 0.0 108.827 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -58.71 -40.38 83.53 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 62.7 mt -62.98 -31.48 52.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -72.28 -22.38 61.21 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 118.947 -1.101 . . . . 0.0 108.086 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -77.43 -45.43 25.8 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.6 -0.687 . . . . 0.0 110.337 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 pp -74.58 -43.98 53.0 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.813 -1.179 . . . . 0.0 109.747 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -50.59 -46.12 57.68 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.554 -0.717 . . . . 0.0 110.144 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -65.65 -13.8 59.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.167 -0.958 . . . . 0.0 110.118 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -81.43 -40.23 23.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.084 -1.01 . . . . 0.0 110.02 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 11.0 pt -78.56 -14.94 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 109.777 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 85.68 81.41 1.12 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -44.42 -16.41 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.779 -0.836 . . . . 0.0 110.583 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 82' ' ' GLY . 44.5 t -50.17 -43.95 52.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.144 -0.973 . . . . 0.0 109.612 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -77.52 9.05 3.59 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.234 -0.916 . . . . 0.0 109.937 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 87' ' ' ARG . 82.0 mt -137.97 158.12 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.2 -0.937 . . . . 0.0 109.1 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.422 ' N ' HG22 ' A' ' 86' ' ' ILE . 65.7 ttt-85 -141.04 122.62 15.12 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.598 -0.689 . . . . 0.0 109.212 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.7 p -89.36 142.51 27.6 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.302 -0.874 . . . . 0.0 109.282 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 89' ' ' VAL . 8.1 p . . . . . 0 N--CA 1.5 2.069 0 O-C-N 121.405 -0.809 . . . . 0.0 110.171 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.8 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -150.76 159.24 44.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.452 -1.028 . . . . 0.0 108.257 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 43.1 ttp -163.82 127.61 2.7 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.131 -0.981 . . . . 0.0 110.391 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 96' ' ' LEU . 9.6 mp -90.2 133.22 35.05 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.88 137.2 50.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -0.931 . . . . 0.0 109.498 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.4 m120 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.618 179.997 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.6 t70 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.311 0.577 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -165.71 113.54 0.95 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.266 -0.896 . . . . 0.0 108.975 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -162.36 157.44 22.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.109 -0.994 . . . . 0.0 110.008 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.4 pt -144.78 162.91 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.309 -0.869 . . . . 0.0 109.008 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 m -143.05 152.92 42.41 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.284 -0.885 . . . . 0.0 109.699 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 9' ' ' VAL . 2.9 p -149.41 99.2 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.54 -116.64 4.74 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -104.06 6.95 36.31 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.439 -1.036 . . . . 0.0 109.622 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.7 mt -100.68 122.08 42.73 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.274 -0.891 . . . . 0.0 109.602 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -114.84 134.44 55.13 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.4 tt -126.55 127.9 46.01 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.553 -0.717 . . . . 0.0 109.823 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 19' ' ' ARG . 5.3 m-20 -121.44 104.41 9.66 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.757 -0.59 . . . . 0.0 109.62 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.2 t -68.77 -30.31 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.264 -0.898 . . . . 0.0 109.44 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.74 -53.98 38.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.908 . . . . 0.0 109.16 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.2 mtp-105 -83.72 -16.52 44.56 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 15' ' ' ASN . 15.1 tpp180 58.78 75.73 0.38 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.449 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 23.9 tp -170.33 127.35 0.81 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.359 -0.838 . . . . 0.0 108.964 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.1 t -104.33 138.21 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.509 -0.745 . . . . 0.0 109.682 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.449 ' CZ3' ' O ' ' A' ' 20' ' ' LEU . 28.5 m-90 -105.6 142.26 35.64 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.454 -0.779 . . . . 0.0 109.225 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.7 tp -118.11 102.26 8.88 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.94 44.95 54.3 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 107.946 -2.062 . . . . 0.0 107.946 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 65.65 -1.23 1.07 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 122.132 -0.628 . . . . 0.0 110.218 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.0 p -99.23 140.94 32.65 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.042 -1.036 . . . . 0.0 109.699 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.53 110.47 1.99 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.921 . . . . 0.0 109.862 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.9 tp -71.43 133.37 45.86 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -91.01 94.06 9.47 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.051 -1.031 . . . . 0.0 110.267 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.902 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.4 pt? -127.45 135.54 50.56 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.1 p -63.81 152.98 85.51 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 120.978 -1.076 . . . . 0.0 109.567 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -44.9 -48.13 11.13 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.848 1.698 . . . . 0.0 112.433 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -53.25 -47.99 68.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.446 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -55.24 -45.16 76.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.249 -0.907 . . . . 0.0 109.289 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -50.2 -30.04 10.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.229 -0.919 . . . . 0.0 109.701 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.8 -49.38 47.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.352 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.594 ' N ' HD12 ' A' ' 37' ' ' LEU . 8.1 mp -59.2 -44.5 92.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.093 -1.004 . . . . 0.0 108.785 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.6 mp -58.01 -42.06 84.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.919 . . . . 0.0 108.521 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.1 m -50.73 -37.08 39.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.229 -0.919 . . . . 0.0 109.653 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -80.22 -43.58 21.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.031 -1.043 . . . . 0.0 109.911 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.7 mt -59.34 -49.07 79.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.12 -0.988 . . . . 0.0 109.961 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 42.2 mtt -66.83 -35.46 80.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.991 -1.068 . . . . 0.0 109.645 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 25.7 ttt -56.05 -29.21 60.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.201 -0.937 . . . . 0.0 108.833 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -116.68 40.69 2.87 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.22 103.15 1.5 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.135 -0.978 . . . . 0.0 109.802 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.402 ' CA ' ' OD1' ' A' ' 98' ' ' ASN . . . 137.85 -13.36 3.64 Favored Glycine 0 N--CA 1.502 3.062 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.9 m -132.56 152.54 80.17 Favored Pre-proline 0 N--CA 1.502 2.131 0 O-C-N 121.697 -0.884 . . . . 0.0 108.806 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -71.73 120.19 6.72 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 121.774 1.649 . . . . 0.0 111.544 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.0 t -91.11 133.72 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.883 . . . . 0.0 109.612 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.413 ' C ' ' N ' ' A' ' 52' ' ' GLU . 10.3 t-160 -65.54 122.5 17.35 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -50.65 -15.94 0.33 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.166 -0.959 . . . . 0.0 109.6 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.531 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 17.0 mm-40 -65.78 -50.5 64.48 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.313 -0.867 . . . . 0.0 109.875 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.9 mt -57.07 -31.92 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.131 -0.98 . . . . 0.0 110.044 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.7 mt -66.47 -33.31 75.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.996 -1.065 . . . . 0.0 108.307 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -73.51 -35.69 65.65 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 41.4 m-80 -63.53 -22.07 66.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.848 -0.533 . . . . 0.0 110.039 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.486 1.374 0 O-C-N 121.027 -1.046 . . . . 0.0 109.243 -179.835 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 90.0 m . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.603 HD23 ' H ' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -70.61 -48.93 52.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 108.88 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -70.3 -25.39 63.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 109.44 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.4 t -75.3 -43.55 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.176 -0.952 . . . . 0.0 109.505 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -54.55 -39.05 67.33 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.3 mt -67.38 -39.55 82.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -60.67 -34.67 74.67 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.122 -0.986 . . . . 0.0 109.072 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -76.73 -40.9 47.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.397 -0.814 . . . . 0.0 108.993 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.648 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -67.71 -43.36 80.24 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -51.76 -50.09 61.34 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.464 -0.772 . . . . 0.0 110.243 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -64.98 -27.37 68.79 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.252 -0.905 . . . . 0.0 110.834 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -71.01 -45.35 64.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.985 -1.072 . . . . 0.0 110.439 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.7 pt -75.04 -18.69 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.977 -1.077 . . . . 0.0 110.718 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 81.28 79.53 0.92 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -46.63 -15.9 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.688 -0.89 . . . . 0.0 110.662 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.514 ' CB ' HH11 ' A' ' 85' ' ' ARG . 10.5 t -48.2 -43.39 31.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.16 -0.962 . . . . 0.0 110.443 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.514 HH11 ' CB ' ' A' ' 84' ' ' SER . 12.5 mpt_? -91.48 11.03 25.33 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.164 -0.96 . . . . 0.0 110.163 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 87' ' ' ARG . 30.2 mm -115.75 164.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 O-C-N 121.35 -0.844 . . . . 0.0 108.98 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.435 ' N ' HG22 ' A' ' 86' ' ' ILE . 61.5 ttt-85 -135.69 118.56 16.24 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.399 -0.813 . . . . 0.0 108.898 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.5 p -94.93 137.64 33.73 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.235 -0.916 . . . . 0.0 109.766 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.5 2.052 0 O-C-N 121.569 -0.707 . . . . 0.0 109.756 -179.868 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.486 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.494 2.516 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 27.3 m-85 -151.44 157.44 42.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.385 -1.068 . . . . 0.0 108.87 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.6 ttp -157.7 128.89 6.66 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.36 -0.837 . . . . 0.0 109.675 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.487 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 9.2 mp -85.47 136.54 33.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.357 -0.839 . . . . 0.0 108.891 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.13 112.54 1.56 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 109.681 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.663 ' N ' HD22 ' A' ' 98' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.29 -0.882 . . . . 0.0 109.414 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.437 ' C ' ' ND2' ' A' ' 5' ' ' ASN . 33.2 t0 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.437 ' ND2' ' C ' ' A' ' 4' ' ' ASP . 14.9 m-80 -156.67 119.77 4.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 0.0 109.081 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -164.94 158.5 17.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.377 -0.827 . . . . 0.0 109.737 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.2 pt -149.94 164.0 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.378 -0.826 . . . . 0.0 108.943 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.1 t -136.96 150.36 48.12 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.392 -0.818 . . . . 0.0 109.283 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.2 t -143.13 93.8 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.27 -108.4 2.48 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -104.88 3.51 31.02 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.48 -1.011 . . . . 0.0 109.863 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.1 mt -97.8 115.1 27.37 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.215 -0.928 . . . . 0.0 109.849 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -106.98 115.54 30.36 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.524 ' N ' HD12 ' A' ' 14' ' ' LEU . 8.2 mp -104.94 138.44 41.16 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.502 -0.749 . . . . 0.0 109.873 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -136.24 101.87 4.82 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.723 -0.611 . . . . 0.0 109.355 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.4 t -76.73 -28.88 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.84 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.415 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -55.97 -54.3 46.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.237 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -93.86 -9.57 36.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.131 -0.981 . . . . 0.0 108.665 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 63.35 78.35 0.29 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.341 0.591 . . . . 0.0 110.017 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.41 HD23 ' CZ2' ' A' ' 22' ' ' TRP . 62.1 tp -166.89 153.25 8.38 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.087 -1.008 . . . . 0.0 108.822 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.9 t -137.5 147.7 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.331 -0.856 . . . . 0.0 109.957 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.41 ' CZ2' HD23 ' A' ' 20' ' ' LEU . 31.2 m-90 -115.84 137.1 52.42 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.5 tp -112.4 105.73 14.06 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.47 39.9 68.62 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 107.578 -2.209 . . . . 0.0 107.578 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 69.06 -3.4 1.51 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 122.197 -0.59 . . . . 0.0 109.924 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.7 p -98.22 139.54 33.85 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.078 -1.014 . . . . 0.0 109.893 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.23 115.05 7.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 110.012 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.0 tp -85.94 138.85 31.7 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 27.0 p-10 -93.81 103.8 15.91 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.101 -0.999 . . . . 0.0 110.732 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.91 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.3 pt? -126.22 135.06 51.14 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.1 p -62.84 151.91 83.98 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.856 -1.153 . . . . 0.0 109.379 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -44.8 -44.12 14.54 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.784 1.656 . . . . 0.0 112.142 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -53.75 -50.54 65.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.272 -0.892 . . . . 0.0 109.686 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.65 ' HG3' HD13 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -54.08 -41.43 68.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.389 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -56.75 -30.33 63.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.101 -1.0 . . . . 0.0 109.289 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.19 -52.53 26.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.079 -1.013 . . . . 0.0 109.77 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.616 ' H ' HD12 ' A' ' 37' ' ' LEU . 7.2 mp -55.87 -39.32 71.33 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.4 tp -58.36 -43.21 88.31 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.5 p -50.72 -39.32 51.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.417 -0.802 . . . . 0.0 110.229 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -79.76 -42.58 24.22 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.855 -1.153 . . . . 0.0 109.828 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 26.3 mt -58.88 -47.75 83.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.155 -0.966 . . . . 0.0 109.897 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.1 ptt? -67.91 -36.0 79.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.022 -1.049 . . . . 0.0 109.975 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 21.7 ttt -54.26 -29.05 45.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -0.885 . . . . 0.0 108.763 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -124.04 45.02 2.58 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.6 133.66 51.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.104 -0.998 . . . . 0.0 110.095 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.53 -10.47 59.36 Favored Glycine 0 N--CA 1.501 3.004 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 p -127.11 151.9 75.03 Favored Pre-proline 0 N--CA 1.504 2.25 0 O-C-N 121.537 -0.978 . . . . 0.0 108.696 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.22 120.15 6.4 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 121.749 1.633 . . . . 0.0 111.652 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.9 t -96.2 136.67 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.412 -0.805 . . . . 0.0 109.736 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.444 ' CD2' ' H ' ' A' ' 52' ' ' GLU . 11.3 t-160 -62.09 120.13 10.26 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.211 -0.931 . . . . 0.0 108.725 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -57.24 -18.76 17.63 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.339 -0.851 . . . . 0.0 109.178 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.546 ' CD ' HD21 ' A' ' 56' ' ' ASN . 0.2 OUTLIER -65.39 -48.81 71.59 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.378 -0.826 . . . . 0.0 108.981 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.5 mt -58.76 -30.23 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.25 -0.906 . . . . 0.0 110.324 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.3 mt -69.61 -29.77 67.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.922 -1.111 . . . . 0.0 108.976 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -71.57 -33.09 68.79 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.546 HD21 ' CD ' ' A' ' 52' ' ' GLU . 17.7 m-80 -65.33 -22.21 66.79 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.655 -0.653 . . . . 0.0 109.941 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 O-C-N 120.902 -1.124 . . . . 0.0 109.403 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.741 HD23 ' H ' ' A' ' 70' ' ' LEU . 1.9 pt? -69.09 -38.9 79.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.041 -1.037 . . . . 0.0 109.76 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.481 ' O ' ' CD2' ' A' ' 75' ' ' HIS . 59.1 mt-10 -71.23 -26.55 62.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.988 -1.07 . . . . 0.0 109.563 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 49.1 t -75.43 -47.85 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.19 -0.943 . . . . 0.0 109.303 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -55.85 -37.18 68.4 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.2 mt -67.51 -39.95 83.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 71' ' ' GLU . 43.1 m170 -60.95 -35.96 78.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.082 -1.011 . . . . 0.0 108.861 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -74.44 -41.73 60.34 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.734 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -67.86 -42.46 81.31 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.485 ' NH2' ' OH ' ' A' ' 94' ' ' TYR . 41.0 ttm180 -49.9 -50.7 45.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.216 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -62.31 -27.08 68.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.241 -0.912 . . . . 0.0 110.817 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -73.22 -43.83 60.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.947 -1.096 . . . . 0.0 110.424 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.0 pt -73.76 -18.53 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.073 -1.017 . . . . 0.0 109.884 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.57 82.12 0.6 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -52.56 -18.23 1.63 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.515 -0.991 . . . . 0.0 110.111 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.9 m -52.37 -46.4 66.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.267 -0.896 . . . . 0.0 109.924 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -87.97 10.69 18.05 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.209 -0.932 . . . . 0.0 110.025 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.7 mm -119.58 168.07 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.461 -0.775 . . . . 0.0 108.962 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 61.3 mtp85 -140.19 114.05 8.86 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.0 p -81.82 138.05 35.18 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.267 -0.896 . . . . 0.0 109.768 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 N--CA 1.5 2.05 0 O-C-N 121.518 -0.738 . . . . 0.0 109.29 179.607 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.485 ' OH ' ' NH2' ' A' ' 78' ' ' ARG . 32.5 m-85 -148.57 169.94 19.19 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.6 ttp -164.09 130.28 3.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.166 -0.959 . . . . 0.0 109.969 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.47 ' N ' HD12 ' A' ' 96' ' ' LEU . 9.8 mp -83.38 144.2 29.8 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.58 -0.7 . . . . 0.0 109.155 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.69 119.69 20.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.493 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.182 -0.949 . . . . 0.0 109.453 -179.937 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 . . . . . 0 N--CA 1.501 2.087 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -169.59 101.29 0.33 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.182 -0.949 . . . . 0.0 109.247 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -162.29 155.76 20.68 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.153 -0.967 . . . . 0.0 109.93 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 7' ' ' ILE . 16.5 pt -147.94 163.33 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.373 -0.83 . . . . 0.0 109.017 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.2 m -144.9 158.96 43.62 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.145 -0.972 . . . . 0.0 109.912 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.0 t -148.35 101.04 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.36 -108.4 2.48 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -109.05 4.6 23.29 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.541 -0.976 . . . . 0.0 109.589 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 12' ' ' LEU . 7.0 mp -95.51 123.55 39.11 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.288 -0.882 . . . . 0.0 108.83 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -118.85 128.78 54.77 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.443 -0.786 . . . . 0.0 109.094 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.541 ' C ' HD22 ' A' ' 15' ' ' ASN . 51.5 tp -116.43 128.28 55.35 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.607 -0.683 . . . . 0.0 109.206 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.541 HD22 ' C ' ' A' ' 14' ' ' LEU . 1.3 m-80 -122.91 98.11 5.75 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.516 -0.74 . . . . 0.0 109.366 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.4 t -71.06 -27.0 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.47 -0.769 . . . . 0.0 109.23 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.7 -53.92 39.78 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.593 -0.692 . . . . 0.0 109.657 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -91.01 -12.83 34.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.249 -0.907 . . . . 0.0 108.862 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.479 ' NE ' ' CD1' ' A' ' 35' ' ' TYR . 9.5 tpt180 64.98 61.62 0.76 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -140.09 154.78 47.15 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.424 -0.798 . . . . 0.0 109.045 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.5 t -139.28 126.82 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.375 -0.828 . . . . 0.0 109.371 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 18.4 m-90 -103.44 148.18 26.24 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.223 -0.923 . . . . 0.0 109.128 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.425 ' O ' ' OG1' ' A' ' 26' ' ' THR . 24.4 tp -128.77 102.89 6.76 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 76.71 46.01 12.06 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 -178.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 61.91 -0.67 0.42 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 122.022 -0.693 . . . . 0.0 110.25 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 50.2 p -103.76 140.32 37.78 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.211 -0.931 . . . . 0.0 109.862 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.95 110.83 1.91 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 109.996 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.9 tp -76.9 134.89 38.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 108.622 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -101.77 111.45 23.71 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.315 -0.866 . . . . 0.0 109.615 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.812 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.1 pt? -140.51 150.86 44.26 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.327 -0.858 . . . . 0.0 109.853 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.4 p -58.07 152.85 37.92 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.361 -0.837 . . . . 0.0 109.239 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.21 -36.35 80.69 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.853 1.702 . . . . 0.0 111.188 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -55.84 -47.4 77.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 108.931 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -58.61 -39.62 80.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.319 -0.863 . . . . 0.0 108.893 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.479 ' CD1' ' NE ' ' A' ' 19' ' ' ARG . 16.7 t80 -52.89 -31.85 41.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.168 -0.958 . . . . 0.0 109.087 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.61 -52.76 10.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -0.87 . . . . 0.0 109.389 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 37' ' ' LEU . 8.6 mp -58.59 -40.66 83.82 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.506 ' O ' HD23 ' A' ' 38' ' ' LEU . 2.3 tt -67.37 -43.89 80.29 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.602 0.715 . . . . 0.0 109.306 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.0 t -48.42 -41.64 29.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.127 -0.983 . . . . 0.0 111.134 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.8 ttt-85 -80.73 -35.06 33.97 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.533 -1.354 . . . . 0.0 109.485 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.5 tp -60.3 -36.73 78.56 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.34 -0.85 . . . . 0.0 109.34 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 41.0 tpp -75.22 -38.68 60.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 0.0 109.259 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 42.1 ttm -52.4 -27.05 14.26 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.6 mmtt -118.99 42.76 2.73 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.29 137.06 55.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 110.215 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.85 -14.31 65.56 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.5 p -117.42 151.85 48.63 Favored Pre-proline 0 N--CA 1.501 2.115 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -73.87 119.43 5.87 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.594 1.529 . . . . 0.0 111.999 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -103.99 135.95 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.518 -0.739 . . . . 0.0 109.475 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -72.87 125.77 28.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.059 -1.026 . . . . 0.0 108.647 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -58.4 -16.25 14.01 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.469 -0.77 . . . . 0.0 109.291 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.568 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 34.1 tt0 -67.61 -50.4 58.33 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.499 -0.75 . . . . 0.0 109.363 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.5 mt -58.1 -25.0 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.36 -0.838 . . . . 0.0 110.381 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 38.1 mt -72.11 -48.16 45.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.038 -1.039 . . . . 0.0 108.356 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -52.25 -34.59 46.76 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.568 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 30.4 m-80 -63.84 -21.13 66.3 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.967 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.493 1.707 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.034 -179.492 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.4 m . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.417 0.627 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 70' ' ' LEU . 9.7 mp -56.0 -49.4 73.72 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.391 -0.818 . . . . 0.0 109.598 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -59.86 -30.02 68.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.156 -0.965 . . . . 0.0 109.729 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 t -70.41 -41.43 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.094 -1.004 . . . . 0.0 109.139 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -54.56 -37.64 65.71 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 35.2 mm -65.63 -41.42 90.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -65.73 -41.55 92.09 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.36 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.599 ' N ' HD22 ' A' ' 76' ' ' ASN . 0.9 OUTLIER -67.88 -44.58 76.72 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.195 -0.941 . . . . 0.0 109.091 179.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 74.3 mt -70.34 -38.63 74.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.417 -0.802 . . . . 0.0 109.919 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.6 ttp85 -49.19 -48.6 45.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.13 -0.981 . . . . 0.0 109.786 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -57.24 -27.28 61.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.957 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -78.4 -40.68 35.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.938 -1.101 . . . . 0.0 110.636 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.411 HD12 HD12 ' A' ' 86' ' ' ILE . 5.7 pt -85.11 -39.56 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.885 -1.135 . . . . 0.0 110.313 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 91.18 106.76 1.42 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 107.386 -2.286 . . . . 0.0 107.386 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 86' ' ' ILE . 52.2 pttt -43.61 -18.15 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.678 -0.895 . . . . 0.0 110.467 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 82' ' ' GLY . 47.3 t -62.93 -54.86 31.98 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.825 -1.172 . . . . 0.0 108.708 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.469 ' NH2' HD11 ' A' ' 86' ' ' ILE . 54.8 ttp85 -54.94 -10.97 0.55 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.396 -0.815 . . . . 0.0 110.803 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.469 HD11 ' NH2' ' A' ' 85' ' ' ARG . 9.4 mt -143.4 119.35 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.394 0 O-C-N 120.891 -1.13 . . . . 0.0 110.646 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 63.4 mtp85 -86.95 130.35 34.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.3 -0.875 . . . . 0.0 108.711 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 p -80.94 128.76 34.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.051 -1.031 . . . . 0.0 109.491 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.0 t . . . . . 0 N--CA 1.5 2.061 0 O-C-N 121.539 -0.725 . . . . 0.0 109.181 179.552 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.391 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -146.16 171.09 15.44 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.467 ' SD ' ' O ' ' A' ' 96' ' ' LEU . 11.6 tmm? -163.57 142.86 8.23 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.85 -1.156 . . . . 0.0 110.704 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.467 ' O ' ' SD ' ' A' ' 95' ' ' MET . 11.1 mp -89.43 132.79 34.83 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.18 121.02 8.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.213 -0.929 . . . . 0.0 109.082 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 0.0 109.712 -179.684 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 5.7 p-10 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -160.43 121.02 2.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.135 -0.978 . . . . 0.0 109.38 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -158.91 156.24 29.17 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.479 -0.763 . . . . 0.0 109.364 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.4 pt -148.83 163.67 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.298 -0.876 . . . . 0.0 109.393 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.6 m -136.2 146.53 46.92 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.472 -0.768 . . . . 0.0 109.542 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -146.46 93.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.67 -114.09 3.91 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -106.06 6.27 30.97 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.492 -1.005 . . . . 0.0 109.66 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.4 mt -100.89 122.04 42.77 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.258 -0.901 . . . . 0.0 109.946 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -115.19 129.46 56.66 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.541 ' C ' HD22 ' A' ' 15' ' ' ASN . 46.9 tp -114.65 138.67 50.4 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.535 -0.728 . . . . 0.0 109.415 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.541 HD22 ' C ' ' A' ' 14' ' ' LEU . 2.1 m-80 -135.02 97.63 3.79 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.576 -0.702 . . . . 0.0 109.236 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.2 t -73.34 -28.51 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.376 -0.827 . . . . 0.0 109.282 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -63.13 -55.47 25.02 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.444 -0.785 . . . . 0.0 109.454 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -88.62 -16.02 33.54 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.307 -0.871 . . . . 0.0 108.847 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? 68.83 65.19 0.3 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.2 mt -143.93 142.32 30.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.303 -0.873 . . . . 0.0 108.724 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -129.61 127.57 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.5 -0.75 . . . . 0.0 108.977 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -103.72 142.21 34.73 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.269 -0.894 . . . . 0.0 109.173 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.422 ' O ' ' OG1' ' A' ' 26' ' ' THR . 28.0 tp -127.2 102.9 7.14 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.93 47.3 11.76 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.131 -1.988 . . . . 0.0 108.131 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 60.68 2.58 0.52 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.979 -0.718 . . . . 0.0 110.33 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 50.4 p -108.81 141.72 40.42 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.15 -0.969 . . . . 0.0 109.846 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.03 115.29 4.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.247 -0.908 . . . . 0.0 110.075 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.3 tp -81.73 132.99 35.3 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -101.34 111.81 24.15 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.305 -0.872 . . . . 0.0 109.483 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.46 147.51 47.23 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.453 -0.779 . . . . 0.0 109.274 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.1 p -57.9 152.15 39.92 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.89 -33.73 92.15 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.84 1.693 . . . . 0.0 111.359 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -57.52 -50.88 71.64 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.206 -0.934 . . . . 0.0 109.045 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -56.89 -35.58 69.14 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.151 -0.968 . . . . 0.0 109.032 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.438 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 7.3 t80 -55.47 -33.9 64.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -0.888 . . . . 0.0 108.962 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.422 ' O ' ' OD2' ' A' ' 57' ' ' ASP . . . -67.89 -52.96 30.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 109.518 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 37' ' ' LEU . 7.2 mp -60.75 -32.61 71.9 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 12.5 tp -63.31 -45.63 90.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.535 -0.728 . . . . 0.0 109.28 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.3 p -53.79 -32.66 53.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.902 . . . . 0.0 109.327 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -79.8 -45.42 18.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 109.549 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.0 mt -58.21 -46.65 85.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.925 . . . . 0.0 109.937 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.545 ' SD ' ' N ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -70.83 -36.15 72.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 110.047 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.545 ' N ' ' SD ' ' A' ' 42' ' ' MET . 22.3 ttt -52.9 -29.2 27.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.099 -1.001 . . . . 0.0 108.873 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -122.39 46.72 2.06 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.37 134.51 52.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.886 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.99 -8.86 78.85 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.3 t -118.46 115.1 35.93 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.61 119.95 4.16 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.038 1.159 . . . . 0.0 112.001 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -98.7 136.67 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.41 -0.806 . . . . 0.0 110.116 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 -71.18 124.25 24.05 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.241 -0.912 . . . . 0.0 108.931 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.469 ' NH1' ' OE1' ' A' ' 71' ' ' GLU . 53.3 ttp180 -51.35 -17.53 0.77 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.402 -0.811 . . . . 0.0 109.31 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.517 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 18.9 tt0 -68.01 -47.8 67.48 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.383 -0.823 . . . . 0.0 109.974 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.0 mt -57.45 -29.55 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.161 -0.962 . . . . 0.0 110.194 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.9 mt -68.58 -46.79 68.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.159 -0.963 . . . . 0.0 108.835 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -60.84 -34.47 74.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 70.3 m-80 -70.08 -21.67 63.12 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.443 -0.785 . . . . 0.0 110.145 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 36' ' ' ALA . 11.3 t0 . . . . . 0 N--CA 1.485 1.304 0 O-C-N 121.0 -1.063 . . . . 0.0 109.414 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.528 ' CD2' ' N ' ' A' ' 70' ' ' LEU . 1.6 mm? -66.1 -49.28 68.09 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.469 ' OE1' ' NH1' ' A' ' 51' ' ' ARG . 64.2 mm-40 -64.07 -24.99 67.91 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.34 -0.85 . . . . 0.0 108.793 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.0 t -74.83 -41.02 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.411 -0.806 . . . . 0.0 109.425 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -54.29 -39.33 66.85 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 35.6 mm -65.08 -40.21 88.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -67.18 -40.69 86.62 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.153 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -64.75 -44.49 89.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.26 -0.9 . . . . 0.0 109.311 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.7 mt -70.19 -34.19 72.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -0.876 . . . . 0.0 109.478 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -49.35 -49.35 44.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.252 -0.905 . . . . 0.0 109.765 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -58.01 -28.9 64.86 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.352 -0.842 . . . . 0.0 109.804 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -74.24 -43.19 58.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.138 -0.976 . . . . 0.0 110.445 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.5 pt -82.6 -36.95 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.935 -1.103 . . . . 0.0 110.171 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 93.12 103.45 1.6 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 107.161 -2.376 . . . . 0.0 107.161 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 86' ' ' ILE . 9.8 ptpp? -42.95 -19.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.791 -0.829 . . . . 0.0 110.724 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 82' ' ' GLY . 36.4 p -64.21 -55.35 22.26 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.966 -1.083 . . . . 0.0 108.905 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -47.9 -14.07 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.307 -0.871 . . . . 0.0 110.793 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 84' ' ' SER . 12.8 pt -135.56 168.5 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.095 -1.003 . . . . 0.0 110.759 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -137.5 122.15 18.58 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 p -90.27 135.54 33.61 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.128 -0.982 . . . . 0.0 109.628 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.501 2.086 0 O-C-N 121.532 -0.73 . . . . 0.0 110.189 -179.343 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.466 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.496 2.662 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.466 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 31.0 m-85 -151.06 162.16 41.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.475 -1.015 . . . . 0.0 108.445 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 55.8 ttp -163.02 127.55 3.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.061 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.444 ' N ' HD12 ' A' ' 96' ' ' LEU . 9.4 mp -82.29 135.11 35.27 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.62 118.43 15.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.931 . . . . 0.0 109.695 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.614 ' N ' HD22 ' A' ' 98' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.261 -0.899 . . . . 0.0 109.433 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 26.6 p-10 . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -167.35 125.58 1.28 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.298 -0.876 . . . . 0.0 109.088 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -163.12 157.91 21.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.907 . . . . 0.0 109.892 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.9 pt -150.68 163.37 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.324 -0.86 . . . . 0.0 108.755 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.2 m -145.15 158.22 43.88 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.214 -0.929 . . . . 0.0 109.926 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 9' ' ' VAL . 3.5 p -152.47 97.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.03 -118.17 4.65 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -101.56 8.99 41.67 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.402 -1.058 . . . . 0.0 110.207 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 17.2 mt -106.52 126.52 52.36 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.275 -0.891 . . . . 0.0 109.925 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -116.85 130.68 56.86 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.462 HD12 HG22 ' A' ' 21' ' ' VAL . 5.9 tp -115.05 116.96 29.28 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.455 -0.778 . . . . 0.0 110.109 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.454 ' C ' ' HH ' ' A' ' 35' ' ' TYR . 7.4 m-20 -111.32 97.69 6.95 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 121.506 -0.746 . . . . 0.0 109.027 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.3 t -69.35 -28.6 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 109.534 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.439 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -64.49 -53.14 52.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.467 -0.771 . . . . 0.0 109.478 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 -90.26 -8.54 50.72 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.181 -0.95 . . . . 0.0 108.803 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 56.45 67.63 0.97 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 98.6 mt -143.72 158.47 43.65 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.462 HG22 HD12 ' A' ' 14' ' ' LEU . 16.6 t -142.5 123.8 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.227 -0.921 . . . . 0.0 110.012 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 16.0 m-90 -99.42 153.39 19.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.367 -0.833 . . . . 0.0 109.121 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tt -146.15 116.05 7.32 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 62.58 39.68 98.18 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 107.623 -2.191 . . . . 0.0 107.623 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 65.87 -4.6 0.61 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 122.263 -0.551 . . . . 0.0 109.875 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.41 ' H ' ' C ' ' A' ' 24' ' ' GLY . 73.7 p -100.27 139.87 35.32 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.082 -1.011 . . . . 0.0 109.535 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.11 115.24 3.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 0.0 110.041 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.1 tp -75.1 127.28 32.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.3 -0.875 . . . . 0.0 108.684 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.402 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 5.7 m-20 -94.16 101.24 13.24 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.242 -0.911 . . . . 0.0 110.303 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.909 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.4 pt? -128.33 137.45 51.94 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.5 p -62.8 151.42 84.97 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.795 -1.191 . . . . 0.0 109.475 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -44.91 -46.94 12.44 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 121.792 1.662 . . . . 0.0 112.35 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -53.34 -42.17 66.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.7 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -63.23 -36.06 82.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.154 -0.966 . . . . 0.0 109.336 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.454 ' HH ' ' C ' ' A' ' 15' ' ' ASN . 13.0 t80 -57.03 -30.65 64.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.295 -0.878 . . . . 0.0 109.243 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.43 -53.3 9.84 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.241 -0.912 . . . . 0.0 109.733 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 37' ' ' LEU . 9.2 mp -62.06 -39.48 92.52 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.6 tp -65.61 -46.12 80.52 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.61 -0.681 . . . . 0.0 109.678 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -50.77 -29.84 12.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 110.378 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.488 ' NH2' ' CG2' ' A' ' 53' ' ' ILE . 6.3 tpt180 -79.18 -36.89 39.58 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.85 -1.157 . . . . 0.0 110.173 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.29 -38.57 91.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.962 -1.086 . . . . 0.0 110.261 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.4 ' SD ' ' CD2' ' A' ' 96' ' ' LEU . 13.0 mmt -65.39 -42.93 92.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.768 -1.207 . . . . 0.0 110.077 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 51.8 mtt -58.72 -32.25 69.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.223 -0.923 . . . . 0.0 109.505 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -106.19 35.34 2.96 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.637 -0.664 . . . . 0.0 109.44 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.1 103.16 2.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 109.885 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.26 -16.58 2.31 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.64 155.72 79.29 Favored Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.718 -0.872 . . . . 0.0 108.707 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.52 120.46 7.13 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.928 1.752 . . . . 0.0 111.554 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.5 t -91.57 136.6 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.8 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.413 ' C ' ' N ' ' A' ' 52' ' ' GLU . 19.7 t-160 -72.26 123.36 22.81 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.156 -0.965 . . . . 0.0 108.607 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -52.99 -15.57 0.82 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 0.0 109.082 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.555 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 36.1 tt0 -69.38 -48.24 61.81 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.601 -0.687 . . . . 0.0 109.764 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.488 ' CG2' ' NH2' ' A' ' 40' ' ' ARG . 77.9 mt -57.83 -30.04 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.048 -1.032 . . . . 0.0 110.099 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.1 mt -67.51 -48.67 66.38 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -54.96 -35.81 64.66 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.555 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 55.8 m-80 -67.3 -22.02 65.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.412 -0.805 . . . . 0.0 110.379 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.56 -179.631 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.409 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 87.1 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.377 0.608 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 pp -67.37 -38.25 84.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.354 -0.841 . . . . 0.0 109.698 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -60.77 -32.79 72.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.032 -1.042 . . . . 0.0 109.877 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.2 t -70.88 -40.11 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.089 -1.007 . . . . 0.0 109.45 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.409 ' ND1' ' O ' ' A' ' 69' ' ' THR . 17.1 m80 -55.74 -37.93 69.12 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.3 mt -66.07 -39.5 84.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -59.05 -36.02 74.31 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.365 -0.934 . . . . 0.0 108.918 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -76.14 -40.24 53.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.447 -0.783 . . . . 0.0 109.088 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.658 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -66.67 -44.07 82.83 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -50.73 -50.28 55.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.388 -0.82 . . . . 0.0 110.228 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -61.74 -27.98 69.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.168 -0.957 . . . . 0.0 110.616 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -74.36 -44.27 52.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.937 -1.102 . . . . 0.0 110.862 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.8 pt -74.43 -21.2 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.854 -1.154 . . . . 0.0 110.212 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 81.27 82.73 0.8 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.413 ' O ' ' O ' ' A' ' 86' ' ' ILE . 18.1 pttp -45.48 -16.57 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.673 -0.898 . . . . 0.0 110.442 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 82' ' ' GLY . 78.8 p -53.66 -49.76 67.24 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.985 -1.072 . . . . 0.0 109.752 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.601 ' C ' HD12 ' A' ' 86' ' ' ILE . 25.3 mmt-85 -79.34 11.02 3.17 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.313 -0.867 . . . . 0.0 110.402 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.601 HD12 ' C ' ' A' ' 85' ' ' ARG . 4.7 mp -138.86 163.56 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.088 -1.007 . . . . 0.0 109.268 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.546 ' N ' HG22 ' A' ' 86' ' ' ILE . 76.6 ttt180 -138.13 127.41 24.52 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.361 -0.837 . . . . 0.0 109.72 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.419 HG22 ' CE2' ' A' ' 94' ' ' TYR . 2.9 p -93.24 142.41 27.34 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.306 -0.871 . . . . 0.0 109.202 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.5 t . . . . . 0 N--CA 1.501 2.088 0 O-C-N 121.412 -0.805 . . . . 0.0 110.119 -179.365 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.473 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.497 2.755 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.473 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 23.8 m-85 -151.33 157.62 42.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.422 -1.046 . . . . 0.0 108.565 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.418 ' C ' ' SD ' ' A' ' 95' ' ' MET . 1.5 tmt? -157.75 123.01 4.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.347 -0.845 . . . . 0.0 109.523 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 96' ' ' LEU . 9.2 mp -82.43 139.09 34.2 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.406 -0.808 . . . . 0.0 108.848 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.89 113.48 1.52 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.929 . . . . 0.0 109.501 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 0.0 109.54 -179.965 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 10.8 p-10 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -164.99 124.87 1.88 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.141 -0.975 . . . . 0.0 109.444 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -163.48 156.06 18.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.465 -0.772 . . . . 0.0 109.474 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.7 pt -147.84 163.97 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.357 -0.839 . . . . 0.0 109.167 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.4 m -133.99 145.43 49.49 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.533 -0.729 . . . . 0.0 109.558 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.4 t -141.44 93.4 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.87 -109.5 2.83 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.687 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -105.84 4.1 29.37 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.593 -0.945 . . . . 0.0 109.865 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.508 ' N ' HD12 ' A' ' 12' ' ' LEU . 10.4 mp -98.68 117.63 33.58 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.234 -0.917 . . . . 0.0 109.602 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 59.9 mtp85 -108.46 116.06 31.27 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 14' ' ' LEU . 9.2 mp -103.11 136.13 43.49 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.482 -0.761 . . . . 0.0 109.428 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -134.98 98.71 4.08 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.7 t -71.64 -29.39 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.498 -0.751 . . . . 0.0 109.449 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.41 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -56.88 -52.7 64.13 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.42 -0.8 . . . . 0.0 109.231 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.6 mtp180 -97.01 -6.71 34.74 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.485 ' NH2' ' O ' ' A' ' 30' ' ' LEU . 1.4 tmt_? 55.23 81.73 0.11 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.81 0.814 . . . . 0.0 109.248 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.409 HD23 ' N ' ' A' ' 21' ' ' VAL . 0.8 OUTLIER -167.76 132.34 1.82 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.409 ' N ' HD23 ' A' ' 20' ' ' LEU . 15.2 t -117.44 132.75 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.587 -0.695 . . . . 0.0 109.816 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -103.97 124.67 49.42 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.425 -0.797 . . . . 0.0 108.967 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 20.4 tp -104.15 111.77 24.5 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.68 37.4 93.48 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 107.311 -2.315 . . . . 0.0 107.311 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 69.89 2.11 3.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 122.35 -0.5 . . . . 0.0 109.826 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.5 p -103.65 138.06 40.83 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.129 -0.982 . . . . 0.0 109.97 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.9 113.14 5.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 110.225 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.3 tp -81.56 136.12 35.58 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -93.06 102.76 15.09 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.023 -1.048 . . . . 0.0 110.464 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.874 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.3 pt? -128.53 136.52 50.88 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 p -55.05 152.99 12.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 120.99 -1.068 . . . . 0.0 108.865 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.06 -40.93 47.58 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 122.054 1.836 . . . . 0.0 111.26 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -55.81 -41.91 74.86 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.188 -0.945 . . . . 0.0 108.509 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -63.32 -36.34 83.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.456 -0.778 . . . . 0.0 109.114 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -56.25 -28.22 57.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.161 -0.962 . . . . 0.0 108.633 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.24 -50.91 34.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.315 -0.866 . . . . 0.0 108.891 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.594 ' N ' HD12 ' A' ' 37' ' ' LEU . 8.4 mp -58.22 -39.96 80.4 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 12.8 tp -58.45 -41.99 86.36 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.543 ' C ' ' HE ' ' A' ' 40' ' ' ARG . 15.7 m -51.7 -35.48 43.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 109.17 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.543 ' HE ' ' C ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -76.38 -43.26 41.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.466 -0.771 . . . . 0.0 109.031 179.307 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.453 HD21 HD11 ' A' ' 54' ' ' LEU . 96.6 mt -59.7 -50.84 72.3 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.219 -0.926 . . . . 0.0 110.018 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -67.65 -36.45 80.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.923 -1.11 . . . . 0.0 110.196 -179.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.548 ' N ' ' SD ' ' A' ' 42' ' ' MET . 10.8 ttt -54.04 -28.4 38.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.089 -1.007 . . . . 0.0 108.96 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -122.34 44.54 2.59 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.37 132.16 49.32 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.195 -0.941 . . . . 0.0 109.909 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.17 -6.09 57.92 Favored Glycine 0 N--CA 1.501 3.032 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.3 m -132.75 150.82 76.81 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.591 -0.946 . . . . 0.0 108.718 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.07 120.25 5.65 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.803 1.669 . . . . 0.0 112.189 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.0 t -93.38 138.33 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -0.838 . . . . 0.0 109.273 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -68.85 122.27 18.27 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.185 -0.947 . . . . 0.0 108.759 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -52.33 -17.12 1.03 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 109.266 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.558 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 68.5 mm-40 -66.53 -50.24 63.84 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.401 -0.812 . . . . 0.0 109.361 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.4 mt -55.0 -29.77 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.271 -0.893 . . . . 0.0 109.784 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.453 HD11 HD21 ' A' ' 41' ' ' LEU . 17.9 mt -72.95 -30.32 63.77 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.211 -0.931 . . . . 0.0 109.385 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -71.4 -34.13 70.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.752 -1.217 . . . . 0.0 107.837 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 24.4 m-80 -62.89 -20.82 65.51 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.362 0.601 . . . . 0.0 109.767 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.305 -1.359 0 O-C-N 120.814 -1.179 . . . . 0.0 109.507 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.66 ' N ' HD12 ' A' ' 70' ' ' LEU . 6.8 mp -59.77 -50.48 73.66 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.449 -0.782 . . . . 0.0 109.855 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -69.7 -26.01 64.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.094 -1.004 . . . . 0.0 109.754 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.6 t -75.23 -45.66 40.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.294 -0.879 . . . . 0.0 109.477 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -55.14 -37.45 66.96 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 89.0 mt -67.35 -40.45 84.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -59.78 -37.37 78.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.194 -0.941 . . . . 0.0 108.681 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.51 ' N ' HD22 ' A' ' 76' ' ' ASN . 1.4 m120 -72.71 -42.12 64.52 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.723 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -64.42 -41.23 96.71 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -49.72 -50.39 44.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.334 -0.854 . . . . 0.0 109.815 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -59.52 -31.78 69.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.873 . . . . 0.0 110.803 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -68.32 -45.5 72.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.875 -1.141 . . . . 0.0 109.817 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.4 pt -74.88 -31.94 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.014 -1.054 . . . . 0.0 109.924 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 86.0 87.9 0.98 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.409 ' O ' ' O ' ' A' ' 86' ' ' ILE . 22.7 pttm -45.54 -17.33 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.573 -0.957 . . . . 0.0 110.31 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 82' ' ' GLY . 48.4 t -56.51 -52.06 66.15 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.185 -0.947 . . . . 0.0 109.897 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -87.75 10.06 19.6 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.179 -0.95 . . . . 0.0 110.942 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.546 HG22 ' N ' ' A' ' 87' ' ' ARG . 5.1 mp -133.08 164.04 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.546 ' N ' HG22 ' A' ' 86' ' ' ILE . 56.4 ttm-85 -140.85 128.02 20.89 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.075 -1.016 . . . . 0.0 110.085 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.435 HG22 ' CE2' ' A' ' 94' ' ' TYR . 2.2 p -88.57 142.24 27.86 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.498 -0.751 . . . . 0.0 109.096 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.7 t . . . . . 0 N--CA 1.502 2.151 0 O-C-N 121.368 -0.832 . . . . 0.0 110.236 -179.318 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.456 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.497 2.736 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 12.1 m-85 -151.29 149.98 30.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.388 -1.066 . . . . 0.0 108.335 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.477 ' O ' ' SD ' ' A' ' 95' ' ' MET . 3.4 ppp? -149.22 127.45 12.11 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.212 -0.93 . . . . 0.0 109.542 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 96' ' ' LEU . 9.8 mp -79.87 132.74 36.16 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.08 132.1 46.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.347 -0.846 . . . . 0.0 109.615 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.9 m120 . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 109.456 179.92 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.4 p30 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 17' ' ' THR . 4.1 p30 -178.09 111.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -163.24 156.01 18.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 109.863 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.2 pt -146.38 163.12 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.347 -0.846 . . . . 0.0 109.084 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.8 t -134.49 142.15 46.97 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.336 -0.852 . . . . 0.0 109.8 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.77 92.88 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.55 -119.79 5.38 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -101.09 10.84 40.53 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.407 -1.055 . . . . 0.0 109.794 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.4 mt -108.33 123.59 49.04 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.413 -0.805 . . . . 0.0 109.672 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -108.1 146.98 31.87 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.6 tp -130.84 120.97 24.48 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.482 -0.762 . . . . 0.0 109.176 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 19' ' ' ARG . 13.2 m-20 -118.55 97.85 5.95 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.531 -0.731 . . . . 0.0 109.525 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.94 -27.51 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.449 -0.782 . . . . 0.0 109.216 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.463 ' N ' ' OD1' ' A' ' 5' ' ' ASN . 0.1 OUTLIER -63.18 -53.83 47.19 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.508 -0.745 . . . . 0.0 109.645 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -92.73 -14.62 27.71 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.153 -0.967 . . . . 0.0 108.814 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 15' ' ' ASN . 5.6 tpt180 68.18 61.31 0.4 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.312 0.577 . . . . 0.0 109.604 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.9 mt -138.89 156.65 47.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.38 -0.825 . . . . 0.0 108.973 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 t -143.69 127.73 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.255 -0.903 . . . . 0.0 109.388 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 12.3 m-90 -102.38 154.87 18.66 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.247 -0.908 . . . . 0.0 108.898 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.404 ' O ' ' OG1' ' A' ' 26' ' ' THR . 1.1 tt -144.5 115.09 7.68 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 63.5 43.47 98.08 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 107.805 -2.118 . . . . 0.0 107.805 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 61.28 0.43 0.42 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 122.129 -0.63 . . . . 0.0 110.213 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 68.1 p -106.47 139.85 40.29 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.215 -0.928 . . . . 0.0 109.452 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.03 114.56 3.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.412 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 32.2 tp -75.27 128.75 36.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.252 -0.905 . . . . 0.0 108.657 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -97.39 104.8 16.86 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.164 -0.96 . . . . 0.0 109.657 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.854 HD23 ' H ' ' A' ' 30' ' ' LEU . 1.4 pt? -131.32 141.83 50.0 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.67 -0.644 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.3 p -62.36 152.19 80.29 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.155 -0.966 . . . . 0.0 109.961 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.04 -45.23 14.5 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.779 1.653 . . . . 0.0 112.013 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -53.63 -48.62 69.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.357 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.46 ' HG2' HD13 ' A' ' 77' ' ' LEU . 37.2 mt-10 -56.43 -35.26 67.64 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.324 -0.86 . . . . 0.0 109.536 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -60.19 -32.97 71.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 109.198 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.82 -53.45 9.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.155 -0.966 . . . . 0.0 108.583 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 tt -55.94 -45.0 78.91 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.9 tp -64.46 -45.74 86.08 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.3 0.572 . . . . 0.0 109.739 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.8 t -50.59 -39.45 49.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.364 -0.835 . . . . 0.0 110.635 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.416 ' CA ' ' HE ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -80.36 -41.68 24.29 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.916 -1.115 . . . . 0.0 109.87 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.6 tp -60.69 -41.83 95.94 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 109.325 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.1 mtp -72.35 -37.3 68.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.058 -1.026 . . . . 0.0 109.296 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 13.5 ttt -51.85 -27.3 12.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.28 -0.888 . . . . 0.0 108.766 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm -119.37 46.05 1.99 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.66 141.58 49.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.33 -0.856 . . . . 0.0 110.512 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.54 -22.14 40.63 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 t -114.43 152.99 46.61 Favored Pre-proline 0 N--CA 1.502 2.134 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.77 119.43 6.08 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.557 1.505 . . . . 0.0 111.629 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.439 HG11 HD21 ' A' ' 54' ' ' LEU . 78.8 t -97.11 133.69 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.293 -0.879 . . . . 0.0 110.047 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -68.44 124.75 24.4 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.184 -0.948 . . . . 0.0 108.673 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -52.31 -18.71 1.69 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.345 -0.847 . . . . 0.0 109.008 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.526 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 58.4 tt0 -60.74 -57.15 13.9 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.46 -0.775 . . . . 0.0 109.379 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.2 mt -56.46 -30.67 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.238 -0.914 . . . . 0.0 109.735 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.439 HD21 HG11 ' A' ' 49' ' ' VAL . 33.8 mt -68.55 -32.53 72.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.096 -1.002 . . . . 0.0 108.959 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -74.1 -35.52 64.18 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 32.8 m-80 -61.19 -22.05 64.37 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 . . . . . 0 C--N 1.304 -1.394 0 O-C-N 121.386 -0.821 . . . . 0.0 109.751 -179.759 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 98.3 m . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.5 pp -68.1 -33.0 73.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.733 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.455 ' O ' ' CD2' ' A' ' 75' ' ' HIS . 75.7 mm-40 -60.23 -32.09 70.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.022 -1.049 . . . . 0.0 110.026 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.1 t -73.84 -45.68 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.039 -1.038 . . . . 0.0 109.279 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.486 ' ND1' ' N ' ' A' ' 73' ' ' HIS . 1.5 m-70 -55.86 -37.49 68.84 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 86.8 mt -67.79 -39.79 82.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.455 ' CD2' ' O ' ' A' ' 71' ' ' GLU . 34.6 m170 -61.25 -35.84 78.38 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.969 -1.082 . . . . 0.0 108.752 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -74.49 -41.66 60.33 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.479 -0.763 . . . . 0.0 109.017 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.665 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -69.11 -42.83 75.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 0.0 108.85 -179.231 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -50.82 -50.64 56.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -0.857 . . . . 0.0 110.726 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -64.71 -26.07 68.21 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.036 -1.04 . . . . 0.0 110.769 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -71.44 -45.35 62.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.856 -1.152 . . . . 0.0 110.077 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 21.7 pt -74.84 -22.29 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.122 -0.986 . . . . 0.0 110.09 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 81.6 84.39 0.76 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.576 -1.81 . . . . 0.0 108.576 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 86' ' ' ILE . 18.3 pttp -45.1 -17.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.658 -0.907 . . . . 0.0 110.425 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 82' ' ' GLY . 36.7 p -54.78 -48.73 72.31 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.168 -0.957 . . . . 0.0 109.751 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.83 9.58 4.09 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.056 -1.028 . . . . 0.0 109.893 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 87' ' ' ARG . 5.2 mp -134.46 159.56 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.214 -0.929 . . . . 0.0 109.307 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.49 ' N ' HG22 ' A' ' 86' ' ' ILE . 95.3 mtt180 -140.73 124.39 17.01 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.419 -0.8 . . . . 0.0 109.689 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.8 p -86.75 138.63 31.45 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.287 -0.883 . . . . 0.0 109.285 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.501 2.117 0 O-C-N 121.375 -0.828 . . . . 0.0 110.535 -179.092 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.428 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.495 2.631 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.428 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 22.7 m-85 -149.51 158.06 43.84 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 45.6 ttp -159.81 126.61 4.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.204 -0.935 . . . . 0.0 110.075 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.404 HD12 ' N ' ' A' ' 96' ' ' LEU . 9.4 mp -84.3 131.88 34.68 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.02 127.14 27.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.189 -0.944 . . . . 0.0 109.215 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.4 m120 . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.238 -0.913 . . . . 0.0 109.629 -179.855 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.348 0.594 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.483 HD22 ' C ' ' A' ' 5' ' ' ASN . 0.4 OUTLIER -161.92 125.01 3.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 108.952 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -150.26 146.5 26.83 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.554 -0.716 . . . . 0.0 109.492 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.3 pt -148.92 163.44 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.271 -0.893 . . . . 0.0 108.905 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.1 t -143.24 152.79 42.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.201 -0.937 . . . . 0.0 109.712 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.1 t -147.35 92.92 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.91 -114.84 4.08 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.7 m-20 -103.09 6.19 38.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.421 -1.046 . . . . 0.0 109.893 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.8 mt -101.78 118.31 36.66 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.351 -0.843 . . . . 0.0 109.887 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -110.84 118.97 37.56 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.414 ' C ' HD22 ' A' ' 15' ' ' ASN . 9.4 mp -106.88 126.47 52.35 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.552 -0.717 . . . . 0.0 109.309 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.414 HD22 ' C ' ' A' ' 14' ' ' LEU . 1.8 m-80 -122.72 97.91 5.67 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.97 -27.34 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.432 -0.792 . . . . 0.0 109.576 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.412 ' H ' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER -63.74 -49.11 74.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.273 -0.892 . . . . 0.0 109.867 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.2 mtp85 -97.14 -7.75 31.79 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.164 -0.96 . . . . 0.0 108.611 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? 56.0 73.35 0.44 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 21' ' ' VAL . 1.1 tt -157.7 128.13 6.34 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.43 ' N ' HD23 ' A' ' 20' ' ' LEU . 12.6 t -114.73 136.72 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.499 -0.75 . . . . 0.0 110.264 -179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 29.0 m-90 -108.18 133.16 52.83 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tt -113.75 110.11 19.64 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.37 39.0 91.66 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 107.623 -2.191 . . . . 0.0 107.623 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 69.65 -0.45 2.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 122.324 -0.515 . . . . 0.0 110.025 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.7 p -101.93 138.99 38.16 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.064 -1.023 . . . . 0.0 109.789 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.98 112.46 1.34 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 110.012 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.4 tp -75.43 127.89 34.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 108.839 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -92.24 98.76 11.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.115 -0.991 . . . . 0.0 109.926 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.907 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.3 pt? -123.84 134.28 53.62 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 121.509 0.671 . . . . 0.0 109.341 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.0 p -59.57 149.15 72.0 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.997 -1.065 . . . . 0.0 109.463 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -45.01 -48.37 11.05 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.719 1.613 . . . . 0.0 112.117 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -54.67 -37.43 65.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.419 -0.801 . . . . 0.0 109.882 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -67.55 -35.06 78.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.095 -1.003 . . . . 0.0 109.261 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -59.12 -33.4 70.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.042 -1.036 . . . . 0.0 108.72 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.53 -53.05 17.7 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.535 HD11 HD13 ' A' ' 54' ' ' LEU . 4.9 tt -52.16 -50.3 62.07 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 13.1 tp -56.09 -40.09 73.13 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.169 0.509 . . . . 0.0 109.854 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.8 m -52.42 -33.31 43.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 109.744 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.51 HH21 ' CE ' ' A' ' 43' ' ' MET . 10.5 mmp_? -78.55 -42.66 28.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.97 . . . . 0.0 109.456 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 17.9 mt -59.22 -48.05 83.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.959 -1.088 . . . . 0.0 110.011 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.417 ' C ' ' SD ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -70.36 -25.96 63.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.985 -1.072 . . . . 0.0 109.746 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.51 ' CE ' HH21 ' A' ' 40' ' ' ARG . 40.2 ttm -61.77 -32.67 72.95 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.161 -0.962 . . . . 0.0 108.872 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -118.13 38.91 3.54 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.79 121.3 9.53 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.262 -0.899 . . . . 0.0 109.753 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.32 -6.85 30.38 Favored Glycine 0 N--CA 1.503 3.14 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.3 m -130.28 151.68 78.9 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 121.535 -0.98 . . . . 0.0 108.771 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.72 120.4 5.51 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.859 1.706 . . . . 0.0 112.186 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.5 t -87.77 131.68 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.241 -0.912 . . . . 0.0 109.78 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -67.15 129.34 39.57 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.309 -0.87 . . . . 0.0 108.675 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.446 ' NH2' ' OE1' ' A' ' 71' ' ' GLU . 13.0 ptm180 -54.04 -22.2 10.15 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.473 -0.767 . . . . 0.0 109.394 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.575 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 38.2 tt0 -72.79 -36.24 67.54 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.524 -0.735 . . . . 0.0 110.409 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.9 mt -75.64 -35.37 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.433 -0.792 . . . . 0.0 111.66 -178.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.639 ' C ' HD12 ' A' ' 54' ' ' LEU . 4.2 pp -76.34 -22.43 54.92 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.818 -1.176 . . . . 0.0 109.474 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.61 ' N ' HD12 ' A' ' 54' ' ' LEU . 63.4 t80 -64.88 -33.36 75.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.903 . . . . 0.0 109.521 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.74 ' H ' HD22 ' A' ' 56' ' ' ASN . 0.4 OUTLIER -61.54 -23.69 66.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 109.669 -179.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.386 -0.822 . . . . 0.0 110.175 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.423 0.63 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.597 HD23 ' H ' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -70.54 -49.28 49.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.373 -0.83 . . . . 0.0 108.892 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.446 ' OE1' ' NH2' ' A' ' 51' ' ' ARG . 29.8 tp10 -69.87 -31.23 68.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.574 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.9 t -72.4 -40.11 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.181 -0.95 . . . . 0.0 109.0 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -56.95 -39.3 74.31 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 89.9 mt -63.82 -35.9 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -61.97 -32.4 72.84 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.48 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -73.04 -41.78 63.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.505 -0.747 . . . . 0.0 109.255 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.8 mt -72.26 -39.39 68.43 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.227 -0.921 . . . . 0.0 109.544 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -50.32 -51.48 44.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.959 . . . . 0.0 110.181 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.43 -24.79 67.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.055 -1.028 . . . . 0.0 109.803 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -70.95 -45.92 63.31 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.984 -1.073 . . . . 0.0 110.135 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.408 HG12 ' H ' ' A' ' 81' ' ' ILE . 16.3 pt -74.89 -19.29 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.104 -0.997 . . . . 0.0 110.121 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 84.19 83.07 0.98 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 86' ' ' ILE . 56.4 pttt -44.51 -17.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.721 -0.87 . . . . 0.0 110.59 -179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 82' ' ' GLY . 57.9 m -59.38 -48.42 81.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.138 -0.976 . . . . 0.0 110.777 -178.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.483 ' N ' ' CD ' ' A' ' 85' ' ' ARG . 10.6 mpt_? -72.72 9.42 1.12 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.025 -1.047 . . . . 0.0 111.003 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' A' ' 83' ' ' LYS . 9.0 tt -146.82 160.96 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 120.934 -1.104 . . . . 0.0 109.29 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -117.1 132.44 56.67 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.42 -0.8 . . . . 0.0 109.703 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.7 p -95.39 142.47 27.74 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.414 -0.804 . . . . 0.0 108.89 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.6 t . . . . . 0 N--CA 1.499 2.002 0 O-C-N 121.352 -0.843 . . . . 0.0 109.787 -179.599 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.472 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.497 2.715 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.472 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 26.0 m-85 -151.21 163.31 39.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.421 -1.046 . . . . 0.0 108.305 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.46 ' SD ' ' O ' ' A' ' 96' ' ' LEU . 1.2 tmt? -163.27 127.79 2.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.981 -1.074 . . . . 0.0 110.261 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.46 ' O ' ' SD ' ' A' ' 95' ' ' MET . 9.6 mp -78.49 142.02 37.77 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.7 120.73 20.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 109.486 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 109.645 -180.0 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -158.26 120.27 3.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.241 -0.912 . . . . 0.0 109.321 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -162.44 154.57 18.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.333 -0.855 . . . . 0.0 109.706 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.8 pt -150.44 164.65 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.5 p -140.39 154.0 46.55 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.294 -0.879 . . . . 0.0 110.028 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.3 t -148.33 93.43 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.67 -115.19 4.19 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -101.44 5.35 41.99 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.396 -1.061 . . . . 0.0 109.837 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.2 mt -101.06 116.24 32.37 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.334 -0.854 . . . . 0.0 109.715 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -108.94 122.04 46.38 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.536 ' C ' HD22 ' A' ' 15' ' ' ASN . 37.1 tp -105.95 134.74 48.6 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.597 -0.69 . . . . 0.0 110.006 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.536 HD22 ' C ' ' A' ' 14' ' ' LEU . 0.9 OUTLIER -131.78 97.36 4.17 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.228 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.9 t -71.89 -27.9 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.317 -0.864 . . . . 0.0 109.403 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.7 -54.75 30.65 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.503 -0.748 . . . . 0.0 109.656 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -86.9 -11.6 50.19 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.169 -0.957 . . . . 0.0 108.697 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 60.29 72.23 0.53 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.441 0.639 . . . . 0.0 109.329 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.5 tp -166.8 153.63 8.83 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.5 t -134.59 135.52 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.298 -0.876 . . . . 0.0 109.876 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 20.0 m-90 -100.0 120.37 39.72 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 26' ' ' THR . 1.2 tt -101.91 110.51 22.5 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.55 43.45 96.54 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 107.212 -2.355 . . . . 0.0 107.212 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 64.75 3.37 1.98 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 122.338 -0.507 . . . . 0.0 110.269 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 23' ' ' LEU . 43.8 p -106.03 138.48 42.14 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 120.95 -1.094 . . . . 0.0 109.711 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.71 113.31 2.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.973 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 28' ' ' LEU . 29.1 tp -71.04 126.25 29.06 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -96.91 104.93 16.98 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.22 -0.925 . . . . 0.0 110.695 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.779 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.1 pt? -143.09 151.48 40.8 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.44 -0.788 . . . . 0.0 109.354 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.08 157.35 62.68 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.141 -0.975 . . . . 0.0 108.71 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -60.8 -39.77 59.72 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.457 2.105 . . . . 0.0 112.069 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -54.54 -36.27 64.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.073 -1.017 . . . . 0.0 109.102 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.486 ' OE2' ' NE2' ' A' ' 73' ' ' HIS . 20.5 mm-40 -70.18 -37.73 75.21 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -55.25 -27.86 49.28 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.421 ' O ' ' OD2' ' A' ' 57' ' ' ASP . . . -72.83 -50.49 23.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.383 -0.823 . . . . 0.0 109.002 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.471 ' CD2' ' O ' ' A' ' 54' ' ' LEU . 9.9 mt -65.71 -37.73 87.24 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.449 ' O ' HD23 ' A' ' 38' ' ' LEU . 1.6 tt -57.58 -42.44 83.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.511 -0.743 . . . . 0.0 109.446 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.5 p -60.78 -45.86 92.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.11 -0.994 . . . . 0.0 109.275 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -55.24 -48.06 74.49 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.368 -0.832 . . . . 0.0 109.29 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.1 mt -61.65 -39.29 90.83 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 109.991 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 8.1 mmt -74.7 -37.03 62.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.874 -1.141 . . . . 0.0 109.888 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 40.5 mtt -55.14 -29.31 57.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.119 -0.988 . . . . 0.0 108.699 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -120.81 47.85 1.73 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.86 129.97 39.89 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.197 -0.94 . . . . 0.0 110.064 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.33 -12.98 43.98 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.8 p -125.75 151.43 70.86 Favored Pre-proline 0 N--CA 1.502 2.165 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.1 119.74 6.2 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.637 1.558 . . . . 0.0 111.709 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.4 t -94.67 135.34 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.349 -0.845 . . . . 0.0 109.81 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.413 ' C ' ' N ' ' A' ' 52' ' ' GLU . 8.2 t-160 -72.72 125.12 26.76 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.044 -1.035 . . . . 0.0 108.492 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.482 ' CD ' ' N ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -50.83 -15.18 0.26 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.489 -0.757 . . . . 0.0 109.787 -179.281 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.544 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 17.2 tt0 -66.47 -49.12 67.69 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.498 -0.751 . . . . 0.0 109.866 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.401 ' HA ' HD22 ' A' ' 56' ' ' ASN . 13.2 mm -56.24 -33.14 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.034 -1.041 . . . . 0.0 109.93 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.471 ' O ' ' CD2' ' A' ' 37' ' ' LEU . 22.7 mt -65.93 -48.95 69.67 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -57.67 -35.98 71.29 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 68.7 m-80 -66.84 -21.79 66.01 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.528 -0.733 . . . . 0.0 110.693 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.421 ' OD2' ' O ' ' A' ' 36' ' ' ALA . 7.2 t0 . . . . . 0 N--CA 1.485 1.305 0 O-C-N 120.764 -1.21 . . . . 0.0 109.347 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.426 0.631 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.632 ' H ' HD12 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -55.49 -50.38 70.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.239 -0.913 . . . . 0.0 109.201 -179.684 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -71.57 -27.44 63.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 110.138 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.65 -48.24 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.105 -0.997 . . . . 0.0 109.413 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.486 ' NE2' ' OE2' ' A' ' 34' ' ' GLU . 81.4 t60 -54.73 -36.72 65.07 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 90.5 mt -71.61 -42.45 71.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -61.39 -35.43 77.48 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.816 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -74.07 -40.86 62.48 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.512 -0.743 . . . . 0.0 109.402 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.673 ' C ' HD12 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -67.71 -42.51 81.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 108.665 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.483 ' NH2' ' OH ' ' A' ' 94' ' ' TYR . 35.6 ttm180 -49.85 -51.29 41.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.524 -0.735 . . . . 0.0 110.448 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -62.16 -27.71 69.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 110.642 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -74.47 -45.04 48.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.981 -1.074 . . . . 0.0 110.94 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.7 pt -76.83 -22.23 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.821 -1.175 . . . . 0.0 110.638 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 83.93 82.12 0.99 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.2 pttt -45.07 -15.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.707 -0.878 . . . . 0.0 110.658 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 82' ' ' GLY . 65.1 p -49.44 -45.53 46.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.954 -1.091 . . . . 0.0 109.841 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.521 ' HE ' ' N ' ' A' ' 85' ' ' ARG . 5.4 mmp_? -84.25 9.5 12.79 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.189 -0.944 . . . . 0.0 110.295 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 87' ' ' ARG . 37.2 mm -116.95 161.5 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 121.372 -0.83 . . . . 0.0 109.617 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.463 ' N ' HG22 ' A' ' 86' ' ' ILE . 47.4 ttt85 -134.04 110.46 9.66 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.3 p -87.37 138.14 31.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.145 -0.972 . . . . 0.0 110.274 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.499 1.991 0 O-C-N 121.539 -0.726 . . . . 0.0 109.597 -179.947 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.496 2.643 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.483 ' OH ' ' NH2' ' A' ' 78' ' ' ARG . 28.0 m-85 -151.21 159.84 44.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.299 -1.118 . . . . 0.0 108.585 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 43.1 ttp -161.15 131.69 5.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 110.065 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 96' ' ' LEU . 9.3 mp -89.64 133.13 34.79 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.17 114.06 1.62 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 109.729 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.294 -0.878 . . . . 0.0 109.243 179.796 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.6 p30 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -158.83 123.93 4.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 108.924 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -161.32 152.36 18.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.394 -0.816 . . . . 0.0 109.546 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.458 HG22 ' N ' ' A' ' 8' ' ' SER . 58.5 mt -137.04 159.97 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.458 ' N ' HG22 ' A' ' 7' ' ' ILE . 72.2 m -142.9 146.69 34.29 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.39 -0.819 . . . . 0.0 109.732 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.5 t -142.66 94.65 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.01 -119.41 4.95 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.624 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 0.8 OUTLIER -100.96 10.11 41.49 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.37 -1.076 . . . . 0.0 109.34 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 17.7 tp -104.45 127.85 52.23 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -123.53 135.65 54.13 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 tt -129.2 121.44 27.67 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.622 -0.674 . . . . 0.0 109.582 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.513 ' C ' ' HH ' ' A' ' 35' ' ' TYR . 3.4 m-20 -112.12 107.11 15.91 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.629 -0.669 . . . . 0.0 110.241 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.1 t -71.9 -28.58 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.284 -0.885 . . . . 0.0 109.561 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 17' ' ' THR . 0.1 OUTLIER -66.69 -54.7 20.33 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.368 -0.832 . . . . 0.0 109.303 -179.722 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -84.01 -18.78 35.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.115 -0.991 . . . . 0.0 108.665 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? 66.11 65.92 0.5 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.9 mt -148.01 158.23 43.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.236 -0.915 . . . . 0.0 108.661 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.7 t -140.35 128.63 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.324 -0.86 . . . . 0.0 109.58 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -103.86 148.0 26.65 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.415 -0.803 . . . . 0.0 109.35 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.9 tp -133.83 102.53 5.48 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 71.85 40.87 57.06 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.315 -1.914 . . . . 0.0 108.315 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 70.62 -10.86 0.67 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 122.034 -0.686 . . . . 0.0 109.695 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.431 ' H ' ' C ' ' A' ' 24' ' ' GLY . 44.3 p -92.85 142.81 26.91 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.077 -1.014 . . . . 0.0 109.638 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.71 116.68 7.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 110.121 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.3 tp -75.14 130.57 39.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.263 -0.898 . . . . 0.0 108.604 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 29' ' ' ASP . 9.5 p-10 -97.45 102.79 14.64 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.231 -0.918 . . . . 0.0 110.046 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.861 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.4 pt? -131.29 140.94 49.88 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.0 p -64.59 151.21 92.48 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.026 -1.046 . . . . 0.0 109.703 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -44.71 -44.58 14.03 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 121.734 1.623 . . . . 0.0 112.087 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -53.6 -46.22 70.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 109.325 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.512 ' HG2' HD13 ' A' ' 77' ' ' LEU . 45.6 mt-10 -55.55 -44.77 77.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.918 . . . . 0.0 109.786 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.513 ' HH ' ' C ' ' A' ' 15' ' ' ASN . 12.5 t80 -56.29 -28.11 57.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.411 -0.805 . . . . 0.0 109.921 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.64 -54.12 8.04 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.908 -1.12 . . . . 0.0 109.681 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 tt -58.28 -42.73 87.2 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 22.4 tp -62.32 -43.08 99.66 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.291 0.567 . . . . 0.0 109.488 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.8 m -51.44 -36.14 42.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.78 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -77.14 -39.25 49.96 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.738 -1.226 . . . . 0.0 109.725 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.7 mt -57.4 -43.99 84.18 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.097 -1.002 . . . . 0.0 108.961 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.3 mmt -67.93 -28.91 67.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.053 -1.029 . . . . 0.0 109.66 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 24.6 ttt -61.59 -33.16 73.41 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.183 -0.948 . . . . 0.0 108.907 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -124.01 47.32 2.08 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.867 -0.521 . . . . 0.0 109.64 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.45 136.95 52.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.108 -0.995 . . . . 0.0 110.254 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.45 -13.99 61.04 Favored Glycine 0 N--CA 1.501 2.984 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.2 p -119.9 151.32 52.34 Favored Pre-proline 0 N--CA 1.502 2.162 0 O-C-N 121.56 -0.965 . . . . 0.0 108.566 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.03 120.2 5.96 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.639 1.559 . . . . 0.0 111.519 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.0 t -100.0 138.38 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.489 -0.757 . . . . 0.0 109.87 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.439 ' C ' ' N ' ' A' ' 52' ' ' GLU . 18.2 t-160 -79.56 126.35 30.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.344 -0.848 . . . . 0.0 108.764 178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.7 ttp-105 -51.06 -16.77 0.5 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 108.816 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.555 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 31.7 tt0 -65.05 -39.02 92.68 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.5 mt -73.54 -35.05 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.273 0.559 . . . . 0.0 109.529 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.9 mt -73.84 -25.03 59.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.174 -0.954 . . . . 0.0 108.906 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -60.21 -37.01 78.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.001 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.758 ' H ' HD22 ' A' ' 56' ' ' ASN . 0.6 OUTLIER -59.13 -28.07 66.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.519 -0.738 . . . . 0.0 109.918 -179.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--N 1.301 -1.521 0 O-C-N 121.341 -0.849 . . . . 0.0 110.047 -179.573 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.4 m . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' A' ' 70' ' ' LEU . 2.1 mm? -64.49 -49.36 71.68 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.296 -0.878 . . . . 0.0 109.166 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.14 -34.68 78.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.896 -1.128 . . . . 0.0 108.781 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.6 t -69.1 -35.33 68.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.16 -38.57 80.04 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.423 ' HA ' HD23 ' A' ' 77' ' ' LEU . 94.1 mt -63.96 -36.66 77.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -62.73 -34.22 76.74 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.789 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -77.37 -41.68 39.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.489 -0.757 . . . . 0.0 109.306 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.63 ' C ' HD12 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -71.73 -39.22 70.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.292 -0.88 . . . . 0.0 109.276 -179.065 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -56.46 -47.78 78.45 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.775 -0.578 . . . . 0.0 110.62 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -62.3 -15.2 46.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.076 -1.015 . . . . 0.0 110.847 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -88.2 -39.64 14.33 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.849 -1.157 . . . . 0.0 110.681 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.2 pt -81.52 -15.74 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.028 -1.045 . . . . 0.0 110.131 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 78.93 85.82 0.54 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -44.78 -16.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.638 -0.919 . . . . 0.0 110.539 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 82' ' ' GLY . 52.0 p -50.01 -44.74 51.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.601 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -75.29 8.79 2.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.18 -0.95 . . . . 0.0 109.971 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.1 mt -137.56 127.71 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.335 -0.853 . . . . 0.0 108.933 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -97.8 98.09 9.54 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.394 -0.816 . . . . 0.0 109.058 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.405 HG23 ' H ' ' A' ' 88' ' ' THR . 2.9 p -67.43 131.23 45.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -0.945 . . . . 0.0 109.336 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.501 2.094 0 O-C-N 121.487 -0.758 . . . . 0.0 110.246 -179.0 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.422 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.493 2.449 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.422 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 31.4 m-85 -151.98 159.74 43.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -1.131 . . . . 0.0 108.795 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 38.8 ttp -161.94 135.1 6.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.278 -0.889 . . . . 0.0 110.188 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.456 ' N ' HD12 ' A' ' 96' ' ' LEU . 9.3 mp -93.12 130.6 38.7 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.44 -0.788 . . . . 0.0 108.921 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.2 123.77 25.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 109.558 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.233 -0.917 . . . . 0.0 109.488 179.997 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -74.16 54.02 0.52 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.345 -0.847 . . . . 0.0 109.462 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 71.07 17.74 75.89 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -167.62 138.48 2.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.306 -1.114 . . . . 0.0 109.501 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.583 HD22 ' N ' ' A' ' 5' ' ' ASN . 0.1 OUTLIER -171.14 124.74 0.63 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 109.213 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.452 ' CD ' ' N ' ' A' ' 6' ' ' GLU . 1.3 pm0 -160.64 155.98 24.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.392 -0.818 . . . . 0.0 109.831 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 7' ' ' ILE . 21.9 pt -147.17 163.03 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.338 -0.851 . . . . 0.0 109.012 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m -143.74 154.36 43.38 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.238 -0.914 . . . . 0.0 109.712 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.5 t -142.67 99.09 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.15 -119.69 5.69 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -99.29 11.37 39.27 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.455 -1.027 . . . . 0.0 109.738 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 29.6 mt -106.82 130.62 54.48 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.356 -0.84 . . . . 0.0 109.455 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -118.59 141.05 48.96 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.1 tt -129.05 143.53 50.9 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.618 -0.676 . . . . 0.0 109.525 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 19' ' ' ARG . 3.3 m-20 -135.48 100.7 4.58 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.622 -0.674 . . . . 0.0 109.721 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.85 -30.34 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.363 -0.835 . . . . 0.0 109.564 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.522 ' N ' HD21 ' A' ' 5' ' ' ASN . 0.0 OUTLIER -60.75 -49.32 77.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.444 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -93.73 -14.53 26.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.129 -0.982 . . . . 0.0 108.378 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 15' ' ' ASN . 5.7 tpt180 64.41 49.25 2.52 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.873 -0.517 . . . . 0.0 109.742 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.3 mt -133.69 153.08 51.96 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.9 t -133.87 134.27 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.422 -0.799 . . . . 0.0 109.319 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -103.17 158.68 16.15 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.429 ' O ' ' OG1' ' A' ' 26' ' ' THR . 1.9 tt -146.41 116.92 7.52 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.27 -0.894 . . . . 0.0 108.714 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.64 41.65 97.66 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 107.727 -2.149 . . . . 0.0 107.727 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 61.63 3.48 0.86 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 122.089 -0.654 . . . . 0.0 110.077 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 60.6 p -108.35 140.8 41.11 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 121.187 -0.946 . . . . 0.0 109.457 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.33 114.58 7.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 109.693 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 28' ' ' LEU . 12.1 tp -84.94 141.27 30.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 109.023 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -99.78 107.5 19.57 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.322 -0.861 . . . . 0.0 109.795 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.3 140.57 51.8 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.8 p -61.11 145.05 90.32 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.107 -0.996 . . . . 0.0 109.48 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -45.0 -42.72 15.76 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.709 1.606 . . . . 0.0 112.32 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -53.31 -48.24 68.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.885 . . . . 0.0 109.767 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -59.48 -33.37 71.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.973 . . . . 0.0 109.381 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.442 ' HH ' ' C ' ' A' ' 15' ' ' ASN . 20.3 t80 -60.04 -32.03 70.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.128 -0.982 . . . . 0.0 109.369 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.409 ' O ' ' OD2' ' A' ' 57' ' ' ASP . . . -74.27 -53.85 8.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.171 -0.956 . . . . 0.0 109.794 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 37' ' ' LEU . 8.5 mp -64.96 -38.47 91.07 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.8 tp -65.23 -46.27 81.3 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.5 m -50.46 -30.15 12.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 109.61 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -77.27 -37.81 52.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.156 -0.965 . . . . 0.0 109.082 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.4 mp -56.53 -47.28 79.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 108.998 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 54.8 mtt -72.28 -30.86 65.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.15 -0.969 . . . . 0.0 109.665 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 20.8 ttt -52.35 -36.03 52.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.159 -0.963 . . . . 0.0 109.443 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -120.92 53.96 1.11 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.64 104.2 3.83 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.305 -0.872 . . . . 0.0 109.919 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.61 -17.45 1.27 Allowed Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.06 159.98 59.72 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.578 -0.954 . . . . 0.0 108.85 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.12 119.97 6.9 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.121 1.88 . . . . 0.0 111.74 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.4 132.63 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.331 -0.856 . . . . 0.0 109.569 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -58.45 147.56 31.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.978 -1.076 . . . . 0.0 108.986 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.0 mtm180 -79.72 -20.94 45.25 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.144 -0.973 . . . . 0.0 110.13 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -72.24 -33.93 67.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.118 -0.989 . . . . 0.0 109.89 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.2 mt -67.16 -33.48 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.029 -1.044 . . . . 0.0 109.548 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.6 mt -64.63 -50.66 66.24 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.403 ' O ' ' O ' ' A' ' 59' ' ' TYR . 32.2 m-85 -58.19 -34.34 70.25 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -70.66 -22.03 62.54 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.528 -0.732 . . . . 0.0 109.958 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.409 ' OD2' ' O ' ' A' ' 36' ' ' ALA . 12.3 t0 -54.58 -54.7 37.86 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.982 -1.074 . . . . 0.0 109.679 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 65.3 mt -83.39 -37.15 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.113 -0.992 . . . . 0.0 109.908 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.458 ' CD1' ' O ' ' A' ' 59' ' ' TYR . 43.0 p90 -163.27 138.57 6.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.057 -1.027 . . . . 0.0 110.094 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.9 t -120.11 20.71 12.02 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.429 ' CD1' ' C ' ' A' ' 61' ' ' TRP . 10.0 t-105 -77.52 -24.8 49.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.337 -0.852 . . . . 0.0 108.939 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 61' ' ' TRP . 16.8 m-20 45.64 97.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.548 -0.72 . . . . 0.0 110.479 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.546 ' ND2' ' H ' ' A' ' 64' ' ' GLU . 8.0 p-10 -78.85 -113.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.93 . . . . 0.0 109.308 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.546 ' H ' ' ND2' ' A' ' 63' ' ' ASN . 59.0 mt-10 -150.78 61.61 4.73 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.065 -1.022 . . . . 0.0 109.272 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.54 83.88 2.08 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.552 2.168 . . . . 0.0 112.026 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.64 -33.67 64.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.223 -0.923 . . . . 0.0 109.438 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -74.27 150.13 40.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.501 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -75.01 125.05 28.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 109.454 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 85.7 m -165.89 -41.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.334 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.579 ' N ' HD12 ' A' ' 70' ' ' LEU . 8.8 mp -62.68 -47.79 82.1 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.43 -0.794 . . . . 0.0 108.938 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -70.99 -31.42 67.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 109.293 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.1 t -73.12 -37.48 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.279 -0.888 . . . . 0.0 109.256 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -56.34 -41.09 75.51 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.49 -36.53 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -64.27 -37.17 86.52 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -68.22 -43.9 76.95 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.0 mt -71.95 -30.0 64.85 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -50.97 -49.25 60.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.665 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -63.87 -26.99 68.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.243 -0.911 . . . . 0.0 110.439 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -71.99 -44.15 63.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.959 -1.088 . . . . 0.0 110.309 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.413 ' H ' HG12 ' A' ' 81' ' ' ILE . 16.0 pt -72.51 -15.37 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.177 -0.952 . . . . 0.0 109.655 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 75.57 82.88 0.45 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -46.96 -17.74 0.06 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.476 -1.014 . . . . 0.0 109.902 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' GLY . 22.7 t -56.91 -51.89 67.33 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.446 -0.784 . . . . 0.0 110.23 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -86.56 9.17 19.26 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.0 -1.062 . . . . 0.0 110.603 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.1 mm -121.6 165.92 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -140.98 114.02 8.48 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.436 -0.79 . . . . 0.0 108.947 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.419 HG22 ' CE2' ' A' ' 94' ' ' TYR . 4.7 p -86.63 138.26 31.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.208 -0.932 . . . . 0.0 109.591 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.9 t -106.1 92.31 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.537 -0.727 . . . . 0.0 109.2 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 50.41 -178.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.293 -0.88 . . . . 0.0 109.732 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.78 55.98 5.0 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -134.74 -31.94 1.02 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.567 -0.96 . . . . 0.0 109.626 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -169.02 -171.73 35.06 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.04 -1.552 . . . . 0.0 110.83 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.419 ' CE2' HG22 ' A' ' 88' ' ' THR . 14.2 m-85 -129.54 157.12 42.93 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 38.6 ttp -153.05 133.15 13.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.291 -0.881 . . . . 0.0 109.736 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.5 mp -91.0 145.49 24.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.567 -0.708 . . . . 0.0 109.092 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 99' ' ' ASN . . . -63.75 105.78 0.87 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -0.878 . . . . 0.0 109.361 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -67.65 68.74 0.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.905 . . . . 0.0 109.433 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 97' ' ' ALA . 2.6 m-80 51.22 42.16 28.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.3 -0.875 . . . . 0.0 109.654 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 47.9 mt -77.07 -12.06 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.316 -0.865 . . . . 0.0 108.817 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.16 -43.85 90.44 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.407 0.622 . . . . 0.0 109.404 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.6 p -79.29 48.92 0.92 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.339 -0.851 . . . . 0.0 109.389 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.574 179.984 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.6 m120 . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 51.39 42.24 29.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.196 -0.94 . . . . 0.0 109.522 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -165.11 23.26 0.15 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -52.38 164.71 0.3 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -1.173 . . . . 0.0 109.519 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.541 ' N ' ' ND2' ' A' ' 5' ' ' ASN . 0.1 OUTLIER -164.53 125.86 2.17 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.261 -0.899 . . . . 0.0 108.962 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -163.5 158.31 20.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.458 -0.776 . . . . 0.0 109.75 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.9 pt -149.32 163.7 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 80.9 p -128.46 132.24 48.39 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.498 -0.751 . . . . 0.0 109.755 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.26 91.49 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.04 -120.3 8.52 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.746 -1.741 . . . . 0.0 108.746 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -95.46 11.84 31.48 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.311 -1.111 . . . . 0.0 109.26 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.541 ' N ' HD12 ' A' ' 12' ' ' LEU . 8.0 mp -104.43 125.77 50.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.492 -0.755 . . . . 0.0 108.988 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -108.7 118.91 38.02 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.476 HD23 ' N ' ' A' ' 15' ' ' ASN . 0.9 OUTLIER -102.3 133.87 46.51 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.486 -0.759 . . . . 0.0 109.366 -179.139 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.476 ' N ' HD23 ' A' ' 14' ' ' LEU . 4.7 m-20 -135.53 98.19 3.87 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.43 -0.794 . . . . 0.0 109.467 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.5 t -73.91 -26.32 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.435 -0.791 . . . . 0.0 109.482 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.433 ' N ' HD21 ' A' ' 5' ' ' ASN . 0.1 OUTLIER -58.37 -50.39 73.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.429 -0.795 . . . . 0.0 109.679 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -98.86 -3.72 34.72 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.42 ' NH1' ' O ' ' A' ' 17' ' ' THR . 6.9 mpt_? 56.44 75.33 0.35 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.423 0.63 . . . . 0.0 109.419 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.409 HD23 ' CZ2' ' A' ' 22' ' ' TRP . 61.8 tp -163.99 149.58 10.84 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.8 t -134.25 146.52 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.381 -0.824 . . . . 0.0 109.807 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.409 ' CZ2' HD23 ' A' ' 20' ' ' LEU . 28.5 m-90 -113.23 142.54 45.69 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.0 tp -121.86 105.47 10.39 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 71.3 40.55 60.63 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.132 -1.987 . . . . 0.0 108.132 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 70.91 -10.79 0.71 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.996 -0.708 . . . . 0.0 109.645 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.426 ' H ' ' C ' ' A' ' 24' ' ' GLY . 32.2 p -91.66 142.14 27.94 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.041 -1.037 . . . . 0.0 109.631 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.42 112.99 2.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 110.245 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.8 tp -74.66 128.38 35.42 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 3.1 m-20 -96.02 100.64 12.29 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.171 -0.956 . . . . 0.0 110.327 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.9 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.3 pt? -121.4 134.13 55.1 Favored 'General case' 0 N--CA 1.504 2.229 0 CA-C-O 121.588 0.709 . . . . 0.0 109.35 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.4 p -52.11 152.48 5.7 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.184 -0.948 . . . . 0.0 109.218 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.34 -45.22 27.98 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.622 1.548 . . . . 0.0 110.804 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -56.19 -47.29 78.64 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.189 -0.944 . . . . 0.0 108.487 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -55.16 -36.36 65.75 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.341 -0.849 . . . . 0.0 109.033 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -57.6 -32.28 67.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.268 -0.895 . . . . 0.0 108.982 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.9 -49.97 63.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 108.983 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.64 ' N ' HD12 ' A' ' 37' ' ' LEU . 7.4 mp -58.8 -39.05 79.98 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 12.8 tp -57.14 -42.6 81.26 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.1 t -54.11 -39.2 66.19 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.347 -0.845 . . . . 0.0 109.549 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.2 mmt-85 -76.37 -45.19 33.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.176 -0.953 . . . . 0.0 109.425 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.8 mt -59.46 -52.33 66.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 110.311 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.51 ' SD ' ' N ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -63.93 -38.07 89.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.089 -1.007 . . . . 0.0 110.429 -178.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.51 ' N ' ' SD ' ' A' ' 42' ' ' MET . 46.3 tpp -55.57 -29.6 59.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.062 -1.024 . . . . 0.0 108.762 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -119.36 42.15 2.93 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.89 132.68 51.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.221 -0.925 . . . . 0.0 109.956 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.4 ' C ' ' SD ' ' A' ' 95' ' ' MET . . . 90.35 -6.22 82.46 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.6 t -121.85 116.17 30.36 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.644 -0.915 . . . . 0.0 108.717 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -47.62 119.89 4.11 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.017 1.145 . . . . 0.0 111.676 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.5 t -97.59 137.23 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.46 -0.775 . . . . 0.0 110.376 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.47 ' CD2' ' H ' ' A' ' 52' ' ' GLU . 17.6 t-160 -63.89 121.07 13.17 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.363 -0.836 . . . . 0.0 108.792 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.487 ' NH1' ' OE1' ' A' ' 71' ' ' GLU . 11.3 ttm180 -52.89 -18.42 1.92 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.389 -0.819 . . . . 0.0 108.937 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.518 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 34.2 tt0 -65.48 -48.87 71.13 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.567 -0.708 . . . . 0.0 109.563 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.1 mt -58.0 -31.75 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.08 -1.012 . . . . 0.0 110.177 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.06 -33.06 74.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.042 -1.036 . . . . 0.0 108.991 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -74.06 -33.23 63.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.999 -1.063 . . . . 0.0 108.43 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 44.0 m-80 -64.82 -22.54 67.01 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.543 -0.723 . . . . 0.0 109.764 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.87 -55.54 31.27 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.1 -1.0 . . . . 0.0 109.253 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.6 mt -77.7 -12.86 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.263 -0.898 . . . . 0.0 109.436 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -145.2 70.61 1.27 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.22 -0.925 . . . . 0.0 109.251 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.472 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 7.9 t -83.06 -48.52 10.5 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.228 -0.92 . . . . 0.0 109.798 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -87.23 41.86 1.0 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.206 -0.934 . . . . 0.0 109.674 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.485 ' C ' HD22 ' A' ' 63' ' ' ASN . 54.2 m-20 -158.31 -55.85 0.07 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.197 -0.939 . . . . 0.0 109.733 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.635 HD22 ' N ' ' A' ' 63' ' ' ASN . 0.6 OUTLIER 54.14 102.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.502 -0.749 . . . . 0.0 109.699 -179.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -157.1 62.74 2.79 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.191 -0.943 . . . . 0.0 109.351 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -78.43 12.79 2.01 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.627 2.218 . . . . 0.0 111.989 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.12 -29.02 66.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 109.472 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 57.2 p -63.86 -141.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 109.527 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.495 ' C ' ' H ' ' A' ' 70' ' ' LEU . 32.4 m120 -156.88 -162.47 1.24 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.277 -0.889 . . . . 0.0 109.33 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.5 m 63.06 -7.47 0.15 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.605 -0.684 . . . . 0.0 110.114 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.495 ' H ' ' C ' ' A' ' 68' ' ' ASN . 2.4 pp -70.47 -43.7 69.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.007 -1.058 . . . . 0.0 109.264 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.487 ' OE1' ' NH1' ' A' ' 51' ' ' ARG . 33.6 tt0 -71.75 -33.01 68.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 109.453 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.0 t -70.77 -38.71 73.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.255 -0.903 . . . . 0.0 108.977 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -56.32 -39.6 73.03 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.99 -37.03 79.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -62.49 -36.5 82.69 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -71.57 -41.88 68.49 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.67 -38.11 73.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 0.0 109.412 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -50.57 -47.84 57.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.927 . . . . 0.0 109.669 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -62.47 -24.93 67.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 110.496 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -75.68 -43.6 46.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.936 -1.102 . . . . 0.0 110.466 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.9 pt -76.61 -22.43 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.142 -0.974 . . . . 0.0 109.945 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 82.67 87.76 0.73 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -44.79 -17.17 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.722 -0.87 . . . . 0.0 110.422 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.533 ' C ' ' HE ' ' A' ' 85' ' ' ARG . 12.9 t -51.72 -47.59 63.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.219 -0.925 . . . . 0.0 109.701 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.563 ' HE ' ' N ' ' A' ' 85' ' ' ARG . 4.4 mmp_? -83.41 9.66 10.56 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.241 -0.912 . . . . 0.0 110.596 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 87' ' ' ARG . 5.1 mp -135.67 159.2 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.197 -0.939 . . . . 0.0 109.754 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.49 ' N ' HG22 ' A' ' 86' ' ' ILE . 39.4 ttm180 -123.09 128.01 49.53 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.4 p -94.09 141.03 29.0 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.082 -1.011 . . . . 0.0 109.778 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.508 HG12 ' H ' ' A' ' 91' ' ' GLY . 22.2 t -107.5 104.49 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -50.5 -11.0 0.07 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.217 -0.927 . . . . 0.0 109.792 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.508 ' H ' HG12 ' A' ' 89' ' ' VAL . . . -64.2 -85.07 0.07 OUTLIER Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.423 ' CD2' ' CD2' ' A' ' 50' ' ' HIS . 1.6 p90 -170.47 23.46 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.384 -1.068 . . . . 0.0 109.539 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.468 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . -146.23 -163.43 10.34 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 40.7 m-85 -150.99 170.69 18.74 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.363 -1.08 . . . . 0.0 108.579 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.4 ' SD ' ' C ' ' A' ' 46' ' ' GLY . 50.4 ttp -162.5 136.66 6.45 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.142 -0.974 . . . . 0.0 110.469 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 96' ' ' LEU . 10.2 mp -88.69 139.04 30.87 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.07 133.48 44.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 109.473 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -53.05 -80.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.571 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -163.76 91.08 0.64 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.473 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.2 mm -73.67 -11.48 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 109.067 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -66.43 -27.85 68.16 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.712 -0.618 . . . . 0.0 109.501 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.9 p -63.74 -15.27 58.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.522 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.228 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -73.78 56.93 0.57 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 109.508 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 60.58 30.07 71.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -170.13 141.05 2.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -1.17 . . . . 0.0 109.613 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -158.72 122.05 3.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.336 -0.852 . . . . 0.0 108.877 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -161.36 155.59 22.65 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.348 -0.845 . . . . 0.0 109.746 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.8 pt -148.03 163.33 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.378 -0.826 . . . . 0.0 109.07 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -142.24 152.55 43.17 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.223 -0.923 . . . . 0.0 109.777 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.6 t -147.98 95.97 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.27 -116.38 4.3 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.061 -1.615 . . . . 0.0 109.061 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -103.5 7.63 37.83 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.49 -1.006 . . . . 0.0 109.697 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 12' ' ' LEU . 9.3 mp -102.35 125.4 49.04 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.346 -0.846 . . . . 0.0 109.224 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -118.07 124.31 47.76 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.537 ' C ' HD22 ' A' ' 15' ' ' ASN . 8.1 mp -107.37 140.24 40.61 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.531 -0.731 . . . . 0.0 109.153 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.537 HD22 ' C ' ' A' ' 14' ' ' LEU . 2.1 m-80 -135.6 97.37 3.65 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.554 -0.716 . . . . 0.0 109.184 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.1 t -69.87 -29.62 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.375 -0.828 . . . . 0.0 109.306 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.425 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -63.94 -55.17 24.56 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.44 -0.787 . . . . 0.0 109.266 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.7 mmt85 -82.68 -16.04 49.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.96 . . . . 0.0 108.481 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 63.36 70.69 0.53 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.609 0.718 . . . . 0.0 109.152 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.7 tp -163.78 154.15 15.42 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.7 t -136.21 143.08 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.297 -0.877 . . . . 0.0 109.853 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -107.93 145.18 34.16 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 67.1 tp -128.75 104.03 7.4 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.7 44.68 38.33 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 64.36 -3.17 0.53 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 122.175 -0.603 . . . . 0.0 110.282 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.4 p -99.31 139.92 34.26 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 120.995 -1.066 . . . . 0.0 109.612 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.3 116.79 5.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.227 -0.921 . . . . 0.0 110.58 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.9 tp -85.0 128.95 34.85 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -103.93 120.84 41.87 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.347 -0.846 . . . . 0.0 109.825 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.834 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.1 pt? -140.51 148.66 41.41 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.398 0.618 . . . . 0.0 109.453 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.3 p -67.32 151.22 97.37 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.057 -1.027 . . . . 0.0 109.83 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -45.19 -41.01 16.65 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 121.928 1.752 . . . . 0.0 112.366 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -53.25 -50.65 64.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.763 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -60.13 -27.62 67.2 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.293 -0.879 . . . . 0.0 109.273 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -71.21 -31.05 67.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.114 -0.991 . . . . 0.0 109.145 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.99 -52.56 10.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.179 -0.95 . . . . 0.0 109.259 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 mt -59.27 -37.08 76.75 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 23.2 tp -63.19 -43.96 96.72 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.712 -0.618 . . . . 0.0 109.706 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.8 m -53.25 -37.75 62.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.225 -0.922 . . . . 0.0 110.158 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -80.35 -43.4 21.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 0.0 109.373 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 27.7 tp -63.73 -40.03 95.75 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.285 -0.885 . . . . 0.0 110.212 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -72.47 -38.95 68.08 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.77 -1.206 . . . . 0.0 109.544 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.468 ' O ' ' SD ' ' A' ' 43' ' ' MET . 1.3 tmt? -53.91 -28.78 38.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.304 -0.872 . . . . 0.0 108.71 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -115.7 43.67 2.04 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.06 140.22 48.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.253 -0.904 . . . . 0.0 110.347 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.09 -17.57 59.0 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.4 m -119.63 151.87 52.49 Favored Pre-proline 0 N--CA 1.501 2.113 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -71.88 119.46 6.21 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.56 1.507 . . . . 0.0 111.519 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.1 t -98.9 136.09 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.399 -0.813 . . . . 0.0 110.209 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -73.7 125.66 28.56 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.276 -0.89 . . . . 0.0 108.619 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.495 ' NE ' ' O ' ' A' ' 92' ' ' PHE . 13.1 ptp180 -55.24 -15.86 2.77 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.223 -0.923 . . . . 0.0 108.779 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.571 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 41.2 tt0 -61.82 -56.82 15.43 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.623 -0.673 . . . . 0.0 109.481 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.6 mt -54.64 -29.28 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.254 -0.904 . . . . 0.0 110.33 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.8 mt -71.24 -46.72 60.41 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 108.609 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.577 ' CE1' ' CD2' ' A' ' 59' ' ' TYR . 57.3 t80 -51.96 -36.05 48.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.957 -1.089 . . . . 0.0 108.957 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.571 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 31.6 m-80 -65.18 -20.86 66.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.663 -0.648 . . . . 0.0 110.476 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.3 -55.48 34.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.694 -1.254 . . . . 0.0 109.895 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.0 mm -82.35 -37.84 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.234 -0.916 . . . . 0.0 110.544 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.577 ' CD2' ' CE1' ' A' ' 55' ' ' TYR . 97.7 m-85 -102.89 152.85 20.81 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.362 -0.836 . . . . 0.0 109.791 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.5 t -165.44 21.19 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.057 -1.027 . . . . 0.0 109.617 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.435 ' H ' ' H ' ' A' ' 62' ' ' ASP . 41.3 p-90 -167.35 0.25 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.274 -0.892 . . . . 0.0 109.014 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 63' ' ' ASN . 11.4 p-10 -60.65 -112.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.412 -0.805 . . . . 0.0 109.432 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.453 ' H ' ' CG ' ' A' ' 62' ' ' ASP . 50.4 m-80 -158.23 -90.48 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.15 -0.969 . . . . 0.0 109.346 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -168.46 61.9 0.51 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.404 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.93 77.22 3.83 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.489 2.126 . . . . 0.0 111.852 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.64 -8.46 55.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 109.542 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 t -54.73 163.63 0.92 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.347 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -68.81 107.72 3.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.921 . . . . 0.0 109.34 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.1 m -165.58 -75.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.366 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 pp -56.08 -37.79 69.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.353 -0.842 . . . . 0.0 109.644 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.417 ' OE2' ' NH1' ' A' ' 51' ' ' ARG . 7.2 tp10 -67.03 -31.19 71.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.169 -0.957 . . . . 0.0 109.456 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.3 t -73.33 -41.31 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.139 -0.976 . . . . 0.0 109.115 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -56.99 -38.22 72.74 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.0 mm -64.14 -36.91 78.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -67.65 -33.45 74.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.23 -0.919 . . . . 0.0 109.4 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -71.05 -41.9 70.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.34 -0.85 . . . . 0.0 109.802 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.0 mt -71.44 -42.23 68.48 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.291 -0.881 . . . . 0.0 109.892 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -49.7 -44.4 48.14 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.084 -1.01 . . . . 0.0 109.247 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -62.83 -26.8 68.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 110.045 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -75.78 -43.22 47.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.987 -1.071 . . . . 0.0 110.508 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 pt -82.21 -30.26 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.023 -1.048 . . . . 0.0 109.575 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 97.39 85.02 1.77 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -44.48 -16.68 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.545 -0.974 . . . . 0.0 110.396 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 82' ' ' GLY . 56.2 m -51.82 -44.8 63.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.083 -1.011 . . . . 0.0 109.381 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -73.71 8.75 1.74 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.296 -0.878 . . . . 0.0 109.481 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 87' ' ' ARG . 96.6 mt -136.37 159.76 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.288 -0.882 . . . . 0.0 109.159 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.49 HH21 ' CE ' ' A' ' 95' ' ' MET . 39.1 ttp180 -137.28 124.2 21.38 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.555 -0.716 . . . . 0.0 109.271 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.3 p -88.87 141.66 28.31 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.142 -0.974 . . . . 0.0 109.386 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.4 t -100.7 106.92 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.479 -0.763 . . . . 0.0 110.377 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.51 ' N ' ' CD ' ' A' ' 90' ' ' ARG . 0.4 OUTLIER 48.72 37.76 10.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.512 -0.743 . . . . 0.0 110.1 179.206 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.63 52.41 20.12 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.539 ' CD2' ' N ' ' A' ' 93' ' ' GLY . 43.9 t80 -132.56 -81.93 0.49 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.627 -0.925 . . . . 0.0 108.611 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.539 ' N ' ' CD2' ' A' ' 92' ' ' PHE . . . -98.78 -147.57 22.23 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -150.98 162.34 41.02 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.357 -1.084 . . . . 0.0 108.407 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.49 ' CE ' HH21 ' A' ' 87' ' ' ARG . 43.9 ttp -163.55 136.16 5.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.179 -0.951 . . . . 0.0 110.548 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.3 mp -91.48 127.32 36.87 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.77 99.69 2.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.318 -0.863 . . . . 0.0 109.42 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -54.11 117.21 3.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.329 -0.857 . . . . 0.0 109.539 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 21.2 m120 53.22 97.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.333 -0.855 . . . . 0.0 109.584 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.4 mt -72.31 -11.94 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.251 -0.906 . . . . 0.0 108.776 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -173.52 -24.38 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.709 -0.619 . . . . 0.0 109.437 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.6 p -59.1 173.0 0.51 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.566 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.462 179.976 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -87.72 50.69 2.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 162.95 -28.79 0.25 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.1 t70 51.7 66.41 1.2 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -1.126 . . . . 0.0 109.754 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -155.87 119.86 4.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.15 -0.969 . . . . 0.0 108.947 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -162.09 157.42 23.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.326 -0.859 . . . . 0.0 109.713 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.4 pt -147.27 162.54 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.297 -0.877 . . . . 0.0 109.163 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.8 t -145.25 156.11 43.64 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.19 -0.944 . . . . 0.0 109.741 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 9' ' ' VAL . 5.1 p -152.72 101.85 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.15 -109.64 2.84 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.666 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -112.07 4.88 18.31 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.506 -0.996 . . . . 0.0 110.093 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 12' ' ' LEU . 10.4 mp -99.07 124.9 44.41 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.151 -0.968 . . . . 0.0 109.083 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -118.53 126.13 51.35 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.528 ' C ' HD22 ' A' ' 15' ' ' ASN . 5.7 tt -114.15 115.19 27.12 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.528 HD22 ' C ' ' A' ' 14' ' ' LEU . 1.7 m120 -113.2 102.21 10.15 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.573 -0.705 . . . . 0.0 109.313 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.3 t -74.9 -27.44 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.439 -0.788 . . . . 0.0 109.454 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.44 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -60.42 -54.1 49.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.536 -0.728 . . . . 0.0 109.507 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.499 ' NH2' ' OD1' ' A' ' 15' ' ' ASN . 89.2 mtm-85 -92.21 -13.43 30.54 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.12 -0.987 . . . . 0.0 108.714 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.5 tpp85 66.31 67.14 0.46 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.419 0.628 . . . . 0.0 109.393 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.5 mt -143.47 158.47 43.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.228 -0.92 . . . . 0.0 108.812 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 t -142.38 120.75 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.283 -0.885 . . . . 0.0 109.757 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 17.8 m-90 -98.93 150.87 21.49 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.175 -0.953 . . . . 0.0 108.812 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.9 tp -136.94 107.05 6.33 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.84 43.59 73.58 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 64.24 -1.65 0.69 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 122.169 -0.606 . . . . 0.0 110.346 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.4 p -100.58 139.9 35.6 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 120.973 -1.079 . . . . 0.0 109.383 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.04 115.54 6.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 0.0 110.161 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.9 tp -78.82 132.31 36.81 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -102.86 112.59 25.46 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.312 -0.868 . . . . 0.0 109.972 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.837 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.2 pt? -139.63 148.9 43.1 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.364 -0.835 . . . . 0.0 109.28 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.407 ' OG1' ' OE2' ' A' ' 34' ' ' GLU . 4.1 p -60.52 152.98 63.47 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.056 -1.027 . . . . 0.0 108.881 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -58.95 -41.67 59.65 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.0 1.8 . . . . 0.0 111.735 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -53.97 -45.66 71.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.027 -1.046 . . . . 0.0 109.252 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.407 ' OE2' ' OG1' ' A' ' 31' ' ' THR . 69.8 mt-10 -60.71 -34.61 74.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.322 -0.861 . . . . 0.0 109.223 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.4 ' OH ' ' O ' ' A' ' 15' ' ' ASN . 15.9 t80 -55.62 -34.1 64.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 108.706 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.05 -53.12 28.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 109.303 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 37' ' ' LEU . 8.3 mp -60.3 -39.42 86.88 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.9 tp -59.57 -43.74 93.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.606 -0.684 . . . . 0.0 109.546 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.502 ' C ' ' HE ' ' A' ' 40' ' ' ARG . 33.8 t -52.91 -34.28 54.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.153 -0.967 . . . . 0.0 109.458 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.502 ' HE ' ' C ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -79.44 -45.29 19.72 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 0.0 109.181 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.3 mt -56.72 -40.66 76.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.045 -1.034 . . . . 0.0 109.285 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.7 tpp -75.44 -35.0 61.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 109.56 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.46 ' SD ' ' NH2' ' A' ' 40' ' ' ARG . 24.7 ttt -53.92 -25.93 22.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.327 -0.858 . . . . 0.0 109.229 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -129.08 43.17 3.19 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.74 -0.6 . . . . 0.0 109.678 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.81 143.8 55.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.025 -1.047 . . . . 0.0 109.958 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.462 ' O ' ' SD ' ' A' ' 95' ' ' MET . . . 101.02 -22.75 38.18 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.08 154.55 64.82 Favored Pre-proline 0 N--CA 1.503 2.206 0 O-C-N 121.599 -0.942 . . . . 0.0 108.676 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.42 120.91 7.83 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.826 1.684 . . . . 0.0 111.083 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 80.5 t -92.77 137.04 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 0.0 110.326 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.437 ' CE1' ' CD ' ' A' ' 52' ' ' GLU . 9.0 t-160 -68.83 121.03 15.71 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -51.21 -16.82 0.56 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 0.0 109.792 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.522 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 80.8 mt-10 -65.97 -48.39 71.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.342 -0.849 . . . . 0.0 109.801 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.2 mt -54.65 -30.87 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.19 -0.944 . . . . 0.0 109.949 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.0 mt -70.58 -34.13 71.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.932 . . . . 0.0 109.199 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.497 ' O ' ' N ' ' A' ' 59' ' ' TYR . 3.0 m-85 -70.93 -35.44 72.24 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 41.3 m-80 -59.39 -20.8 57.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.545 -0.722 . . . . 0.0 110.051 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.06 -53.63 52.82 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.074 -1.016 . . . . 0.0 109.89 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.49 ' O ' ' CG ' ' A' ' 59' ' ' TYR . 4.1 mt -125.92 15.91 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-O 121.508 0.67 . . . . 0.0 109.555 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.497 ' N ' ' O ' ' A' ' 55' ' ' TYR . 78.4 m-85 -156.26 98.26 1.84 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.945 -1.097 . . . . 0.0 109.674 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.7 t -89.91 -18.56 25.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.293 -0.879 . . . . 0.0 109.367 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.405 ' C ' ' N ' ' A' ' 63' ' ' ASN . 91.3 m95 -54.11 -26.89 29.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.0 109.603 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.9 t70 53.3 11.6 0.27 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 109.625 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 20.3 p-10 -53.69 -41.07 66.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.502 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 52.13 71.84 1.36 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.345 -0.847 . . . . 0.0 109.809 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -48.0 129.86 18.93 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.64 2.227 . . . . 0.0 112.082 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.32 -27.74 68.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.14 -0.975 . . . . 0.0 109.634 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.8 p -71.58 142.23 50.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.564 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.0 m-20 -58.8 128.04 35.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.403 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.0 m -165.92 -74.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 109.419 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.7 mt -70.12 -37.46 75.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.298 -0.876 . . . . 0.0 109.658 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -60.3 -32.43 71.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.081 -1.012 . . . . 0.0 109.504 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.85 -38.92 74.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.214 -0.929 . . . . 0.0 109.096 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -57.22 -38.01 73.1 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.2 mt -63.81 -38.93 83.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.418 ' CE1' HH21 ' A' ' 78' ' ' ARG . 1.2 t60 -60.17 -36.55 77.84 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.511 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.576 ' ND2' ' NZ ' ' A' ' 80' ' ' LYS . 3.2 t-20 -73.34 -41.61 63.26 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.689 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -66.41 -42.93 87.06 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.418 HH21 ' CE1' ' A' ' 75' ' ' HIS . 52.6 ttp180 -50.15 -50.99 47.07 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.513 -0.742 . . . . 0.0 110.936 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -65.24 -29.27 70.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.963 -1.086 . . . . 0.0 110.613 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.576 ' NZ ' ' ND2' ' A' ' 76' ' ' ASN . 61.7 mttp -66.44 -47.94 71.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.9 -1.125 . . . . 0.0 110.2 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 21.6 pt -74.83 -24.6 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.979 -1.075 . . . . 0.0 110.17 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 84.3 84.37 0.95 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -45.05 -17.01 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.689 -0.889 . . . . 0.0 110.484 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 82' ' ' GLY . 59.5 m -55.12 -48.9 73.0 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.243 -0.911 . . . . 0.0 110.069 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.702 ' C ' HD12 ' A' ' 86' ' ' ILE . 8.5 mpt_? -81.48 9.78 6.86 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.972 -1.08 . . . . 0.0 110.473 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.702 HD12 ' C ' ' A' ' 85' ' ' ARG . 3.6 mp -130.67 162.63 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.5 ' N ' HG22 ' A' ' 86' ' ' ILE . 40.3 ttm180 -118.75 93.61 4.16 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.443 -0.786 . . . . 0.0 109.478 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.0 p -66.1 134.77 53.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.315 -0.866 . . . . 0.0 109.511 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 91' ' ' GLY . 59.2 t -102.3 98.34 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.6 mtm-85 -61.61 78.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.407 -0.808 . . . . 0.0 109.122 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 89' ' ' VAL . . . -164.29 -69.34 0.02 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -170.87 19.36 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.209 -1.171 . . . . 0.0 109.583 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.46 -167.3 19.08 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.455 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -146.04 170.06 17.42 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.462 ' SD ' ' O ' ' A' ' 46' ' ' GLY . 6.1 ttt -161.1 127.81 4.02 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.932 -1.105 . . . . 0.0 110.133 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 96' ' ' LEU . 9.4 mp -81.27 139.98 35.12 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.13 106.19 5.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 109.455 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.408 ' O ' ' O ' ' A' ' 99' ' ' ASN . 10.2 p30 -70.18 124.37 23.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.451 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.408 ' O ' ' O ' ' A' ' 98' ' ' ASN . 2.3 m-80 51.1 97.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.324 -0.86 . . . . 0.0 109.773 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.2 mm -68.43 -13.04 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.173 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -76.6 -14.95 59.95 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.708 -0.62 . . . . 0.0 109.497 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.1 t -167.77 152.18 6.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.207 -0.933 . . . . 0.0 109.499 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.412 179.973 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -71.72 65.29 0.49 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.359 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 65.35 32.32 83.27 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 29.4 p-10 -164.13 179.13 7.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -1.169 . . . . 0.0 109.468 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -172.37 107.97 0.2 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.024 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -161.55 154.29 20.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.114 -0.991 . . . . 0.0 109.911 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.7 pt -145.86 163.29 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.476 -0.765 . . . . 0.0 108.983 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.8 p -139.88 151.99 46.08 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.304 -0.873 . . . . 0.0 109.623 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.1 t -146.79 97.6 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.475 ' CA ' HD22 ' A' ' 99' ' ' ASN . . . 75.61 -113.68 4.0 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -105.52 5.92 31.86 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.457 -1.025 . . . . 0.0 110.079 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.5 mt -100.69 126.46 47.21 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.129 -0.982 . . . . 0.0 109.186 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -118.05 124.84 49.08 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.475 HD12 HG22 ' A' ' 21' ' ' VAL . 5.6 tp -106.87 141.4 38.15 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.737 -0.602 . . . . 0.0 109.579 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.59 ' ND2' ' NH2' ' A' ' 18' ' ' ARG . 14.8 m120 -135.57 97.69 3.74 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.325 -0.859 . . . . 0.0 109.143 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.1 t -76.63 -28.93 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.297 -0.877 . . . . 0.0 109.97 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.406 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -57.65 -53.44 58.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 0.0 109.405 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.59 ' NH2' ' ND2' ' A' ' 15' ' ' ASN . 12.7 ptt-85 -96.5 -10.32 27.66 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.277 -0.889 . . . . 0.0 108.807 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 64.81 73.66 0.41 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.456 0.646 . . . . 0.0 109.3 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.0 tp -156.98 154.42 29.62 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.475 HG22 HD12 ' A' ' 14' ' ' LEU . 12.3 t -140.1 133.54 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.273 -0.892 . . . . 0.0 109.773 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.488 ' CZ3' ' OD1' ' A' ' 15' ' ' ASN . 8.5 m-90 -100.34 144.26 29.56 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.345 -0.847 . . . . 0.0 109.238 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 25' ' ' GLU . 10.7 tp -117.96 100.24 7.43 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.67 -73.2 0.25 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 23' ' ' LEU . 74.0 mt-10 -154.45 23.13 0.47 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.219 -1.165 . . . . 0.0 109.406 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.3 p -138.83 141.82 38.67 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.455 -0.778 . . . . 0.0 110.07 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.9 121.92 16.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.502 -0.749 . . . . 0.0 109.538 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.5 tp -78.48 128.45 33.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 108.614 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -101.4 110.59 22.61 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.328 -0.858 . . . . 0.0 109.923 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.75 145.75 48.74 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.2 p -58.33 140.26 83.91 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.1 -1.0 . . . . 0.0 109.455 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -44.68 -43.99 14.26 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.526 1.484 . . . . 0.0 112.052 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.446 ' CD ' ' H ' ' A' ' 33' ' ' LYS . 2.4 mptp? -53.54 -46.43 70.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 108.99 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -59.49 -35.07 73.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.348 -0.845 . . . . 0.0 109.213 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.464 ' HH ' ' C ' ' A' ' 15' ' ' ASN . 15.0 t80 -56.66 -33.16 66.09 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.916 . . . . 0.0 109.066 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.422 ' O ' ' OD2' ' A' ' 57' ' ' ASP . . . -68.62 -52.82 27.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.431 -0.793 . . . . 0.0 109.524 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.611 ' N ' HD12 ' A' ' 37' ' ' LEU . 7.7 mp -63.54 -36.59 84.27 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.3 tp -64.46 -46.98 80.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.55 -0.719 . . . . 0.0 109.329 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.8 m -53.28 -29.68 34.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.321 -0.862 . . . . 0.0 109.956 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -75.73 -40.57 55.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.065 -1.022 . . . . 0.0 110.018 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.8 mt -61.04 -44.39 97.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.975 -1.078 . . . . 0.0 110.179 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.7 mmm -65.87 -37.07 85.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.819 -1.176 . . . . 0.0 109.739 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 18.1 ttt -57.41 -32.36 66.77 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 108.994 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -116.05 43.46 2.14 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.06 129.12 39.0 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.245 -0.909 . . . . 0.0 110.165 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.89 -11.93 52.87 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 p -124.71 151.89 68.51 Favored Pre-proline 0 N--CA 1.504 2.242 0 O-C-N 121.529 -0.983 . . . . 0.0 108.652 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.18 120.46 6.59 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.781 1.654 . . . . 0.0 111.634 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.5 t -95.69 132.87 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.263 -0.898 . . . . 0.0 109.95 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.591 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 15.2 t-160 -73.04 126.19 29.41 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.19 -0.944 . . . . 0.0 108.545 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -50.36 -15.07 0.21 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.223 -0.923 . . . . 0.0 109.836 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.527 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 77.4 mt-10 -66.87 -46.35 75.23 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.319 -0.863 . . . . 0.0 109.881 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.5 mm -57.56 -32.36 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.083 -1.011 . . . . 0.0 109.923 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.42 -45.3 69.5 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.241 -0.912 . . . . 0.0 108.746 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -62.33 -36.86 83.52 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 74.1 m-80 -70.33 -21.77 62.87 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.641 -0.662 . . . . 0.0 109.993 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 36' ' ' ALA . 5.2 t0 -55.27 -54.31 45.15 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 120.81 -1.181 . . . . 0.0 109.271 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 68.2 mt -93.94 -37.64 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.276 -0.89 . . . . 0.0 109.504 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -103.86 -163.24 0.96 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.763 0.792 . . . . 0.0 109.792 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.7 m -171.57 -31.97 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.506 ' O ' ' CD2' ' A' ' 61' ' ' TRP . 31.7 p-90 -75.89 82.02 2.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.0 108.973 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 25.8 p-10 -61.73 -125.03 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.354 -0.841 . . . . 0.0 109.792 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 52.51 16.31 0.61 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.916 -1.115 . . . . 0.0 109.354 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -70.1 150.71 96.13 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.145 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.68 145.22 41.07 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.111 1.874 . . . . 0.0 111.819 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.5 8.35 1.86 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 109.565 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.2 m -57.93 141.85 48.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -0.931 . . . . 0.0 109.611 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.427 ' O ' ' ND2' ' A' ' 68' ' ' ASN . 2.6 p-10 -65.39 117.64 8.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.882 . . . . 0.0 109.474 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.6 m -165.75 -75.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.923 . . . . 0.0 109.334 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 13.9 mt -70.64 -33.49 71.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 109.403 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -60.36 -35.59 76.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.009 . . . . 0.0 109.385 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.2 t -73.82 -38.95 51.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.166 -0.959 . . . . 0.0 108.827 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -58.71 -40.38 83.53 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 62.7 mt -62.98 -31.48 52.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -72.28 -22.38 61.21 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 118.947 -1.101 . . . . 0.0 108.086 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -77.43 -45.43 25.8 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.6 -0.687 . . . . 0.0 110.337 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 pp -74.58 -43.98 53.0 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.813 -1.179 . . . . 0.0 109.747 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -50.59 -46.12 57.68 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.554 -0.717 . . . . 0.0 110.144 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -65.65 -13.8 59.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.167 -0.958 . . . . 0.0 110.118 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -81.43 -40.23 23.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.084 -1.01 . . . . 0.0 110.02 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 11.0 pt -78.56 -14.94 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 109.777 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 85.68 81.41 1.12 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -44.42 -16.41 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.779 -0.836 . . . . 0.0 110.583 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 82' ' ' GLY . 44.5 t -50.17 -43.95 52.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.144 -0.973 . . . . 0.0 109.612 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -77.52 9.05 3.59 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.234 -0.916 . . . . 0.0 109.937 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 87' ' ' ARG . 82.0 mt -137.97 158.12 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.2 -0.937 . . . . 0.0 109.1 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.422 ' N ' HG22 ' A' ' 86' ' ' ILE . 65.7 ttt-85 -141.04 122.62 15.12 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.598 -0.689 . . . . 0.0 109.212 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.7 p -89.36 142.51 27.6 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.302 -0.874 . . . . 0.0 109.282 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 89' ' ' VAL . 8.1 p -101.62 124.37 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.405 -0.809 . . . . 0.0 110.171 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.5 ttp85 45.0 28.88 0.41 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.513 -0.742 . . . . 0.0 110.204 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.44 55.66 12.73 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.591 ' CZ ' ' CD2' ' A' ' 50' ' ' HIS . 16.7 t80 -138.53 -68.66 0.45 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.524 -0.986 . . . . 0.0 108.829 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.46 ' N ' ' CD2' ' A' ' 92' ' ' PHE . . . -102.08 -147.8 20.14 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -150.76 159.24 44.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.452 -1.028 . . . . 0.0 108.257 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 43.1 ttp -163.82 127.61 2.7 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.131 -0.981 . . . . 0.0 110.391 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 96' ' ' LEU . 9.6 mp -90.2 133.22 35.05 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.88 137.2 50.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -0.931 . . . . 0.0 109.498 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -51.63 -75.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.618 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.475 HD22 ' CA ' ' A' ' 10' ' ' GLY . 31.3 m120 -158.12 41.71 0.28 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.388 -0.82 . . . . 0.0 109.551 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.3 mt -80.71 -2.06 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.274 -0.891 . . . . 0.0 108.858 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -75.82 -30.09 58.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 76.4 p -58.17 96.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.408 -0.808 . . . . 0.0 109.376 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.576 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.458 ' C ' ' H ' ' A' ' 3' ' ' GLY . 11.9 m120 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -71.0 40.67 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 0.0 109.795 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 1' ' ' ASN . . . -160.85 19.62 0.21 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -164.05 78.66 0.39 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.312 -1.11 . . . . 0.0 109.444 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -165.71 113.54 0.95 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.266 -0.896 . . . . 0.0 108.975 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -162.36 157.44 22.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.109 -0.994 . . . . 0.0 110.008 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.4 pt -144.78 162.91 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.309 -0.869 . . . . 0.0 109.008 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 m -143.05 152.92 42.41 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.284 -0.885 . . . . 0.0 109.699 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 9' ' ' VAL . 2.9 p -149.41 99.2 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.54 -116.64 4.74 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -104.06 6.95 36.31 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.439 -1.036 . . . . 0.0 109.622 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.7 mt -100.68 122.08 42.73 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.274 -0.891 . . . . 0.0 109.602 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -114.84 134.44 55.13 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.4 tt -126.55 127.9 46.01 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.553 -0.717 . . . . 0.0 109.823 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 19' ' ' ARG . 5.3 m-20 -121.44 104.41 9.66 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.757 -0.59 . . . . 0.0 109.62 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.2 t -68.77 -30.31 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.264 -0.898 . . . . 0.0 109.44 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.74 -53.98 38.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.908 . . . . 0.0 109.16 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.2 mtp-105 -83.72 -16.52 44.56 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 15' ' ' ASN . 15.1 tpp180 58.78 75.73 0.38 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.449 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 23.9 tp -170.33 127.35 0.81 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.359 -0.838 . . . . 0.0 108.964 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.1 t -104.33 138.21 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.509 -0.745 . . . . 0.0 109.682 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.449 ' CZ3' ' O ' ' A' ' 20' ' ' LEU . 28.5 m-90 -105.6 142.26 35.64 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.454 -0.779 . . . . 0.0 109.225 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.7 tp -118.11 102.26 8.88 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.94 44.95 54.3 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 107.946 -2.062 . . . . 0.0 107.946 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 65.65 -1.23 1.07 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 122.132 -0.628 . . . . 0.0 110.218 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.0 p -99.23 140.94 32.65 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.042 -1.036 . . . . 0.0 109.699 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.53 110.47 1.99 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.921 . . . . 0.0 109.862 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.9 tp -71.43 133.37 45.86 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -91.01 94.06 9.47 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.051 -1.031 . . . . 0.0 110.267 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.902 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.4 pt? -127.45 135.54 50.56 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.1 p -63.81 152.98 85.51 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 120.978 -1.076 . . . . 0.0 109.567 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -44.9 -48.13 11.13 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.848 1.698 . . . . 0.0 112.433 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -53.25 -47.99 68.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.446 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -55.24 -45.16 76.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.249 -0.907 . . . . 0.0 109.289 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -50.2 -30.04 10.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.229 -0.919 . . . . 0.0 109.701 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.8 -49.38 47.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.352 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.594 ' N ' HD12 ' A' ' 37' ' ' LEU . 8.1 mp -59.2 -44.5 92.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.093 -1.004 . . . . 0.0 108.785 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.6 mp -58.01 -42.06 84.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.919 . . . . 0.0 108.521 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.1 m -50.73 -37.08 39.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.229 -0.919 . . . . 0.0 109.653 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -80.22 -43.58 21.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.031 -1.043 . . . . 0.0 109.911 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.7 mt -59.34 -49.07 79.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.12 -0.988 . . . . 0.0 109.961 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 42.2 mtt -66.83 -35.46 80.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.991 -1.068 . . . . 0.0 109.645 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 25.7 ttt -56.05 -29.21 60.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.201 -0.937 . . . . 0.0 108.833 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -116.68 40.69 2.87 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.22 103.15 1.5 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.135 -0.978 . . . . 0.0 109.802 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.402 ' CA ' ' OD1' ' A' ' 98' ' ' ASN . . . 137.85 -13.36 3.64 Favored Glycine 0 N--CA 1.502 3.062 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.9 m -132.56 152.54 80.17 Favored Pre-proline 0 N--CA 1.502 2.131 0 O-C-N 121.697 -0.884 . . . . 0.0 108.806 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -71.73 120.19 6.72 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 121.774 1.649 . . . . 0.0 111.544 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.0 t -91.11 133.72 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.883 . . . . 0.0 109.612 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.413 ' C ' ' N ' ' A' ' 52' ' ' GLU . 10.3 t-160 -65.54 122.5 17.35 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -50.65 -15.94 0.33 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.166 -0.959 . . . . 0.0 109.6 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.531 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 17.0 mm-40 -65.78 -50.5 64.48 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.313 -0.867 . . . . 0.0 109.875 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.9 mt -57.07 -31.92 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.131 -0.98 . . . . 0.0 110.044 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.7 mt -66.47 -33.31 75.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.996 -1.065 . . . . 0.0 108.307 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 59' ' ' TYR . 22.4 t80 -73.51 -35.69 65.65 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 41.4 m-80 -63.53 -22.07 66.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.848 -0.533 . . . . 0.0 110.039 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.09 -54.23 42.32 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.027 -1.046 . . . . 0.0 109.243 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.439 HG22 ' CD2' ' A' ' 59' ' ' TYR . 5.6 mm -85.83 -37.46 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.22 -0.925 . . . . 0.0 109.872 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.439 ' CD2' HG22 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -179.94 168.25 1.29 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.047 -1.033 . . . . 0.0 110.158 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.43 ' C ' ' N ' ' A' ' 62' ' ' ASP . 1.7 t -173.81 -31.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.336 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -54.06 -10.56 0.35 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -0.905 . . . . 0.0 109.38 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.43 ' N ' ' C ' ' A' ' 60' ' ' SER . 28.0 m-20 -156.42 -137.35 0.06 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.378 -0.826 . . . . 0.0 109.057 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 62' ' ' ASP . 13.5 m120 53.01 97.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.931 . . . . 0.0 109.614 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -165.29 61.97 0.82 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.339 -0.85 . . . . 0.0 109.31 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.7 157.97 31.8 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.614 2.209 . . . . 0.0 111.902 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.96 -51.65 30.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 0.0 109.496 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.6 m -55.53 150.31 12.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.225 -0.922 . . . . 0.0 109.554 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -73.27 139.08 45.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 109.497 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 90.0 m -165.79 -36.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.317 -0.864 . . . . 0.0 109.452 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.603 HD23 ' H ' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -70.61 -48.93 52.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 108.88 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -70.3 -25.39 63.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 109.44 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.4 t -75.3 -43.55 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.176 -0.952 . . . . 0.0 109.505 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -54.55 -39.05 67.33 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.3 mt -67.38 -39.55 82.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -60.67 -34.67 74.67 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.122 -0.986 . . . . 0.0 109.072 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -76.73 -40.9 47.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.397 -0.814 . . . . 0.0 108.993 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.648 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -67.71 -43.36 80.24 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -51.76 -50.09 61.34 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.464 -0.772 . . . . 0.0 110.243 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -64.98 -27.37 68.79 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.252 -0.905 . . . . 0.0 110.834 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -71.01 -45.35 64.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.985 -1.072 . . . . 0.0 110.439 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.7 pt -75.04 -18.69 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.977 -1.077 . . . . 0.0 110.718 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 81.28 79.53 0.92 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -46.63 -15.9 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.688 -0.89 . . . . 0.0 110.662 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.514 ' CB ' HH11 ' A' ' 85' ' ' ARG . 10.5 t -48.2 -43.39 31.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.16 -0.962 . . . . 0.0 110.443 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.514 HH11 ' CB ' ' A' ' 84' ' ' SER . 12.5 mpt_? -91.48 11.03 25.33 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.164 -0.96 . . . . 0.0 110.163 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 87' ' ' ARG . 30.2 mm -115.75 164.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 O-C-N 121.35 -0.844 . . . . 0.0 108.98 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.435 ' N ' HG22 ' A' ' 86' ' ' ILE . 61.5 ttt-85 -135.69 118.56 16.24 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.399 -0.813 . . . . 0.0 108.898 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.5 p -94.93 137.64 33.73 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.235 -0.916 . . . . 0.0 109.766 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.8 t -102.14 102.25 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.569 -0.707 . . . . 0.0 109.756 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.479 ' C ' ' H ' ' A' ' 92' ' ' PHE . 40.9 ttt85 52.47 27.12 4.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 109.542 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.78 1.85 1.54 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.519 ' CD2' ' N ' ' A' ' 93' ' ' GLY . 53.6 t80 -75.34 -81.89 0.07 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.233 -1.157 . . . . 0.0 108.756 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.519 ' N ' ' CD2' ' A' ' 92' ' ' PHE . . . -98.36 -150.63 26.31 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 27.3 m-85 -151.44 157.44 42.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.385 -1.068 . . . . 0.0 108.87 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.6 ttp -157.7 128.89 6.66 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.36 -0.837 . . . . 0.0 109.675 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.487 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 9.2 mp -85.47 136.54 33.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.357 -0.839 . . . . 0.0 108.891 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.13 112.54 1.56 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 109.681 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.663 ' N ' HD22 ' A' ' 98' ' ' ASN . 0.9 OUTLIER -75.89 81.0 2.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -0.882 . . . . 0.0 109.414 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 53.43 88.58 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.567 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.2 mt -145.05 -2.02 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.293 -0.879 . . . . 0.0 108.66 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.07 -35.48 61.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.367 -0.833 . . . . 0.0 109.36 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.1 m -78.22 111.03 13.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.869 . . . . 0.0 109.433 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.417 179.964 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.627 HD22 ' H1 ' ' A' ' 1' ' ' ASN . 1.7 m120 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -75.93 62.22 1.57 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.28 -0.888 . . . . 0.0 109.554 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.12 18.99 79.84 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.437 ' C ' ' ND2' ' A' ' 5' ' ' ASN . 33.2 t0 -170.2 155.09 5.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.24 -1.153 . . . . 0.0 109.471 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.496 ' OD1' ' ND2' ' A' ' 1' ' ' ASN . 14.9 m-80 -156.67 119.77 4.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 0.0 109.081 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -164.94 158.5 17.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.377 -0.827 . . . . 0.0 109.737 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.2 pt -149.94 164.0 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.378 -0.826 . . . . 0.0 108.943 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.1 t -136.96 150.36 48.12 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.392 -0.818 . . . . 0.0 109.283 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.2 t -143.13 93.8 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.27 -108.4 2.48 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -104.88 3.51 31.02 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.48 -1.011 . . . . 0.0 109.863 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.1 mt -97.8 115.1 27.37 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.215 -0.928 . . . . 0.0 109.849 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -106.98 115.54 30.36 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.524 ' N ' HD12 ' A' ' 14' ' ' LEU . 8.2 mp -104.94 138.44 41.16 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.502 -0.749 . . . . 0.0 109.873 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -136.24 101.87 4.82 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.723 -0.611 . . . . 0.0 109.355 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.4 t -76.73 -28.88 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.84 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.415 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -55.97 -54.3 46.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.237 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -93.86 -9.57 36.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.131 -0.981 . . . . 0.0 108.665 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 63.35 78.35 0.29 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.341 0.591 . . . . 0.0 110.017 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.41 HD23 ' CZ2' ' A' ' 22' ' ' TRP . 62.1 tp -166.89 153.25 8.38 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.087 -1.008 . . . . 0.0 108.822 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.9 t -137.5 147.7 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.331 -0.856 . . . . 0.0 109.957 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.41 ' CZ2' HD23 ' A' ' 20' ' ' LEU . 31.2 m-90 -115.84 137.1 52.42 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.5 tp -112.4 105.73 14.06 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.47 39.9 68.62 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 107.578 -2.209 . . . . 0.0 107.578 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 69.06 -3.4 1.51 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 122.197 -0.59 . . . . 0.0 109.924 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.7 p -98.22 139.54 33.85 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.078 -1.014 . . . . 0.0 109.893 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.23 115.05 7.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 110.012 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.0 tp -85.94 138.85 31.7 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 27.0 p-10 -93.81 103.8 15.91 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.101 -0.999 . . . . 0.0 110.732 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.91 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.3 pt? -126.22 135.06 51.14 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.1 p -62.84 151.91 83.98 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.856 -1.153 . . . . 0.0 109.379 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -44.8 -44.12 14.54 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.784 1.656 . . . . 0.0 112.142 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -53.75 -50.54 65.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.272 -0.892 . . . . 0.0 109.686 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.65 ' HG3' HD13 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -54.08 -41.43 68.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.389 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -56.75 -30.33 63.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.101 -1.0 . . . . 0.0 109.289 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.19 -52.53 26.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.079 -1.013 . . . . 0.0 109.77 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.616 ' H ' HD12 ' A' ' 37' ' ' LEU . 7.2 mp -55.87 -39.32 71.33 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.4 tp -58.36 -43.21 88.31 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.5 p -50.72 -39.32 51.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.417 -0.802 . . . . 0.0 110.229 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -79.76 -42.58 24.22 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.855 -1.153 . . . . 0.0 109.828 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 26.3 mt -58.88 -47.75 83.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.155 -0.966 . . . . 0.0 109.897 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.1 ptt? -67.91 -36.0 79.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.022 -1.049 . . . . 0.0 109.975 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 21.7 ttt -54.26 -29.05 45.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -0.885 . . . . 0.0 108.763 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -124.04 45.02 2.58 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.6 133.66 51.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.104 -0.998 . . . . 0.0 110.095 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.53 -10.47 59.36 Favored Glycine 0 N--CA 1.501 3.004 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 p -127.11 151.9 75.03 Favored Pre-proline 0 N--CA 1.504 2.25 0 O-C-N 121.537 -0.978 . . . . 0.0 108.696 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.22 120.15 6.4 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 121.749 1.633 . . . . 0.0 111.652 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.9 t -96.2 136.67 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.412 -0.805 . . . . 0.0 109.736 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.444 ' CD2' ' H ' ' A' ' 52' ' ' GLU . 11.3 t-160 -62.09 120.13 10.26 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.211 -0.931 . . . . 0.0 108.725 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -57.24 -18.76 17.63 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.339 -0.851 . . . . 0.0 109.178 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.546 ' CD ' HD21 ' A' ' 56' ' ' ASN . 0.2 OUTLIER -65.39 -48.81 71.59 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.378 -0.826 . . . . 0.0 108.981 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.5 mt -58.76 -30.23 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.25 -0.906 . . . . 0.0 110.324 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.3 mt -69.61 -29.77 67.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.922 -1.111 . . . . 0.0 108.976 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -71.57 -33.09 68.79 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.546 HD21 ' CD ' ' A' ' 52' ' ' GLU . 17.7 m-80 -65.33 -22.21 66.79 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.655 -0.653 . . . . 0.0 109.941 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.76 -55.45 32.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.902 -1.124 . . . . 0.0 109.403 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.5 mt -74.01 -37.76 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.224 -0.923 . . . . 0.0 110.291 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.413 ' O ' ' O ' ' A' ' 56' ' ' ASN . 87.6 m-85 -105.36 125.46 51.01 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.404 -0.81 . . . . 0.0 109.792 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.6 m -146.13 20.46 1.41 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.092 -1.005 . . . . 0.0 109.454 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.4 ' H ' ' H ' ' A' ' 62' ' ' ASP . 66.5 p-90 -169.46 -17.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.155 -0.966 . . . . 0.0 109.532 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.4 ' H ' ' H ' ' A' ' 61' ' ' TRP . 24.0 t70 -75.68 -48.7 20.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.28 -0.888 . . . . 0.0 109.435 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.3 m120 51.18 96.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.425 -0.797 . . . . 0.0 109.72 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -166.87 71.45 1.06 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.453 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -47.11 95.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.669 2.246 . . . . 0.0 112.311 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.38 -18.81 60.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.257 -0.902 . . . . 0.0 109.463 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.3 m 57.31 11.65 1.18 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.16 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.474 ' C ' ' H ' ' A' ' 70' ' ' LEU . 63.7 t30 -162.82 163.65 26.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.175 -0.953 . . . . 0.0 109.471 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 m 72.36 -28.6 0.19 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.605 -0.684 . . . . 0.0 109.795 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.741 HD23 ' H ' ' A' ' 70' ' ' LEU . 1.9 pt? -69.09 -38.9 79.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.041 -1.037 . . . . 0.0 109.76 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.481 ' O ' ' CD2' ' A' ' 75' ' ' HIS . 59.1 mt-10 -71.23 -26.55 62.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.988 -1.07 . . . . 0.0 109.563 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 49.1 t -75.43 -47.85 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.19 -0.943 . . . . 0.0 109.303 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -55.85 -37.18 68.4 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.2 mt -67.51 -39.95 83.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 71' ' ' GLU . 43.1 m170 -60.95 -35.96 78.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.082 -1.011 . . . . 0.0 108.861 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -74.44 -41.73 60.34 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.734 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -67.86 -42.46 81.31 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.485 ' NH2' ' OH ' ' A' ' 94' ' ' TYR . 41.0 ttm180 -49.9 -50.7 45.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.216 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -62.31 -27.08 68.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.241 -0.912 . . . . 0.0 110.817 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -73.22 -43.83 60.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.947 -1.096 . . . . 0.0 110.424 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.0 pt -73.76 -18.53 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.073 -1.017 . . . . 0.0 109.884 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.57 82.12 0.6 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -52.56 -18.23 1.63 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.515 -0.991 . . . . 0.0 110.111 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.9 m -52.37 -46.4 66.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.267 -0.896 . . . . 0.0 109.924 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -87.97 10.69 18.05 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.209 -0.932 . . . . 0.0 110.025 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.7 mm -119.58 168.07 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.461 -0.775 . . . . 0.0 108.962 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 61.3 mtp85 -140.19 114.05 8.86 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.0 p -81.82 138.05 35.18 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.267 -0.896 . . . . 0.0 109.768 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.606 ' CG1' HH21 ' A' ' 90' ' ' ARG . 61.7 t -104.36 92.12 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.518 -0.738 . . . . 0.0 109.29 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.606 HH21 ' CG1' ' A' ' 89' ' ' VAL . 0.7 OUTLIER 49.93 -177.01 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.291 -0.881 . . . . 0.0 109.211 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.88 55.34 4.63 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -135.55 -29.23 1.07 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.552 -0.969 . . . . 0.0 109.651 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.91 -153.57 7.96 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.008 -1.568 . . . . 0.0 110.921 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.485 ' OH ' ' NH2' ' A' ' 78' ' ' ARG . 32.5 m-85 -148.57 169.94 19.19 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.6 ttp -164.09 130.28 3.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.166 -0.959 . . . . 0.0 109.969 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.47 ' N ' HD12 ' A' ' 96' ' ' LEU . 9.8 mp -83.38 144.2 29.8 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.58 -0.7 . . . . 0.0 109.155 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.69 119.69 20.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.493 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -63.45 -16.75 61.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.182 -0.949 . . . . 0.0 109.453 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 102' ' ' THR . 1.2 p30 -171.93 128.05 0.61 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.386 -0.821 . . . . 0.0 109.372 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 11.8 mm -59.05 -14.93 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 108.864 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -82.51 -7.56 59.64 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.437 ' N ' ' OD1' ' A' ' 99' ' ' ASN . 9.5 t -52.43 142.3 17.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 109.668 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.52 179.961 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.438 ' N ' ' CD ' ' A' ' 2' ' ' GLN . 3.9 mp0 46.43 27.43 0.6 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.316 -0.865 . . . . 0.0 110.238 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.98 -36.32 7.77 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -104.14 98.08 7.95 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.507 -0.996 . . . . 0.0 109.537 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -169.59 101.29 0.33 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.182 -0.949 . . . . 0.0 109.247 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -162.29 155.76 20.68 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.153 -0.967 . . . . 0.0 109.93 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 7' ' ' ILE . 16.5 pt -147.94 163.33 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.373 -0.83 . . . . 0.0 109.017 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.2 m -144.9 158.96 43.62 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.145 -0.972 . . . . 0.0 109.912 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.0 t -148.35 101.04 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.36 -108.4 2.48 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -109.05 4.6 23.29 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.541 -0.976 . . . . 0.0 109.589 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 12' ' ' LEU . 7.0 mp -95.51 123.55 39.11 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.288 -0.882 . . . . 0.0 108.83 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -118.85 128.78 54.77 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.443 -0.786 . . . . 0.0 109.094 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.541 ' C ' HD22 ' A' ' 15' ' ' ASN . 51.5 tp -116.43 128.28 55.35 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.607 -0.683 . . . . 0.0 109.206 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.541 HD22 ' C ' ' A' ' 14' ' ' LEU . 1.3 m-80 -122.91 98.11 5.75 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.516 -0.74 . . . . 0.0 109.366 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.4 t -71.06 -27.0 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.47 -0.769 . . . . 0.0 109.23 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.7 -53.92 39.78 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.593 -0.692 . . . . 0.0 109.657 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -91.01 -12.83 34.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.249 -0.907 . . . . 0.0 108.862 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.479 ' NE ' ' CD1' ' A' ' 35' ' ' TYR . 9.5 tpt180 64.98 61.62 0.76 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -140.09 154.78 47.15 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.424 -0.798 . . . . 0.0 109.045 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.5 t -139.28 126.82 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.375 -0.828 . . . . 0.0 109.371 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 18.4 m-90 -103.44 148.18 26.24 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.223 -0.923 . . . . 0.0 109.128 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.425 ' O ' ' OG1' ' A' ' 26' ' ' THR . 24.4 tp -128.77 102.89 6.76 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 76.71 46.01 12.06 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 -178.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 61.91 -0.67 0.42 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 122.022 -0.693 . . . . 0.0 110.25 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 50.2 p -103.76 140.32 37.78 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.211 -0.931 . . . . 0.0 109.862 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.95 110.83 1.91 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 109.996 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.9 tp -76.9 134.89 38.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 108.622 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -101.77 111.45 23.71 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.315 -0.866 . . . . 0.0 109.615 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.812 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.1 pt? -140.51 150.86 44.26 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.327 -0.858 . . . . 0.0 109.853 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.4 p -58.07 152.85 37.92 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.361 -0.837 . . . . 0.0 109.239 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.21 -36.35 80.69 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.853 1.702 . . . . 0.0 111.188 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -55.84 -47.4 77.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 108.931 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -58.61 -39.62 80.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.319 -0.863 . . . . 0.0 108.893 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.479 ' CD1' ' NE ' ' A' ' 19' ' ' ARG . 16.7 t80 -52.89 -31.85 41.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.168 -0.958 . . . . 0.0 109.087 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.61 -52.76 10.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -0.87 . . . . 0.0 109.389 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 37' ' ' LEU . 8.6 mp -58.59 -40.66 83.82 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.506 ' O ' HD23 ' A' ' 38' ' ' LEU . 2.3 tt -67.37 -43.89 80.29 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.602 0.715 . . . . 0.0 109.306 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.0 t -48.42 -41.64 29.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.127 -0.983 . . . . 0.0 111.134 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.8 ttt-85 -80.73 -35.06 33.97 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.533 -1.354 . . . . 0.0 109.485 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.5 tp -60.3 -36.73 78.56 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.34 -0.85 . . . . 0.0 109.34 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 41.0 tpp -75.22 -38.68 60.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 0.0 109.259 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 42.1 ttm -52.4 -27.05 14.26 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.6 mmtt -118.99 42.76 2.73 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.29 137.06 55.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 110.215 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.85 -14.31 65.56 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.5 p -117.42 151.85 48.63 Favored Pre-proline 0 N--CA 1.501 2.115 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -73.87 119.43 5.87 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.594 1.529 . . . . 0.0 111.999 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -103.99 135.95 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.518 -0.739 . . . . 0.0 109.475 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -72.87 125.77 28.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.059 -1.026 . . . . 0.0 108.647 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -58.4 -16.25 14.01 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.469 -0.77 . . . . 0.0 109.291 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.568 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 34.1 tt0 -67.61 -50.4 58.33 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.499 -0.75 . . . . 0.0 109.363 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.5 mt -58.1 -25.0 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.36 -0.838 . . . . 0.0 110.381 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 38.1 mt -72.11 -48.16 45.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.038 -1.039 . . . . 0.0 108.356 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.413 ' O ' ' O ' ' A' ' 59' ' ' TYR . 23.6 m-85 -52.25 -34.59 46.76 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.568 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 30.4 m-80 -63.84 -21.13 66.3 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.967 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.17 -53.75 31.88 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.034 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.7 mm -94.0 -37.68 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.142 -0.974 . . . . 0.0 110.782 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.413 ' O ' ' O ' ' A' ' 55' ' ' TYR . 38.5 p90 -169.09 176.42 5.31 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.828 -1.17 . . . . 0.0 110.5 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.5 t -168.09 -34.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.225 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 54.6 p-90 -83.34 -3.7 57.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.27 -0.894 . . . . 0.0 109.491 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.19 -80.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.196 -0.94 . . . . 0.0 109.449 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.486 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 1.3 p-10 -155.95 96.33 1.71 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.459 -0.775 . . . . 0.0 109.112 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.581 ' N ' ' CD ' ' A' ' 65' ' ' PRO . 8.1 mt-10 -75.99 -34.79 1.53 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 111.162 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 64' ' ' GLU . 62.5 Cg_endo -90.37 47.2 0.78 Allowed 'Trans proline' 0 N--CA 1.487 1.133 0 C-N-CA 122.109 1.873 . . . . 0.0 112.097 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.461 ' HB2' HD22 ' A' ' 63' ' ' ASN . . . -80.8 8.67 7.65 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.213 -0.93 . . . . 0.0 109.458 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m 60.42 -127.63 1.01 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.47 -0.769 . . . . 0.0 109.465 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -73.04 98.17 2.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.098 -1.001 . . . . 0.0 109.654 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.4 m -165.67 -73.6 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.291 -0.88 . . . . 0.0 109.574 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 70' ' ' LEU . 9.7 mp -56.0 -49.4 73.72 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.391 -0.818 . . . . 0.0 109.598 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -59.86 -30.02 68.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.156 -0.965 . . . . 0.0 109.729 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 t -70.41 -41.43 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.094 -1.004 . . . . 0.0 109.139 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -54.56 -37.64 65.71 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 35.2 mm -65.63 -41.42 90.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -65.73 -41.55 92.09 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.36 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.599 ' N ' HD22 ' A' ' 76' ' ' ASN . 0.9 OUTLIER -67.88 -44.58 76.72 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.195 -0.941 . . . . 0.0 109.091 179.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 74.3 mt -70.34 -38.63 74.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.417 -0.802 . . . . 0.0 109.919 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.6 ttp85 -49.19 -48.6 45.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.13 -0.981 . . . . 0.0 109.786 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -57.24 -27.28 61.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.957 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -78.4 -40.68 35.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.938 -1.101 . . . . 0.0 110.636 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.411 HD12 HD12 ' A' ' 86' ' ' ILE . 5.7 pt -85.11 -39.56 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.885 -1.135 . . . . 0.0 110.313 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 91.18 106.76 1.42 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 107.386 -2.286 . . . . 0.0 107.386 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 86' ' ' ILE . 52.2 pttt -43.61 -18.15 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.678 -0.895 . . . . 0.0 110.467 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 82' ' ' GLY . 47.3 t -62.93 -54.86 31.98 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.825 -1.172 . . . . 0.0 108.708 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.469 ' NH2' HD11 ' A' ' 86' ' ' ILE . 54.8 ttp85 -54.94 -10.97 0.55 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.396 -0.815 . . . . 0.0 110.803 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.469 HD11 ' NH2' ' A' ' 85' ' ' ARG . 9.4 mt -143.4 119.35 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.394 0 O-C-N 120.891 -1.13 . . . . 0.0 110.646 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 63.4 mtp85 -86.95 130.35 34.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.3 -0.875 . . . . 0.0 108.711 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 p -80.94 128.76 34.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.051 -1.031 . . . . 0.0 109.491 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.408 ' O ' ' O ' ' A' ' 90' ' ' ARG . 21.0 t -104.17 92.12 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.539 -0.725 . . . . 0.0 109.181 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.408 ' O ' ' O ' ' A' ' 89' ' ' VAL . 79.6 mtt-85 52.15 177.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 109.554 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.96 55.04 4.97 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -138.33 -29.98 0.8 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.399 -1.06 . . . . 0.0 109.916 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -165.06 -155.72 8.67 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 118.997 -1.573 . . . . 0.0 110.826 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -146.16 171.09 15.44 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.467 ' SD ' ' O ' ' A' ' 96' ' ' LEU . 11.6 tmm? -163.57 142.86 8.23 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.85 -1.156 . . . . 0.0 110.704 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.467 ' O ' ' SD ' ' A' ' 95' ' ' MET . 11.1 mp -89.43 132.79 34.83 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' A' ' 99' ' ' ASN . . . -56.18 121.02 8.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.213 -0.929 . . . . 0.0 109.082 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -68.14 67.33 0.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 0.0 109.712 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 97' ' ' ALA . 61.7 t-20 49.39 41.06 20.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.188 -0.945 . . . . 0.0 109.874 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.8 mt -78.79 -2.51 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.287 -0.883 . . . . 0.0 108.825 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 102' ' ' THR . 3.2 p30 -65.11 -27.63 68.88 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.225 -0.922 . . . . 0.0 109.386 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.486 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 93.3 m -68.46 -87.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.383 -0.823 . . . . 0.0 109.452 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.419 -179.994 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -71.21 64.21 0.37 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.299 -0.876 . . . . 0.0 109.554 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -177.55 25.12 0.05 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 5.7 p-10 -175.33 107.72 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.29 -1.123 . . . . 0.0 109.229 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -160.43 121.02 2.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.135 -0.978 . . . . 0.0 109.38 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -158.91 156.24 29.17 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.479 -0.763 . . . . 0.0 109.364 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.4 pt -148.83 163.67 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.298 -0.876 . . . . 0.0 109.393 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.6 m -136.2 146.53 46.92 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.472 -0.768 . . . . 0.0 109.542 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -146.46 93.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.67 -114.09 3.91 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -106.06 6.27 30.97 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.492 -1.005 . . . . 0.0 109.66 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.4 mt -100.89 122.04 42.77 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.258 -0.901 . . . . 0.0 109.946 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -115.19 129.46 56.66 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.541 ' C ' HD22 ' A' ' 15' ' ' ASN . 46.9 tp -114.65 138.67 50.4 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.535 -0.728 . . . . 0.0 109.415 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.541 HD22 ' C ' ' A' ' 14' ' ' LEU . 2.1 m-80 -135.02 97.63 3.79 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.576 -0.702 . . . . 0.0 109.236 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.2 t -73.34 -28.51 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.376 -0.827 . . . . 0.0 109.282 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -63.13 -55.47 25.02 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.444 -0.785 . . . . 0.0 109.454 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -88.62 -16.02 33.54 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.307 -0.871 . . . . 0.0 108.847 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? 68.83 65.19 0.3 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.2 mt -143.93 142.32 30.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.303 -0.873 . . . . 0.0 108.724 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -129.61 127.57 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.5 -0.75 . . . . 0.0 108.977 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -103.72 142.21 34.73 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.269 -0.894 . . . . 0.0 109.173 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.422 ' O ' ' OG1' ' A' ' 26' ' ' THR . 28.0 tp -127.2 102.9 7.14 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.93 47.3 11.76 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.131 -1.988 . . . . 0.0 108.131 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 60.68 2.58 0.52 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.979 -0.718 . . . . 0.0 110.33 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 50.4 p -108.81 141.72 40.42 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.15 -0.969 . . . . 0.0 109.846 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.03 115.29 4.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.247 -0.908 . . . . 0.0 110.075 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.3 tp -81.73 132.99 35.3 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -101.34 111.81 24.15 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.305 -0.872 . . . . 0.0 109.483 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.46 147.51 47.23 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.453 -0.779 . . . . 0.0 109.274 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.1 p -57.9 152.15 39.92 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.89 -33.73 92.15 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.84 1.693 . . . . 0.0 111.359 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -57.52 -50.88 71.64 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.206 -0.934 . . . . 0.0 109.045 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -56.89 -35.58 69.14 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.151 -0.968 . . . . 0.0 109.032 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.438 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 7.3 t80 -55.47 -33.9 64.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -0.888 . . . . 0.0 108.962 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.422 ' O ' ' OD2' ' A' ' 57' ' ' ASP . . . -67.89 -52.96 30.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 109.518 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 37' ' ' LEU . 7.2 mp -60.75 -32.61 71.9 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 12.5 tp -63.31 -45.63 90.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.535 -0.728 . . . . 0.0 109.28 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.3 p -53.79 -32.66 53.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.902 . . . . 0.0 109.327 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -79.8 -45.42 18.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 109.549 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.0 mt -58.21 -46.65 85.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.925 . . . . 0.0 109.937 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.545 ' SD ' ' N ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -70.83 -36.15 72.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 110.047 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.545 ' N ' ' SD ' ' A' ' 42' ' ' MET . 22.3 ttt -52.9 -29.2 27.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.099 -1.001 . . . . 0.0 108.873 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -122.39 46.72 2.06 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.37 134.51 52.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.886 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.99 -8.86 78.85 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.3 t -118.46 115.1 35.93 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.61 119.95 4.16 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.038 1.159 . . . . 0.0 112.001 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -98.7 136.67 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.41 -0.806 . . . . 0.0 110.116 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.514 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 17.5 t-160 -71.18 124.25 24.05 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.241 -0.912 . . . . 0.0 108.931 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.469 ' NH1' ' OE1' ' A' ' 71' ' ' GLU . 53.3 ttp180 -51.35 -17.53 0.77 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.402 -0.811 . . . . 0.0 109.31 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.517 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 18.9 tt0 -68.01 -47.8 67.48 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.383 -0.823 . . . . 0.0 109.974 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.0 mt -57.45 -29.55 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.161 -0.962 . . . . 0.0 110.194 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.9 mt -68.58 -46.79 68.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.159 -0.963 . . . . 0.0 108.835 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -60.84 -34.47 74.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 70.3 m-80 -70.08 -21.67 63.12 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.443 -0.785 . . . . 0.0 110.145 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 36' ' ' ALA . 11.3 t0 -54.49 -52.52 61.68 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.0 -1.063 . . . . 0.0 109.414 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.8 mt -99.83 -37.12 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.487 -0.758 . . . . 0.0 110.172 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -99.79 78.77 2.16 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.275 -0.89 . . . . 0.0 109.956 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.3 p -61.44 -57.42 12.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 109.301 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 27.9 m0 -82.42 51.92 1.94 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.4 -0.812 . . . . 0.0 108.969 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -62.94 -120.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.465 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 53.12 60.26 3.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.057 -1.027 . . . . 0.0 109.587 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -169.68 61.77 0.43 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 109.422 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -77.64 103.51 1.73 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.584 2.19 . . . . 0.0 111.939 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.06 -50.07 21.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 109.459 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.453 ' OG1' ' N ' ' A' ' 68' ' ' ASN . 1.7 t -172.37 -173.98 1.14 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.453 ' N ' ' OG1' ' A' ' 67' ' ' THR . 8.6 t-20 -54.51 107.05 0.24 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.522 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.5 m -165.55 -44.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.343 -0.848 . . . . 0.0 109.248 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.528 ' CD2' ' N ' ' A' ' 70' ' ' LEU . 1.6 mm? -66.1 -49.28 68.09 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.469 ' OE1' ' NH1' ' A' ' 51' ' ' ARG . 64.2 mm-40 -64.07 -24.99 67.91 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.34 -0.85 . . . . 0.0 108.793 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.0 t -74.83 -41.02 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.411 -0.806 . . . . 0.0 109.425 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -54.29 -39.33 66.85 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 35.6 mm -65.08 -40.21 88.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -67.18 -40.69 86.62 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.153 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -64.75 -44.49 89.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.26 -0.9 . . . . 0.0 109.311 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.7 mt -70.19 -34.19 72.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -0.876 . . . . 0.0 109.478 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -49.35 -49.35 44.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.252 -0.905 . . . . 0.0 109.765 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -58.01 -28.9 64.86 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.352 -0.842 . . . . 0.0 109.804 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -74.24 -43.19 58.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.138 -0.976 . . . . 0.0 110.445 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.5 pt -82.6 -36.95 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.935 -1.103 . . . . 0.0 110.171 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 93.12 103.45 1.6 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 107.161 -2.376 . . . . 0.0 107.161 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 86' ' ' ILE . 9.8 ptpp? -42.95 -19.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.791 -0.829 . . . . 0.0 110.724 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 82' ' ' GLY . 36.4 p -64.21 -55.35 22.26 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.966 -1.083 . . . . 0.0 108.905 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -47.9 -14.07 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.307 -0.871 . . . . 0.0 110.793 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 84' ' ' SER . 12.8 pt -135.56 168.5 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.095 -1.003 . . . . 0.0 110.759 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -137.5 122.15 18.58 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 p -90.27 135.54 33.61 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.128 -0.982 . . . . 0.0 109.628 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.85 119.91 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.532 -0.73 . . . . 0.0 110.189 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 49.7 29.1 2.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.504 -0.748 . . . . 0.0 110.027 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.22 52.5 17.83 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.514 ' CZ ' ' CD2' ' A' ' 50' ' ' HIS . 26.1 t80 -138.25 -69.57 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.509 -0.995 . . . . 0.0 108.757 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.466 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . -99.92 -151.83 26.27 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.466 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 31.0 m-85 -151.06 162.16 41.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.475 -1.015 . . . . 0.0 108.445 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 55.8 ttp -163.02 127.55 3.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.061 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.444 ' N ' HD12 ' A' ' 96' ' ' LEU . 9.4 mp -82.29 135.11 35.27 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.62 118.43 15.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.931 . . . . 0.0 109.695 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.614 ' N ' HD22 ' A' ' 98' ' ' ASN . 0.8 OUTLIER -82.0 103.08 11.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.261 -0.899 . . . . 0.0 109.433 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.414 ' O ' ' O ' ' A' ' 98' ' ' ASN . 2.9 m120 59.46 115.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.435 -0.79 . . . . 0.0 109.822 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.6 mt -75.43 -4.18 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.185 -0.947 . . . . 0.0 109.118 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -170.64 36.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.287 -0.883 . . . . 0.0 109.54 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.4 m 53.56 66.68 1.16 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 109.497 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.496 -179.971 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 58.33 41.48 23.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 109.308 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 50.28 32.73 22.24 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 26.6 p-10 -53.63 113.0 1.03 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.253 -1.145 . . . . 0.0 109.514 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -167.35 125.58 1.28 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.298 -0.876 . . . . 0.0 109.088 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -163.12 157.91 21.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.907 . . . . 0.0 109.892 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.9 pt -150.68 163.37 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.324 -0.86 . . . . 0.0 108.755 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.2 m -145.15 158.22 43.88 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.214 -0.929 . . . . 0.0 109.926 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 9' ' ' VAL . 3.5 p -152.47 97.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.03 -118.17 4.65 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -101.56 8.99 41.67 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.402 -1.058 . . . . 0.0 110.207 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 17.2 mt -106.52 126.52 52.36 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.275 -0.891 . . . . 0.0 109.925 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -116.85 130.68 56.86 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.462 HD12 HG22 ' A' ' 21' ' ' VAL . 5.9 tp -115.05 116.96 29.28 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.455 -0.778 . . . . 0.0 110.109 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.454 ' C ' ' HH ' ' A' ' 35' ' ' TYR . 7.4 m-20 -111.32 97.69 6.95 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 121.506 -0.746 . . . . 0.0 109.027 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.3 t -69.35 -28.6 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 109.534 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.439 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -64.49 -53.14 52.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.467 -0.771 . . . . 0.0 109.478 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 -90.26 -8.54 50.72 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.181 -0.95 . . . . 0.0 108.803 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 56.45 67.63 0.97 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 98.6 mt -143.72 158.47 43.65 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.462 HG22 HD12 ' A' ' 14' ' ' LEU . 16.6 t -142.5 123.8 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.227 -0.921 . . . . 0.0 110.012 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 16.0 m-90 -99.42 153.39 19.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.367 -0.833 . . . . 0.0 109.121 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tt -146.15 116.05 7.32 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 62.58 39.68 98.18 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 107.623 -2.191 . . . . 0.0 107.623 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 65.87 -4.6 0.61 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 122.263 -0.551 . . . . 0.0 109.875 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.41 ' H ' ' C ' ' A' ' 24' ' ' GLY . 73.7 p -100.27 139.87 35.32 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.082 -1.011 . . . . 0.0 109.535 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.11 115.24 3.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 0.0 110.041 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.1 tp -75.1 127.28 32.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.3 -0.875 . . . . 0.0 108.684 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.402 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 5.7 m-20 -94.16 101.24 13.24 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.242 -0.911 . . . . 0.0 110.303 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.909 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.4 pt? -128.33 137.45 51.94 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.5 p -62.8 151.42 84.97 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.795 -1.191 . . . . 0.0 109.475 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -44.91 -46.94 12.44 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 121.792 1.662 . . . . 0.0 112.35 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -53.34 -42.17 66.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.7 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -63.23 -36.06 82.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.154 -0.966 . . . . 0.0 109.336 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.454 ' HH ' ' C ' ' A' ' 15' ' ' ASN . 13.0 t80 -57.03 -30.65 64.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.295 -0.878 . . . . 0.0 109.243 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.43 -53.3 9.84 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.241 -0.912 . . . . 0.0 109.733 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 37' ' ' LEU . 9.2 mp -62.06 -39.48 92.52 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.6 tp -65.61 -46.12 80.52 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.61 -0.681 . . . . 0.0 109.678 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -50.77 -29.84 12.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 110.378 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.488 ' NH2' ' CG2' ' A' ' 53' ' ' ILE . 6.3 tpt180 -79.18 -36.89 39.58 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.85 -1.157 . . . . 0.0 110.173 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.29 -38.57 91.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.962 -1.086 . . . . 0.0 110.261 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.4 ' SD ' ' CD2' ' A' ' 96' ' ' LEU . 13.0 mmt -65.39 -42.93 92.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.768 -1.207 . . . . 0.0 110.077 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 51.8 mtt -58.72 -32.25 69.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.223 -0.923 . . . . 0.0 109.505 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -106.19 35.34 2.96 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.637 -0.664 . . . . 0.0 109.44 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.1 103.16 2.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 109.885 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.26 -16.58 2.31 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.64 155.72 79.29 Favored Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.718 -0.872 . . . . 0.0 108.707 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.52 120.46 7.13 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.928 1.752 . . . . 0.0 111.554 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.5 t -91.57 136.6 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.8 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.477 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 19.7 t-160 -72.26 123.36 22.81 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.156 -0.965 . . . . 0.0 108.607 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -52.99 -15.57 0.82 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 0.0 109.082 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.555 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 36.1 tt0 -69.38 -48.24 61.81 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.601 -0.687 . . . . 0.0 109.764 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.488 ' CG2' ' NH2' ' A' ' 40' ' ' ARG . 77.9 mt -57.83 -30.04 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.048 -1.032 . . . . 0.0 110.099 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.1 mt -67.51 -48.67 66.38 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -54.96 -35.81 64.66 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.555 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 55.8 m-80 -67.3 -22.02 65.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.412 -0.805 . . . . 0.0 110.379 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.28 -51.12 60.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.56 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.9 mt -107.63 -34.58 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.553 -0.717 . . . . 0.0 110.853 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -96.98 90.98 5.38 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.023 -1.048 . . . . 0.0 110.175 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.1 m -74.28 56.28 0.63 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.359 -0.838 . . . . 0.0 108.991 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.492 ' NE1' ' OD1' ' A' ' 56' ' ' ASN . 2.2 m-90 61.13 46.75 7.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.594 -0.692 . . . . 0.0 109.616 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -79.42 -99.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.185 -0.947 . . . . 0.0 109.302 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -76.67 -40.56 48.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.108 -0.995 . . . . 0.0 109.424 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 53.2 69.86 2.09 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.906 . . . . 0.0 109.602 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -45.45 162.74 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.629 2.219 . . . . 0.0 112.284 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.64 -51.97 11.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 109.598 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -175.93 174.66 2.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.87 . . . . 0.0 109.457 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.7 t30 52.22 61.76 3.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 109.552 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.409 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 87.1 m -166.07 -76.9 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.905 . . . . 0.0 109.39 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 pp -67.37 -38.25 84.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.354 -0.841 . . . . 0.0 109.698 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -60.77 -32.79 72.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.032 -1.042 . . . . 0.0 109.877 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.2 t -70.88 -40.11 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.089 -1.007 . . . . 0.0 109.45 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.409 ' ND1' ' O ' ' A' ' 69' ' ' THR . 17.1 m80 -55.74 -37.93 69.12 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.3 mt -66.07 -39.5 84.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -59.05 -36.02 74.31 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.365 -0.934 . . . . 0.0 108.918 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -76.14 -40.24 53.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.447 -0.783 . . . . 0.0 109.088 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.658 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -66.67 -44.07 82.83 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -50.73 -50.28 55.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.388 -0.82 . . . . 0.0 110.228 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -61.74 -27.98 69.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.168 -0.957 . . . . 0.0 110.616 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -74.36 -44.27 52.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.937 -1.102 . . . . 0.0 110.862 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.8 pt -74.43 -21.2 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.854 -1.154 . . . . 0.0 110.212 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 81.27 82.73 0.8 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.413 ' O ' ' O ' ' A' ' 86' ' ' ILE . 18.1 pttp -45.48 -16.57 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.673 -0.898 . . . . 0.0 110.442 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 82' ' ' GLY . 78.8 p -53.66 -49.76 67.24 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.985 -1.072 . . . . 0.0 109.752 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.601 ' C ' HD12 ' A' ' 86' ' ' ILE . 25.3 mmt-85 -79.34 11.02 3.17 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.313 -0.867 . . . . 0.0 110.402 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.601 HD12 ' C ' ' A' ' 85' ' ' ARG . 4.7 mp -138.86 163.56 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.088 -1.007 . . . . 0.0 109.268 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.546 ' N ' HG22 ' A' ' 86' ' ' ILE . 76.6 ttt180 -138.13 127.41 24.52 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.361 -0.837 . . . . 0.0 109.72 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.419 HG22 ' CE2' ' A' ' 94' ' ' TYR . 2.9 p -93.24 142.41 27.34 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.306 -0.871 . . . . 0.0 109.202 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.5 t -101.78 115.39 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.412 -0.805 . . . . 0.0 110.119 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 48.39 29.61 2.05 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.443 -0.786 . . . . 0.0 110.374 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.0 56.55 11.84 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.477 ' CZ ' ' CD2' ' A' ' 50' ' ' HIS . 22.2 t80 -138.79 -67.23 0.46 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.555 -0.968 . . . . 0.0 108.701 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.473 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . -106.91 -151.94 18.48 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.473 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 23.8 m-85 -151.33 157.62 42.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.422 -1.046 . . . . 0.0 108.565 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.418 ' C ' ' SD ' ' A' ' 95' ' ' MET . 1.5 tmt? -157.75 123.01 4.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.347 -0.845 . . . . 0.0 109.523 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 96' ' ' LEU . 9.2 mp -82.43 139.09 34.2 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.406 -0.808 . . . . 0.0 108.848 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 99' ' ' ASN . . . -55.89 113.48 1.52 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.929 . . . . 0.0 109.501 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -69.2 66.78 0.17 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 0.0 109.54 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 97' ' ' ALA . 11.3 t-20 51.5 44.45 29.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.203 -0.936 . . . . 0.0 109.754 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.5 mt -74.45 -7.87 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.24 -0.913 . . . . 0.0 108.741 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -57.5 -30.05 64.81 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.436 -0.79 . . . . 0.0 109.398 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 74.3 p -68.61 132.63 47.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 0.0 109.484 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.434 -179.942 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.0 m120 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.354 0.597 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -146.77 48.09 1.16 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.196 -0.94 . . . . 0.0 109.337 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 56.89 31.65 61.4 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 10.8 p-10 -54.06 147.74 12.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.182 -1.187 . . . . 0.0 109.341 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -164.99 124.87 1.88 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.141 -0.975 . . . . 0.0 109.444 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -163.48 156.06 18.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.465 -0.772 . . . . 0.0 109.474 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.7 pt -147.84 163.97 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.357 -0.839 . . . . 0.0 109.167 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.4 m -133.99 145.43 49.49 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.533 -0.729 . . . . 0.0 109.558 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.4 t -141.44 93.4 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.87 -109.5 2.83 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.687 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -105.84 4.1 29.37 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.593 -0.945 . . . . 0.0 109.865 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.508 ' N ' HD12 ' A' ' 12' ' ' LEU . 10.4 mp -98.68 117.63 33.58 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.234 -0.917 . . . . 0.0 109.602 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 59.9 mtp85 -108.46 116.06 31.27 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 14' ' ' LEU . 9.2 mp -103.11 136.13 43.49 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.482 -0.761 . . . . 0.0 109.428 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -134.98 98.71 4.08 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.7 t -71.64 -29.39 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.498 -0.751 . . . . 0.0 109.449 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.41 ' H ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -56.88 -52.7 64.13 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.42 -0.8 . . . . 0.0 109.231 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.6 mtp180 -97.01 -6.71 34.74 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.485 ' NH2' ' O ' ' A' ' 30' ' ' LEU . 1.4 tmt_? 55.23 81.73 0.11 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.81 0.814 . . . . 0.0 109.248 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.409 HD23 ' N ' ' A' ' 21' ' ' VAL . 0.8 OUTLIER -167.76 132.34 1.82 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.409 ' N ' HD23 ' A' ' 20' ' ' LEU . 15.2 t -117.44 132.75 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.587 -0.695 . . . . 0.0 109.816 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -103.97 124.67 49.42 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.425 -0.797 . . . . 0.0 108.967 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 20.4 tp -104.15 111.77 24.5 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.68 37.4 93.48 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 107.311 -2.315 . . . . 0.0 107.311 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 69.89 2.11 3.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 122.35 -0.5 . . . . 0.0 109.826 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.5 p -103.65 138.06 40.83 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.129 -0.982 . . . . 0.0 109.97 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.9 113.14 5.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 110.225 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.3 tp -81.56 136.12 35.58 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -93.06 102.76 15.09 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.023 -1.048 . . . . 0.0 110.464 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.874 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.3 pt? -128.53 136.52 50.88 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 p -55.05 152.99 12.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 120.99 -1.068 . . . . 0.0 108.865 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.06 -40.93 47.58 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 122.054 1.836 . . . . 0.0 111.26 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -55.81 -41.91 74.86 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.188 -0.945 . . . . 0.0 108.509 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -63.32 -36.34 83.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.456 -0.778 . . . . 0.0 109.114 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -56.25 -28.22 57.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.161 -0.962 . . . . 0.0 108.633 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.24 -50.91 34.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.315 -0.866 . . . . 0.0 108.891 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.594 ' N ' HD12 ' A' ' 37' ' ' LEU . 8.4 mp -58.22 -39.96 80.4 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 12.8 tp -58.45 -41.99 86.36 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.543 ' C ' ' HE ' ' A' ' 40' ' ' ARG . 15.7 m -51.7 -35.48 43.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 109.17 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.543 ' HE ' ' C ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -76.38 -43.26 41.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.466 -0.771 . . . . 0.0 109.031 179.307 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.453 HD21 HD11 ' A' ' 54' ' ' LEU . 96.6 mt -59.7 -50.84 72.3 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.219 -0.926 . . . . 0.0 110.018 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -67.65 -36.45 80.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.923 -1.11 . . . . 0.0 110.196 -179.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.548 ' N ' ' SD ' ' A' ' 42' ' ' MET . 10.8 ttt -54.04 -28.4 38.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.089 -1.007 . . . . 0.0 108.96 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -122.34 44.54 2.59 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.37 132.16 49.32 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.195 -0.941 . . . . 0.0 109.909 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.17 -6.09 57.92 Favored Glycine 0 N--CA 1.501 3.032 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.3 m -132.75 150.82 76.81 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.591 -0.946 . . . . 0.0 108.718 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.07 120.25 5.65 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.803 1.669 . . . . 0.0 112.189 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.0 t -93.38 138.33 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -0.838 . . . . 0.0 109.273 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.473 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 10.4 t-160 -68.85 122.27 18.27 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.185 -0.947 . . . . 0.0 108.759 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -52.33 -17.12 1.03 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 109.266 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.558 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 68.5 mm-40 -66.53 -50.24 63.84 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.401 -0.812 . . . . 0.0 109.361 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.4 mt -55.0 -29.77 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.271 -0.893 . . . . 0.0 109.784 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.453 HD11 HD21 ' A' ' 41' ' ' LEU . 17.9 mt -72.95 -30.32 63.77 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.211 -0.931 . . . . 0.0 109.385 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -71.4 -34.13 70.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.752 -1.217 . . . . 0.0 107.837 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 24.4 m-80 -62.89 -20.82 65.51 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.362 0.601 . . . . 0.0 109.767 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.09 -54.53 43.55 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.814 -1.179 . . . . 0.0 109.507 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.8 mt -80.26 -38.08 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.509 -0.744 . . . . 0.0 110.538 -178.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.452 ' O ' ' O ' ' A' ' 56' ' ' ASN . 96.7 m-85 -110.17 162.81 14.23 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.421 -0.8 . . . . 0.0 109.932 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.3 m -169.16 -37.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.135 -0.978 . . . . 0.0 109.397 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 58.9 m95 -81.72 -26.56 34.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.302 -0.874 . . . . 0.0 109.853 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -158.3 120.01 3.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.188 -0.945 . . . . 0.0 109.457 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -60.48 -47.25 86.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 109.592 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 53.39 64.14 7.29 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.266 -0.896 . . . . 0.0 109.399 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -77.11 104.68 1.94 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.519 2.146 . . . . 0.0 112.102 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.58 -13.09 60.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.238 -0.914 . . . . 0.0 109.511 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.5 m 60.17 24.86 14.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.402 -0.811 . . . . 0.0 109.581 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.45 HD22 ' C ' ' A' ' 68' ' ' ASN . 0.5 OUTLIER -171.63 42.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -0.978 . . . . 0.0 109.513 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 68' ' ' ASN . 33.3 m -167.35 -35.98 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.47 -0.769 . . . . 0.0 109.07 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.66 ' N ' HD12 ' A' ' 70' ' ' LEU . 6.8 mp -59.77 -50.48 73.66 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.449 -0.782 . . . . 0.0 109.855 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -69.7 -26.01 64.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.094 -1.004 . . . . 0.0 109.754 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.6 t -75.23 -45.66 40.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.294 -0.879 . . . . 0.0 109.477 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -55.14 -37.45 66.96 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 89.0 mt -67.35 -40.45 84.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -59.78 -37.37 78.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.194 -0.941 . . . . 0.0 108.681 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.51 ' N ' HD22 ' A' ' 76' ' ' ASN . 1.4 m120 -72.71 -42.12 64.52 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.723 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -64.42 -41.23 96.71 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -49.72 -50.39 44.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.334 -0.854 . . . . 0.0 109.815 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -59.52 -31.78 69.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.873 . . . . 0.0 110.803 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -68.32 -45.5 72.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.875 -1.141 . . . . 0.0 109.817 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.4 pt -74.88 -31.94 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.014 -1.054 . . . . 0.0 109.924 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 86.0 87.9 0.98 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.409 ' O ' ' O ' ' A' ' 86' ' ' ILE . 22.7 pttm -45.54 -17.33 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.573 -0.957 . . . . 0.0 110.31 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 82' ' ' GLY . 48.4 t -56.51 -52.06 66.15 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.185 -0.947 . . . . 0.0 109.897 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -87.75 10.06 19.6 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.179 -0.95 . . . . 0.0 110.942 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.546 HG22 ' N ' ' A' ' 87' ' ' ARG . 5.1 mp -133.08 164.04 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.546 ' N ' HG22 ' A' ' 86' ' ' ILE . 56.4 ttm-85 -140.85 128.02 20.89 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.075 -1.016 . . . . 0.0 110.085 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.435 HG22 ' CE2' ' A' ' 94' ' ' TYR . 2.2 p -88.57 142.24 27.86 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.498 -0.751 . . . . 0.0 109.096 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.7 t -102.12 112.0 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.368 -0.832 . . . . 0.0 110.236 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 47.11 34.47 2.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.443 -0.785 . . . . 0.0 110.552 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.4 54.8 11.92 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.473 ' CZ ' ' CD2' ' A' ' 50' ' ' HIS . 58.3 t80 -135.8 -74.71 0.45 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.471 -1.017 . . . . 0.0 108.73 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.456 ' O ' ' CD1' ' A' ' 94' ' ' TYR . . . -103.1 -153.08 24.02 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 12.1 m-85 -151.29 149.98 30.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.388 -1.066 . . . . 0.0 108.335 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.477 ' O ' ' SD ' ' A' ' 95' ' ' MET . 3.4 ppp? -149.22 127.45 12.11 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.212 -0.93 . . . . 0.0 109.542 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 96' ' ' LEU . 9.8 mp -79.87 132.74 36.16 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.08 132.1 46.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.347 -0.846 . . . . 0.0 109.615 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.455 ' O ' ' ND2' ' A' ' 99' ' ' ASN . 28.9 m120 -55.04 -85.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 109.456 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 33.5 m120 -156.67 49.42 0.47 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.325 -0.86 . . . . 0.0 109.305 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 45.5 mt -68.67 -11.74 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.919 . . . . 0.0 108.83 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 0.9 OUTLIER -75.28 -8.22 56.06 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.659 -0.65 . . . . 0.0 109.357 179.742 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.5 t -58.05 -173.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.397 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.516 -179.979 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 34.1 t30 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.438 ' N ' ' CD ' ' A' ' 2' ' ' GLN . 3.1 pm0 -154.8 45.4 0.52 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.334 -0.854 . . . . 0.0 109.312 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 83.42 15.48 71.27 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -166.1 175.63 8.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -1.162 . . . . 0.0 109.381 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 17' ' ' THR . 4.1 p30 -178.09 111.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -163.24 156.01 18.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 109.863 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.2 pt -146.38 163.12 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.347 -0.846 . . . . 0.0 109.084 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.8 t -134.49 142.15 46.97 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.336 -0.852 . . . . 0.0 109.8 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.77 92.88 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.55 -119.79 5.38 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -101.09 10.84 40.53 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.407 -1.055 . . . . 0.0 109.794 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.4 mt -108.33 123.59 49.04 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.413 -0.805 . . . . 0.0 109.672 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -108.1 146.98 31.87 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.6 tp -130.84 120.97 24.48 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.482 -0.762 . . . . 0.0 109.176 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 19' ' ' ARG . 13.2 m-20 -118.55 97.85 5.95 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.531 -0.731 . . . . 0.0 109.525 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.94 -27.51 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.449 -0.782 . . . . 0.0 109.216 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.463 ' N ' ' OD1' ' A' ' 5' ' ' ASN . 0.1 OUTLIER -63.18 -53.83 47.19 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.508 -0.745 . . . . 0.0 109.645 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -92.73 -14.62 27.71 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.153 -0.967 . . . . 0.0 108.814 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 15' ' ' ASN . 5.6 tpt180 68.18 61.31 0.4 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.312 0.577 . . . . 0.0 109.604 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.9 mt -138.89 156.65 47.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.38 -0.825 . . . . 0.0 108.973 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 t -143.69 127.73 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.255 -0.903 . . . . 0.0 109.388 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 12.3 m-90 -102.38 154.87 18.66 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.247 -0.908 . . . . 0.0 108.898 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.404 ' O ' ' OG1' ' A' ' 26' ' ' THR . 1.1 tt -144.5 115.09 7.68 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 63.5 43.47 98.08 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 107.805 -2.118 . . . . 0.0 107.805 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 61.28 0.43 0.42 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 122.129 -0.63 . . . . 0.0 110.213 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 68.1 p -106.47 139.85 40.29 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.215 -0.928 . . . . 0.0 109.452 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.03 114.56 3.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.412 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 32.2 tp -75.27 128.75 36.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.252 -0.905 . . . . 0.0 108.657 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -97.39 104.8 16.86 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.164 -0.96 . . . . 0.0 109.657 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.854 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.4 pt? -131.32 141.83 50.0 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.67 -0.644 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.3 p -62.36 152.19 80.29 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.155 -0.966 . . . . 0.0 109.961 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.04 -45.23 14.5 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.779 1.653 . . . . 0.0 112.013 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -53.63 -48.62 69.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.357 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.46 ' HG2' HD13 ' A' ' 77' ' ' LEU . 37.2 mt-10 -56.43 -35.26 67.64 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.324 -0.86 . . . . 0.0 109.536 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -60.19 -32.97 71.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 109.198 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.82 -53.45 9.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.155 -0.966 . . . . 0.0 108.583 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 tt -55.94 -45.0 78.91 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.9 tp -64.46 -45.74 86.08 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.3 0.572 . . . . 0.0 109.739 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.8 t -50.59 -39.45 49.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.364 -0.835 . . . . 0.0 110.635 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.416 ' CA ' ' HE ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -80.36 -41.68 24.29 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.916 -1.115 . . . . 0.0 109.87 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.6 tp -60.69 -41.83 95.94 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 109.325 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.1 mtp -72.35 -37.3 68.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.058 -1.026 . . . . 0.0 109.296 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 13.5 ttt -51.85 -27.3 12.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.28 -0.888 . . . . 0.0 108.766 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm -119.37 46.05 1.99 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.66 141.58 49.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.33 -0.856 . . . . 0.0 110.512 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.54 -22.14 40.63 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 t -114.43 152.99 46.61 Favored Pre-proline 0 N--CA 1.502 2.134 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.77 119.43 6.08 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.557 1.505 . . . . 0.0 111.629 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.439 HG11 HD21 ' A' ' 54' ' ' LEU . 78.8 t -97.11 133.69 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.293 -0.879 . . . . 0.0 110.047 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.586 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 17.9 t-160 -68.44 124.75 24.4 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.184 -0.948 . . . . 0.0 108.673 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -52.31 -18.71 1.69 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.345 -0.847 . . . . 0.0 109.008 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.526 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 58.4 tt0 -60.74 -57.15 13.9 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.46 -0.775 . . . . 0.0 109.379 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.2 mt -56.46 -30.67 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.238 -0.914 . . . . 0.0 109.735 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.439 HD21 HG11 ' A' ' 49' ' ' VAL . 33.8 mt -68.55 -32.53 72.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.096 -1.002 . . . . 0.0 108.959 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -74.1 -35.52 64.18 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 32.8 m-80 -61.19 -22.05 64.37 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -71.33 -54.03 12.18 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.386 -0.821 . . . . 0.0 109.751 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.5 mt -77.93 -26.19 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.349 -0.845 . . . . 0.0 110.227 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 56' ' ' ASN . 82.0 m-85 -143.22 -164.98 1.97 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.177 -0.952 . . . . 0.0 109.605 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.9 t 175.58 -31.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.346 -0.846 . . . . 0.0 109.101 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.432 ' O ' ' O ' ' A' ' 62' ' ' ASP . 61.0 m95 -78.71 -14.84 59.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.276 -0.89 . . . . 0.0 109.685 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 61' ' ' TRP . 34.0 m-20 50.8 101.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.533 -0.73 . . . . 0.0 110.151 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -73.08 -92.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.675 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -165.4 62.57 0.86 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.332 -0.855 . . . . 0.0 109.515 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.9 112.61 3.3 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.593 2.195 . . . . 0.0 111.962 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.76 -47.28 40.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.883 . . . . 0.0 109.612 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.0 m -164.67 -87.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 109.43 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -62.11 101.99 0.26 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.108 -0.995 . . . . 0.0 109.299 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 98.3 m -165.59 -87.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -0.876 . . . . 0.0 109.352 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.5 pp -68.1 -33.0 73.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.733 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.455 ' O ' ' CD2' ' A' ' 75' ' ' HIS . 75.7 mm-40 -60.23 -32.09 70.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.022 -1.049 . . . . 0.0 110.026 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.1 t -73.84 -45.68 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.039 -1.038 . . . . 0.0 109.279 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.486 ' N ' ' ND1' ' A' ' 73' ' ' HIS . 1.5 m-70 -55.86 -37.49 68.84 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 86.8 mt -67.79 -39.79 82.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.455 ' CD2' ' O ' ' A' ' 71' ' ' GLU . 34.6 m170 -61.25 -35.84 78.38 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.969 -1.082 . . . . 0.0 108.752 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -74.49 -41.66 60.33 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.479 -0.763 . . . . 0.0 109.017 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.665 ' O ' HD12 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -69.11 -42.83 75.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 0.0 108.85 -179.231 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -50.82 -50.64 56.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -0.857 . . . . 0.0 110.726 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -64.71 -26.07 68.21 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.036 -1.04 . . . . 0.0 110.769 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -71.44 -45.35 62.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.856 -1.152 . . . . 0.0 110.077 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 21.7 pt -74.84 -22.29 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.122 -0.986 . . . . 0.0 110.09 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 81.6 84.39 0.76 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.576 -1.81 . . . . 0.0 108.576 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 86' ' ' ILE . 18.3 pttp -45.1 -17.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.658 -0.907 . . . . 0.0 110.425 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 82' ' ' GLY . 36.7 p -54.78 -48.73 72.31 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.168 -0.957 . . . . 0.0 109.751 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.83 9.58 4.09 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.056 -1.028 . . . . 0.0 109.893 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 87' ' ' ARG . 5.2 mp -134.46 159.56 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.214 -0.929 . . . . 0.0 109.307 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.49 ' N ' HG22 ' A' ' 86' ' ' ILE . 95.3 mtt180 -140.73 124.39 17.01 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.419 -0.8 . . . . 0.0 109.689 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.8 p -86.75 138.63 31.45 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.287 -0.883 . . . . 0.0 109.285 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.8 t -101.58 121.0 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.375 -0.828 . . . . 0.0 110.535 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 49.7 ttp85 47.87 28.38 1.36 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.569 -0.707 . . . . 0.0 110.343 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.37 49.18 26.4 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.586 ' CZ ' ' CD2' ' A' ' 50' ' ' HIS . 25.2 t80 -137.11 -69.37 0.46 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.578 -0.954 . . . . 0.0 108.432 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.433 ' N ' ' CD2' ' A' ' 92' ' ' PHE . . . -100.44 -151.39 25.5 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.428 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 22.7 m-85 -149.51 158.06 43.84 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 45.6 ttp -159.81 126.61 4.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.204 -0.935 . . . . 0.0 110.075 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.404 HD12 ' N ' ' A' ' 96' ' ' LEU . 9.4 mp -84.3 131.88 34.68 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.02 127.14 27.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.189 -0.944 . . . . 0.0 109.215 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -51.47 -69.45 0.11 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.238 -0.913 . . . . 0.0 109.629 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -158.55 40.22 0.24 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.376 -0.827 . . . . 0.0 109.252 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 41.0 mt -84.85 -10.72 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 121.889 0.852 . . . . 0.0 108.821 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -61.24 -33.36 73.38 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.548 -0.72 . . . . 0.0 109.547 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.7 p -75.47 169.49 17.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.208 -0.932 . . . . 0.0 109.362 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.462 -179.995 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.481 ' N ' HD22 ' A' ' 1' ' ' ASN . 1.4 m120 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 67.7 58.48 0.5 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 4' ' ' ASP . . . 162.73 -37.94 0.35 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 3' ' ' GLY . 18.6 m-20 51.14 -179.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.451 -1.029 . . . . 0.0 109.768 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.483 HD22 ' C ' ' A' ' 5' ' ' ASN . 0.4 OUTLIER -161.92 125.01 3.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 108.952 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -150.26 146.5 26.83 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.554 -0.716 . . . . 0.0 109.492 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.3 pt -148.92 163.44 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.271 -0.893 . . . . 0.0 108.905 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.1 t -143.24 152.79 42.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.201 -0.937 . . . . 0.0 109.712 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.1 t -147.35 92.92 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.91 -114.84 4.08 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.7 m-20 -103.09 6.19 38.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.421 -1.046 . . . . 0.0 109.893 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.8 mt -101.78 118.31 36.66 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.351 -0.843 . . . . 0.0 109.887 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -110.84 118.97 37.56 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.414 ' C ' HD22 ' A' ' 15' ' ' ASN . 9.4 mp -106.88 126.47 52.35 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.552 -0.717 . . . . 0.0 109.309 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.414 HD22 ' C ' ' A' ' 14' ' ' LEU . 1.8 m-80 -122.72 97.91 5.67 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.97 -27.34 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.432 -0.792 . . . . 0.0 109.576 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.412 ' H ' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER -63.74 -49.11 74.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.273 -0.892 . . . . 0.0 109.867 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.2 mtp85 -97.14 -7.75 31.79 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.164 -0.96 . . . . 0.0 108.611 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? 56.0 73.35 0.44 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 21' ' ' VAL . 1.1 tt -157.7 128.13 6.34 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.43 ' N ' HD23 ' A' ' 20' ' ' LEU . 12.6 t -114.73 136.72 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.499 -0.75 . . . . 0.0 110.264 -179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 29.0 m-90 -108.18 133.16 52.83 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tt -113.75 110.11 19.64 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.37 39.0 91.66 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 107.623 -2.191 . . . . 0.0 107.623 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 69.65 -0.45 2.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 122.324 -0.515 . . . . 0.0 110.025 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.7 p -101.93 138.99 38.16 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.064 -1.023 . . . . 0.0 109.789 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.98 112.46 1.34 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 110.012 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.4 tp -75.43 127.89 34.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 108.839 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -92.24 98.76 11.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.115 -0.991 . . . . 0.0 109.926 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.907 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.3 pt? -123.84 134.28 53.62 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 121.509 0.671 . . . . 0.0 109.341 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.0 p -59.57 149.15 72.0 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.997 -1.065 . . . . 0.0 109.463 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -45.01 -48.37 11.05 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.719 1.613 . . . . 0.0 112.117 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -54.67 -37.43 65.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.419 -0.801 . . . . 0.0 109.882 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -67.55 -35.06 78.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.095 -1.003 . . . . 0.0 109.261 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -59.12 -33.4 70.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.042 -1.036 . . . . 0.0 108.72 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.53 -53.05 17.7 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.535 HD11 HD13 ' A' ' 54' ' ' LEU . 4.9 tt -52.16 -50.3 62.07 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 13.1 tp -56.09 -40.09 73.13 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.169 0.509 . . . . 0.0 109.854 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.8 m -52.42 -33.31 43.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 109.744 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.51 HH21 ' CE ' ' A' ' 43' ' ' MET . 10.5 mmp_? -78.55 -42.66 28.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.97 . . . . 0.0 109.456 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 17.9 mt -59.22 -48.05 83.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.959 -1.088 . . . . 0.0 110.011 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.417 ' C ' ' SD ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -70.36 -25.96 63.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.985 -1.072 . . . . 0.0 109.746 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.51 ' CE ' HH21 ' A' ' 40' ' ' ARG . 40.2 ttm -61.77 -32.67 72.95 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.161 -0.962 . . . . 0.0 108.872 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -118.13 38.91 3.54 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.79 121.3 9.53 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.262 -0.899 . . . . 0.0 109.753 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.32 -6.85 30.38 Favored Glycine 0 N--CA 1.503 3.14 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.3 m -130.28 151.68 78.9 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 121.535 -0.98 . . . . 0.0 108.771 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.72 120.4 5.51 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.859 1.706 . . . . 0.0 112.186 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.5 t -87.77 131.68 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.241 -0.912 . . . . 0.0 109.78 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.417 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 22.7 t-160 -67.15 129.34 39.57 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.309 -0.87 . . . . 0.0 108.675 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.446 ' NH2' ' OE1' ' A' ' 71' ' ' GLU . 13.0 ptm180 -54.04 -22.2 10.15 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.473 -0.767 . . . . 0.0 109.394 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.575 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 38.2 tt0 -72.79 -36.24 67.54 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.524 -0.735 . . . . 0.0 110.409 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.9 mt -75.64 -35.37 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.433 -0.792 . . . . 0.0 111.66 -178.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.639 ' C ' HD12 ' A' ' 54' ' ' LEU . 4.2 pp -76.34 -22.43 54.92 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.818 -1.176 . . . . 0.0 109.474 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.61 ' N ' HD12 ' A' ' 54' ' ' LEU . 63.4 t80 -64.88 -33.36 75.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.903 . . . . 0.0 109.521 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.74 ' H ' HD22 ' A' ' 56' ' ' ASN . 0.4 OUTLIER -61.54 -23.69 66.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 109.669 -179.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.17 -56.74 18.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.386 -0.822 . . . . 0.0 110.175 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.5 mt -73.63 -37.7 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.323 -0.861 . . . . 0.0 110.452 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.561 ' CD1' ' CZ ' ' A' ' 55' ' ' TYR . 88.9 m-85 -110.12 133.8 52.85 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.495 -0.753 . . . . 0.0 109.854 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.4 m -77.13 42.28 0.32 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.192 -0.943 . . . . 0.0 109.14 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 21.2 t90 53.88 44.1 29.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.344 -0.847 . . . . 0.0 109.432 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.419 ' O ' ' O ' ' A' ' 63' ' ' ASN . 12.7 t70 -80.87 -33.7 34.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.239 -0.913 . . . . 0.0 109.663 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 62' ' ' ASP . 2.2 m120 60.51 120.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.518 -0.739 . . . . 0.0 109.782 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.454 ' H ' ' HD2' ' A' ' 65' ' ' PRO . 0.9 OUTLIER -178.45 -51.16 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.298 -0.877 . . . . 0.0 109.546 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.454 ' HD2' ' H ' ' A' ' 64' ' ' GLU . 64.5 Cg_endo -85.44 81.98 1.69 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.066 1.844 . . . . 0.0 112.07 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.94 -19.15 59.0 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.883 . . . . 0.0 109.587 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 62.8 p -61.95 175.06 0.73 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.64 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.539 HD22 ' N ' ' A' ' 68' ' ' ASN . 1.5 m120 -76.16 110.25 10.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.895 . . . . 0.0 109.553 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.7 m -165.93 -35.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.877 . . . . 0.0 109.353 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.597 HD23 ' H ' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -70.54 -49.28 49.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.373 -0.83 . . . . 0.0 108.892 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.446 ' OE1' ' NH2' ' A' ' 51' ' ' ARG . 29.8 tp10 -69.87 -31.23 68.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.574 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.9 t -72.4 -40.11 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.181 -0.95 . . . . 0.0 109.0 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -56.95 -39.3 74.31 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 89.9 mt -63.82 -35.9 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -61.97 -32.4 72.84 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.48 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -73.04 -41.78 63.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.505 -0.747 . . . . 0.0 109.255 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.8 mt -72.26 -39.39 68.43 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.227 -0.921 . . . . 0.0 109.544 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -50.32 -51.48 44.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.959 . . . . 0.0 110.181 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.43 -24.79 67.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.055 -1.028 . . . . 0.0 109.803 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -70.95 -45.92 63.31 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.984 -1.073 . . . . 0.0 110.135 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.408 HG12 ' H ' ' A' ' 81' ' ' ILE . 16.3 pt -74.89 -19.29 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.104 -0.997 . . . . 0.0 110.121 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 84.19 83.07 0.98 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 86' ' ' ILE . 56.4 pttt -44.51 -17.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.721 -0.87 . . . . 0.0 110.59 -179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 82' ' ' GLY . 57.9 m -59.38 -48.42 81.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.138 -0.976 . . . . 0.0 110.777 -178.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.483 ' N ' ' CD ' ' A' ' 85' ' ' ARG . 10.6 mpt_? -72.72 9.42 1.12 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.025 -1.047 . . . . 0.0 111.003 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' A' ' 83' ' ' LYS . 9.0 tt -146.82 160.96 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 120.934 -1.104 . . . . 0.0 109.29 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -117.1 132.44 56.67 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.42 -0.8 . . . . 0.0 109.703 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.7 p -95.39 142.47 27.74 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.414 -0.804 . . . . 0.0 108.89 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.6 t -101.74 92.75 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.352 -0.843 . . . . 0.0 109.787 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.8 mtp85 47.52 32.31 2.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.317 -0.865 . . . . 0.0 110.461 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.22 0.99 6.41 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.491 ' CD2' ' N ' ' A' ' 93' ' ' GLY . 60.0 t80 -74.61 -81.73 0.07 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.078 -1.248 . . . . 0.0 108.536 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.491 ' N ' ' CD2' ' A' ' 92' ' ' PHE . . . -105.17 -150.41 19.8 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.472 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 26.0 m-85 -151.21 163.31 39.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.421 -1.046 . . . . 0.0 108.305 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.46 ' SD ' ' O ' ' A' ' 96' ' ' LEU . 1.2 tmt? -163.27 127.79 2.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.981 -1.074 . . . . 0.0 110.261 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.46 ' O ' ' SD ' ' A' ' 95' ' ' MET . 9.6 mp -78.49 142.02 37.77 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.7 120.73 20.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 109.486 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -53.29 -24.8 12.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 109.645 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.428 ' N ' ' OD1' ' A' ' 99' ' ' ASN . 12.6 p-10 -171.25 111.06 0.33 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.279 -0.888 . . . . 0.0 109.483 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.8 mt -70.39 -12.61 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 108.688 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 102' ' ' THR . 18.3 p30 -173.83 -17.97 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.414 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 8.5 m -74.01 56.47 0.6 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.239 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.545 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 20.2 m120 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.393 0.616 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 48.85 61.0 3.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.289 -0.882 . . . . 0.0 109.559 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 164.67 -36.49 0.29 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -77.81 142.56 38.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.295 -1.121 . . . . 0.0 109.297 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -158.26 120.27 3.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.241 -0.912 . . . . 0.0 109.321 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -162.44 154.57 18.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.333 -0.855 . . . . 0.0 109.706 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.8 pt -150.44 164.65 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.5 p -140.39 154.0 46.55 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.294 -0.879 . . . . 0.0 110.028 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.3 t -148.33 93.43 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.67 -115.19 4.19 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -101.44 5.35 41.99 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.396 -1.061 . . . . 0.0 109.837 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.2 mt -101.06 116.24 32.37 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.334 -0.854 . . . . 0.0 109.715 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -108.94 122.04 46.38 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.536 ' C ' HD22 ' A' ' 15' ' ' ASN . 37.1 tp -105.95 134.74 48.6 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.597 -0.69 . . . . 0.0 110.006 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.536 HD22 ' C ' ' A' ' 14' ' ' LEU . 0.9 OUTLIER -131.78 97.36 4.17 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.228 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.9 t -71.89 -27.9 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.317 -0.864 . . . . 0.0 109.403 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.7 -54.75 30.65 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.503 -0.748 . . . . 0.0 109.656 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -86.9 -11.6 50.19 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.169 -0.957 . . . . 0.0 108.697 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 60.29 72.23 0.53 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.441 0.639 . . . . 0.0 109.329 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.5 tp -166.8 153.63 8.83 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.5 t -134.59 135.52 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.298 -0.876 . . . . 0.0 109.876 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 20.0 m-90 -100.0 120.37 39.72 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 26' ' ' THR . 1.2 tt -101.91 110.51 22.5 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.55 43.45 96.54 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 107.212 -2.355 . . . . 0.0 107.212 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 64.75 3.37 1.98 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 122.338 -0.507 . . . . 0.0 110.269 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 23' ' ' LEU . 43.8 p -106.03 138.48 42.14 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 120.95 -1.094 . . . . 0.0 109.711 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.71 113.31 2.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.973 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 28' ' ' LEU . 29.1 tp -71.04 126.25 29.06 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -96.91 104.93 16.98 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.22 -0.925 . . . . 0.0 110.695 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.779 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.1 pt? -143.09 151.48 40.8 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.44 -0.788 . . . . 0.0 109.354 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.08 157.35 62.68 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.141 -0.975 . . . . 0.0 108.71 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -60.8 -39.77 59.72 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.457 2.105 . . . . 0.0 112.069 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -54.54 -36.27 64.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.073 -1.017 . . . . 0.0 109.102 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.486 ' OE2' ' NE2' ' A' ' 73' ' ' HIS . 20.5 mm-40 -70.18 -37.73 75.21 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -55.25 -27.86 49.28 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.421 ' O ' ' OD2' ' A' ' 57' ' ' ASP . . . -72.83 -50.49 23.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.383 -0.823 . . . . 0.0 109.002 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.471 ' CD2' ' O ' ' A' ' 54' ' ' LEU . 9.9 mt -65.71 -37.73 87.24 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.449 ' O ' HD23 ' A' ' 38' ' ' LEU . 1.6 tt -57.58 -42.44 83.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.511 -0.743 . . . . 0.0 109.446 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.5 p -60.78 -45.86 92.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.11 -0.994 . . . . 0.0 109.275 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -55.24 -48.06 74.49 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.368 -0.832 . . . . 0.0 109.29 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.1 mt -61.65 -39.29 90.83 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 109.991 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 8.1 mmt -74.7 -37.03 62.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.874 -1.141 . . . . 0.0 109.888 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 40.5 mtt -55.14 -29.31 57.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.119 -0.988 . . . . 0.0 108.699 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -120.81 47.85 1.73 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.86 129.97 39.89 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.197 -0.94 . . . . 0.0 110.064 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.33 -12.98 43.98 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.8 p -125.75 151.43 70.86 Favored Pre-proline 0 N--CA 1.502 2.165 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.1 119.74 6.2 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.637 1.558 . . . . 0.0 111.709 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.4 t -94.67 135.34 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.349 -0.845 . . . . 0.0 109.81 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.413 ' C ' ' N ' ' A' ' 52' ' ' GLU . 8.2 t-160 -72.72 125.12 26.76 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.044 -1.035 . . . . 0.0 108.492 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.482 ' CD ' ' N ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -50.83 -15.18 0.26 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.489 -0.757 . . . . 0.0 109.787 -179.281 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.544 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 17.2 tt0 -66.47 -49.12 67.69 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.498 -0.751 . . . . 0.0 109.866 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.401 ' HA ' HD22 ' A' ' 56' ' ' ASN . 13.2 mm -56.24 -33.14 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.034 -1.041 . . . . 0.0 109.93 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.471 ' O ' ' CD2' ' A' ' 37' ' ' LEU . 22.7 mt -65.93 -48.95 69.67 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.524 ' CE1' ' CD2' ' A' ' 59' ' ' TYR . 34.0 t80 -57.67 -35.98 71.29 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' ' 52' ' ' GLU . 68.7 m-80 -66.84 -21.79 66.01 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.528 -0.733 . . . . 0.0 110.693 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.421 ' OD2' ' O ' ' A' ' 36' ' ' ALA . 7.2 t0 -56.85 -54.7 43.46 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.764 -1.21 . . . . 0.0 109.347 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.8 mm -94.72 -36.46 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.348 -0.845 . . . . 0.0 110.081 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.524 ' CD2' ' CE1' ' A' ' 55' ' ' TYR . 74.9 m-85 -99.6 -174.59 2.76 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.199 -0.938 . . . . 0.0 109.638 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.3 p -173.57 -29.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.474 -0.766 . . . . 0.0 109.372 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.447 ' C ' ' H ' ' A' ' 63' ' ' ASN . 41.1 p-90 -157.58 -9.68 0.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 0.0 109.313 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -74.61 15.05 0.4 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.325 -0.859 . . . . 0.0 109.337 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.447 ' H ' ' C ' ' A' ' 61' ' ' TRP . 12.9 m-80 -50.16 -95.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.429 -0.795 . . . . 0.0 109.976 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.488 ' O ' ' N ' ' A' ' 66' ' ' ALA . 30.5 tt0 53.44 69.3 2.33 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.462 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -45.59 82.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.766 2.311 . . . . 0.0 112.5 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 64' ' ' GLU . . . -82.96 -37.08 24.56 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.02 -1.05 . . . . 0.0 109.348 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.463 HG22 ' N ' ' A' ' 68' ' ' ASN . 85.7 m -165.13 161.12 19.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.337 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.463 ' N ' HG22 ' A' ' 67' ' ' THR . 45.1 m-80 -52.02 126.56 18.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -0.938 . . . . 0.0 109.6 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 75.3 m -165.79 -46.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.417 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.632 ' H ' HD12 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -55.49 -50.38 70.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.239 -0.913 . . . . 0.0 109.201 -179.684 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -71.57 -27.44 63.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 110.138 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.65 -48.24 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.105 -0.997 . . . . 0.0 109.413 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.486 ' NE2' ' OE2' ' A' ' 34' ' ' GLU . 81.4 t60 -54.73 -36.72 65.07 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 90.5 mt -71.61 -42.45 71.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -61.39 -35.43 77.48 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.816 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -74.07 -40.86 62.48 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.512 -0.743 . . . . 0.0 109.402 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.673 ' C ' HD12 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -67.71 -42.51 81.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 108.665 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.483 ' NH2' ' OH ' ' A' ' 94' ' ' TYR . 35.6 ttm180 -49.85 -51.29 41.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.524 -0.735 . . . . 0.0 110.448 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -62.16 -27.71 69.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 110.642 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -74.47 -45.04 48.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.981 -1.074 . . . . 0.0 110.94 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.7 pt -76.83 -22.23 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.821 -1.175 . . . . 0.0 110.638 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 83.93 82.12 0.99 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.2 pttt -45.07 -15.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.707 -0.878 . . . . 0.0 110.658 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 82' ' ' GLY . 65.1 p -49.44 -45.53 46.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.954 -1.091 . . . . 0.0 109.841 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.521 ' HE ' ' N ' ' A' ' 85' ' ' ARG . 5.4 mmp_? -84.25 9.5 12.79 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.189 -0.944 . . . . 0.0 110.295 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 87' ' ' ARG . 37.2 mm -116.95 161.5 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 121.372 -0.83 . . . . 0.0 109.617 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.463 ' N ' HG22 ' A' ' 86' ' ' ILE . 47.4 ttt85 -134.04 110.46 9.66 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.3 p -87.37 138.14 31.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.145 -0.972 . . . . 0.0 110.274 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.7 t -102.07 100.03 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.539 -0.726 . . . . 0.0 109.597 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.47 ' C ' ' H ' ' A' ' 92' ' ' PHE . 15.5 mmt85 52.24 28.01 5.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.306 -0.871 . . . . 0.0 109.726 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.65 0.98 2.26 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.539 ' CD2' ' N ' ' A' ' 93' ' ' GLY . 41.4 t80 -73.29 -87.79 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.309 -1.112 . . . . 0.0 108.761 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.539 ' N ' ' CD2' ' A' ' 92' ' ' PHE . . . -95.23 -149.52 25.82 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.483 ' OH ' ' NH2' ' A' ' 78' ' ' ARG . 28.0 m-85 -151.21 159.84 44.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.299 -1.118 . . . . 0.0 108.585 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 43.1 ttp -161.15 131.69 5.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 110.065 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 96' ' ' LEU . 9.3 mp -89.64 133.13 34.79 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.17 114.06 1.62 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 109.729 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -77.57 98.78 5.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.294 -0.878 . . . . 0.0 109.243 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.4 m120 50.85 94.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.227 -0.92 . . . . 0.0 109.689 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.3 mt -58.07 -12.38 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 108.873 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 0.7 OUTLIER -73.99 -37.33 64.47 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.641 -0.662 . . . . 0.0 109.444 179.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.5 m 52.24 81.74 0.08 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.315 -0.866 . . . . 0.0 109.658 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.489 -179.954 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -72.52 57.38 0.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.884 . . . . 0.0 109.533 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -157.15 19.54 0.4 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.6 p30 -172.08 172.74 4.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.322 -1.105 . . . . 0.0 109.394 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -158.83 123.93 4.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 108.924 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -161.32 152.36 18.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.394 -0.816 . . . . 0.0 109.546 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.458 HG22 ' N ' ' A' ' 8' ' ' SER . 58.5 mt -137.04 159.97 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.458 ' N ' HG22 ' A' ' 7' ' ' ILE . 72.2 m -142.9 146.69 34.29 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.39 -0.819 . . . . 0.0 109.732 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.5 t -142.66 94.65 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.01 -119.41 4.95 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.624 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 0.8 OUTLIER -100.96 10.11 41.49 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.37 -1.076 . . . . 0.0 109.34 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 17.7 tp -104.45 127.85 52.23 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -123.53 135.65 54.13 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 tt -129.2 121.44 27.67 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.622 -0.674 . . . . 0.0 109.582 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.513 ' C ' ' HH ' ' A' ' 35' ' ' TYR . 3.4 m-20 -112.12 107.11 15.91 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.629 -0.669 . . . . 0.0 110.241 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.1 t -71.9 -28.58 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.284 -0.885 . . . . 0.0 109.561 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 17' ' ' THR . 0.1 OUTLIER -66.69 -54.7 20.33 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.368 -0.832 . . . . 0.0 109.303 -179.722 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -84.01 -18.78 35.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.115 -0.991 . . . . 0.0 108.665 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? 66.11 65.92 0.5 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.9 mt -148.01 158.23 43.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.236 -0.915 . . . . 0.0 108.661 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.7 t -140.35 128.63 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.324 -0.86 . . . . 0.0 109.58 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -103.86 148.0 26.65 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.415 -0.803 . . . . 0.0 109.35 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.9 tp -133.83 102.53 5.48 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 26' ' ' THR . . . 71.85 40.87 57.06 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.315 -1.914 . . . . 0.0 108.315 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 70.62 -10.86 0.67 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 122.034 -0.686 . . . . 0.0 109.695 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.431 ' H ' ' C ' ' A' ' 24' ' ' GLY . 44.3 p -92.85 142.81 26.91 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.077 -1.014 . . . . 0.0 109.638 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.71 116.68 7.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 110.121 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.3 tp -75.14 130.57 39.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.263 -0.898 . . . . 0.0 108.604 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 29' ' ' ASP . 9.5 p-10 -97.45 102.79 14.64 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.231 -0.918 . . . . 0.0 110.046 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.861 ' H ' HD23 ' A' ' 30' ' ' LEU . 1.4 pt? -131.29 140.94 49.88 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.0 p -64.59 151.21 92.48 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.026 -1.046 . . . . 0.0 109.703 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -44.71 -44.58 14.03 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 121.734 1.623 . . . . 0.0 112.087 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -53.6 -46.22 70.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 109.325 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.512 ' HG2' HD13 ' A' ' 77' ' ' LEU . 45.6 mt-10 -55.55 -44.77 77.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.918 . . . . 0.0 109.786 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.513 ' HH ' ' C ' ' A' ' 15' ' ' ASN . 12.5 t80 -56.29 -28.11 57.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.411 -0.805 . . . . 0.0 109.921 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.64 -54.12 8.04 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.908 -1.12 . . . . 0.0 109.681 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 tt -58.28 -42.73 87.2 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 22.4 tp -62.32 -43.08 99.66 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.291 0.567 . . . . 0.0 109.488 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.8 m -51.44 -36.14 42.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.78 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -77.14 -39.25 49.96 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.738 -1.226 . . . . 0.0 109.725 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.7 mt -57.4 -43.99 84.18 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.097 -1.002 . . . . 0.0 108.961 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.3 mmt -67.93 -28.91 67.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.053 -1.029 . . . . 0.0 109.66 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 24.6 ttt -61.59 -33.16 73.41 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.183 -0.948 . . . . 0.0 108.907 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -124.01 47.32 2.08 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.867 -0.521 . . . . 0.0 109.64 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.45 136.95 52.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.108 -0.995 . . . . 0.0 110.254 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.45 -13.99 61.04 Favored Glycine 0 N--CA 1.501 2.984 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.2 p -119.9 151.32 52.34 Favored Pre-proline 0 N--CA 1.502 2.162 0 O-C-N 121.56 -0.965 . . . . 0.0 108.566 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.03 120.2 5.96 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.639 1.559 . . . . 0.0 111.519 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.0 t -100.0 138.38 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.489 -0.757 . . . . 0.0 109.87 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.439 ' C ' ' N ' ' A' ' 52' ' ' GLU . 18.2 t-160 -79.56 126.35 30.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.344 -0.848 . . . . 0.0 108.764 178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.7 ttp-105 -51.06 -16.77 0.5 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 108.816 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.555 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 31.7 tt0 -65.05 -39.02 92.68 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.5 mt -73.54 -35.05 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.273 0.559 . . . . 0.0 109.529 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.9 mt -73.84 -25.03 59.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.174 -0.954 . . . . 0.0 108.906 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -60.21 -37.01 78.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.001 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.758 ' H ' HD22 ' A' ' 56' ' ' ASN . 0.6 OUTLIER -59.13 -28.07 66.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.519 -0.738 . . . . 0.0 109.918 -179.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.9 -54.39 19.2 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.341 -0.849 . . . . 0.0 110.047 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.6 mm -70.92 -28.8 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.244 -0.91 . . . . 0.0 110.239 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -49.95 -67.09 0.29 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.101 -1.0 . . . . 0.0 109.497 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.0 t 54.98 13.55 0.78 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.405 -0.809 . . . . 0.0 109.608 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 3.6 m0 52.8 50.04 18.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 109.658 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -157.2 -33.75 0.08 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.184 -0.947 . . . . 0.0 109.68 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -59.25 -35.24 73.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.209 -0.932 . . . . 0.0 109.55 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 52.76 76.37 0.54 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.174 -0.954 . . . . 0.0 109.585 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -46.43 105.04 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.597 2.198 . . . . 0.0 112.373 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.07 -52.2 7.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.272 -0.893 . . . . 0.0 109.654 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.429 ' OG1' ' N ' ' A' ' 68' ' ' ASN . 9.0 t -171.15 -153.69 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.256 -0.903 . . . . 0.0 109.516 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.429 ' N ' ' OG1' ' A' ' 67' ' ' THR . 30.4 m120 -57.7 98.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.444 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.4 m -167.15 -36.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.462 -0.774 . . . . 0.0 109.074 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' A' ' 70' ' ' LEU . 2.1 mm? -64.49 -49.36 71.68 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.296 -0.878 . . . . 0.0 109.166 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.14 -34.68 78.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.896 -1.128 . . . . 0.0 108.781 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.6 t -69.1 -35.33 68.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.16 -38.57 80.04 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.423 ' HA ' HD23 ' A' ' 77' ' ' LEU . 94.1 mt -63.96 -36.66 77.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -62.73 -34.22 76.74 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.789 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -77.37 -41.68 39.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.489 -0.757 . . . . 0.0 109.306 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.63 ' C ' HD12 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -71.73 -39.22 70.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.292 -0.88 . . . . 0.0 109.276 -179.065 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -56.46 -47.78 78.45 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.775 -0.578 . . . . 0.0 110.62 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -62.3 -15.2 46.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.076 -1.015 . . . . 0.0 110.847 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -88.2 -39.64 14.33 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.849 -1.157 . . . . 0.0 110.681 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.2 pt -81.52 -15.74 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.028 -1.045 . . . . 0.0 110.131 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 84' ' ' SER . . . 78.93 85.82 0.54 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -44.78 -16.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.638 -0.919 . . . . 0.0 110.539 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 82' ' ' GLY . 52.0 p -50.01 -44.74 51.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.601 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -75.29 8.79 2.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.18 -0.95 . . . . 0.0 109.971 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.1 mt -137.56 127.71 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.335 -0.853 . . . . 0.0 108.933 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -97.8 98.09 9.54 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.394 -0.816 . . . . 0.0 109.058 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.405 HG23 ' H ' ' A' ' 88' ' ' THR . 2.9 p -67.43 131.23 45.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -0.945 . . . . 0.0 109.336 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.1 t -101.01 110.85 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.487 -0.758 . . . . 0.0 110.246 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.479 ' C ' ' H ' ' A' ' 92' ' ' PHE . 65.4 mtp85 47.88 20.4 0.23 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.482 -0.761 . . . . 0.0 110.254 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.98 -2.2 2.2 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.546 ' CD2' ' N ' ' A' ' 93' ' ' GLY . 25.4 t80 -75.76 -77.36 0.13 Allowed 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.31 -1.112 . . . . 0.0 108.428 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.546 ' N ' ' CD2' ' A' ' 92' ' ' PHE . . . -98.84 -149.23 24.43 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.422 ' CD1' ' O ' ' A' ' 93' ' ' GLY . 31.4 m-85 -151.98 159.74 43.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -1.131 . . . . 0.0 108.795 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 38.8 ttp -161.94 135.1 6.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.278 -0.889 . . . . 0.0 110.188 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.456 ' N ' HD12 ' A' ' 96' ' ' LEU . 9.3 mp -93.12 130.6 38.7 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.44 -0.788 . . . . 0.0 108.921 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.2 123.77 25.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 109.558 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -80.13 107.72 13.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.233 -0.917 . . . . 0.0 109.488 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.436 ' C ' ' H ' ' A' ' 101' ' ' ASP . 63.3 m-20 51.26 93.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.314 -0.866 . . . . 0.0 109.823 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.9 mt -69.05 1.84 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.436 ' H ' ' C ' ' A' ' 99' ' ' ASN . 4.0 t70 72.8 45.21 0.33 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.7 m -163.34 145.25 9.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.367 -0.833 . . . . 0.0 109.477 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.434 -179.992 . . . . . . . . 0 0 . 1 stop_ save_